{"items":[{"accepts":[{"amount":"100000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0x7d9C21AcB6be3F6EA4723c148A32DC327a3eCB5b","scheme":"exact"},{"amount":"0.1","asset":"524C555344000000000000000000000000000000","extra":{"invoiceId":"1c433ca5-a833-406c-80a6-19666f0d15ba","issuer":"rMxCKbEDwqr76QuheSUMdEGf4B9xJ8m5De","sourceTag":402402402},"maxTimeoutSeconds":300,"network":"xrpl:0","payTo":"rKv7LTd19CUsKKirVzdZWK4HuFChHf4Hp7","scheme":"exact"},{"amount":"100000","asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"D6ZhtNQ5nT9ZnTHUbqXZsTx5MH2rPFiBBggX4hY1WePM"},"maxTimeoutSeconds":300,"network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","payTo":"2s11RMxZBjoFh8NJvZwA8LUKcaTRx2fHGUSSvQsM7Lib","scheme":"exact"},{"amount":"100000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0x408C4610F6879a75c25722cfCd18A2Eff99dc20F","scheme":"exact"},{"amount":"100000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0x408C4610F6879a75c25722cfCd18A2Eff99dc20F","scheme":"exact"}],"description":"Premium Treasury-curve synthesis spanning 2Y, 10Y and 30Y levels, rate momentum, 2s10s and 3m10y slopes and curve-shape change. Purpose: Summarise US rates and curve pressure for another agent without requiring it to compose several individual rate sensors. 6-hour freshness target; missing evidence is reported explicitly rather than invented.","extensions":{"bazaar":{"info":{"input":{"method":"GET","queryParams":{},"type":"http"},"output":{"example":{"analysis":{"family":"macro","intents":["momentum","evidence","rates","yield"],"summary":"Fresh US Rates Intelligence findings appear here."},"dataStatus":"complete","disclaimer":"General, impersonal market research; not investment advice or a buy, sell or hold recommendation.","evidence":{"assets":["USA"],"policy":"point-in-time","sources":"Reported from the actual live report; never inferred from this example."},"generatedAt":"2026-08-31T00:00:00.000Z","limitations":["Coverage, source freshness and unavailable evidence are stated in every paid report."],"provenance":{"issuer":"https://edge-agents.ai","signed":true},"quality":{"confidence":"high","status":"strong"},"schemaVersion":"2.0","serviceId":"us-rates-intelligence"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"method":{"enum":["GET"],"type":"string"},"queryParams":{"additionalProperties":false,"description":"No parameters are required. The report is generated from fresh eligible evidence at purchase time.","properties":{},"required":[],"type":"object"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"additionalProperties":true,"properties":{"analysis":{"description":"Product-specific findings calculated from eligible evidence.","type":"object"},"dataStatus":{"description":"Completeness of eligible evidence used by the live report.","enum":["complete","partial","unavailable"],"type":"string"},"deliveryId":{"description":"Unique delivery identifier returned after a successful paid request.","type":"string"},"disclaimer":{"type":"string"},"evidence":{"description":"Observed evidence, providers, timestamps and source lineage supporting the analysis.","type":"object"},"generatedAt":{"description":"RFC3339 date-time timestamp.","pattern":"^\\d{4}-\\d{2}-\\d{2}T\\d{2}:\\d{2}:\\d{2}(?:\\.\\d+)?(?:Z|[+-]\\d{2}:\\d{2})$","type":"string"},"limitations":{"items":{"type":"string"},"type":"array"},"provenance":{"description":"Issuer and signature/verification status when available.","type":"object"},"quality":{"description":"Evidence-quality assessment; not probability of profit.","type":"object"},"reportId":{"description":"Product report identifier when the service exposes one.","type":"string"},"schemaVersion":{"description":"Version of the machine-readable report contract.","type":"string"},"serviceId":{"const":"us-rates-intelligence","type":"string"}},"required":["serviceId","generatedAt","dataStatus","analysis"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-09-15T09:46:40.315Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-15T09:46:40.089Z"},"resource":"https://pay.edge-agents.ai/v1/services/us-rates-intelligence","serviceName":"Edge Agents AI","tags":["macro","usa","momentum","evidence","finance"],"type":"http","x402Version":2},{"accepts":[{"amount":"100000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0x7d9C21AcB6be3F6EA4723c148A32DC327a3eCB5b","scheme":"exact"},{"amount":"0.1","asset":"524C555344000000000000000000000000000000","extra":{"invoiceId":"516750d6-d68d-44e6-a901-690a15c8b51a","issuer":"rMxCKbEDwqr76QuheSUMdEGf4B9xJ8m5De","sourceTag":402402402},"maxTimeoutSeconds":300,"network":"xrpl:0","payTo":"rKv7LTd19CUsKKirVzdZWK4HuFChHf4Hp7","scheme":"exact"},{"amount":"100000","asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"Hc3sdEAsCGQcpgfivywog9uwtk8gUBUZgsxdME1EJy88"},"maxTimeoutSeconds":300,"network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","payTo":"2s11RMxZBjoFh8NJvZwA8LUKcaTRx2fHGUSSvQsM7Lib","scheme":"exact"},{"amount":"100000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0x408C4610F6879a75c25722cfCd18A2Eff99dc20F","scheme":"exact"},{"amount":"100000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0x408C4610F6879a75c25722cfCd18A2Eff99dc20F","scheme":"exact"}],"description":"UK Growth and Demand from official ONS/Eurostat evidence with source timing, provenance, missingness and bounded interpretation for autonomous agents. Purpose: combine monthly output, production and retail volume into a UK real-economy demand brief 24-hour freshness target; missing evidence is reported explicitly rather than invented.","extensions":{"bazaar":{"info":{"input":{"method":"GET","queryParams":{},"type":"http"},"output":{"example":{"analysis":{"family":"cross-market","intents":["evidence","growth"],"summary":"Fresh UK Growth and Demand findings appear here."},"dataStatus":"complete","disclaimer":"General, impersonal market research; not investment advice or a buy, sell or hold recommendation.","evidence":{"assets":["EUR"],"policy":"mixed","sources":"Reported from the actual live report; never inferred from this example."},"generatedAt":"2026-08-31T00:00:00.000Z","limitations":["Coverage, source freshness and unavailable evidence are stated in every paid report."],"provenance":{"issuer":"https://edge-agents.ai","signed":true},"quality":{"confidence":"high","status":"strong"},"schemaVersion":"2.0","serviceId":"eurostat-ons-uk-growth-demand"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"method":{"enum":["GET"],"type":"string"},"queryParams":{"additionalProperties":false,"description":"No parameters are required. The report is generated from fresh eligible evidence at purchase time.","properties":{},"required":[],"type":"object"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"additionalProperties":true,"properties":{"analysis":{"description":"Product-specific findings calculated from eligible evidence.","type":"object"},"dataStatus":{"description":"Completeness of eligible evidence used by the live report.","enum":["complete","partial","unavailable"],"type":"string"},"deliveryId":{"description":"Unique delivery identifier returned after a successful paid request.","type":"string"},"disclaimer":{"type":"string"},"evidence":{"description":"Observed evidence, providers, timestamps and source lineage supporting the analysis.","type":"object"},"generatedAt":{"description":"RFC3339 date-time timestamp.","pattern":"^\\d{4}-\\d{2}-\\d{2}T\\d{2}:\\d{2}:\\d{2}(?:\\.\\d+)?(?:Z|[+-]\\d{2}:\\d{2})$","type":"string"},"limitations":{"items":{"type":"string"},"type":"array"},"provenance":{"description":"Issuer and signature/verification status when available.","type":"object"},"quality":{"description":"Evidence-quality assessment; not probability of profit.","type":"object"},"reportId":{"description":"Product report identifier when the service exposes one.","type":"string"},"schemaVersion":{"description":"Version of the machine-readable report contract.","type":"string"},"serviceId":{"const":"eurostat-ons-uk-growth-demand","type":"string"}},"required":["serviceId","generatedAt","dataStatus","analysis"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-09-15T09:45:19.439Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-15T09:45:19.235Z"},"resource":"https://pay.edge-agents.ai/v1/services/eurostat-ons-uk-growth-demand","serviceName":"Edge Agents AI","tags":["cross-market","eur","evidence","growth","finance"],"type":"http","x402Version":2},{"accepts":[{"amount":"100000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0x7d9C21AcB6be3F6EA4723c148A32DC327a3eCB5b","scheme":"exact"},{"amount":"0.1","asset":"524C555344000000000000000000000000000000","extra":{"invoiceId":"988ab924-14f5-4f87-b534-86aa338b78e7","issuer":"rMxCKbEDwqr76QuheSUMdEGf4B9xJ8m5De","sourceTag":402402402},"maxTimeoutSeconds":300,"network":"xrpl:0","payTo":"rKv7LTd19CUsKKirVzdZWK4HuFChHf4Hp7","scheme":"exact"},{"amount":"100000","asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"GVJJ7rdGiXr5xaYbRwRbjfaJL7fmwRygFi1H6aGqDveb"},"maxTimeoutSeconds":300,"network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","payTo":"2s11RMxZBjoFh8NJvZwA8LUKcaTRx2fHGUSSvQsM7Lib","scheme":"exact"},{"amount":"100000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0x408C4610F6879a75c25722cfCd18A2Eff99dc20F","scheme":"exact"},{"amount":"100000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0x408C4610F6879a75c25722cfCd18A2Eff99dc20F","scheme":"exact"}],"description":"Euro Money Market Regime from official ECB statistics, normalized for autonomous-agent use with explicit source timing, evidence and limitations. Purpose: synthesize ECB policy corridor, €STR and monetary-liquidity evidence into a bounded euro money-market regime brief 24-hour freshness target; missing evidence is reported explicitly rather than invented.","extensions":{"bazaar":{"info":{"input":{"method":"GET","queryParams":{},"type":"http"},"output":{"example":{"analysis":{"family":"cross-market","intents":["liquidity","evidence","cycle","policy"],"summary":"Fresh Euro Money Market Regime findings appear here."},"dataStatus":"complete","disclaimer":"General, impersonal market research; not investment advice or a buy, sell or hold recommendation.","evidence":{"assets":["EUR"],"policy":"mixed","sources":"Reported from the actual live report; never inferred from this example."},"generatedAt":"2026-08-31T00:00:00.000Z","limitations":["Coverage, source freshness and unavailable evidence are stated in every paid report."],"provenance":{"issuer":"https://edge-agents.ai","signed":true},"quality":{"confidence":"high","status":"strong"},"schemaVersion":"2.0","serviceId":"ecb-money-market-regime"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"method":{"enum":["GET"],"type":"string"},"queryParams":{"additionalProperties":false,"description":"No parameters are required. The report is generated from fresh eligible evidence at purchase time.","properties":{},"required":[],"type":"object"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"additionalProperties":true,"properties":{"analysis":{"description":"Product-specific findings calculated from eligible evidence.","type":"object"},"dataStatus":{"description":"Completeness of eligible evidence used by the live report.","enum":["complete","partial","unavailable"],"type":"string"},"deliveryId":{"description":"Unique delivery identifier returned after a successful paid request.","type":"string"},"disclaimer":{"type":"string"},"evidence":{"description":"Observed evidence, providers, timestamps and source lineage supporting the analysis.","type":"object"},"generatedAt":{"description":"RFC3339 date-time timestamp.","pattern":"^\\d{4}-\\d{2}-\\d{2}T\\d{2}:\\d{2}:\\d{2}(?:\\.\\d+)?(?:Z|[+-]\\d{2}:\\d{2})$","type":"string"},"limitations":{"items":{"type":"string"},"type":"array"},"provenance":{"description":"Issuer and signature/verification status when available.","type":"object"},"quality":{"description":"Evidence-quality assessment; not probability of profit.","type":"object"},"reportId":{"description":"Product report identifier when the service exposes one.","type":"string"},"schemaVersion":{"description":"Version of the machine-readable report contract.","type":"string"},"serviceId":{"const":"ecb-money-market-regime","type":"string"}},"required":["serviceId","generatedAt","dataStatus","analysis"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-09-15T09:45:13.83Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-15T09:45:13.45Z"},"resource":"https://pay.edge-agents.ai/v1/services/ecb-money-market-regime","serviceName":"Edge Agents AI","tags":["cross-market","eur","liquidity","evidence","finance"],"type":"http","x402Version":2},{"accepts":[{"amount":"100000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0x7d9C21AcB6be3F6EA4723c148A32DC327a3eCB5b","scheme":"exact"},{"amount":"0.1","asset":"524C555344000000000000000000000000000000","extra":{"invoiceId":"7a7b1586-f147-443d-a7d1-ee46f3e8fe2c","issuer":"rMxCKbEDwqr76QuheSUMdEGf4B9xJ8m5De","sourceTag":402402402},"maxTimeoutSeconds":300,"network":"xrpl:0","payTo":"rKv7LTd19CUsKKirVzdZWK4HuFChHf4Hp7","scheme":"exact"},{"amount":"100000","asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"GVJJ7rdGiXr5xaYbRwRbjfaJL7fmwRygFi1H6aGqDveb"},"maxTimeoutSeconds":300,"network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","payTo":"2s11RMxZBjoFh8NJvZwA8LUKcaTRx2fHGUSSvQsM7Lib","scheme":"exact"},{"amount":"100000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0x408C4610F6879a75c25722cfCd18A2Eff99dc20F","scheme":"exact"},{"amount":"100000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0x408C4610F6879a75c25722cfCd18A2Eff99dc20F","scheme":"exact"}],"description":"Euro Liquidity Regime from official ECB statistics, normalized for autonomous-agent use with explicit source timing, evidence and limitations. Purpose: combine ECB balance-sheet size and M3 evidence with policy rates to describe the euro-area liquidity backdrop 24-hour freshness target; missing evidence is reported explicitly rather than invented.","extensions":{"bazaar":{"info":{"input":{"method":"GET","queryParams":{},"type":"http"},"output":{"example":{"analysis":{"family":"cross-market","intents":["liquidity","evidence","cycle","policy"],"summary":"Fresh Euro Liquidity Regime findings appear here."},"dataStatus":"complete","disclaimer":"General, impersonal market research; not investment advice or a buy, sell or hold recommendation.","evidence":{"assets":["EUR"],"policy":"mixed","sources":"Reported from the actual live report; never inferred from this example."},"generatedAt":"2026-08-31T00:00:00.000Z","limitations":["Coverage, source freshness and unavailable evidence are stated in every paid report."],"provenance":{"issuer":"https://edge-agents.ai","signed":true},"quality":{"confidence":"high","status":"strong"},"schemaVersion":"2.0","serviceId":"ecb-euro-liquidity-regime"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"method":{"enum":["GET"],"type":"string"},"queryParams":{"additionalProperties":false,"description":"No parameters are required. The report is generated from fresh eligible evidence at purchase time.","properties":{},"required":[],"type":"object"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"additionalProperties":true,"properties":{"analysis":{"description":"Product-specific findings calculated from eligible evidence.","type":"object"},"dataStatus":{"description":"Completeness of eligible evidence used by the live report.","enum":["complete","partial","unavailable"],"type":"string"},"deliveryId":{"description":"Unique delivery identifier returned after a successful paid request.","type":"string"},"disclaimer":{"type":"string"},"evidence":{"description":"Observed evidence, providers, timestamps and source lineage supporting the analysis.","type":"object"},"generatedAt":{"description":"RFC3339 date-time timestamp.","pattern":"^\\d{4}-\\d{2}-\\d{2}T\\d{2}:\\d{2}:\\d{2}(?:\\.\\d+)?(?:Z|[+-]\\d{2}:\\d{2})$","type":"string"},"limitations":{"items":{"type":"string"},"type":"array"},"provenance":{"description":"Issuer and signature/verification status when available.","type":"object"},"quality":{"description":"Evidence-quality assessment; not probability of profit.","type":"object"},"reportId":{"description":"Product report identifier when the service exposes one.","type":"string"},"schemaVersion":{"description":"Version of the machine-readable report contract.","type":"string"},"serviceId":{"const":"ecb-euro-liquidity-regime","type":"string"}},"required":["serviceId","generatedAt","dataStatus","analysis"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-09-15T09:45:10.822Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-15T09:45:10.636Z"},"resource":"https://pay.edge-agents.ai/v1/services/ecb-euro-liquidity-regime","serviceName":"Edge Agents AI","tags":["cross-market","eur","liquidity","evidence","finance"],"type":"http","x402Version":2},{"accepts":[{"amount":"100000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0x7d9C21AcB6be3F6EA4723c148A32DC327a3eCB5b","scheme":"exact"},{"amount":"0.1","asset":"524C555344000000000000000000000000000000","extra":{"invoiceId":"a92f4063-6640-498e-bed9-f20db71a7b29","issuer":"rMxCKbEDwqr76QuheSUMdEGf4B9xJ8m5De","sourceTag":402402402},"maxTimeoutSeconds":300,"network":"xrpl:0","payTo":"rKv7LTd19CUsKKirVzdZWK4HuFChHf4Hp7","scheme":"exact"},{"amount":"100000","asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"Hc3sdEAsCGQcpgfivywog9uwtk8gUBUZgsxdME1EJy88"},"maxTimeoutSeconds":300,"network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","payTo":"2s11RMxZBjoFh8NJvZwA8LUKcaTRx2fHGUSSvQsM7Lib","scheme":"exact"},{"amount":"100000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0x408C4610F6879a75c25722cfCd18A2Eff99dc20F","scheme":"exact"},{"amount":"100000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0x408C4610F6879a75c25722cfCd18A2Eff99dc20F","scheme":"exact"}],"description":"UK Money Market Regime from official Bank of England statistical data, normalized for autonomous-agent use with source timestamp, recent history and explicit limitations. Purpose: synthesize policy, overnight, interbank and secured funding evidence into a current UK money-market regime brief 24-hour freshness target; missing evidence is reported explicitly rather than invented.","extensions":{"bazaar":{"info":{"input":{"method":"GET","queryParams":{},"type":"http"},"output":{"example":{"analysis":{"family":"cross-market","intents":["leverage","evidence","cycle","policy"],"summary":"Fresh UK Money Market Regime findings appear here."},"dataStatus":"complete","disclaimer":"General, impersonal market research; not investment advice or a buy, sell or hold recommendation.","evidence":{"assets":["GBP"],"policy":"live","sources":"Reported from the actual live report; never inferred from this example."},"generatedAt":"2026-08-31T00:00:00.000Z","limitations":["Coverage, source freshness and unavailable evidence are stated in every paid report."],"provenance":{"issuer":"https://edge-agents.ai","signed":true},"quality":{"confidence":"high","status":"strong"},"schemaVersion":"2.0","serviceId":"uk-money-market-regime"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"method":{"enum":["GET"],"type":"string"},"queryParams":{"additionalProperties":false,"description":"No parameters are required. The report is generated from fresh eligible evidence at purchase time.","properties":{},"required":[],"type":"object"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"additionalProperties":true,"properties":{"analysis":{"description":"Product-specific findings calculated from eligible evidence.","type":"object"},"dataStatus":{"description":"Completeness of eligible evidence used by the live report.","enum":["complete","partial","unavailable"],"type":"string"},"deliveryId":{"description":"Unique delivery identifier returned after a successful paid request.","type":"string"},"disclaimer":{"type":"string"},"evidence":{"description":"Observed evidence, providers, timestamps and source lineage supporting the analysis.","type":"object"},"generatedAt":{"description":"RFC3339 date-time timestamp.","pattern":"^\\d{4}-\\d{2}-\\d{2}T\\d{2}:\\d{2}:\\d{2}(?:\\.\\d+)?(?:Z|[+-]\\d{2}:\\d{2})$","type":"string"},"limitations":{"items":{"type":"string"},"type":"array"},"provenance":{"description":"Issuer and signature/verification status when available.","type":"object"},"quality":{"description":"Evidence-quality assessment; not probability of profit.","type":"object"},"reportId":{"description":"Product report identifier when the service exposes one.","type":"string"},"schemaVersion":{"description":"Version of the machine-readable report contract.","type":"string"},"serviceId":{"const":"uk-money-market-regime","type":"string"}},"required":["serviceId","generatedAt","dataStatus","analysis"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-09-15T09:44:58.525Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-15T09:44:58.322Z"},"resource":"https://pay.edge-agents.ai/v1/services/uk-money-market-regime","serviceName":"Edge Agents AI","tags":["cross-market","gbp","leverage","evidence","finance"],"type":"http","x402Version":2},{"accepts":[{"amount":"100000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0x7d9C21AcB6be3F6EA4723c148A32DC327a3eCB5b","scheme":"exact"},{"amount":"0.1","asset":"524C555344000000000000000000000000000000","extra":{"invoiceId":"2a92cf85-ab99-4af0-abd0-2877cf029610","issuer":"rMxCKbEDwqr76QuheSUMdEGf4B9xJ8m5De","sourceTag":402402402},"maxTimeoutSeconds":300,"network":"xrpl:0","payTo":"rKv7LTd19CUsKKirVzdZWK4HuFChHf4Hp7","scheme":"exact"},{"amount":"100000","asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"BFK9TLC3edb13K6v4YyH3DwPb5DSUpkWvb7XnqCL9b4F"},"maxTimeoutSeconds":300,"network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","payTo":"2s11RMxZBjoFh8NJvZwA8LUKcaTRx2fHGUSSvQsM7Lib","scheme":"exact"},{"amount":"100000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0x408C4610F6879a75c25722cfCd18A2Eff99dc20F","scheme":"exact"},{"amount":"100000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0x408C4610F6879a75c25722cfCd18A2Eff99dc20F","scheme":"exact"}],"description":"Premium comparison of the latest available trade openness across 30 major economies and financial centres using one normalized World Bank indicator definition. Purpose: Rank and compare major economies on trade openness while exposing observation-year differences and missing coverage rather than pretending all countries are synchronized. 24-hour freshness target; missing evidence is reported explicitly rather than invented.","extensions":{"bazaar":{"info":{"input":{"method":"GET","queryParams":{},"type":"http"},"output":{"example":{"analysis":{"family":"macro","intents":["evidence","trade"],"summary":"Fresh Global Trade Openness Comparison findings appear here."},"dataStatus":"complete","disclaimer":"General, impersonal market research; not investment advice or a buy, sell or hold recommendation.","evidence":{"assets":[],"policy":"point-in-time","sources":"Reported from the actual live report; never inferred from this example."},"generatedAt":"2026-08-31T00:00:00.000Z","limitations":["Coverage, source freshness and unavailable evidence are stated in every paid report."],"provenance":{"issuer":"https://edge-agents.ai","signed":true},"quality":{"confidence":"high","status":"strong"},"schemaVersion":"2.0","serviceId":"macro-global-trade-openness-comparison"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"method":{"enum":["GET"],"type":"string"},"queryParams":{"additionalProperties":false,"description":"No parameters are required. The report is generated from fresh eligible evidence at purchase time.","properties":{},"required":[],"type":"object"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"additionalProperties":true,"properties":{"analysis":{"description":"Product-specific findings calculated from eligible evidence.","type":"object"},"dataStatus":{"description":"Completeness of eligible evidence used by the live report.","enum":["complete","partial","unavailable"],"type":"string"},"deliveryId":{"description":"Unique delivery identifier returned after a successful paid request.","type":"string"},"disclaimer":{"type":"string"},"evidence":{"description":"Observed evidence, providers, timestamps and source lineage supporting the analysis.","type":"object"},"generatedAt":{"description":"RFC3339 date-time timestamp.","pattern":"^\\d{4}-\\d{2}-\\d{2}T\\d{2}:\\d{2}:\\d{2}(?:\\.\\d+)?(?:Z|[+-]\\d{2}:\\d{2})$","type":"string"},"limitations":{"items":{"type":"string"},"type":"array"},"provenance":{"description":"Issuer and signature/verification status when available.","type":"object"},"quality":{"description":"Evidence-quality assessment; not probability of profit.","type":"object"},"reportId":{"description":"Product report identifier when the service exposes one.","type":"string"},"schemaVersion":{"description":"Version of the machine-readable report contract.","type":"string"},"serviceId":{"const":"macro-global-trade-openness-comparison","type":"string"}},"required":["serviceId","generatedAt","dataStatus","analysis"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-09-15T09:44:54.598Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-15T09:44:54.363Z"},"resource":"https://pay.edge-agents.ai/v1/services/macro-global-trade-openness-comparison","serviceName":"Edge Agents AI","tags":["macro","evidence","trade","finance","x402"],"type":"http","x402Version":2},{"accepts":[{"amount":"100000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0x7d9C21AcB6be3F6EA4723c148A32DC327a3eCB5b","scheme":"exact"},{"amount":"0.1","asset":"524C555344000000000000000000000000000000","extra":{"invoiceId":"724bced5-50e5-46f7-9f2a-27781104983e","issuer":"rMxCKbEDwqr76QuheSUMdEGf4B9xJ8m5De","sourceTag":402402402},"maxTimeoutSeconds":300,"network":"xrpl:0","payTo":"rKv7LTd19CUsKKirVzdZWK4HuFChHf4Hp7","scheme":"exact"},{"amount":"100000","asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"BFK9TLC3edb13K6v4YyH3DwPb5DSUpkWvb7XnqCL9b4F"},"maxTimeoutSeconds":300,"network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","payTo":"2s11RMxZBjoFh8NJvZwA8LUKcaTRx2fHGUSSvQsM7Lib","scheme":"exact"},{"amount":"100000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0x408C4610F6879a75c25722cfCd18A2Eff99dc20F","scheme":"exact"},{"amount":"100000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0x408C4610F6879a75c25722cfCd18A2Eff99dc20F","scheme":"exact"}],"description":"Premium twelve-indicator structural macro profile for Thailand, covering growth, inflation, labour, external balance, trade, savings, investment, reserves, real rates and central-government debt where available. Purpose: Provide an autonomous agent one normalized Thailand structural macro brief with explicit coverage, latest observation years and missing indicators. 24-hour freshness target; missing evidence is reported explicitly rather than invented.","extensions":{"bazaar":{"info":{"input":{"method":"GET","queryParams":{},"type":"http"},"output":{"example":{"analysis":{"family":"macro","intents":["evidence","cycle","inflation","labour","growth","sovereign-debt"],"summary":"Fresh Thailand Structural Macro Profile findings appear here."},"dataStatus":"complete","disclaimer":"General, impersonal market research; not investment advice or a buy, sell or hold recommendation.","evidence":{"assets":["THA"],"policy":"point-in-time","sources":"Reported from the actual live report; never inferred from this example."},"generatedAt":"2026-08-31T00:00:00.000Z","limitations":["Coverage, source freshness and unavailable evidence are stated in every paid report."],"provenance":{"issuer":"https://edge-agents.ai","signed":true},"quality":{"confidence":"high","status":"strong"},"schemaVersion":"2.0","serviceId":"macro-th-structural-profile"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"method":{"enum":["GET"],"type":"string"},"queryParams":{"additionalProperties":false,"description":"No parameters are required. The report is generated from fresh eligible evidence at purchase time.","properties":{},"required":[],"type":"object"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"additionalProperties":true,"properties":{"analysis":{"description":"Product-specific findings calculated from eligible evidence.","type":"object"},"dataStatus":{"description":"Completeness of eligible evidence used by the live report.","enum":["complete","partial","unavailable"],"type":"string"},"deliveryId":{"description":"Unique delivery identifier returned after a successful paid request.","type":"string"},"disclaimer":{"type":"string"},"evidence":{"description":"Observed evidence, providers, timestamps and source lineage supporting the analysis.","type":"object"},"generatedAt":{"description":"RFC3339 date-time timestamp.","pattern":"^\\d{4}-\\d{2}-\\d{2}T\\d{2}:\\d{2}:\\d{2}(?:\\.\\d+)?(?:Z|[+-]\\d{2}:\\d{2})$","type":"string"},"limitations":{"items":{"type":"string"},"type":"array"},"provenance":{"description":"Issuer and signature/verification status when available.","type":"object"},"quality":{"description":"Evidence-quality assessment; not probability of profit.","type":"object"},"reportId":{"description":"Product report identifier when the service exposes one.","type":"string"},"schemaVersion":{"description":"Version of the machine-readable report contract.","type":"string"},"serviceId":{"const":"macro-th-structural-profile","type":"string"}},"required":["serviceId","generatedAt","dataStatus","analysis"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-09-15T09:44:51.624Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-15T09:44:51.443Z"},"resource":"https://pay.edge-agents.ai/v1/services/macro-th-structural-profile","serviceName":"Edge Agents AI","tags":["macro","tha","evidence","cycle","finance"],"type":"http","x402Version":2},{"accepts":[{"amount":"100000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0x7d9C21AcB6be3F6EA4723c148A32DC327a3eCB5b","scheme":"exact"},{"amount":"0.1","asset":"524C555344000000000000000000000000000000","extra":{"invoiceId":"ed86809c-126d-46e1-b32a-36380c787b1f","issuer":"rMxCKbEDwqr76QuheSUMdEGf4B9xJ8m5De","sourceTag":402402402},"maxTimeoutSeconds":300,"network":"xrpl:0","payTo":"rKv7LTd19CUsKKirVzdZWK4HuFChHf4Hp7","scheme":"exact"},{"amount":"100000","asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"BFK9TLC3edb13K6v4YyH3DwPb5DSUpkWvb7XnqCL9b4F"},"maxTimeoutSeconds":300,"network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","payTo":"2s11RMxZBjoFh8NJvZwA8LUKcaTRx2fHGUSSvQsM7Lib","scheme":"exact"},{"amount":"100000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0x408C4610F6879a75c25722cfCd18A2Eff99dc20F","scheme":"exact"},{"amount":"100000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0x408C4610F6879a75c25722cfCd18A2Eff99dc20F","scheme":"exact"}],"description":"Premium twelve-indicator structural macro profile for Spain, covering growth, inflation, labour, external balance, trade, savings, investment, reserves, real rates and central-government debt where available. Purpose: Provide an autonomous agent one normalized Spain structural macro brief with explicit coverage, latest observation years and missing indicators. 24-hour freshness target; missing evidence is reported explicitly rather than invented.","extensions":{"bazaar":{"info":{"input":{"method":"GET","queryParams":{},"type":"http"},"output":{"example":{"analysis":{"family":"macro","intents":["evidence","cycle","inflation","labour","growth","sovereign-debt"],"summary":"Fresh Spain Structural Macro Profile findings appear here."},"dataStatus":"complete","disclaimer":"General, impersonal market research; not investment advice or a buy, sell or hold recommendation.","evidence":{"assets":["ESP"],"policy":"point-in-time","sources":"Reported from the actual live report; never inferred from this example."},"generatedAt":"2026-08-31T00:00:00.000Z","limitations":["Coverage, source freshness and unavailable evidence are stated in every paid report."],"provenance":{"issuer":"https://edge-agents.ai","signed":true},"quality":{"confidence":"high","status":"strong"},"schemaVersion":"2.0","serviceId":"macro-es-structural-profile"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"method":{"enum":["GET"],"type":"string"},"queryParams":{"additionalProperties":false,"description":"No parameters are required. The report is generated from fresh eligible evidence at purchase time.","properties":{},"required":[],"type":"object"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"additionalProperties":true,"properties":{"analysis":{"description":"Product-specific findings calculated from eligible evidence.","type":"object"},"dataStatus":{"description":"Completeness of eligible evidence used by the live report.","enum":["complete","partial","unavailable"],"type":"string"},"deliveryId":{"description":"Unique delivery identifier returned after a successful paid request.","type":"string"},"disclaimer":{"type":"string"},"evidence":{"description":"Observed evidence, providers, timestamps and source lineage supporting the analysis.","type":"object"},"generatedAt":{"description":"RFC3339 date-time timestamp.","pattern":"^\\d{4}-\\d{2}-\\d{2}T\\d{2}:\\d{2}:\\d{2}(?:\\.\\d+)?(?:Z|[+-]\\d{2}:\\d{2})$","type":"string"},"limitations":{"items":{"type":"string"},"type":"array"},"provenance":{"description":"Issuer and signature/verification status when available.","type":"object"},"quality":{"description":"Evidence-quality assessment; not probability of profit.","type":"object"},"reportId":{"description":"Product report identifier when the service exposes one.","type":"string"},"schemaVersion":{"description":"Version of the machine-readable report contract.","type":"string"},"serviceId":{"const":"macro-es-structural-profile","type":"string"}},"required":["serviceId","generatedAt","dataStatus","analysis"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-09-15T09:44:48.325Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-15T09:44:48.142Z"},"resource":"https://pay.edge-agents.ai/v1/services/macro-es-structural-profile","serviceName":"Edge Agents AI","tags":["macro","esp","evidence","cycle","finance"],"type":"http","x402Version":2},{"accepts":[{"amount":"100000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0x7d9C21AcB6be3F6EA4723c148A32DC327a3eCB5b","scheme":"exact"},{"amount":"0.1","asset":"524C555344000000000000000000000000000000","extra":{"invoiceId":"37a89ed1-5138-4b84-b63c-e6a527243b0a","issuer":"rMxCKbEDwqr76QuheSUMdEGf4B9xJ8m5De","sourceTag":402402402},"maxTimeoutSeconds":300,"network":"xrpl:0","payTo":"rKv7LTd19CUsKKirVzdZWK4HuFChHf4Hp7","scheme":"exact"},{"amount":"100000","asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"D6ZhtNQ5nT9ZnTHUbqXZsTx5MH2rPFiBBggX4hY1WePM"},"maxTimeoutSeconds":300,"network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","payTo":"2s11RMxZBjoFh8NJvZwA8LUKcaTRx2fHGUSSvQsM7Lib","scheme":"exact"},{"amount":"100000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0x408C4610F6879a75c25722cfCd18A2Eff99dc20F","scheme":"exact"},{"amount":"100000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0x408C4610F6879a75c25722cfCd18A2Eff99dc20F","scheme":"exact"}],"description":"Premium cross-family brief combining direct inflation, labour, industrial-growth and Treasury-rate evidence, with explicit family disagreement and coverage gates. Purpose: Give an autonomous buyer one compact US macro regime read while preserving the underlying inflation, labour, growth and rates evidence boundaries. 6-hour freshness target; missing evidence is reported explicitly rather than invented.","extensions":{"bazaar":{"info":{"input":{"method":"GET","queryParams":{},"type":"http"},"output":{"example":{"analysis":{"family":"macro","intents":["evidence","cycle","inflation","labour","rates","growth"],"summary":"Fresh US Macro Regime Brief findings appear here."},"dataStatus":"complete","disclaimer":"General, impersonal market research; not investment advice or a buy, sell or hold recommendation.","evidence":{"assets":["USA"],"policy":"point-in-time","sources":"Reported from the actual live report; never inferred from this example."},"generatedAt":"2026-08-31T00:00:00.000Z","limitations":["Coverage, source freshness and unavailable evidence are stated in every paid report."],"provenance":{"issuer":"https://edge-agents.ai","signed":true},"quality":{"confidence":"high","status":"strong"},"schemaVersion":"2.0","serviceId":"us-macro-regime-brief"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"method":{"enum":["GET"],"type":"string"},"queryParams":{"additionalProperties":false,"description":"No parameters are required. The report is generated from fresh eligible evidence at purchase time.","properties":{},"required":[],"type":"object"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"additionalProperties":true,"properties":{"analysis":{"description":"Product-specific findings calculated from eligible evidence.","type":"object"},"dataStatus":{"description":"Completeness of eligible evidence used by the live report.","enum":["complete","partial","unavailable"],"type":"string"},"deliveryId":{"description":"Unique delivery identifier returned after a successful paid request.","type":"string"},"disclaimer":{"type":"string"},"evidence":{"description":"Observed evidence, providers, timestamps and source lineage supporting the analysis.","type":"object"},"generatedAt":{"description":"RFC3339 date-time timestamp.","pattern":"^\\d{4}-\\d{2}-\\d{2}T\\d{2}:\\d{2}:\\d{2}(?:\\.\\d+)?(?:Z|[+-]\\d{2}:\\d{2})$","type":"string"},"limitations":{"items":{"type":"string"},"type":"array"},"provenance":{"description":"Issuer and signature/verification status when available.","type":"object"},"quality":{"description":"Evidence-quality assessment; not probability of profit.","type":"object"},"reportId":{"description":"Product report identifier when the service exposes one.","type":"string"},"schemaVersion":{"description":"Version of the machine-readable report contract.","type":"string"},"serviceId":{"const":"us-macro-regime-brief","type":"string"}},"required":["serviceId","generatedAt","dataStatus","analysis"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-09-15T09:44:12.963Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-15T09:44:12.691Z"},"resource":"https://pay.edge-agents.ai/v1/services/us-macro-regime-brief","serviceName":"Edge Agents AI","tags":["macro","usa","evidence","cycle","finance"],"type":"http","x402Version":2},{"accepts":[{"amount":"100000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0x7d9C21AcB6be3F6EA4723c148A32DC327a3eCB5b","scheme":"exact"},{"amount":"0.1","asset":"524C555344000000000000000000000000000000","extra":{"invoiceId":"7297fc24-7915-484e-bd68-29a6c096ddb6","issuer":"rMxCKbEDwqr76QuheSUMdEGf4B9xJ8m5De","sourceTag":402402402},"maxTimeoutSeconds":300,"network":"xrpl:0","payTo":"rKv7LTd19CUsKKirVzdZWK4HuFChHf4Hp7","scheme":"exact"},{"amount":"100000","asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"GVJJ7rdGiXr5xaYbRwRbjfaJL7fmwRygFi1H6aGqDveb"},"maxTimeoutSeconds":300,"network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","payTo":"2s11RMxZBjoFh8NJvZwA8LUKcaTRx2fHGUSSvQsM7Lib","scheme":"exact"},{"amount":"100000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0x408C4610F6879a75c25722cfCd18A2Eff99dc20F","scheme":"exact"},{"amount":"100000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0x408C4610F6879a75c25722cfCd18A2Eff99dc20F","scheme":"exact"}],"description":"Premium synthesis of CFTC asset-manager and leveraged-fund positioning, weekly changes and cross-class divergence across 32 financial-futures contracts. Purpose: Summarise institutional and leveraged positioning breadth across financial futures positioning regime while exposing missing contracts and disagreement rather than producing a market-return forecast. 168-hour freshness target; missing evidence is reported explicitly rather than invented.","extensions":{"bazaar":{"info":{"input":{"method":"GET","queryParams":{},"type":"http"},"output":{"example":{"analysis":{"family":"cross-market","intents":["leverage","rotation","anomaly","evidence","cycle","forecast","institutional","positioning","leveraged-funds","asset-manager"],"summary":"Fresh Financial Futures Positioning Regime findings appear here."},"dataStatus":"complete","disclaimer":"General, impersonal market research; not investment advice or a buy, sell or hold recommendation.","evidence":{"assets":[],"policy":"point-in-time","sources":"Reported from the actual live report; never inferred from this example."},"generatedAt":"2026-08-31T00:00:00.000Z","limitations":["Coverage, source freshness and unavailable evidence are stated in every paid report."],"provenance":{"issuer":"https://edge-agents.ai","signed":true},"quality":{"confidence":"high","status":"strong"},"schemaVersion":"2.0","serviceId":"financial-futures-positioning-regime"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"method":{"enum":["GET"],"type":"string"},"queryParams":{"additionalProperties":false,"description":"No parameters are required. The report is generated from fresh eligible evidence at purchase time.","properties":{},"required":[],"type":"object"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"additionalProperties":true,"properties":{"analysis":{"description":"Product-specific findings calculated from eligible evidence.","type":"object"},"dataStatus":{"description":"Completeness of eligible evidence used by the live report.","enum":["complete","partial","unavailable"],"type":"string"},"deliveryId":{"description":"Unique delivery identifier returned after a successful paid request.","type":"string"},"disclaimer":{"type":"string"},"evidence":{"description":"Observed evidence, providers, timestamps and source lineage supporting the analysis.","type":"object"},"generatedAt":{"description":"RFC3339 date-time timestamp.","pattern":"^\\d{4}-\\d{2}-\\d{2}T\\d{2}:\\d{2}:\\d{2}(?:\\.\\d+)?(?:Z|[+-]\\d{2}:\\d{2})$","type":"string"},"limitations":{"items":{"type":"string"},"type":"array"},"provenance":{"description":"Issuer and signature/verification status when available.","type":"object"},"quality":{"description":"Evidence-quality assessment; not probability of profit.","type":"object"},"reportId":{"description":"Product report identifier when the service exposes one.","type":"string"},"schemaVersion":{"description":"Version of the machine-readable report contract.","type":"string"},"serviceId":{"const":"financial-futures-positioning-regime","type":"string"}},"required":["serviceId","generatedAt","dataStatus","analysis"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-09-14T23:27:28.798Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-14T23:27:28.05Z"},"resource":"https://pay.edge-agents.ai/v1/services/financial-futures-positioning-regime","serviceName":"Edge Agents AI","tags":["cross-market","leverage","rotation","finance","x402"],"type":"http","x402Version":2},{"accepts":[{"amount":"100000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0x7d9C21AcB6be3F6EA4723c148A32DC327a3eCB5b","scheme":"exact"},{"amount":"0.1","asset":"524C555344000000000000000000000000000000","extra":{"invoiceId":"8904dbb1-40c6-4557-aee7-dd63bf26fb5a","issuer":"rMxCKbEDwqr76QuheSUMdEGf4B9xJ8m5De","sourceTag":402402402},"maxTimeoutSeconds":300,"network":"xrpl:0","payTo":"rKv7LTd19CUsKKirVzdZWK4HuFChHf4Hp7","scheme":"exact"},{"amount":"100000","asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"Hc3sdEAsCGQcpgfivywog9uwtk8gUBUZgsxdME1EJy88"},"maxTimeoutSeconds":300,"network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","payTo":"2s11RMxZBjoFh8NJvZwA8LUKcaTRx2fHGUSSvQsM7Lib","scheme":"exact"},{"amount":"100000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0x408C4610F6879a75c25722cfCd18A2Eff99dc20F","scheme":"exact"},{"amount":"100000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0x408C4610F6879a75c25722cfCd18A2Eff99dc20F","scheme":"exact"}],"description":"Premium comparison of the latest available gross capital formation across 30 major economies and financial centres using one normalized World Bank indicator definition. Purpose: Rank and compare major economies on gross capital formation while exposing observation-year differences and missing coverage rather than pretending all countries are synchronized. 24-hour freshness target; missing evidence is reported explicitly rather than invented.","extensions":{"bazaar":{"info":{"input":{"method":"GET","queryParams":{},"type":"http"},"output":{"example":{"analysis":{"family":"macro","intents":["evidence","investment"],"summary":"Fresh Global Gross Capital Formation Comparison findings appear here."},"dataStatus":"complete","disclaimer":"General, impersonal market research; not investment advice or a buy, sell or hold recommendation.","evidence":{"assets":[],"policy":"point-in-time","sources":"Reported from the actual live report; never inferred from this example."},"generatedAt":"2026-08-31T00:00:00.000Z","limitations":["Coverage, source freshness and unavailable evidence are stated in every paid report."],"provenance":{"issuer":"https://edge-agents.ai","signed":true},"quality":{"confidence":"high","status":"strong"},"schemaVersion":"2.0","serviceId":"macro-global-capital-formation-comparison"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"method":{"enum":["GET"],"type":"string"},"queryParams":{"additionalProperties":false,"description":"No parameters are required. The report is generated from fresh eligible evidence at purchase time.","properties":{},"required":[],"type":"object"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"additionalProperties":true,"properties":{"analysis":{"description":"Product-specific findings calculated from eligible evidence.","type":"object"},"dataStatus":{"description":"Completeness of eligible evidence used by the live report.","enum":["complete","partial","unavailable"],"type":"string"},"deliveryId":{"description":"Unique delivery identifier returned after a successful paid request.","type":"string"},"disclaimer":{"type":"string"},"evidence":{"description":"Observed evidence, providers, timestamps and source lineage supporting the analysis.","type":"object"},"generatedAt":{"description":"RFC3339 date-time timestamp.","pattern":"^\\d{4}-\\d{2}-\\d{2}T\\d{2}:\\d{2}:\\d{2}(?:\\.\\d+)?(?:Z|[+-]\\d{2}:\\d{2})$","type":"string"},"limitations":{"items":{"type":"string"},"type":"array"},"provenance":{"description":"Issuer and signature/verification status when available.","type":"object"},"quality":{"description":"Evidence-quality assessment; not probability of profit.","type":"object"},"reportId":{"description":"Product report identifier when the service exposes one.","type":"string"},"schemaVersion":{"description":"Version of the machine-readable report contract.","type":"string"},"serviceId":{"const":"macro-global-capital-formation-comparison","type":"string"}},"required":["serviceId","generatedAt","dataStatus","analysis"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-09-14T23:25:55.705Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-14T23:25:55.505Z"},"resource":"https://pay.edge-agents.ai/v1/services/macro-global-capital-formation-comparison","serviceName":"Edge Agents AI","tags":["macro","evidence","investment","finance","x402"],"type":"http","x402Version":2},{"accepts":[{"amount":"100000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0x7d9C21AcB6be3F6EA4723c148A32DC327a3eCB5b","scheme":"exact"},{"amount":"0.1","asset":"524C555344000000000000000000000000000000","extra":{"invoiceId":"9813e0f9-5e5c-472d-8f92-6b2ab0853d08","issuer":"rMxCKbEDwqr76QuheSUMdEGf4B9xJ8m5De","sourceTag":402402402},"maxTimeoutSeconds":300,"network":"xrpl:0","payTo":"rKv7LTd19CUsKKirVzdZWK4HuFChHf4Hp7","scheme":"exact"},{"amount":"100000","asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"BENrLoUbndxoNMUS5JXApGMtNykLjFXXixMtpDwDR9SP"},"maxTimeoutSeconds":300,"network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","payTo":"2s11RMxZBjoFh8NJvZwA8LUKcaTRx2fHGUSSvQsM7Lib","scheme":"exact"},{"amount":"100000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0x408C4610F6879a75c25722cfCd18A2Eff99dc20F","scheme":"exact"},{"amount":"100000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0x408C4610F6879a75c25722cfCd18A2Eff99dc20F","scheme":"exact"}],"description":"UK-Euro Macro Divergence from official ONS/Eurostat evidence with source timing, provenance, missingness and bounded interpretation for autonomous agents. Purpose: compare UK and euro-area inflation, activity and labour evidence without forcing differently timed releases into false synchrony 24-hour freshness target; missing evidence is reported explicitly rather than invented.","extensions":{"bazaar":{"info":{"input":{"method":"GET","queryParams":{},"type":"http"},"output":{"example":{"analysis":{"family":"cross-market","intents":["anomaly","evidence","adoption","inflation","labour"],"summary":"Fresh UK-Euro Macro Divergence findings appear here."},"dataStatus":"complete","disclaimer":"General, impersonal market research; not investment advice or a buy, sell or hold recommendation.","evidence":{"assets":["EUR"],"policy":"mixed","sources":"Reported from the actual live report; never inferred from this example."},"generatedAt":"2026-08-31T00:00:00.000Z","limitations":["Coverage, source freshness and unavailable evidence are stated in every paid report."],"provenance":{"issuer":"https://edge-agents.ai","signed":true},"quality":{"confidence":"high","status":"strong"},"schemaVersion":"2.0","serviceId":"eurostat-ons-uk-euro-divergence"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"method":{"enum":["GET"],"type":"string"},"queryParams":{"additionalProperties":false,"description":"No parameters are required. The report is generated from fresh eligible evidence at purchase time.","properties":{},"required":[],"type":"object"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"additionalProperties":true,"properties":{"analysis":{"description":"Product-specific findings calculated from eligible evidence.","type":"object"},"dataStatus":{"description":"Completeness of eligible evidence used by the live report.","enum":["complete","partial","unavailable"],"type":"string"},"deliveryId":{"description":"Unique delivery identifier returned after a successful paid request.","type":"string"},"disclaimer":{"type":"string"},"evidence":{"description":"Observed evidence, providers, timestamps and source lineage supporting the analysis.","type":"object"},"generatedAt":{"description":"RFC3339 date-time timestamp.","pattern":"^\\d{4}-\\d{2}-\\d{2}T\\d{2}:\\d{2}:\\d{2}(?:\\.\\d+)?(?:Z|[+-]\\d{2}:\\d{2})$","type":"string"},"limitations":{"items":{"type":"string"},"type":"array"},"provenance":{"description":"Issuer and signature/verification status when available.","type":"object"},"quality":{"description":"Evidence-quality assessment; not probability of profit.","type":"object"},"reportId":{"description":"Product report identifier when the service exposes one.","type":"string"},"schemaVersion":{"description":"Version of the machine-readable report contract.","type":"string"},"serviceId":{"const":"eurostat-ons-uk-euro-divergence","type":"string"}},"required":["serviceId","generatedAt","dataStatus","analysis"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-09-14T23:23:26.706Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-14T23:23:26.497Z"},"resource":"https://pay.edge-agents.ai/v1/services/eurostat-ons-uk-euro-divergence","serviceName":"Edge Agents AI","tags":["cross-market","eur","anomaly","evidence","finance"],"type":"http","x402Version":2},{"accepts":[{"amount":"250000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0x7d9C21AcB6be3F6EA4723c148A32DC327a3eCB5b","scheme":"exact"},{"amount":"0.25","asset":"524C555344000000000000000000000000000000","extra":{"invoiceId":"68758439-1304-42d3-b7e0-04b5a91d94ca","issuer":"rMxCKbEDwqr76QuheSUMdEGf4B9xJ8m5De","sourceTag":402402402},"maxTimeoutSeconds":300,"network":"xrpl:0","payTo":"rKv7LTd19CUsKKirVzdZWK4HuFChHf4Hp7","scheme":"exact"},{"amount":"250000","asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"BFK9TLC3edb13K6v4YyH3DwPb5DSUpkWvb7XnqCL9b4F"},"maxTimeoutSeconds":300,"network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","payTo":"2s11RMxZBjoFh8NJvZwA8LUKcaTRx2fHGUSSvQsM7Lib","scheme":"exact"},{"amount":"250000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0x408C4610F6879a75c25722cfCd18A2Eff99dc20F","scheme":"exact"},{"amount":"250000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0x408C4610F6879a75c25722cfCd18A2Eff99dc20F","scheme":"exact"}],"description":"Strategic Inflection Radar. Combines macro, market and risk evidence into strategic scenarios, timing questions and option-value context. Purpose: Improve strategic choices by making assumptions, reversibility, triggers and evidence gaps explicit. 15-minute freshness target; missing evidence is reported explicitly rather than invented.","extensions":{"bazaar":{"info":{"input":{"method":"GET","queryParams":{},"type":"http"},"output":{"example":{"analysis":{"family":"cross-market","intents":["risk","evidence"],"summary":"Fresh Strategic Inflection Radar findings appear here."},"dataStatus":"complete","disclaimer":"General, impersonal market research; not investment advice or a buy, sell or hold recommendation.","evidence":{"assets":[],"policy":"mixed","sources":"Reported from the actual live report; never inferred from this example."},"generatedAt":"2026-08-31T00:00:00.000Z","limitations":["Coverage, source freshness and unavailable evidence are stated in every paid report."],"provenance":{"issuer":"https://edge-agents.ai","signed":true},"quality":{"confidence":"high","status":"strong"},"schemaVersion":"2.0","serviceId":"strategic-inflection-radar"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"method":{"enum":["GET"],"type":"string"},"queryParams":{"additionalProperties":false,"description":"No parameters are required. The report is generated from fresh eligible evidence at purchase time.","properties":{},"required":[],"type":"object"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"additionalProperties":true,"properties":{"analysis":{"description":"Product-specific findings calculated from eligible evidence.","type":"object"},"dataStatus":{"description":"Completeness of eligible evidence used by the live report.","enum":["complete","partial","unavailable"],"type":"string"},"deliveryId":{"description":"Unique delivery identifier returned after a successful paid request.","type":"string"},"disclaimer":{"type":"string"},"evidence":{"description":"Observed evidence, providers, timestamps and source lineage supporting the analysis.","type":"object"},"generatedAt":{"description":"RFC3339 date-time timestamp.","pattern":"^\\d{4}-\\d{2}-\\d{2}T\\d{2}:\\d{2}:\\d{2}(?:\\.\\d+)?(?:Z|[+-]\\d{2}:\\d{2})$","type":"string"},"limitations":{"items":{"type":"string"},"type":"array"},"provenance":{"description":"Issuer and signature/verification status when available.","type":"object"},"quality":{"description":"Evidence-quality assessment; not probability of profit.","type":"object"},"reportId":{"description":"Product report identifier when the service exposes one.","type":"string"},"schemaVersion":{"description":"Version of the machine-readable report contract.","type":"string"},"serviceId":{"const":"strategic-inflection-radar","type":"string"}},"required":["serviceId","generatedAt","dataStatus","analysis"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-09-14T22:58:25.459Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-14T22:58:25.252Z"},"resource":"https://pay.edge-agents.ai/v1/services/strategic-inflection-radar","serviceName":"Edge Agents AI","tags":["cross-market","risk","evidence","finance","x402"],"type":"http","x402Version":2},{"accepts":[{"amount":"100000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0x7d9C21AcB6be3F6EA4723c148A32DC327a3eCB5b","scheme":"exact"},{"amount":"0.1","asset":"524C555344000000000000000000000000000000","extra":{"invoiceId":"0e487b9c-ee96-4a95-9a5b-6ed8946476ca","issuer":"rMxCKbEDwqr76QuheSUMdEGf4B9xJ8m5De","sourceTag":402402402},"maxTimeoutSeconds":300,"network":"xrpl:0","payTo":"rKv7LTd19CUsKKirVzdZWK4HuFChHf4Hp7","scheme":"exact"},{"amount":"100000","asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"GVJJ7rdGiXr5xaYbRwRbjfaJL7fmwRygFi1H6aGqDveb"},"maxTimeoutSeconds":300,"network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","payTo":"2s11RMxZBjoFh8NJvZwA8LUKcaTRx2fHGUSSvQsM7Lib","scheme":"exact"},{"amount":"100000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0x408C4610F6879a75c25722cfCd18A2Eff99dc20F","scheme":"exact"},{"amount":"100000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0x408C4610F6879a75c25722cfCd18A2Eff99dc20F","scheme":"exact"}],"description":"Premium twelve-indicator structural macro profile for Mexico, covering growth, inflation, labour, external balance, trade, savings, investment, reserves, real rates and central-government debt where available. Purpose: Provide an autonomous agent one normalized Mexico structural macro brief with explicit coverage, latest observation years and missing indicators. 24-hour freshness target; missing evidence is reported explicitly rather than invented.","extensions":{"bazaar":{"info":{"input":{"method":"GET","queryParams":{},"type":"http"},"output":{"example":{"analysis":{"family":"macro","intents":["evidence","cycle","inflation","labour","growth","sovereign-debt"],"summary":"Fresh Mexico Structural Macro Profile findings appear here."},"dataStatus":"complete","disclaimer":"General, impersonal market research; not investment advice or a buy, sell or hold recommendation.","evidence":{"assets":["MEX"],"policy":"point-in-time","sources":"Reported from the actual live report; never inferred from this example."},"generatedAt":"2026-08-31T00:00:00.000Z","limitations":["Coverage, source freshness and unavailable evidence are stated in every paid report."],"provenance":{"issuer":"https://edge-agents.ai","signed":true},"quality":{"confidence":"high","status":"strong"},"schemaVersion":"2.0","serviceId":"macro-mx-structural-profile"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"method":{"enum":["GET"],"type":"string"},"queryParams":{"additionalProperties":false,"description":"No parameters are required. The report is generated from fresh eligible evidence at purchase time.","properties":{},"required":[],"type":"object"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"additionalProperties":true,"properties":{"analysis":{"description":"Product-specific findings calculated from eligible evidence.","type":"object"},"dataStatus":{"description":"Completeness of eligible evidence used by the live report.","enum":["complete","partial","unavailable"],"type":"string"},"deliveryId":{"description":"Unique delivery identifier returned after a successful paid request.","type":"string"},"disclaimer":{"type":"string"},"evidence":{"description":"Observed evidence, providers, timestamps and source lineage supporting the analysis.","type":"object"},"generatedAt":{"description":"RFC3339 date-time timestamp.","pattern":"^\\d{4}-\\d{2}-\\d{2}T\\d{2}:\\d{2}:\\d{2}(?:\\.\\d+)?(?:Z|[+-]\\d{2}:\\d{2})$","type":"string"},"limitations":{"items":{"type":"string"},"type":"array"},"provenance":{"description":"Issuer and signature/verification status when available.","type":"object"},"quality":{"description":"Evidence-quality assessment; not probability of profit.","type":"object"},"reportId":{"description":"Product report identifier when the service exposes one.","type":"string"},"schemaVersion":{"description":"Version of the machine-readable report contract.","type":"string"},"serviceId":{"const":"macro-mx-structural-profile","type":"string"}},"required":["serviceId","generatedAt","dataStatus","analysis"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-09-14T22:57:47.387Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-14T22:57:46.716Z"},"resource":"https://pay.edge-agents.ai/v1/services/macro-mx-structural-profile","serviceName":"Edge Agents AI","tags":["macro","mex","evidence","cycle","finance"],"type":"http","x402Version":2},{"accepts":[{"amount":"100000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0x7d9C21AcB6be3F6EA4723c148A32DC327a3eCB5b","scheme":"exact"},{"amount":"0.1","asset":"524C555344000000000000000000000000000000","extra":{"invoiceId":"414d3005-a2bb-4110-a9c4-c1aab867d8eb","issuer":"rMxCKbEDwqr76QuheSUMdEGf4B9xJ8m5De","sourceTag":402402402},"maxTimeoutSeconds":300,"network":"xrpl:0","payTo":"rKv7LTd19CUsKKirVzdZWK4HuFChHf4Hp7","scheme":"exact"},{"amount":"100000","asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"GVJJ7rdGiXr5xaYbRwRbjfaJL7fmwRygFi1H6aGqDveb"},"maxTimeoutSeconds":300,"network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","payTo":"2s11RMxZBjoFh8NJvZwA8LUKcaTRx2fHGUSSvQsM7Lib","scheme":"exact"},{"amount":"100000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0x408C4610F6879a75c25722cfCd18A2Eff99dc20F","scheme":"exact"},{"amount":"100000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0x408C4610F6879a75c25722cfCd18A2Eff99dc20F","scheme":"exact"}],"description":"Premium short-horizon Bitcoin fragility assessment combining spot shock, broad-market risk and exchange-native leverage evidence; no uncalibrated crash or squeeze probability is published. Purpose: Measure current Bitcoin downside and squeeze fragility while keeping probability, liquidation and options evidence unavailable unless directly supported. 15-minute freshness target; missing evidence is reported explicitly rather than invented.","extensions":{"bazaar":{"info":{"input":{"method":"GET","queryParams":{},"type":"http"},"output":{"example":{"analysis":{"family":"bitcoin","intents":["risk","leverage","evidence"],"summary":"Fresh BTC Crash / Squeeze Risk findings appear here."},"dataStatus":"complete","disclaimer":"General, impersonal market research; not investment advice or a buy, sell or hold recommendation.","evidence":{"assets":["BTC"],"policy":"point-in-time","sources":"Reported from the actual live report; never inferred from this example."},"generatedAt":"2026-08-31T00:00:00.000Z","limitations":["Coverage, source freshness and unavailable evidence are stated in every paid report."],"provenance":{"issuer":"https://edge-agents.ai","signed":true},"quality":{"confidence":"high","status":"strong"},"schemaVersion":"2.0","serviceId":"btc-crash-squeeze-risk"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"method":{"enum":["GET"],"type":"string"},"queryParams":{"additionalProperties":false,"description":"No parameters are required. The report is generated from fresh eligible evidence at purchase time.","properties":{},"required":[],"type":"object"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"additionalProperties":true,"properties":{"analysis":{"description":"Product-specific findings calculated from eligible evidence.","type":"object"},"dataStatus":{"description":"Completeness of eligible evidence used by the live report.","enum":["complete","partial","unavailable"],"type":"string"},"deliveryId":{"description":"Unique delivery identifier returned after a successful paid request.","type":"string"},"disclaimer":{"type":"string"},"evidence":{"description":"Observed evidence, providers, timestamps and source lineage supporting the analysis.","type":"object"},"generatedAt":{"description":"RFC3339 date-time timestamp.","pattern":"^\\d{4}-\\d{2}-\\d{2}T\\d{2}:\\d{2}:\\d{2}(?:\\.\\d+)?(?:Z|[+-]\\d{2}:\\d{2})$","type":"string"},"limitations":{"items":{"type":"string"},"type":"array"},"provenance":{"description":"Issuer and signature/verification status when available.","type":"object"},"quality":{"description":"Evidence-quality assessment; not probability of profit.","type":"object"},"reportId":{"description":"Product report identifier when the service exposes one.","type":"string"},"schemaVersion":{"description":"Version of the machine-readable report contract.","type":"string"},"serviceId":{"const":"btc-crash-squeeze-risk","type":"string"}},"required":["serviceId","generatedAt","dataStatus","analysis"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-09-14T22:51:02.196Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-14T22:51:01.529Z"},"resource":"https://pay.edge-agents.ai/v1/services/btc-crash-squeeze-risk","serviceName":"Edge Agents AI","tags":["bitcoin","btc","risk","leverage","finance"],"type":"http","x402Version":2},{"accepts":[{"amount":"10000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0x93053f1e7A5eFEDa532Fe69CbbE43cBEc3A0F13f","scheme":"exact"},{"amount":"10000","asset":"0x779Ded0c9e1022225f8E0630b35a9b54bE713736","extra":{"name":"USD₮0","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:196","payTo":"0x93053f1e7A5eFEDa532Fe69CbbE43cBEc3A0F13f","scheme":"exact"},{"amount":"10000000000000000","asset":"0xcE24439F2D9C6a2289F741120FE202248B666666","extra":{"assetTransferMethod":"eip3009","name":"United Stables","signerAddress":"0x34F7a661160780Ce1346e6D7B96D2bE244590899","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:56","payTo":"0x93053f1e7A5eFEDa532Fe69CbbE43cBEc3A0F13f","scheme":"exact"},{"amount":"10000000000000000","asset":"0x8d0d000ee44948fc98c9b98a4fa4921476f08b0d","extra":{"assetTransferMethod":"eip3009","name":"World Liberty Financial USD","signerAddress":"0x34F7a661160780Ce1346e6D7B96D2bE244590899","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:56","payTo":"0x93053f1e7A5eFEDa532Fe69CbbE43cBEc3A0F13f","scheme":"exact"},{"amount":"10000000000000000","asset":"0x55d398326f99059fF775485246999027B3197955","extra":{"assetTransferMethod":"permit2-exact","name":"Tether USD","signerAddress":"0x34F7a661160780Ce1346e6D7B96D2bE244590899","spenderAddress":"0x3038f7ac3b4D1a3fe886BdCB5cD01e9f6BDd8633","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:56","payTo":"0x93053f1e7A5eFEDa532Fe69CbbE43cBEc3A0F13f","scheme":"exact"},{"amount":"10000000000000000","asset":"0x8AC76a51cc950d9822D68b83fE1Ad97B32Cd580d","extra":{"assetTransferMethod":"permit2-exact","name":"USD Coin","signerAddress":"0x34F7a661160780Ce1346e6D7B96D2bE244590899","spenderAddress":"0x3038f7ac3b4D1a3fe886BdCB5cD01e9f6BDd8633","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:56","payTo":"0x93053f1e7A5eFEDa532Fe69CbbE43cBEc3A0F13f","scheme":"exact"},{"amount":"10000","asset":"0x754704Bc059F8C67012fEd69BC8A327a5aafb603","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:143","payTo":"0x93053f1e7A5eFEDa532Fe69CbbE43cBEc3A0F13f","scheme":"exact"},{"amount":"10000","asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"CjNFTjvBhbJJd2B5ePPMHRLx1ELZpa8dwQgGL727eKww"},"maxTimeoutSeconds":300,"network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","payTo":"J7ZvJEspvwP1oRxQZ7mYmNmT22NTm3GWq3t7HEbvPZYx","scheme":"exact"}],"description":"Get Wallet DEX Trades","extensions":{"bazaar":{"info":{"input":{"body":{"address":"0x28c6c06298d514db089934071355e5743bf21d60","chain":"ethereum","date":{"from":"2024-01-01","to":"2024-01-31"}},"bodyType":"json","method":"POST","type":"http"},"output":{"example":{"data":[],"pagination":{}},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"properties":{"address":{"type":"string"},"chain":{"type":"string"},"date":{"type":"object"},"filters":{"type":"object"},"order_by":{"type":"array"},"pagination":{"type":"object"}},"required":["address","chain","date"],"type":"object"},"bodyType":{"enum":["json","form-data","text"],"type":"string"},"method":{"enum":["POST","PUT","PATCH"],"type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method","bodyType","body"],"type":"object"},"output":{"properties":{"example":{"properties":{"data":{"items":{"properties":{"block_timestamp":{"type":"string"},"chain":{"type":"string"},"token_bought_address":{"type":"string"},"token_bought_age_days":{"type":"integer"},"token_bought_amount":{"type":"number"},"token_bought_fdv":{"type":"number"},"token_bought_market_cap":{"type":"number"},"token_bought_symbol":{"type":"string"},"token_sold_address":{"type":"string"},"token_sold_age_days":{"type":"integer"},"token_sold_amount":{"type":"number"},"token_sold_fdv":{"type":"number"},"token_sold_market_cap":{"type":"number"},"token_sold_symbol":{"type":"string"},"trade_value_usd":{"type":"number"},"trader_address":{"type":"string"},"trader_address_label":{"type":"string"},"transaction_hash":{"type":"string"}},"required":["chain","block_timestamp","transaction_hash","trader_address","token_bought_address","token_sold_address"],"type":"object"},"type":"array"},"pagination":{"properties":{"is_last_page":{"type":"boolean"},"page":{"type":"integer"},"per_page":{"type":"integer"}},"type":"object"}},"required":["pagination","data"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"iconUrl":"https://res.cloudinary.com/bdb-prod/image/upload/c_fill,ar_1:1,w_256,h_256,f_auto,q_auto/v1780076798/bazaar-icons/d6ed3d2e7dd37d8a.png","lastUpdated":"2026-10-01T04:45:13.405Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-01T04:45:13.194Z"},"resource":"https://api.nansen.ai/api/v1/profiler/dex-trades","serviceName":"Nansen","tags":["crypto","analytics","smart-money","on-chain"],"type":"http","x402Version":2},{"accepts":[{"amount":"150000","asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"GVJJ7rdGiXr5xaYbRwRbjfaJL7fmwRygFi1H6aGqDveb"},"maxTimeoutSeconds":300,"network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","payTo":"Bn7sLNmcL9ru5kt9gNwVn8e8Sx912dBTxiUBNiwjbiY8","scheme":"exact"}],"description":"Full holder breakdown for a token: every detected wallet-funding network with member wallets + ownership %, top individual holders, exchange-funded distribution, rugger tags, and lock/stake flags. Pass `analysis` to fetch a historical snapshot.","extensions":{"bazaar":{"info":{"input":{"method":"GET","queryParams":{"mint":"DezXAZ8z7PnrnRJjz3wXBoRgixCa6xjnB7YaB1pPB263"},"type":"http"},"output":{"example":{"individualHolders":[{"address":"…","percentage":3.1,"riskLevel":"OK"}],"mint":"DezXAZ8z7PnrnRJjz3wXBoRgixCa6xjnB7YaB1pPB263","networkBundles":[{"accounts":[],"address":"NetworkRoot…","name":"Coinbase-funded cluster","percentOwnership":4.2,"riskLevel":"OK"}],"topNetworkOwnership":4.2,"totalHolders":8400,"walletsAnalyzed":300},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"method":{"enum":["GET"],"type":"string"},"queryParams":{"properties":{"analysis":{"description":"Unix epoch-second timestamp of a historical holder-analysis snapshot. Omit for the latest.","example":"1761157858","type":"string"},"mint":{"description":"Solana token mint address (base58). pump.fun tokens end in \"pump\".","example":"DezXAZ8z7PnrnRJjz3wXBoRgixCa6xjnB7YaB1pPB263","type":"string"}},"required":["mint"],"type":"object"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-09-25T06:00:46.914Z","quality":{"l30DaysTotalCalls":14,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-25T06:00:54.704Z"},"resource":"https://api.deepnets.ai/api/token-details","type":"http","x402Version":2},{"accepts":[{"amount":"100000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","outputSchema":{"properties":{"duration":{"type":"number"},"model":{"type":"string"},"text":{"type":"string"}},"required":["text","duration","model"],"type":"object"},"payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"100000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"100000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"100000","asset":"0x754704Bc059F8C67012fEd69BC8A327a5aafb603","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:143","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"100000","asset":"0xB97EF9Ef8734C71904D8002F8b6Bc66Dd9c48a6E","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:43114","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"100000","asset":"0xe15fC38F6D8c56aF07bbCBe3BAf5708A2Bf42392","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:1329","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"101000","asset":"0x0b2C639c533813f4Aa9D7837CAf62653d097Ff85","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:10","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"100000","asset":"0x5fc5360D0400a0Fd4f2af552ADD042D716F1d168","extra":{"name":"Global Dollar","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:4663","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"100000","asset":"0xcebA9300f2b948710d2653dD7B07f33A8B32118C","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42220","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"100000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"permit2","facilitatorAddress":"0xE74817F4cDC15844314812B2271276E64e890fAE","name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"upto"},{"amount":"100000","asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"BFK9TLC3edb13K6v4YyH3DwPb5DSUpkWvb7XnqCL9b4F"},"maxTimeoutSeconds":300,"network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","payTo":"J7aN3PLJnTCF5qpEnvJHJsnCjcGuqC2rYtEM8Gv3xwg","scheme":"exact"},{"amount":"1000000","asset":"CCW67TSZV3SSS2HXMBQ5JFGCKJNXKZM7UQUWUZPUTHXSTZLEO7SJMI75","extra":{"areFeesSponsored":true},"maxTimeoutSeconds":300,"network":"stellar:pubnet","payTo":"GDNJXCKW7ZM7GEEVP674TWPU26YJNBQ2FI4ZIPRKTPTNUEJMDHFJWWRL","scheme":"exact"},{"amount":"100000","asset":"31566704","extra":{"feePayer":"ZMFK2OI7ZBD2U27ISERZC4S6LKM6WMFJPZQ4MYNJDZ2VNBNMBA67RA22AA","tag":"x402-global-challenge"},"maxTimeoutSeconds":300,"network":"algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73ktiC1qzkkit8=","payTo":"C7IIHG7SPLPZ5H7ZT6HW3UV2OQMQQE6Y2HBNGZXSLRJULE42BEE2OY2XIE","scheme":"exact"}],"description":"OpenAI's transcription wire on the ten-minute tier: POST multipart/form-data with a `file` part. Same model as /v1/audio/transcriptions with a longer cap, for a recording a four-minute route refuses.","extensions":{"bazaar":{"info":{"input":{"body":{"file":"\u003caudio bytes, multipart part named file\u003e"},"bodyType":"form-data","method":"POST","type":"http"},"output":{"example":{"duration":420.5,"model":"gpt-transcribe","text":"Example transcript."},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"properties":{"file":{"description":"The audio file, as a multipart part named `file`","type":"string"},"language":{"description":"Optional ISO-639-1 hint","type":"string"}},"required":["file"],"type":"object"},"bodyType":{"enum":["json","form-data","text"],"type":"string"},"method":{"enum":["POST"],"type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method","bodyType","body"],"type":"object"},"output":{"properties":{"example":{"properties":{"duration":{"type":"number"},"model":{"type":"string"},"text":{"type":"string"}},"required":["text","duration","model"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}},"builder-code":{"info":{"a":"bc_b4aw4uzd"},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false,"properties":{"a":{"description":"App builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"},"s":{"description":"Service builder codes","items":{"pattern":"^[a-z0-9_]{1,32}$","type":"string"},"maxItems":11,"type":"array"},"w":{"description":"Wallet builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"}},"type":"object"}},"payment-identifier":{"info":{"required":false},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"id":{"maxLength":128,"minLength":16,"pattern":"^[a-zA-Z0-9_-]+$","type":"string"},"required":{"type":"boolean"}},"required":["required"],"type":"object"}}},"iconUrl":"https://res.cloudinary.com/bdb-prod/image/upload/c_fill,ar_1:1,w_256,h_256,f_auto,q_auto/v1788138502/bazaar-icons/478aced8e219894c.png","lastUpdated":"2026-10-05T00:45:18.807Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T00:45:18.574Z"},"resource":"https://agent402.tools/v1/pro/audio/transcriptions","serviceName":"Speech-to-text, long audio","tags":["ai","stt","speech-to-text","transcription","audio"],"type":"http","x402Version":2},{"accepts":[{"amount":"30000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","outputSchema":{"properties":{"duration":{"type":"number"},"model":{"type":"string"},"text":{"type":"string"}},"required":["text","duration","model"],"type":"object"},"payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"30000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"30000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"30000","asset":"0x754704Bc059F8C67012fEd69BC8A327a5aafb603","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:143","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"30000","asset":"0xB97EF9Ef8734C71904D8002F8b6Bc66Dd9c48a6E","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:43114","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"30000","asset":"0xe15fC38F6D8c56aF07bbCBe3BAf5708A2Bf42392","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:1329","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"31000","asset":"0x0b2C639c533813f4Aa9D7837CAf62653d097Ff85","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:10","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"30000","asset":"0x5fc5360D0400a0Fd4f2af552ADD042D716F1d168","extra":{"name":"Global Dollar","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:4663","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"30000","asset":"0xcebA9300f2b948710d2653dD7B07f33A8B32118C","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42220","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"30000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"permit2","facilitatorAddress":"0xE74817F4cDC15844314812B2271276E64e890fAE","name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"upto"},{"amount":"30000","asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"BFK9TLC3edb13K6v4YyH3DwPb5DSUpkWvb7XnqCL9b4F"},"maxTimeoutSeconds":300,"network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","payTo":"J7aN3PLJnTCF5qpEnvJHJsnCjcGuqC2rYtEM8Gv3xwg","scheme":"exact"},{"amount":"300000","asset":"CCW67TSZV3SSS2HXMBQ5JFGCKJNXKZM7UQUWUZPUTHXSTZLEO7SJMI75","extra":{"areFeesSponsored":true},"maxTimeoutSeconds":300,"network":"stellar:pubnet","payTo":"GDNJXCKW7ZM7GEEVP674TWPU26YJNBQ2FI4ZIPRKTPTNUEJMDHFJWWRL","scheme":"exact"},{"amount":"30000","asset":"31566704","extra":{"feePayer":"ZMFK2OI7ZBD2U27ISERZC4S6LKM6WMFJPZQ4MYNJDZ2VNBNMBA67RA22AA","tag":"x402-global-challenge"},"maxTimeoutSeconds":300,"network":"algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73ktiC1qzkkit8=","payTo":"C7IIHG7SPLPZ5H7ZT6HW3UV2OQMQQE6Y2HBNGZXSLRJULE42BEE2OY2XIE","scheme":"exact"}],"description":"OpenAI's own transcription wire: POST multipart/form-data with a `file` part and get the transcript back. Point any Whisper-shaped SDK at this gateway and pay per call with USDC, no account and no API key. Same model and same four-minute cap as /api/transcribe, which takes a URL instead of an upload; /v1/pro/audio/transcriptions takes it to ten minutes.","extensions":{"bazaar":{"info":{"input":{"body":{"file":"\u003caudio bytes, multipart part named file\u003e","language":"en"},"bodyType":"form-data","method":"POST","type":"http"},"output":{"example":{"duration":3.2,"model":"gpt-transcribe","text":"Example transcript."},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"properties":{"file":{"description":"The audio file, as a multipart part named `file`","type":"string"},"language":{"description":"Optional ISO-639-1 hint","type":"string"}},"required":["file"],"type":"object"},"bodyType":{"enum":["json","form-data","text"],"type":"string"},"method":{"enum":["POST"],"type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method","bodyType","body"],"type":"object"},"output":{"properties":{"example":{"properties":{"duration":{"type":"number"},"model":{"type":"string"},"text":{"type":"string"}},"required":["text","duration","model"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}},"builder-code":{"info":{"a":"bc_b4aw4uzd"},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false,"properties":{"a":{"description":"App builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"},"s":{"description":"Service builder codes","items":{"pattern":"^[a-z0-9_]{1,32}$","type":"string"},"maxItems":11,"type":"array"},"w":{"description":"Wallet builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"}},"type":"object"}},"payment-identifier":{"info":{"required":false},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"id":{"maxLength":128,"minLength":16,"pattern":"^[a-zA-Z0-9_-]+$","type":"string"},"required":{"type":"boolean"}},"required":["required"],"type":"object"}}},"iconUrl":"https://res.cloudinary.com/bdb-prod/image/upload/c_fill,ar_1:1,w_256,h_256,f_auto,q_auto/v1788138502/bazaar-icons/478aced8e219894c.png","lastUpdated":"2026-10-05T00:45:14.503Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T00:45:14.279Z"},"resource":"https://agent402.tools/v1/audio/transcriptions","serviceName":"Speech-to-text (OpenAI","tags":["ai","stt","speech-to-text","transcription","audio"],"type":"http","x402Version":2},{"accepts":[{"amount":"500000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","outputSchema":{"properties":{"candidates":{"items":{"properties":{"content":{"type":"object"},"finishReason":{"type":"string"},"index":{"type":"integer"}},"type":"object"},"type":"array"},"modelVersion":{"type":"string"},"usageMetadata":{"properties":{"candidatesTokenCount":{"type":"integer"},"promptTokenCount":{"type":"integer"},"totalTokenCount":{"type":"integer"}},"type":"object"}},"required":["candidates","usageMetadata","modelVersion"],"type":"object"},"payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"500000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"500000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"500000","asset":"0x754704Bc059F8C67012fEd69BC8A327a5aafb603","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:143","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"500000","asset":"0xB97EF9Ef8734C71904D8002F8b6Bc66Dd9c48a6E","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:43114","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"500000","asset":"0xe15fC38F6D8c56aF07bbCBe3BAf5708A2Bf42392","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:1329","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"501000","asset":"0x0b2C639c533813f4Aa9D7837CAf62653d097Ff85","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:10","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"500000","asset":"0x5fc5360D0400a0Fd4f2af552ADD042D716F1d168","extra":{"name":"Global Dollar","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:4663","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"500000","asset":"0xcebA9300f2b948710d2653dD7B07f33A8B32118C","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42220","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"500000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"permit2","facilitatorAddress":"0x772003A2E9c2cCC8af956870a37A66F64F8CEC38","name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"upto"},{"amount":"500000","asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"BFK9TLC3edb13K6v4YyH3DwPb5DSUpkWvb7XnqCL9b4F"},"maxTimeoutSeconds":300,"network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","payTo":"J7aN3PLJnTCF5qpEnvJHJsnCjcGuqC2rYtEM8Gv3xwg","scheme":"exact"},{"amount":"5000000","asset":"CCW67TSZV3SSS2HXMBQ5JFGCKJNXKZM7UQUWUZPUTHXSTZLEO7SJMI75","extra":{"areFeesSponsored":true},"maxTimeoutSeconds":300,"network":"stellar:pubnet","payTo":"GDNJXCKW7ZM7GEEVP674TWPU26YJNBQ2FI4ZIPRKTPTNUEJMDHFJWWRL","scheme":"exact"},{"amount":"500000","asset":"31566704","extra":{"feePayer":"ZMFK2OI7ZBD2U27ISERZC4S6LKM6WMFJPZQ4MYNJDZ2VNBNMBA67RA22AA","tag":"x402-global-challenge"},"maxTimeoutSeconds":300,"network":"algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73ktiC1qzkkit8=","payTo":"C7IIHG7SPLPZ5H7ZT6HW3UV2OQMQQE6Y2HBNGZXSLRJULE42BEE2OY2XIE","scheme":"exact"}],"description":"Google's native generateContent wire on the premium tier. Send Gemini's own request shape (contents, systemInstruction, generationConfig, function declarations) and get Gemini's own response shape (candidates, usageMetadata) back. Point a Google GenAI SDK at this gateway and pay per request with USDC, no account. Also answers the Google-shaped path /v1beta/models/\u003cmodel\u003e:generateContent.","extensions":{"bazaar":{"info":{"input":{"body":{"contents":[{"parts":[{"text":"Summarize x402 in one sentence."}],"role":"user"}],"generationConfig":{"maxOutputTokens":256}},"bodyType":"json","method":"POST","type":"http"},"output":{"example":{"candidates":[{"content":{"parts":[{"text":"x402 is an HTTP-native way for agents to pay per request with USDC."}],"role":"model"},"finishReason":"STOP","index":0}],"modelVersion":"google/gemini-2.5-flash","usageMetadata":{"candidatesTokenCount":18,"promptTokenCount":14,"totalTokenCount":32}},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"properties":{"contents":{"description":"Gemini turns: [{role, parts:[{text}|{inlineData}]}]","type":"array"},"generationConfig":{"description":"maxOutputTokens, temperature, topP, stopSequences, responseMimeType, responseSchema","type":"object"},"model":{"description":"Optional; the Google-shaped path carries it (/v1beta/models/\u003cmodel\u003e:generateContent)","type":"string"},"systemInstruction":{"description":"Optional system turn: {parts:[{text}]}","type":"object"},"tools":{"description":"[{functionDeclarations:[{name, description, parameters}]}]","type":"array"}},"required":["contents"],"type":"object"},"bodyType":{"enum":["json","form-data","text"],"type":"string"},"method":{"enum":["POST"],"type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method","bodyType","body"],"type":"object"},"output":{"properties":{"example":{"properties":{"candidates":{"items":{"properties":{"content":{"type":"object"},"finishReason":{"type":"string"},"index":{"type":"integer"}},"type":"object"},"type":"array"},"modelVersion":{"type":"string"},"usageMetadata":{"properties":{"candidatesTokenCount":{"type":"integer"},"promptTokenCount":{"type":"integer"},"totalTokenCount":{"type":"integer"}},"type":"object"}},"required":["candidates","usageMetadata","modelVersion"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}},"builder-code":{"info":{"a":"bc_b4aw4uzd"},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false,"properties":{"a":{"description":"App builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"},"s":{"description":"Service builder codes","items":{"pattern":"^[a-z0-9_]{1,32}$","type":"string"},"maxItems":11,"type":"array"},"w":{"description":"Wallet builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"}},"type":"object"}},"payment-identifier":{"info":{"required":false},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"id":{"maxLength":128,"minLength":16,"pattern":"^[a-zA-Z0-9_-]+$","type":"string"},"required":{"type":"boolean"}},"required":["required"],"type":"object"}}},"iconUrl":"https://res.cloudinary.com/bdb-prod/image/upload/c_fill,ar_1:1,w_256,h_256,f_auto,q_auto/v1788138502/bazaar-icons/478aced8e219894c.png","lastUpdated":"2026-09-22T16:39:40.24Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-22T16:39:39.93Z"},"resource":"https://agent402.tools/v1/premium/gemini","serviceName":"Gemini generateContent (premium","tags":["llm","gemini","google","generatecontent","chat"],"type":"http","x402Version":2},{"accepts":[{"amount":"100000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","outputSchema":{"properties":{"candidates":{"items":{"properties":{"content":{"type":"object"},"finishReason":{"type":"string"},"index":{"type":"integer"}},"type":"object"},"type":"array"},"modelVersion":{"type":"string"},"usageMetadata":{"properties":{"candidatesTokenCount":{"type":"integer"},"promptTokenCount":{"type":"integer"},"totalTokenCount":{"type":"integer"}},"type":"object"}},"required":["candidates","usageMetadata","modelVersion"],"type":"object"},"payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"100000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"100000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"100000","asset":"0x754704Bc059F8C67012fEd69BC8A327a5aafb603","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:143","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"100000","asset":"0xB97EF9Ef8734C71904D8002F8b6Bc66Dd9c48a6E","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:43114","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"100000","asset":"0xe15fC38F6D8c56aF07bbCBe3BAf5708A2Bf42392","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:1329","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"101000","asset":"0x0b2C639c533813f4Aa9D7837CAf62653d097Ff85","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:10","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"100000","asset":"0x5fc5360D0400a0Fd4f2af552ADD042D716F1d168","extra":{"name":"Global Dollar","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:4663","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"100000","asset":"0xcebA9300f2b948710d2653dD7B07f33A8B32118C","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42220","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"100000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"permit2","facilitatorAddress":"0x772003A2E9c2cCC8af956870a37A66F64F8CEC38","name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"upto"},{"amount":"100000","asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"BFK9TLC3edb13K6v4YyH3DwPb5DSUpkWvb7XnqCL9b4F"},"maxTimeoutSeconds":300,"network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","payTo":"J7aN3PLJnTCF5qpEnvJHJsnCjcGuqC2rYtEM8Gv3xwg","scheme":"exact"},{"amount":"1000000","asset":"CCW67TSZV3SSS2HXMBQ5JFGCKJNXKZM7UQUWUZPUTHXSTZLEO7SJMI75","extra":{"areFeesSponsored":true},"maxTimeoutSeconds":300,"network":"stellar:pubnet","payTo":"GDNJXCKW7ZM7GEEVP674TWPU26YJNBQ2FI4ZIPRKTPTNUEJMDHFJWWRL","scheme":"exact"},{"amount":"100000","asset":"31566704","extra":{"feePayer":"ZMFK2OI7ZBD2U27ISERZC4S6LKM6WMFJPZQ4MYNJDZ2VNBNMBA67RA22AA","tag":"x402-global-challenge"},"maxTimeoutSeconds":300,"network":"algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73ktiC1qzkkit8=","payTo":"C7IIHG7SPLPZ5H7ZT6HW3UV2OQMQQE6Y2HBNGZXSLRJULE42BEE2OY2XIE","scheme":"exact"}],"description":"Google's native generateContent wire on the pro tier. Send Gemini's own request shape (contents, systemInstruction, generationConfig, function declarations) and get Gemini's own response shape (candidates, usageMetadata) back. Point a Google GenAI SDK at this gateway and pay per request with USDC, no account. Also answers the Google-shaped path /v1beta/models/\u003cmodel\u003e:generateContent.","extensions":{"bazaar":{"info":{"input":{"body":{"contents":[{"parts":[{"text":"Summarize x402 in one sentence."}],"role":"user"}],"generationConfig":{"maxOutputTokens":256}},"bodyType":"json","method":"POST","type":"http"},"output":{"example":{"candidates":[{"content":{"parts":[{"text":"x402 is an HTTP-native way for agents to pay per request with USDC."}],"role":"model"},"finishReason":"STOP","index":0}],"modelVersion":"google/gemini-2.5-flash","usageMetadata":{"candidatesTokenCount":18,"promptTokenCount":14,"totalTokenCount":32}},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"properties":{"contents":{"description":"Gemini turns: [{role, parts:[{text}|{inlineData}]}]","type":"array"},"generationConfig":{"description":"maxOutputTokens, temperature, topP, stopSequences, responseMimeType, responseSchema","type":"object"},"model":{"description":"Optional; the Google-shaped path carries it (/v1beta/models/\u003cmodel\u003e:generateContent)","type":"string"},"systemInstruction":{"description":"Optional system turn: {parts:[{text}]}","type":"object"},"tools":{"description":"[{functionDeclarations:[{name, description, parameters}]}]","type":"array"}},"required":["contents"],"type":"object"},"bodyType":{"enum":["json","form-data","text"],"type":"string"},"method":{"enum":["POST"],"type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method","bodyType","body"],"type":"object"},"output":{"properties":{"example":{"properties":{"candidates":{"items":{"properties":{"content":{"type":"object"},"finishReason":{"type":"string"},"index":{"type":"integer"}},"type":"object"},"type":"array"},"modelVersion":{"type":"string"},"usageMetadata":{"properties":{"candidatesTokenCount":{"type":"integer"},"promptTokenCount":{"type":"integer"},"totalTokenCount":{"type":"integer"}},"type":"object"}},"required":["candidates","usageMetadata","modelVersion"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}},"builder-code":{"info":{"a":"bc_b4aw4uzd"},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false,"properties":{"a":{"description":"App builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"},"s":{"description":"Service builder codes","items":{"pattern":"^[a-z0-9_]{1,32}$","type":"string"},"maxItems":11,"type":"array"},"w":{"description":"Wallet builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"}},"type":"object"}},"payment-identifier":{"info":{"required":false},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"id":{"maxLength":128,"minLength":16,"pattern":"^[a-zA-Z0-9_-]+$","type":"string"},"required":{"type":"boolean"}},"required":["required"],"type":"object"}}},"iconUrl":"https://res.cloudinary.com/bdb-prod/image/upload/c_fill,ar_1:1,w_256,h_256,f_auto,q_auto/v1788138502/bazaar-icons/478aced8e219894c.png","lastUpdated":"2026-09-22T16:39:32.271Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-22T16:39:32.053Z"},"resource":"https://agent402.tools/v1/pro/gemini","serviceName":"Gemini generateContent (pro","tags":["llm","gemini","google","generatecontent","chat"],"type":"http","x402Version":2},{"accepts":[{"amount":"119000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","outputSchema":{"properties":{"args":{"properties":{"question":{"type":"string"}},"type":"object"},"pack":{"type":"string"},"steps":{"items":{"properties":{"ok":{"type":"boolean"},"result":{"type":"object"},"slug":{"type":"string"}},"type":"object"},"type":"array"},"summary":{"type":"string"}},"required":["pack","args","steps","summary"],"type":"object"},"payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"119000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"119000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"119000","asset":"0x754704Bc059F8C67012fEd69BC8A327a5aafb603","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:143","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"119000","asset":"0xB97EF9Ef8734C71904D8002F8b6Bc66Dd9c48a6E","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:43114","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"119000","asset":"0xe15fC38F6D8c56aF07bbCBe3BAf5708A2Bf42392","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:1329","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"120000","asset":"0x0b2C639c533813f4Aa9D7837CAf62653d097Ff85","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:10","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"119000","asset":"0x5fc5360D0400a0Fd4f2af552ADD042D716F1d168","extra":{"name":"Global Dollar","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:4663","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"119000","asset":"0xcebA9300f2b948710d2653dD7B07f33A8B32118C","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42220","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"119000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"permit2","facilitatorAddress":"0x772003A2E9c2cCC8af956870a37A66F64F8CEC38","name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"upto"},{"amount":"119000","asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"BFK9TLC3edb13K6v4YyH3DwPb5DSUpkWvb7XnqCL9b4F"},"maxTimeoutSeconds":300,"network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","payTo":"J7aN3PLJnTCF5qpEnvJHJsnCjcGuqC2rYtEM8Gv3xwg","scheme":"exact"},{"amount":"1190000","asset":"CCW67TSZV3SSS2HXMBQ5JFGCKJNXKZM7UQUWUZPUTHXSTZLEO7SJMI75","extra":{"areFeesSponsored":true},"maxTimeoutSeconds":300,"network":"stellar:pubnet","payTo":"GDNJXCKW7ZM7GEEVP674TWPU26YJNBQ2FI4ZIPRKTPTNUEJMDHFJWWRL","scheme":"exact"},{"amount":"119000","asset":"31566704","extra":{"feePayer":"ZMFK2OI7ZBD2U27ISERZC4S6LKM6WMFJPZQ4MYNJDZ2VNBNMBA67RA22AA","tag":"x402-global-challenge"},"maxTimeoutSeconds":300,"network":"algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73ktiC1qzkkit8=","payTo":"C7IIHG7SPLPZ5H7ZT6HW3UV2OQMQQE6Y2HBNGZXSLRJULE42BEE2OY2XIE","scheme":"exact"}],"description":"Bundled execution of the Answer-a-question with sources workflow - The 'research a question, return an answer with citations' workflow. Brave answer for the AI-synthesized take with citations, Brave web for the canonical SERP, Brave news for time-sensitive context, then a deterministic web-fetch + extract pass on the top citations to verify the answer hasn't hallucinated. Five tools, one cited paragraph, every claim traced back to a fetched URL.","extensions":{"bazaar":{"info":{"input":{"body":{"question":"What is the Sahm Rule and has it triggered recently?"},"bodyType":"json","method":"POST","type":"http"},"output":{"example":{"args":{"question":"What is the Sahm Rule and has it triggered recently?"},"pack":"search-and-cite","steps":[{"ok":true,"result":{},"slug":"answer"},{"ok":true,"result":{},"slug":"search"},{"ok":true,"result":{},"slug":"search-news"},{"ok":true,"result":{},"slug":"extract"},{"ok":true,"result":{},"slug":"extract-entities"}],"summary":"5/5 steps succeeded"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"properties":{"question":{"description":"the research question to answer with citations","type":"string"}},"required":["question"]},"bodyType":{"enum":["json","form-data","text"],"type":"string"},"method":{"enum":["POST"],"type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method","bodyType","body"],"type":"object"},"output":{"properties":{"example":{"properties":{"args":{"properties":{"question":{"type":"string"}},"type":"object"},"pack":{"type":"string"},"steps":{"items":{"properties":{"ok":{"type":"boolean"},"result":{"type":"object"},"slug":{"type":"string"}},"type":"object"},"type":"array"},"summary":{"type":"string"}},"required":["pack","args","steps","summary"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}},"builder-code":{"info":{"a":"bc_b4aw4uzd"},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false,"properties":{"a":{"description":"App builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"},"s":{"description":"Service builder codes","items":{"pattern":"^[a-z0-9_]{1,32}$","type":"string"},"maxItems":11,"type":"array"},"w":{"description":"Wallet builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"}},"type":"object"}},"payment-identifier":{"info":{"required":false},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"id":{"maxLength":128,"minLength":16,"pattern":"^[a-zA-Z0-9_-]+$","type":"string"},"required":{"type":"boolean"}},"required":["required"],"type":"object"}}},"iconUrl":"https://res.cloudinary.com/bdb-prod/image/upload/c_fill,ar_1:1,w_256,h_256,f_auto,q_auto/v1784423094/bazaar-icons/478aced8e219894c.png","lastUpdated":"2026-09-22T16:38:01.364Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-22T16:38:01.162Z"},"resource":"https://agent402.tools/api/skill/search-and-cite","serviceName":"Skill: Answer-a-question with","tags":["skill-pack","workflow","search-and-cite","agents","x402"],"type":"http","x402Version":2},{"accepts":[{"amount":"71000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","outputSchema":{"properties":{"args":{"type":"object"},"pack":{"type":"string"},"steps":{"items":{"properties":{"ok":{"type":"boolean"},"result":{"type":"object"},"slug":{"type":"string"}},"type":"object"},"type":"array"},"summary":{"type":"string"}},"required":["pack","args","steps","summary"],"type":"object"},"payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"71000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"71000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"71000","asset":"0x754704Bc059F8C67012fEd69BC8A327a5aafb603","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:143","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"71000","asset":"0xB97EF9Ef8734C71904D8002F8b6Bc66Dd9c48a6E","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:43114","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"71000","asset":"0xe15fC38F6D8c56aF07bbCBe3BAf5708A2Bf42392","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:1329","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"72000","asset":"0x0b2C639c533813f4Aa9D7837CAf62653d097Ff85","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:10","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"71000","asset":"0x5fc5360D0400a0Fd4f2af552ADD042D716F1d168","extra":{"name":"Global Dollar","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:4663","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"71000","asset":"0xcebA9300f2b948710d2653dD7B07f33A8B32118C","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42220","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"71000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"permit2","facilitatorAddress":"0x772003A2E9c2cCC8af956870a37A66F64F8CEC38","name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"upto"},{"amount":"71000","asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"BFK9TLC3edb13K6v4YyH3DwPb5DSUpkWvb7XnqCL9b4F"},"maxTimeoutSeconds":300,"network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","payTo":"J7aN3PLJnTCF5qpEnvJHJsnCjcGuqC2rYtEM8Gv3xwg","scheme":"exact"},{"amount":"710000","asset":"CCW67TSZV3SSS2HXMBQ5JFGCKJNXKZM7UQUWUZPUTHXSTZLEO7SJMI75","extra":{"areFeesSponsored":true},"maxTimeoutSeconds":300,"network":"stellar:pubnet","payTo":"GDNJXCKW7ZM7GEEVP674TWPU26YJNBQ2FI4ZIPRKTPTNUEJMDHFJWWRL","scheme":"exact"},{"amount":"71000","asset":"31566704","extra":{"feePayer":"ZMFK2OI7ZBD2U27ISERZC4S6LKM6WMFJPZQ4MYNJDZ2VNBNMBA67RA22AA","tag":"x402-global-challenge"},"maxTimeoutSeconds":300,"network":"algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73ktiC1qzkkit8=","payTo":"C7IIHG7SPLPZ5H7ZT6HW3UV2OQMQQE6Y2HBNGZXSLRJULE42BEE2OY2XIE","scheme":"exact"}],"description":"Bundled execution of the Macro dashboard refresh workflow - The full macro + crypto dashboard in one call: 5 FRED series, 5 Treasury reads, yield-curve spread, crypto market/trending/global, and live gas - the 14-tool basket recurring buyers refresh every cycle, bundled below its a la carte price.","extensions":{"bazaar":{"info":{"input":{"body":{},"bodyType":"json","method":"POST","type":"http"},"output":{"example":{"args":{},"pack":"macro-dashboard","steps":[{"ok":true,"result":{},"slug":"fred-release-calendar"},{"ok":true,"result":{},"slug":"fed-funds"},{"ok":true,"result":{},"slug":"cpi-yoy"},{"ok":true,"result":{},"slug":"unemployment-rate"},{"ok":true,"result":{},"slug":"sahm-rule"},{"ok":true,"result":{},"slug":"yield-curve-spread"},{"ok":true,"result":{},"slug":"treasury-yield-curve"},{"ok":true,"result":{},"slug":"treasury-yield-history"},{"ok":true,"result":{},"slug":"treasury-debt"},{"ok":true,"result":{},"slug":"treasury-avg-rates"},{"ok":true,"result":{},"slug":"crypto-market"},{"ok":true,"result":{},"slug":"crypto-trending"},{"ok":true,"result":{},"slug":"crypto-global"},{"ok":true,"result":{},"slug":"gas-estimate"}],"summary":"14/14 steps succeeded"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"properties":{},"required":[]},"bodyType":{"enum":["json","form-data","text"],"type":"string"},"method":{"enum":["POST"],"type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method","bodyType","body"],"type":"object"},"output":{"properties":{"example":{"properties":{"args":{"type":"object"},"pack":{"type":"string"},"steps":{"items":{"properties":{"ok":{"type":"boolean"},"result":{"type":"object"},"slug":{"type":"string"}},"type":"object"},"type":"array"},"summary":{"type":"string"}},"required":["pack","args","steps","summary"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}},"builder-code":{"info":{"a":"bc_b4aw4uzd"},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false,"properties":{"a":{"description":"App builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"},"s":{"description":"Service builder codes","items":{"pattern":"^[a-z0-9_]{1,32}$","type":"string"},"maxItems":11,"type":"array"},"w":{"description":"Wallet builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"}},"type":"object"}},"payment-identifier":{"info":{"required":false},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"id":{"maxLength":128,"minLength":16,"pattern":"^[a-zA-Z0-9_-]+$","type":"string"},"required":{"type":"boolean"}},"required":["required"],"type":"object"}}},"iconUrl":"https://res.cloudinary.com/bdb-prod/image/upload/c_fill,ar_1:1,w_256,h_256,f_auto,q_auto/v1784423094/bazaar-icons/478aced8e219894c.png","lastUpdated":"2026-09-22T16:37:56.228Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-22T16:37:53.19Z"},"resource":"https://agent402.tools/api/skill/macro-dashboard","serviceName":"Skill: Macro dashboard refresh","tags":["skill-pack","workflow","macro-dashboard","agents","x402"],"type":"http","x402Version":2},{"accepts":[{"amount":"108000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","outputSchema":{"properties":{"args":{"properties":{"topic":{"type":"string"}},"type":"object"},"pack":{"type":"string"},"steps":{"items":{"properties":{"ok":{"type":"boolean"},"result":{"type":"object"},"slug":{"type":"string"}},"type":"object"},"type":"array"},"summary":{"type":"string"}},"required":["pack","args","steps","summary"],"type":"object"},"payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"108000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"108000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"108000","asset":"0x754704Bc059F8C67012fEd69BC8A327a5aafb603","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:143","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"108000","asset":"0xB97EF9Ef8734C71904D8002F8b6Bc66Dd9c48a6E","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:43114","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"108000","asset":"0xe15fC38F6D8c56aF07bbCBe3BAf5708A2Bf42392","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:1329","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"109000","asset":"0x0b2C639c533813f4Aa9D7837CAf62653d097Ff85","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:10","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"108000","asset":"0x5fc5360D0400a0Fd4f2af552ADD042D716F1d168","extra":{"name":"Global Dollar","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:4663","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"108000","asset":"0xcebA9300f2b948710d2653dD7B07f33A8B32118C","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42220","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"108000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"permit2","facilitatorAddress":"0x772003A2E9c2cCC8af956870a37A66F64F8CEC38","name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"upto"},{"amount":"108000","asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"BFK9TLC3edb13K6v4YyH3DwPb5DSUpkWvb7XnqCL9b4F"},"maxTimeoutSeconds":300,"network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","payTo":"J7aN3PLJnTCF5qpEnvJHJsnCjcGuqC2rYtEM8Gv3xwg","scheme":"exact"},{"amount":"1080000","asset":"CCW67TSZV3SSS2HXMBQ5JFGCKJNXKZM7UQUWUZPUTHXSTZLEO7SJMI75","extra":{"areFeesSponsored":true},"maxTimeoutSeconds":300,"network":"stellar:pubnet","payTo":"GDNJXCKW7ZM7GEEVP674TWPU26YJNBQ2FI4ZIPRKTPTNUEJMDHFJWWRL","scheme":"exact"},{"amount":"108000","asset":"31566704","extra":{"feePayer":"ZMFK2OI7ZBD2U27ISERZC4S6LKM6WMFJPZQ4MYNJDZ2VNBNMBA67RA22AA","tag":"x402-global-challenge"},"maxTimeoutSeconds":300,"network":"algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73ktiC1qzkkit8=","payTo":"C7IIHG7SPLPZ5H7ZT6HW3UV2OQMQQE6Y2HBNGZXSLRJULE42BEE2OY2XIE","scheme":"exact"}],"description":"Bundled execution of the Article digest workflow - Quick research brief on any topic - web search results plus an AI-generated answer in one pass. One x402 payment runs 3 underlying tools (search, answer, search-news); partial-success per step.","extensions":{"bazaar":{"info":{"input":{"body":{"topic":"x402 payment protocol"},"bodyType":"json","method":"POST","type":"http"},"output":{"example":{"args":{"topic":"x402 payment protocol"},"pack":"article-digest","steps":[{"ok":true,"result":{},"slug":"search"},{"ok":true,"result":{},"slug":"answer"},{"ok":true,"result":{},"slug":"search-news"}],"summary":"3/3 steps succeeded"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"properties":{"topic":{"description":"Topic to research (e.g. x402 payment protocol)","type":"string"}},"required":["topic"]},"bodyType":{"enum":["json","form-data","text"],"type":"string"},"method":{"enum":["POST"],"type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method","bodyType","body"],"type":"object"},"output":{"properties":{"example":{"properties":{"args":{"properties":{"topic":{"type":"string"}},"type":"object"},"pack":{"type":"string"},"steps":{"items":{"properties":{"ok":{"type":"boolean"},"result":{"type":"object"},"slug":{"type":"string"}},"type":"object"},"type":"array"},"summary":{"type":"string"}},"required":["pack","args","steps","summary"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}},"builder-code":{"info":{"a":"bc_b4aw4uzd"},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false,"properties":{"a":{"description":"App builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"},"s":{"description":"Service builder codes","items":{"pattern":"^[a-z0-9_]{1,32}$","type":"string"},"maxItems":11,"type":"array"},"w":{"description":"Wallet builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"}},"type":"object"}},"payment-identifier":{"info":{"required":false},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"id":{"maxLength":128,"minLength":16,"pattern":"^[a-zA-Z0-9_-]+$","type":"string"},"required":{"type":"boolean"}},"required":["required"],"type":"object"}}},"iconUrl":"https://res.cloudinary.com/bdb-prod/image/upload/c_fill,ar_1:1,w_256,h_256,f_auto,q_auto/v1788138502/bazaar-icons/478aced8e219894c.png","lastUpdated":"2026-09-22T16:36:02.224Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-22T16:36:02.035Z"},"resource":"https://agent402.tools/api/skill/article-digest","serviceName":"Skill: Article digest","tags":["skill-pack","workflow","article-digest","agents","x402"],"type":"http","x402Version":2},{"accepts":[{"amount":"63000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","outputSchema":{"properties":{"args":{"properties":{"coin":{"type":"string"}},"type":"object"},"pack":{"type":"string"},"steps":{"items":{"properties":{"ok":{"type":"boolean"},"result":{"type":"object"},"slug":{"type":"string"}},"type":"object"},"type":"array"},"summary":{"type":"string"}},"required":["pack","args","steps","summary"],"type":"object"},"payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"63000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"63000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"63000","asset":"0x754704Bc059F8C67012fEd69BC8A327a5aafb603","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:143","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"63000","asset":"0xB97EF9Ef8734C71904D8002F8b6Bc66Dd9c48a6E","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:43114","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"63000","asset":"0xe15fC38F6D8c56aF07bbCBe3BAf5708A2Bf42392","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:1329","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"64000","asset":"0x0b2C639c533813f4Aa9D7837CAf62653d097Ff85","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:10","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"63000","asset":"0x5fc5360D0400a0Fd4f2af552ADD042D716F1d168","extra":{"name":"Global Dollar","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:4663","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"63000","asset":"0xcebA9300f2b948710d2653dD7B07f33A8B32118C","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42220","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"63000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"permit2","facilitatorAddress":"0x772003A2E9c2cCC8af956870a37A66F64F8CEC38","name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"upto"},{"amount":"63000","asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"BFK9TLC3edb13K6v4YyH3DwPb5DSUpkWvb7XnqCL9b4F"},"maxTimeoutSeconds":300,"network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","payTo":"J7aN3PLJnTCF5qpEnvJHJsnCjcGuqC2rYtEM8Gv3xwg","scheme":"exact"},{"amount":"630000","asset":"CCW67TSZV3SSS2HXMBQ5JFGCKJNXKZM7UQUWUZPUTHXSTZLEO7SJMI75","extra":{"areFeesSponsored":true},"maxTimeoutSeconds":300,"network":"stellar:pubnet","payTo":"GDNJXCKW7ZM7GEEVP674TWPU26YJNBQ2FI4ZIPRKTPTNUEJMDHFJWWRL","scheme":"exact"},{"amount":"63000","asset":"31566704","extra":{"feePayer":"ZMFK2OI7ZBD2U27ISERZC4S6LKM6WMFJPZQ4MYNJDZ2VNBNMBA67RA22AA","tag":"x402-global-challenge"},"maxTimeoutSeconds":300,"network":"algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73ktiC1qzkkit8=","payTo":"C7IIHG7SPLPZ5H7ZT6HW3UV2OQMQQE6Y2HBNGZXSLRJULE42BEE2OY2XIE","scheme":"exact"}],"description":"Bundled execution of the Crypto research workflow - Pull live price, market structure, OHLC history, trending status, global market context, and recent news for a single coin in one pass. One x402 payment runs 7 underlying tools (crypto-price, crypto-market, crypto-history, crypto-trending, crypto-global, search-news, extract); partial-success per step.","extensions":{"bazaar":{"info":{"input":{"body":{"coin":"BTC"},"bodyType":"json","method":"POST","type":"http"},"output":{"example":{"args":{"coin":"BTC"},"pack":"crypto-research","steps":[{"ok":true,"result":{},"slug":"crypto-price"},{"ok":true,"result":{},"slug":"crypto-market"},{"ok":true,"result":{},"slug":"crypto-history"},{"ok":true,"result":{},"slug":"crypto-trending"},{"ok":true,"result":{},"slug":"crypto-global"},{"ok":true,"result":{},"slug":"search-news"},{"ok":true,"result":{},"slug":"extract"}],"summary":"7/7 steps succeeded"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"properties":{"coin":{"description":"Coin ticker or CoinGecko id (e.g. BTC, ETH, bitcoin)","type":"string"}},"required":["coin"]},"bodyType":{"enum":["json","form-data","text"],"type":"string"},"method":{"enum":["POST"],"type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method","bodyType","body"],"type":"object"},"output":{"properties":{"example":{"properties":{"args":{"properties":{"coin":{"type":"string"}},"type":"object"},"pack":{"type":"string"},"steps":{"items":{"properties":{"ok":{"type":"boolean"},"result":{"type":"object"},"slug":{"type":"string"}},"type":"object"},"type":"array"},"summary":{"type":"string"}},"required":["pack","args","steps","summary"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}},"builder-code":{"info":{"a":"bc_b4aw4uzd"},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false,"properties":{"a":{"description":"App builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"},"s":{"description":"Service builder codes","items":{"pattern":"^[a-z0-9_]{1,32}$","type":"string"},"maxItems":11,"type":"array"},"w":{"description":"Wallet builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"}},"type":"object"}},"payment-identifier":{"info":{"required":false},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"id":{"maxLength":128,"minLength":16,"pattern":"^[a-zA-Z0-9_-]+$","type":"string"},"required":{"type":"boolean"}},"required":["required"],"type":"object"}}},"iconUrl":"https://res.cloudinary.com/bdb-prod/image/upload/c_fill,ar_1:1,w_256,h_256,f_auto,q_auto/v1784423094/bazaar-icons/478aced8e219894c.png","lastUpdated":"2026-09-22T16:35:57.527Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-22T16:35:57.308Z"},"resource":"https://agent402.tools/api/skill/crypto-research","serviceName":"Skill: Crypto research","tags":["skill-pack","workflow","crypto-research","agents","x402"],"type":"http","x402Version":2},{"accepts":[{"amount":"50000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","outputSchema":{"properties":{"receipt":{"properties":{"callRef":{"type":"string"},"paidUsd":{"type":"number"},"resolvedBy":{"type":"string"},"route":{"type":"string"},"routingFeeUsd":{"type":"number"},"seller":{"type":"string"},"slug":{"type":"string"},"ts":{"type":"string"},"underlyingPriceUsd":{"type":"number"}},"type":"object"},"result":{"properties":{"algo":{"type":"string"},"base64":{"type":"string"},"hex":{"type":"string"}},"type":"object"}},"required":["receipt","result"],"type":"object"},"payTo":"0x77065d81e18ad403BCD6e9A0616b288e16744121","scheme":"exact"},{"amount":"50000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"50000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"50000","asset":"0x754704Bc059F8C67012fEd69BC8A327a5aafb603","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:143","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"50000","asset":"0xB97EF9Ef8734C71904D8002F8b6Bc66Dd9c48a6E","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:43114","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"50000","asset":"0xe15fC38F6D8c56aF07bbCBe3BAf5708A2Bf42392","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:1329","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"51000","asset":"0x0b2C639c533813f4Aa9D7837CAf62653d097Ff85","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:10","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"50000","asset":"0x5fc5360D0400a0Fd4f2af552ADD042D716F1d168","extra":{"name":"Global Dollar","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:4663","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"50000","asset":"0xcebA9300f2b948710d2653dD7B07f33A8B32118C","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42220","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"50000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"permit2","facilitatorAddress":"0x772003A2E9c2cCC8af956870a37A66F64F8CEC38","name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0x77065d81e18ad403BCD6e9A0616b288e16744121","scheme":"upto"},{"amount":"50000","asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"BFK9TLC3edb13K6v4YyH3DwPb5DSUpkWvb7XnqCL9b4F"},"maxTimeoutSeconds":300,"network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","payTo":"J7aN3PLJnTCF5qpEnvJHJsnCjcGuqC2rYtEM8Gv3xwg","scheme":"exact"},{"amount":"500000","asset":"CCW67TSZV3SSS2HXMBQ5JFGCKJNXKZM7UQUWUZPUTHXSTZLEO7SJMI75","extra":{"areFeesSponsored":true},"maxTimeoutSeconds":300,"network":"stellar:pubnet","payTo":"GDNJXCKW7ZM7GEEVP674TWPU26YJNBQ2FI4ZIPRKTPTNUEJMDHFJWWRL","scheme":"exact"},{"amount":"50000","asset":"31566704","extra":{"feePayer":"ZMFK2OI7ZBD2U27ISERZC4S6LKM6WMFJPZQ4MYNJDZ2VNBNMBA67RA22AA","tag":"x402-global-challenge"},"maxTimeoutSeconds":300,"network":"algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73ktiC1qzkkit8=","payTo":"W4GZHN36X35LGSJTTLNZNFPGSSBLMJKFLCMZK4NBLQGUS6PYPPCDB67UOE","scheme":"exact"}],"description":"Describe a task (or name a slug) and the Smart Order Router resolves the best-matching tool and RUNS it in the same call - flat $0.05 covering any tool listed at $0.04 or less, from THIS host's catalog or any external seller in the open index - x402 sellers, or MPP sellers on Tempo (paid on your behalf over x402 or MPP, result relayed). One payment, one request, result + receipt. /api/route quotes which tier a task needs; pricier tools return a self-correcting 409 with their direct route.","extensions":{"bazaar":{"info":{"input":{"body":{"params":{"algo":"sha256","text":"agent402"},"slug":"hash"},"bodyType":"json","method":"POST","type":"http"},"output":{"example":{"receipt":{"callRef":"sha256:…  (recomputable: sha256 of {\"nonce\":\u003cpayment authorization nonce\u003e,\"slug\":…,\"ts\":…} - null on nonce-less calls)","paidUsd":0.05,"resolvedBy":"slug","route":"POST /api/hash","routingFeeUsd":0.009,"seller":"internal","slug":"hash","ts":"2026-07-10T00:00:00.000Z","underlyingPriceUsd":0.001},"result":{"algo":"sha256","base64":"…","hex":"…"}},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"properties":{"include":{"description":"Where to route: default runs a tool from THIS host's catalog; \"external\" routes to the best-matching x402 seller in the OPEN index and pays it on your behalf (result relayed, marked untrustedContent). Requires task (not slug).","type":"string"},"maxUsd":{"description":"Refuse tools listed above this underlying price (default and ceiling: $0.04)","type":"number"},"params":{"description":"Input for the resolved tool, matching its inputSchema (default {})","type":"object"},"slug":{"description":"Exact tool slug to execute (skips ranking). Provide task OR slug.","type":"string"},"task":{"description":"Plain-language task, e.g. \"sha256 hash of a string\" - resolved via the same ranker as /api/find. Provide task OR slug.","type":"string"}}},"bodyType":{"enum":["json","form-data","text"],"type":"string"},"method":{"enum":["POST"],"type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method","bodyType","body"],"type":"object"},"output":{"properties":{"example":{"properties":{"receipt":{"properties":{"callRef":{"type":"string"},"paidUsd":{"type":"number"},"resolvedBy":{"type":"string"},"route":{"type":"string"},"routingFeeUsd":{"type":"number"},"seller":{"type":"string"},"slug":{"type":"string"},"ts":{"type":"string"},"underlyingPriceUsd":{"type":"number"}},"type":"object"},"result":{"properties":{"algo":{"type":"string"},"base64":{"type":"string"},"hex":{"type":"string"}},"type":"object"}},"required":["receipt","result"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}},"builder-code":{"info":{"a":"bc_b4aw4uzd"},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false,"properties":{"a":{"description":"App builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"},"s":{"description":"Service builder codes","items":{"pattern":"^[a-z0-9_]{1,32}$","type":"string"},"maxItems":11,"type":"array"},"w":{"description":"Wallet builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"}},"type":"object"}},"payment-identifier":{"info":{"required":false},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"id":{"maxLength":128,"minLength":16,"pattern":"^[a-zA-Z0-9_-]+$","type":"string"},"required":{"type":"boolean"}},"required":["required"],"type":"object"}}},"iconUrl":"https://res.cloudinary.com/bdb-prod/image/upload/c_fill,ar_1:1,w_256,h_256,f_auto,q_auto/v1784423094/bazaar-icons/478aced8e219894c.png","lastUpdated":"2026-09-22T16:33:47.468Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-22T16:33:47.277Z"},"resource":"https://agent402.tools/api/route/execute-plus","serviceName":"Route and execute (plus tier)","tags":["agent","router","sor","execute","dispatch"],"type":"http","x402Version":2},{"accepts":[{"amount":"150000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","outputSchema":{"properties":{"count":{"type":"integer"},"fetchedAt":{"type":"string"},"notFound":{"items":{"type":"string"},"type":"array"},"source":{"type":"string"},"users":{"items":{"type":"object"},"type":"array"}},"required":["source","fetchedAt","count","users","notFound"],"type":"object"},"payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"150000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"150000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"150000","asset":"0x754704Bc059F8C67012fEd69BC8A327a5aafb603","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:143","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"150000","asset":"0xB97EF9Ef8734C71904D8002F8b6Bc66Dd9c48a6E","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:43114","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"150000","asset":"0xe15fC38F6D8c56aF07bbCBe3BAf5708A2Bf42392","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:1329","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"151000","asset":"0x0b2C639c533813f4Aa9D7837CAf62653d097Ff85","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:10","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"150000","asset":"0x5fc5360D0400a0Fd4f2af552ADD042D716F1d168","extra":{"name":"Global Dollar","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:4663","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"150000","asset":"0xcebA9300f2b948710d2653dD7B07f33A8B32118C","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42220","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"150000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"permit2","facilitatorAddress":"0x67B9CE703d9ce658d7C4ac3c289cEa112fE662Af","name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"upto"},{"amount":"150000","asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"D6ZhtNQ5nT9ZnTHUbqXZsTx5MH2rPFiBBggX4hY1WePM"},"maxTimeoutSeconds":300,"network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","payTo":"J7aN3PLJnTCF5qpEnvJHJsnCjcGuqC2rYtEM8Gv3xwg","scheme":"exact"},{"amount":"1500000","asset":"CCW67TSZV3SSS2HXMBQ5JFGCKJNXKZM7UQUWUZPUTHXSTZLEO7SJMI75","extra":{"areFeesSponsored":true},"maxTimeoutSeconds":300,"network":"stellar:pubnet","payTo":"GDNJXCKW7ZM7GEEVP674TWPU26YJNBQ2FI4ZIPRKTPTNUEJMDHFJWWRL","scheme":"exact"},{"amount":"150000","asset":"31566704","extra":{"feePayer":"ZMFK2OI7ZBD2U27ISERZC4S6LKM6WMFJPZQ4MYNJDZ2VNBNMBA67RA22AA","tag":"x402-global-challenge"},"maxTimeoutSeconds":300,"network":"algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73ktiC1qzkkit8=","payTo":"C7IIHG7SPLPZ5H7ZT6HW3UV2OQMQQE6Y2HBNGZXSLRJULE42BEE2OY2XIE","scheme":"exact"}],"description":"Look up up to 10 X (Twitter) accounts by username in one call. Returns each found profile with public metrics (followers, following, tweets, listed), verification status and bio, plus the list of usernames X did not resolve.","extensions":{"bazaar":{"info":{"input":{"body":{"usernames":["coinbase","base"]},"bodyType":"json","method":"POST","type":"http"},"output":{"example":{"count":1,"fetchedAt":"2026-08-20T14:10:00.000Z","notFound":["nosuchuser_xyz"],"source":"x-api-v2","users":[{"createdAt":"2012-05-07T23:46:41.000Z","description":"The future of money is here.","id":"574032254","location":"Global","metrics":{"followers":6400000,"following":250,"listed":9000,"tweets":19000},"name":"Coinbase","profileImageUrl":"https://pbs.twimg.com/profile_images/.../normal.jpg","profileUrl":"https://x.com/coinbase","protected":false,"url":"https://coinbase.com","username":"coinbase","verified":true,"verifiedType":"business"}]},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"properties":{"usernames":{"description":"1-10 usernames (array, or a comma-separated string).","items":{"type":"string"},"type":"array"}},"required":["usernames"]},"bodyType":{"enum":["json","form-data","text"],"type":"string"},"method":{"enum":["POST"],"type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method","bodyType","body"],"type":"object"},"output":{"properties":{"example":{"properties":{"count":{"type":"integer"},"fetchedAt":{"type":"string"},"notFound":{"items":{"type":"string"},"type":"array"},"source":{"type":"string"},"users":{"items":{"type":"object"},"type":"array"}},"required":["source","fetchedAt","count","users","notFound"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}},"builder-code":{"info":{"a":"bc_b4aw4uzd"},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false,"properties":{"a":{"description":"App builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"},"s":{"description":"Service builder codes","items":{"pattern":"^[a-z0-9_]{1,32}$","type":"string"},"maxItems":11,"type":"array"},"w":{"description":"Wallet builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"}},"type":"object"}},"payment-identifier":{"info":{"required":false},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"id":{"maxLength":128,"minLength":16,"pattern":"^[a-zA-Z0-9_-]+$","type":"string"},"required":{"type":"boolean"}},"required":["required"],"type":"object"}}},"iconUrl":"https://res.cloudinary.com/bdb-prod/image/upload/c_fill,ar_1:1,w_256,h_256,f_auto,q_auto/v1788138502/bazaar-icons/478aced8e219894c.png","lastUpdated":"2026-09-11T12:42:03.523Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-11T12:42:03.286Z"},"resource":"https://agent402.tools/api/x-users-lookup","serviceName":"X bulk user lookup","tags":["web","x","twitter","social","x-api"],"type":"http","x402Version":2},{"accepts":[{"amount":"80000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","outputSchema":{"properties":{"count":{"type":"integer"},"fetchedAt":{"type":"string"},"nextToken":{"type":"string"},"source":{"type":"string"},"tweets":{"items":{"type":"object"},"type":"array"},"user":{"properties":{"id":{"type":"string"},"name":{"type":"string"},"username":{"type":"string"},"verified":{"type":"boolean"}},"type":"object"}},"required":["source","fetchedAt","user","count","tweets","nextToken"],"type":"object"},"payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"80000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"80000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"80000","asset":"0x754704Bc059F8C67012fEd69BC8A327a5aafb603","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:143","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"80000","asset":"0xB97EF9Ef8734C71904D8002F8b6Bc66Dd9c48a6E","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:43114","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"80000","asset":"0xe15fC38F6D8c56aF07bbCBe3BAf5708A2Bf42392","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:1329","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"81000","asset":"0x0b2C639c533813f4Aa9D7837CAf62653d097Ff85","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:10","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"80000","asset":"0x5fc5360D0400a0Fd4f2af552ADD042D716F1d168","extra":{"name":"Global Dollar","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:4663","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"80000","asset":"0xcebA9300f2b948710d2653dD7B07f33A8B32118C","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42220","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"80000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"permit2","facilitatorAddress":"0x67B9CE703d9ce658d7C4ac3c289cEa112fE662Af","name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"upto"},{"amount":"80000","asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"D6ZhtNQ5nT9ZnTHUbqXZsTx5MH2rPFiBBggX4hY1WePM"},"maxTimeoutSeconds":300,"network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","payTo":"J7aN3PLJnTCF5qpEnvJHJsnCjcGuqC2rYtEM8Gv3xwg","scheme":"exact"},{"amount":"800000","asset":"CCW67TSZV3SSS2HXMBQ5JFGCKJNXKZM7UQUWUZPUTHXSTZLEO7SJMI75","extra":{"areFeesSponsored":true},"maxTimeoutSeconds":300,"network":"stellar:pubnet","payTo":"GDNJXCKW7ZM7GEEVP674TWPU26YJNBQ2FI4ZIPRKTPTNUEJMDHFJWWRL","scheme":"exact"},{"amount":"80000","asset":"31566704","extra":{"feePayer":"ZMFK2OI7ZBD2U27ISERZC4S6LKM6WMFJPZQ4MYNJDZ2VNBNMBA67RA22AA","tag":"x402-global-challenge"},"maxTimeoutSeconds":300,"network":"algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73ktiC1qzkkit8=","payTo":"C7IIHG7SPLPZ5H7ZT6HW3UV2OQMQQE6Y2HBNGZXSLRJULE42BEE2OY2XIE","scheme":"exact"}],"description":"Fetch an X (Twitter) account's most recent tweets by user id or username (username is resolved first). Options to exclude retweets and replies, page with pagination_token, or fetch only tweets newer than since_id. Each tweet carries text, created time, language and engagement metrics.","extensions":{"bazaar":{"info":{"input":{"body":{"exclude_replies":true,"exclude_retweets":true,"max_results":10,"username":"coinbase"},"bodyType":"json","method":"POST","type":"http"},"output":{"example":{"count":1,"fetchedAt":"2026-08-20T14:10:00.000Z","nextToken":"7140dibdnow9c7btw4xxxxx","source":"x-api-v2","tweets":[{"author":{"name":"Coinbase","username":"coinbase","verified":true},"authorId":"574032254","conversationId":"20","createdAt":"2006-03-21T20:50:14.000Z","id":"20","lang":"en","metrics":{"bookmarks":5000,"impressions":0,"likes":180000,"quotes":30000,"replies":10000,"retweets":120000},"possiblySensitive":false,"text":"just setting up my twttr","url":"https://x.com/coinbase/status/1800000000000000000"}],"user":{"id":"574032254","name":"Coinbase","username":"coinbase","verified":true}},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"properties":{"exclude_replies":{"description":"Drop replies (default false).","type":"boolean"},"exclude_retweets":{"description":"Drop retweets (default false).","type":"boolean"},"id":{"description":"Numeric X user id. Provide id OR username.","type":"string"},"max_results":{"description":"Tweets per page, 5-10 (default 10). The upstream bills per post returned, so the page size is capped.","type":"number"},"pagination_token":{"description":"Pagination token from a previous response.","type":"string"},"since_id":{"description":"Only tweets with an id greater than this.","type":"string"},"username":{"description":"X username (resolved to an id first). Provide id OR username.","type":"string"}}},"bodyType":{"enum":["json","form-data","text"],"type":"string"},"method":{"enum":["POST"],"type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method","bodyType","body"],"type":"object"},"output":{"properties":{"example":{"properties":{"count":{"type":"integer"},"fetchedAt":{"type":"string"},"nextToken":{"type":"string"},"source":{"type":"string"},"tweets":{"items":{"type":"object"},"type":"array"},"user":{"properties":{"id":{"type":"string"},"name":{"type":"string"},"username":{"type":"string"},"verified":{"type":"boolean"}},"type":"object"}},"required":["source","fetchedAt","user","count","tweets","nextToken"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}},"builder-code":{"info":{"a":"bc_b4aw4uzd"},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false,"properties":{"a":{"description":"App builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"},"s":{"description":"Service builder codes","items":{"pattern":"^[a-z0-9_]{1,32}$","type":"string"},"maxItems":11,"type":"array"},"w":{"description":"Wallet builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"}},"type":"object"}},"payment-identifier":{"info":{"required":false},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"id":{"maxLength":128,"minLength":16,"pattern":"^[a-zA-Z0-9_-]+$","type":"string"},"required":{"type":"boolean"}},"required":["required"],"type":"object"}}},"iconUrl":"https://res.cloudinary.com/bdb-prod/image/upload/c_fill,ar_1:1,w_256,h_256,f_auto,q_auto/v1788138502/bazaar-icons/478aced8e219894c.png","lastUpdated":"2026-09-11T12:41:59.573Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-11T12:41:59.323Z"},"resource":"https://agent402.tools/api/x-user-tweets","serviceName":"X user timeline","tags":["web","x","twitter","social","x-api"],"type":"http","x402Version":2},{"accepts":[{"amount":"600000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","outputSchema":{"properties":{"meta":{"properties":{"ongoing":{"type":"integer"},"query":{"type":"string"},"records":{"type":"integer"},"scope":{"type":"string"},"sources_cited":{"type":"integer"},"synthesis_model":{"type":"string"},"tier":{"type":"string"}},"type":"object"},"query":{"type":"string"},"report":{"type":"string"},"sources":{"items":{"type":"object"},"type":"array"},"tables":{"items":{"type":"object"},"type":"array"}},"required":["report","query","sources","tables","meta"],"type":"object"},"payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0x754704Bc059F8C67012fEd69BC8A327a5aafb603","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:143","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0xB97EF9Ef8734C71904D8002F8b6Bc66Dd9c48a6E","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:43114","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0xe15fC38F6D8c56aF07bbCBe3BAf5708A2Bf42392","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:1329","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"601000","asset":"0x0b2C639c533813f4Aa9D7837CAf62653d097Ff85","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:10","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0x5fc5360D0400a0Fd4f2af552ADD042D716F1d168","extra":{"name":"Global Dollar","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:4663","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0xcebA9300f2b948710d2653dD7B07f33A8B32118C","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42220","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"}],"description":"Name a drug, food, ingredient, brand or medical device and get one cited FDA recall report: every matching enforcement record across the drug, food and device feeds (firm, class I/II/III, status, reason, distribution, date), organized and explained, with a downloadable records appendix. Live openFDA data, not medical advice. USDC (x402/MPP) or card (Stripe). Not cached.","extensions":{"bazaar":{"info":{"input":{"body":{"query":"losartan"},"bodyType":"json","method":"POST","type":"http"},"output":{"example":{"meta":{"ongoing":2,"query":"losartan","records":7,"scope":"all","sources_cited":3,"synthesis_model":"anthropic/claude-opus-5","tier":"recall-report"},"query":"losartan","report":"# FDA Recall Report: losartan\n\n**7 records** across 3 FDA enforcement feeds · 2 ongoing\n\n## Snapshot\n...\n\n## Sources\n[1] FDA drug recalls matching \"losartan\" - openFDA enforcement - https://api.fda.gov/drug/enforcement.json?...","sources":[{"n":1,"title":"FDA drug recalls matching \"losartan\" - openFDA enforcement","url":"https://api.fda.gov/drug/enforcement.json?search=product_description%3A%22losartan%22\u0026limit=20"}],"tables":[{"columns":["Feed","Initiated","Class","Status","Firm","Product","Reason","Distribution","Recall number"],"label":"FDA recall records","name":"recalls","rows":[["drug","2019-11-08","Class II","Terminated","Torrent Pharmaceuticals","Losartan Potassium Tablets","Presence of an impurity","Nationwide","D-123-2020"]]}]},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"properties":{"query":{"description":"A drug, food, ingredient, brand or medical device to search FDA recalls for, e.g. \"losartan\", \"peanut butter\", \"insulin pump\".","type":"string"},"scope":{"description":"Which FDA enforcement feeds to search (default all).","enum":["all","drug","food","device"],"type":"string"}},"required":["query"],"type":"object"},"bodyType":{"enum":["json","form-data","text"],"type":"string"},"method":{"enum":["POST"],"type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method","bodyType","body"],"type":"object"},"output":{"properties":{"example":{"properties":{"meta":{"properties":{"ongoing":{"type":"integer"},"query":{"type":"string"},"records":{"type":"integer"},"scope":{"type":"string"},"sources_cited":{"type":"integer"},"synthesis_model":{"type":"string"},"tier":{"type":"string"}},"type":"object"},"query":{"type":"string"},"report":{"type":"string"},"sources":{"items":{"type":"object"},"type":"array"},"tables":{"items":{"type":"object"},"type":"array"}},"required":["report","query","sources","tables","meta"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}},"builder-code":{"info":{"a":"bc_b4aw4uzd"},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false,"properties":{"a":{"description":"App builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"},"s":{"description":"Service builder codes","items":{"pattern":"^[a-z0-9_]{1,32}$","type":"string"},"maxItems":11,"type":"array"},"w":{"description":"Wallet builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"}},"type":"object"}},"payment-identifier":{"info":{"required":false},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"id":{"maxLength":128,"minLength":16,"pattern":"^[a-zA-Z0-9_-]+$","type":"string"},"required":{"type":"boolean"}},"required":["required"],"type":"object"}}},"iconUrl":"https://res.cloudinary.com/bdb-prod/image/upload/c_fill,ar_1:1,w_256,h_256,f_auto,q_auto/v1788138502/bazaar-icons/478aced8e219894c.png","lastUpdated":"2026-09-11T12:39:59.794Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-11T12:39:59.516Z"},"resource":"https://agent402.tools/v1/recall-report","serviceName":"FDA recall report (drug, food,","tags":["llm","fda","recall","drug","food"],"type":"http","x402Version":2},{"accepts":[{"amount":"500000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","outputSchema":{"properties":{"id":{"type":"string"},"model":{"type":"string"},"object":{"type":"string"},"output":{"items":{"type":"object"},"type":"array"},"status":{"type":"string"},"usage":{"properties":{"input_tokens":{"type":"integer"},"output_tokens":{"type":"integer"},"total_tokens":{"type":"integer"}},"type":"object"}},"required":["id","object","status","model","output","usage"],"type":"object"},"payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"500000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"500000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"500000","asset":"0x754704Bc059F8C67012fEd69BC8A327a5aafb603","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:143","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"500000","asset":"0xB97EF9Ef8734C71904D8002F8b6Bc66Dd9c48a6E","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:43114","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"500000","asset":"0xe15fC38F6D8c56aF07bbCBe3BAf5708A2Bf42392","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:1329","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"501000","asset":"0x0b2C639c533813f4Aa9D7837CAf62653d097Ff85","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:10","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"500000","asset":"0x5fc5360D0400a0Fd4f2af552ADD042D716F1d168","extra":{"name":"Global Dollar","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:4663","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"500000","asset":"0xcebA9300f2b948710d2653dD7B07f33A8B32118C","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42220","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"500000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"permit2","facilitatorAddress":"0x67B9CE703d9ce658d7C4ac3c289cEa112fE662Af","name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"upto"},{"amount":"500000","asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"D6ZhtNQ5nT9ZnTHUbqXZsTx5MH2rPFiBBggX4hY1WePM"},"maxTimeoutSeconds":300,"network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","payTo":"J7aN3PLJnTCF5qpEnvJHJsnCjcGuqC2rYtEM8Gv3xwg","scheme":"exact"},{"amount":"5000000","asset":"CCW67TSZV3SSS2HXMBQ5JFGCKJNXKZM7UQUWUZPUTHXSTZLEO7SJMI75","extra":{"areFeesSponsored":true},"maxTimeoutSeconds":300,"network":"stellar:pubnet","payTo":"GDNJXCKW7ZM7GEEVP674TWPU26YJNBQ2FI4ZIPRKTPTNUEJMDHFJWWRL","scheme":"exact"},{"amount":"500000","asset":"31566704","extra":{"feePayer":"ZMFK2OI7ZBD2U27ISERZC4S6LKM6WMFJPZQ4MYNJDZ2VNBNMBA67RA22AA","tag":"x402-global-challenge"},"maxTimeoutSeconds":300,"network":"algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73ktiC1qzkkit8=","payTo":"C7IIHG7SPLPZ5H7ZT6HW3UV2OQMQQE6Y2HBNGZXSLRJULE42BEE2OY2XIE","scheme":"exact"}],"description":"OpenAI Responses API over x402 - point the OpenAI SDK's responses.create() (or the OpenAI Agents SDK) at base_url https://agent402.tools/v1/premium and pay $0.50 per call in USDC, no API key, no signup. Same models, caps and price as this tier's /chat/completions route; any model here is served through the Responses wire.","extensions":{"bazaar":{"info":{"input":{"body":{"input":"Summarize x402 in one sentence.","model":"anthropic/claude-opus-5"},"bodyType":"json","method":"POST","type":"http"},"output":{"example":{"id":"resp_…","model":"openai/gpt-4o-mini","object":"response","output":[{"content":[{"annotations":[],"text":"x402 is an HTTP-native way for agents to pay per request with USDC.","type":"output_text"}],"id":"msg_…","role":"assistant","status":"completed","type":"message"}],"status":"completed","usage":{"input_tokens":14,"output_tokens":18,"total_tokens":32}},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"properties":{"input":{"description":"A string, or an array of input items ({role, content} messages with input_text / input_image parts, function_call, function_call_output)"},"instructions":{"description":"Optional system/developer instructions","type":"string"},"max_output_tokens":{"description":"Optional output cap (clamped to the tier cap)","type":"integer"},"model":{"description":"Model id (OpenRouter naming) - allowlisted per tier; omit (or \"auto\") on the auto tier","type":"string"},"reasoning":{"description":"Optional {effort: \"none\"|\"minimal\"|\"low\"|\"medium\"|\"high\"|\"xhigh\"|\"max\"} - reasoning tokens count against max_output_tokens","type":"object"},"stream":{"description":"Responses SSE events (response.created … response.completed)","type":"boolean"},"text":{"description":"Optional {format: {type: \"text\"|\"json_schema\"|\"json_object\", ...}}","type":"object"},"tools":{"description":"Optional function tools ({type:\"function\", name, parameters}); server-side tools are not served","type":"array"},"zdr":{"description":"Optional - zero-data-retention providers only","type":"boolean"}},"required":["input"]},"bodyType":{"enum":["json","form-data","text"],"type":"string"},"method":{"enum":["POST"],"type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method","bodyType","body"],"type":"object"},"output":{"properties":{"example":{"properties":{"id":{"type":"string"},"model":{"type":"string"},"object":{"type":"string"},"output":{"items":{"type":"object"},"type":"array"},"status":{"type":"string"},"usage":{"properties":{"input_tokens":{"type":"integer"},"output_tokens":{"type":"integer"},"total_tokens":{"type":"integer"}},"type":"object"}},"required":["id","object","status","model","output","usage"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}},"builder-code":{"info":{"a":"bc_b4aw4uzd"},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false,"properties":{"a":{"description":"App builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"},"s":{"description":"Service builder codes","items":{"pattern":"^[a-z0-9_]{1,32}$","type":"string"},"maxItems":11,"type":"array"},"w":{"description":"Wallet builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"}},"type":"object"}},"payment-identifier":{"info":{"required":false},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"id":{"maxLength":128,"minLength":16,"pattern":"^[a-zA-Z0-9_-]+$","type":"string"},"required":{"type":"boolean"}},"required":["required"],"type":"object"}}},"iconUrl":"https://res.cloudinary.com/bdb-prod/image/upload/c_fill,ar_1:1,w_256,h_256,f_auto,q_auto/v1788138502/bazaar-icons/478aced8e219894c.png","lastUpdated":"2026-09-11T12:13:45.588Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-11T12:13:45.355Z"},"resource":"https://agent402.tools/v1/premium/responses","serviceName":"Responses premium (OpenAI","tags":["llm","ai","inference","openai-compatible","responses-api"],"type":"http","x402Version":2},{"accepts":[{"amount":"100000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","outputSchema":{"properties":{"id":{"type":"string"},"model":{"type":"string"},"object":{"type":"string"},"output":{"items":{"type":"object"},"type":"array"},"status":{"type":"string"},"usage":{"properties":{"input_tokens":{"type":"integer"},"output_tokens":{"type":"integer"},"total_tokens":{"type":"integer"}},"type":"object"}},"required":["id","object","status","model","output","usage"],"type":"object"},"payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"100000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"100000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"100000","asset":"0x754704Bc059F8C67012fEd69BC8A327a5aafb603","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:143","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"100000","asset":"0xB97EF9Ef8734C71904D8002F8b6Bc66Dd9c48a6E","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:43114","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"100000","asset":"0xe15fC38F6D8c56aF07bbCBe3BAf5708A2Bf42392","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:1329","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"101000","asset":"0x0b2C639c533813f4Aa9D7837CAf62653d097Ff85","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:10","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"100000","asset":"0x5fc5360D0400a0Fd4f2af552ADD042D716F1d168","extra":{"name":"Global Dollar","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:4663","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"100000","asset":"0xcebA9300f2b948710d2653dD7B07f33A8B32118C","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42220","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"100000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"permit2","facilitatorAddress":"0x67B9CE703d9ce658d7C4ac3c289cEa112fE662Af","name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"upto"},{"amount":"100000","asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"D6ZhtNQ5nT9ZnTHUbqXZsTx5MH2rPFiBBggX4hY1WePM"},"maxTimeoutSeconds":300,"network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","payTo":"J7aN3PLJnTCF5qpEnvJHJsnCjcGuqC2rYtEM8Gv3xwg","scheme":"exact"},{"amount":"1000000","asset":"CCW67TSZV3SSS2HXMBQ5JFGCKJNXKZM7UQUWUZPUTHXSTZLEO7SJMI75","extra":{"areFeesSponsored":true},"maxTimeoutSeconds":300,"network":"stellar:pubnet","payTo":"GDNJXCKW7ZM7GEEVP674TWPU26YJNBQ2FI4ZIPRKTPTNUEJMDHFJWWRL","scheme":"exact"},{"amount":"100000","asset":"31566704","extra":{"feePayer":"ZMFK2OI7ZBD2U27ISERZC4S6LKM6WMFJPZQ4MYNJDZ2VNBNMBA67RA22AA","tag":"x402-global-challenge"},"maxTimeoutSeconds":300,"network":"algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73ktiC1qzkkit8=","payTo":"C7IIHG7SPLPZ5H7ZT6HW3UV2OQMQQE6Y2HBNGZXSLRJULE42BEE2OY2XIE","scheme":"exact"}],"description":"OpenAI Responses API over x402 - point the OpenAI SDK's responses.create() (or the OpenAI Agents SDK) at base_url https://agent402.tools/v1/pro and pay $0.10 per call in USDC, no API key, no signup. Same models, caps and price as this tier's /chat/completions route; any model here is served through the Responses wire.","extensions":{"bazaar":{"info":{"input":{"body":{"input":"Summarize x402 in one sentence.","max_output_tokens":128,"model":"openai/gpt-4o"},"bodyType":"json","method":"POST","type":"http"},"output":{"example":{"id":"resp_…","model":"openai/gpt-4o-mini","object":"response","output":[{"content":[{"annotations":[],"text":"x402 is an HTTP-native way for agents to pay per request with USDC.","type":"output_text"}],"id":"msg_…","role":"assistant","status":"completed","type":"message"}],"status":"completed","usage":{"input_tokens":14,"output_tokens":18,"total_tokens":32}},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"properties":{"input":{"description":"A string, or an array of input items ({role, content} messages with input_text / input_image parts, function_call, function_call_output)"},"instructions":{"description":"Optional system/developer instructions","type":"string"},"max_output_tokens":{"description":"Optional output cap (clamped to the tier cap)","type":"integer"},"model":{"description":"Model id (OpenRouter naming) - allowlisted per tier; omit (or \"auto\") on the auto tier","type":"string"},"reasoning":{"description":"Optional {effort: \"none\"|\"minimal\"|\"low\"|\"medium\"|\"high\"|\"xhigh\"|\"max\"} - reasoning tokens count against max_output_tokens","type":"object"},"stream":{"description":"Responses SSE events (response.created … response.completed)","type":"boolean"},"text":{"description":"Optional {format: {type: \"text\"|\"json_schema\"|\"json_object\", ...}}","type":"object"},"tools":{"description":"Optional function tools ({type:\"function\", name, parameters}); server-side tools are not served","type":"array"},"zdr":{"description":"Optional - zero-data-retention providers only","type":"boolean"}},"required":["input"]},"bodyType":{"enum":["json","form-data","text"],"type":"string"},"method":{"enum":["POST"],"type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method","bodyType","body"],"type":"object"},"output":{"properties":{"example":{"properties":{"id":{"type":"string"},"model":{"type":"string"},"object":{"type":"string"},"output":{"items":{"type":"object"},"type":"array"},"status":{"type":"string"},"usage":{"properties":{"input_tokens":{"type":"integer"},"output_tokens":{"type":"integer"},"total_tokens":{"type":"integer"}},"type":"object"}},"required":["id","object","status","model","output","usage"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}},"builder-code":{"info":{"a":"bc_b4aw4uzd"},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false,"properties":{"a":{"description":"App builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"},"s":{"description":"Service builder codes","items":{"pattern":"^[a-z0-9_]{1,32}$","type":"string"},"maxItems":11,"type":"array"},"w":{"description":"Wallet builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"}},"type":"object"}},"payment-identifier":{"info":{"required":false},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"id":{"maxLength":128,"minLength":16,"pattern":"^[a-zA-Z0-9_-]+$","type":"string"},"required":{"type":"boolean"}},"required":["required"],"type":"object"}}},"iconUrl":"https://res.cloudinary.com/bdb-prod/image/upload/c_fill,ar_1:1,w_256,h_256,f_auto,q_auto/v1788138502/bazaar-icons/478aced8e219894c.png","lastUpdated":"2026-09-11T12:13:21.382Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-11T12:13:21.144Z"},"resource":"https://agent402.tools/v1/pro/responses","serviceName":"Responses pro (OpenAI Responses","tags":["llm","ai","inference","openai-compatible","responses-api"],"type":"http","x402Version":2},{"accepts":[{"amount":"100000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","outputSchema":{"properties":{"content":{"items":{"properties":{"text":{"type":"string"},"type":{"type":"string"}},"type":"object"},"type":"array"},"id":{"type":"string"},"model":{"type":"string"},"role":{"type":"string"},"stop_reason":{"type":"string"},"type":{"type":"string"},"usage":{"properties":{"input_tokens":{"type":"integer"},"output_tokens":{"type":"integer"}},"type":"object"}},"required":["id","type","role","model","content","stop_reason","usage"],"type":"object"},"payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"100000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"100000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"100000","asset":"0x754704Bc059F8C67012fEd69BC8A327a5aafb603","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:143","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"100000","asset":"0xB97EF9Ef8734C71904D8002F8b6Bc66Dd9c48a6E","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:43114","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"100000","asset":"0xe15fC38F6D8c56aF07bbCBe3BAf5708A2Bf42392","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:1329","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"101000","asset":"0x0b2C639c533813f4Aa9D7837CAf62653d097Ff85","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:10","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"100000","asset":"0x5fc5360D0400a0Fd4f2af552ADD042D716F1d168","extra":{"name":"Global Dollar","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:4663","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"100000","asset":"0xcebA9300f2b948710d2653dD7B07f33A8B32118C","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42220","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"100000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"permit2","facilitatorAddress":"0x67B9CE703d9ce658d7C4ac3c289cEa112fE662Af","name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"upto"},{"amount":"100000","asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"D6ZhtNQ5nT9ZnTHUbqXZsTx5MH2rPFiBBggX4hY1WePM"},"maxTimeoutSeconds":300,"network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","payTo":"J7aN3PLJnTCF5qpEnvJHJsnCjcGuqC2rYtEM8Gv3xwg","scheme":"exact"},{"amount":"1000000","asset":"CCW67TSZV3SSS2HXMBQ5JFGCKJNXKZM7UQUWUZPUTHXSTZLEO7SJMI75","extra":{"areFeesSponsored":true},"maxTimeoutSeconds":300,"network":"stellar:pubnet","payTo":"GDNJXCKW7ZM7GEEVP674TWPU26YJNBQ2FI4ZIPRKTPTNUEJMDHFJWWRL","scheme":"exact"},{"amount":"100000","asset":"31566704","extra":{"feePayer":"ZMFK2OI7ZBD2U27ISERZC4S6LKM6WMFJPZQ4MYNJDZ2VNBNMBA67RA22AA","tag":"x402-global-challenge"},"maxTimeoutSeconds":300,"network":"algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73ktiC1qzkkit8=","payTo":"C7IIHG7SPLPZ5H7ZT6HW3UV2OQMQQE6Y2HBNGZXSLRJULE42BEE2OY2XIE","scheme":"exact"}],"description":"Anthropic Messages API over x402 - point the Anthropic SDK (or Claude Code / the Agent SDK) at base_url https://agent402.tools/v1/pro and pay $0.10 per call in USDC, no API key, no signup. Same models, caps and price as this tier's /chat/completions route; any model here is served through the Messages wire (Claude natively, others translated). Up to 48,000 input chars and 4096 output tokens; streaming supported.","extensions":{"bazaar":{"info":{"input":{"body":{"max_tokens":256,"messages":[{"content":"Summarize x402 in one sentence.","role":"user"}],"model":"anthropic/claude-sonnet-5"},"bodyType":"json","method":"POST","type":"http"},"output":{"example":{"content":[{"text":"x402 is an HTTP-native way for agents to pay per request with USDC.","type":"text"}],"id":"msg_…","model":"anthropic/claude-sonnet-5","role":"assistant","stop_reason":"end_turn","type":"message","usage":{"input_tokens":14,"output_tokens":18}},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"properties":{"max_tokens":{"description":"Required by the Messages API; clamped to the tier's output cap","type":"integer"},"messages":{"description":"Anthropic messages: {role: user|assistant, content: string | [text|image|tool_use|tool_result blocks]}","type":"array"},"model":{"description":"Model id (OpenRouter naming, e.g. anthropic/claude-sonnet-5) - allowlisted per tier; omit (or \"auto\") on the auto tier","type":"string"},"stream":{"description":"Anthropic SSE (message_start … message_stop)","type":"boolean"},"system":{"description":"Optional system prompt (string or text blocks)","type":"string"},"thinking":{"description":"Optional {type:\"enabled\", budget_tokens} | {type:\"adaptive\"} | {type:\"disabled\"} - thinking tokens are output tokens","type":"object"},"tools":{"description":"Optional client tools {name, description, input_schema}; server/built-in tools are not served","type":"array"},"zdr":{"description":"Optional - zero-data-retention providers only","type":"boolean"}},"required":["max_tokens","messages"]},"bodyType":{"enum":["json","form-data","text"],"type":"string"},"method":{"enum":["POST"],"type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method","bodyType","body"],"type":"object"},"output":{"properties":{"example":{"properties":{"content":{"items":{"properties":{"text":{"type":"string"},"type":{"type":"string"}},"type":"object"},"type":"array"},"id":{"type":"string"},"model":{"type":"string"},"role":{"type":"string"},"stop_reason":{"type":"string"},"type":{"type":"string"},"usage":{"properties":{"input_tokens":{"type":"integer"},"output_tokens":{"type":"integer"}},"type":"object"}},"required":["id","type","role","model","content","stop_reason","usage"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}},"builder-code":{"info":{"a":"bc_b4aw4uzd"},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false,"properties":{"a":{"description":"App builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"},"s":{"description":"Service builder codes","items":{"pattern":"^[a-z0-9_]{1,32}$","type":"string"},"maxItems":11,"type":"array"},"w":{"description":"Wallet builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"}},"type":"object"}},"payment-identifier":{"info":{"required":false},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"id":{"maxLength":128,"minLength":16,"pattern":"^[a-zA-Z0-9_-]+$","type":"string"},"required":{"type":"boolean"}},"required":["required"],"type":"object"}}},"iconUrl":"https://res.cloudinary.com/bdb-prod/image/upload/c_fill,ar_1:1,w_256,h_256,f_auto,q_auto/v1788138502/bazaar-icons/478aced8e219894c.png","lastUpdated":"2026-09-11T12:13:16.313Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-11T12:13:16.05Z"},"resource":"https://agent402.tools/v1/pro/messages","serviceName":"Messages pro","tags":["llm","ai","inference","anthropic-compatible","messages-api"],"type":"http","x402Version":2},{"accepts":[{"amount":"1100000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","outputSchema":{"properties":{"article":{"type":"object"},"images":{"type":"array"},"meta":{"type":"object"},"post":{"type":"object"},"report":{"type":"string"},"sources":{"type":"array"},"tables":{"type":"array"},"title":{"type":"string"}},"required":["report","title","article","post","images","sources","tables","meta"],"type":"object"},"payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"1100000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"1100000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"1100000","asset":"0x754704Bc059F8C67012fEd69BC8A327a5aafb603","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:143","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"1100000","asset":"0xB97EF9Ef8734C71904D8002F8b6Bc66Dd9c48a6E","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:43114","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"1100000","asset":"0xe15fC38F6D8c56aF07bbCBe3BAf5708A2Bf42392","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:1329","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"1101000","asset":"0x0b2C639c533813f4Aa9D7837CAf62653d097Ff85","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:10","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"1100000","asset":"0x5fc5360D0400a0Fd4f2af552ADD042D716F1d168","extra":{"name":"Global Dollar","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:4663","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"1100000","asset":"0xcebA9300f2b948710d2653dD7B07f33A8B32118C","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42220","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"}],"description":"Hand over a topic and get a publish-ready LinkedIn article back: grounded web research with cited sources, three headline options, a hook-first body under subheads with facts linked to their sources, key takeaways, a companion post with hashtags, and generated images delivered at LinkedIn's own sizes (article cover 1920x1080, link-share 1200x627, feed square and portrait, in-article 16:9) as inline JPEG under 3 MB. Optional byline, angle, audience, tone and CTA.","extensions":{"bazaar":{"info":{"input":{"body":{"audience":"fintech product leaders","length":"standard","topic":"Why AI agents will pay for APIs with stablecoins"},"bodyType":"json","method":"POST","type":"http"},"output":{"example":{"article":{"body_markdown":"...","headline":"Why agent payments settle on chain","headlines":["Why agent payments settle on chain","...","..."],"key_takeaways":["..."],"subtitle":"One line of context","word_count":980},"images":[{"alt":"An abstract network of nodes exchanging tokens","files":[{"b64":"/9j/4AAQ…","bytes":412000,"format":"jpeg","height":1080,"media_type":"image/jpeg","name":"article-cover","use":"LinkedIn article cover image","width":1920},{"b64":"/9j/4AAQ…","bytes":180000,"format":"jpeg","height":627,"media_type":"image/jpeg","name":"post-link-share","use":"LinkedIn post / link-share image (1.91:1)","width":1200}],"prompt":"...","slot":"cover","source":{"height":1024,"model":"black-forest-labs/flux.2-klein-4b","width":1024}}],"meta":{"image_files":5,"images":2,"post_chars":1120,"sources_full_text":4,"sources_listed":12,"synthesis_model":"anthropic/claude-opus-5","tier":"linkedin-article","words":980},"post":{"caption":"...\n#AgenticFinance #Payments #AI #Stablecoins","chars":1120,"hashtags":["#AgenticFinance","#Payments","#AI","#Stablecoins"]},"report":"# Why agent payments settle on chain\n*One line of context*\n\n...\n\n## Sources\n1. [Example](https://example.com/...)\n\n---\n## Companion post (paste as a LinkedIn post, 1,120 of 3000 characters)\n...","sources":[{"fullText":true,"n":1,"snippet":"...","title":"Example","url":"https://example.com/..."}],"tables":[],"title":"Why agent payments settle on chain"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"properties":{"angle":{"description":"Optional: the take or thesis to argue.","type":"string"},"audience":{"description":"Optional: who it is for, e.g. CFOs at mid-market SaaS.","type":"string"},"author":{"description":"Optional byline the article is written as.","properties":{"name":{"type":"string"},"role":{"type":"string"}},"type":"object"},"cta":{"description":"Optional closing call to action.","type":"string"},"hashtags":{"description":"Hashtags on the companion post, 0-5 (default 4).","type":"number"},"images":{"properties":{"cover":{"description":"Generate the cover image (default true).","type":"boolean"},"inline":{"description":"In-article images, 0 or 1 (default 1).","type":"number"},"style":{"description":"Visual style for the generated images.","type":"string"}},"type":"object"},"length":{"description":"~600 / ~1,000 / ~1,500 words (default standard).","enum":["short","standard","long"],"type":"string"},"tone":{"description":"Optional voice, default: professional, first-person, direct.","type":"string"},"topic":{"description":"What the article is about (up to 600 chars). The research runs on this.","type":"string"}},"required":["topic"],"type":"object"},"bodyType":{"enum":["json","form-data","text"],"type":"string"},"method":{"enum":["POST"],"type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method","bodyType","body"],"type":"object"},"output":{"properties":{"example":{"properties":{"article":{"type":"object"},"images":{"type":"array"},"meta":{"type":"object"},"post":{"type":"object"},"report":{"type":"string"},"sources":{"type":"array"},"tables":{"type":"array"},"title":{"type":"string"}},"required":["report","title","article","post","images","sources","tables","meta"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}},"builder-code":{"info":{"a":"bc_b4aw4uzd"},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false,"properties":{"a":{"description":"App builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"},"s":{"description":"Service builder codes","items":{"pattern":"^[a-z0-9_]{1,32}$","type":"string"},"maxItems":11,"type":"array"},"w":{"description":"Wallet builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"}},"type":"object"}},"payment-identifier":{"info":{"required":false},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"id":{"maxLength":128,"minLength":16,"pattern":"^[a-zA-Z0-9_-]+$","type":"string"},"required":{"type":"boolean"}},"required":["required"],"type":"object"}}},"iconUrl":"https://res.cloudinary.com/bdb-prod/image/upload/c_fill,ar_1:1,w_256,h_256,f_auto,q_auto/v1788138502/bazaar-icons/478aced8e219894c.png","lastUpdated":"2026-09-11T12:13:05.834Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-11T12:13:05.594Z"},"resource":"https://agent402.tools/v1/linkedin-article","serviceName":"LinkedIn article, ready to","tags":["llm","linkedin","linkedin-article","ghostwriting","thought-leadership"],"type":"http","x402Version":2},{"accepts":[{"amount":"600000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","outputSchema":{"properties":{"cik":{"type":"string"},"company":{"type":"string"},"meta":{"type":"object"},"report":{"type":"string"},"sources":{"type":"array"},"tables":{"type":"array"},"ticker":{"type":"string"}},"required":["report","company","ticker","cik","sources","tables","meta"],"type":"object"},"payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0x754704Bc059F8C67012fEd69BC8A327a5aafb603","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:143","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0xB97EF9Ef8734C71904D8002F8b6Bc66Dd9c48a6E","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:43114","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0xe15fC38F6D8c56aF07bbCBe3BAf5708A2Bf42392","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:1329","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"601000","asset":"0x0b2C639c533813f4Aa9D7837CAf62653d097Ff85","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:10","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0x5fc5360D0400a0Fd4f2af552ADD042D716F1d168","extra":{"name":"Global Dollar","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:4663","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0xcebA9300f2b948710d2653dD7B07f33A8B32118C","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42220","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"}],"description":"Name a US ticker and get one cited insider-flow report: every Form 4 against the company in the window with the actual transactions parsed from the filings - open-market buys and sales (who, when, how much, at what price) separated from awards, option exercises and tax withholding - aggregated per insider and as a net flow, with a grounded signal read and a downloadable transactions appendix. SEC EDGAR data, not investment advice. USDC (x402/MPP) or card (Stripe). Not cached.","extensions":{"bazaar":{"info":{"input":{"body":{"days":90,"ticker":"AAPL"},"bodyType":"json","method":"POST","type":"http"},"output":{"example":{"cik":"0000000000","company":"Example Corp","meta":{"buy_usd":240000,"company":"Example Corp","filings_read":6,"net_open_market_usd":-1610000,"open_market_buys":1,"open_market_sells":3,"sell_usd":1850000,"sources_cited":7,"synthesis_model":"anthropic/claude-opus-5","ticker":"EXMP","tier":"insider-report","transactions":9,"window_days":90},"report":"# Insider Flow Report: Example Corp (EXMP)\n\n**2026-05-24 to 2026-08-22** · 6 Form 4 filings read · 1 open-market buy ($240,000) · 3 open-market sales ($1,850,000)\n\n## Snapshot\n...\n\n## Sources\n[1] Form 4 filed 2026-08-18 by Example Officer - SEC EDGAR - https://www.sec.gov/Archives/edgar/data/0000000000/000000000000000000/form4.xml","sources":[{"n":1,"title":"Form 4 filed 2026-08-18 by Example Officer - SEC EDGAR","url":"https://www.sec.gov/Archives/edgar/data/0000000000/000000000000000000/form4.xml"}],"tables":[{"columns":["Date","Filed","Insider","Role","Security","Code","Kind","Shares","Price","Value (USD)","Owned after","10b5-1","Filing"],"label":"Form 4 transactions","name":"transactions","rows":[["2026-08-16","2026-08-18","Example Officer","Chief Financial Officer","Common Stock","S","open-market sale","5000","120.5","602500","41000","noted","https://www.sec.gov/Archives/edgar/data/0000000000/000000000000000000/form4.xml"]]}],"ticker":"EXMP"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"properties":{"cik":{"description":"SEC CIK of the company (alternative to ticker).","type":"string"},"days":{"description":"Lookback window in days, 7-365 (default 90).","type":"number"},"ticker":{"description":"US stock ticker, e.g. AAPL (or pass cik).","type":"string"}},"type":"object"},"bodyType":{"enum":["json","form-data","text"],"type":"string"},"method":{"enum":["POST"],"type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method","bodyType","body"],"type":"object"},"output":{"properties":{"example":{"properties":{"cik":{"type":"string"},"company":{"type":"string"},"meta":{"type":"object"},"report":{"type":"string"},"sources":{"type":"array"},"tables":{"type":"array"},"ticker":{"type":"string"}},"required":["report","company","ticker","cik","sources","tables","meta"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}},"builder-code":{"info":{"a":"bc_b4aw4uzd"},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false,"properties":{"a":{"description":"App builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"},"s":{"description":"Service builder codes","items":{"pattern":"^[a-z0-9_]{1,32}$","type":"string"},"maxItems":11,"type":"array"},"w":{"description":"Wallet builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"}},"type":"object"}},"payment-identifier":{"info":{"required":false},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"id":{"maxLength":128,"minLength":16,"pattern":"^[a-zA-Z0-9_-]+$","type":"string"},"required":{"type":"boolean"}},"required":["required"],"type":"object"}}},"iconUrl":"https://res.cloudinary.com/bdb-prod/image/upload/c_fill,ar_1:1,w_256,h_256,f_auto,q_auto/v1788138502/bazaar-icons/478aced8e219894c.png","lastUpdated":"2026-09-11T12:10:37.187Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-11T12:10:36.843Z"},"resource":"https://agent402.tools/v1/insider-report","serviceName":"Insider flow report (Form 4","tags":["llm","insider","form-4","sec","edgar"],"type":"http","x402Version":2},{"accepts":[{"amount":"850000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","outputSchema":{"properties":{"cik":{"type":"string"},"company":{"type":"string"},"meta":{"type":"object"},"report":{"type":"string"},"sources":{"type":"array"},"tables":{"type":"array"},"ticker":{"type":"string"}},"required":["report","company","ticker","cik","sources","tables","meta"],"type":"object"},"payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0x754704Bc059F8C67012fEd69BC8A327a5aafb603","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:143","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0xB97EF9Ef8734C71904D8002F8b6Bc66Dd9c48a6E","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:43114","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0xe15fC38F6D8c56aF07bbCBe3BAf5708A2Bf42392","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:1329","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"851000","asset":"0x0b2C639c533813f4Aa9D7837CAf62653d097Ff85","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:10","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0x5fc5360D0400a0Fd4f2af552ADD042D716F1d168","extra":{"name":"Global Dollar","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:4663","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0xcebA9300f2b948710d2653dD7B07f33A8B32118C","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42220","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"}],"description":"Name a US ticker and get one cited report on what the company just filed with the SEC: every filing in EDGAR's index for the window (8-K, 10-Q, 10-K, S-1, 424B4, DEF 14A and the rest, minus any form you exclude), the primary documents of the most consequential ones read in full and explained in plain language, and what changed versus the prior period where the filing itself says so, with a downloadable filings appendix. Not investment advice. Not cached.","extensions":{"bazaar":{"info":{"input":{"body":{"days":30,"ticker":"AAPL"},"bodyType":"json","method":"POST","type":"http"},"output":{"example":{"cik":"0000000042","company":"Example Corp","meta":{"cik":"0000000042","company":"Example Corp","disclaimer":"SEC filings as filed with the Commission (public domain); summary of public documents, not investment advice.","documents_read":3,"filings":4,"sources_cited":5,"synthesis_model":"anthropic/claude-opus-5","ticker":"EXMP","tier":"filing-report","window_days":30},"report":"# SEC Filing Report: Example Corp (EXMP)\n\n**Last 30 days** · 4 filings (8-K x2, 10-Q x1, 4 x1) · 3 primary documents read in full\n\n## Snapshot\n...\n\n## Sources\n[1] 8-K filed 2026-08-20 - Example Corp - SEC EDGAR - https://www.sec.gov/Archives/edgar/data/42/000000000000000000/ex8k.htm","sources":[{"n":1,"title":"8-K filed 2026-08-20 - Example Corp - SEC EDGAR","url":"https://www.sec.gov/Archives/edgar/data/42/000000000000000000/ex8k.htm"}],"tables":[{"columns":["Filed","Form","Form meaning","Period","Description","Accession","Read in full","URL"],"label":"SEC filings in the window","name":"filings","rows":[["2026-08-20","8-K","current report (material event)","2026-08-19","8-K","0000000042-26-000011","yes","https://www.sec.gov/Archives/edgar/data/42/000000000000000000/ex8k.htm"]]}],"ticker":"EXMP"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"properties":{"cik":{"description":"SEC CIK of the company (alternative to ticker).","type":"string"},"days":{"description":"Lookback window in days, 1-365 (default 30).","type":"number"},"exclude":{"description":"Form types to ignore, comma-separated or an array, e.g. \"4,3,5\" to drop insider ownership forms.","type":"string"},"focus":{"description":"Optional accession numbers to read in full first, comma-separated or an array (e.g. the filing that just landed).","type":"string"},"forms":{"description":"Optional allowlist of form types, comma-separated or an array, e.g. \"8-K,10-Q\". Omit for every form.","type":"string"},"ticker":{"description":"US stock ticker, e.g. AAPL (or pass cik).","type":"string"}},"type":"object"},"bodyType":{"enum":["json","form-data","text"],"type":"string"},"method":{"enum":["POST"],"type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method","bodyType","body"],"type":"object"},"output":{"properties":{"example":{"properties":{"cik":{"type":"string"},"company":{"type":"string"},"meta":{"type":"object"},"report":{"type":"string"},"sources":{"type":"array"},"tables":{"type":"array"},"ticker":{"type":"string"}},"required":["report","company","ticker","cik","sources","tables","meta"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}},"builder-code":{"info":{"a":"bc_b4aw4uzd"},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false,"properties":{"a":{"description":"App builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"},"s":{"description":"Service builder codes","items":{"pattern":"^[a-z0-9_]{1,32}$","type":"string"},"maxItems":11,"type":"array"},"w":{"description":"Wallet builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"}},"type":"object"}},"payment-identifier":{"info":{"required":false},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"id":{"maxLength":128,"minLength":16,"pattern":"^[a-zA-Z0-9_-]+$","type":"string"},"required":{"type":"boolean"}},"required":["required"],"type":"object"}}},"iconUrl":"https://res.cloudinary.com/bdb-prod/image/upload/c_fill,ar_1:1,w_256,h_256,f_auto,q_auto/v1788138502/bazaar-icons/478aced8e219894c.png","lastUpdated":"2026-09-11T12:09:49.839Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-11T12:09:49.609Z"},"resource":"https://agent402.tools/v1/filing-report","serviceName":"SEC filing report (what the","tags":["llm","sec","edgar","filings","8-k"],"type":"http","x402Version":2},{"accepts":[{"amount":"2000000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","outputSchema":{"type":"object"},"payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"2000000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"2000000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"2000000","asset":"0x754704Bc059F8C67012fEd69BC8A327a5aafb603","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:143","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"2000000","asset":"0xB97EF9Ef8734C71904D8002F8b6Bc66Dd9c48a6E","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:43114","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"2000000","asset":"0xe15fC38F6D8c56aF07bbCBe3BAf5708A2Bf42392","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:1329","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"2001000","asset":"0x0b2C639c533813f4Aa9D7837CAf62653d097Ff85","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:10","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"2000000","asset":"0x5fc5360D0400a0Fd4f2af552ADD042D716F1d168","extra":{"name":"Global Dollar","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:4663","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"2000000","asset":"0xcebA9300f2b948710d2653dD7B07f33A8B32118C","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42220","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"}],"description":"One ticker, one purchase, the full picture. Runs the company due-diligence dossier (SEC filings, XBRL financials, grounded web research), the Form 4 insider-flow report with the actual transactions parsed, and a 13F institutional-holder sample read live off SEC EDGAR full-text search, then stitches them into ONE cited report: company, filings, insider flow, institutional holders and what to check next, with a merged source list and downloadable data appendices.","extensions":{"bazaar":{"info":{"input":{"body":{"days":90,"ticker":"AAPL"},"bodyType":"json","method":"POST","type":"http"},"output":{"example":{"note":"full example in /openapi.json","truncated":true},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"properties":{"days":{"description":"Insider-flow lookback in days, 7-365 (default 90).","type":"number"},"focus":{"description":"Optional aspects for the dossier leg to emphasize (\u003c= 8), e.g. [\"litigation\", \"debt\"].","items":{"type":"string"},"type":"array"},"ticker":{"description":"US stock ticker to cover, e.g. AAPL.","type":"string"}},"required":["ticker"],"type":"object"},"bodyType":{"enum":["json","form-data","text"],"type":"string"},"method":{"enum":["POST"],"type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method","bodyType","body"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}},"builder-code":{"info":{"a":"bc_b4aw4uzd"},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false,"properties":{"a":{"description":"App builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"},"s":{"description":"Service builder codes","items":{"pattern":"^[a-z0-9_]{1,32}$","type":"string"},"maxItems":11,"type":"array"},"w":{"description":"Wallet builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"}},"type":"object"}},"payment-identifier":{"info":{"required":false},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"id":{"maxLength":128,"minLength":16,"pattern":"^[a-zA-Z0-9_-]+$","type":"string"},"required":{"type":"boolean"}},"required":["required"],"type":"object"}}},"iconUrl":"https://res.cloudinary.com/bdb-prod/image/upload/c_fill,ar_1:1,w_256,h_256,f_auto,q_auto/v1788138502/bazaar-icons/478aced8e219894c.png","lastUpdated":"2026-09-11T12:09:02.928Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-11T12:09:02.652Z"},"resource":"https://agent402.tools/v1/ticker-pack","serviceName":"Ticker pack: dossier, insider","tags":["llm","research","due-diligence","bundle","sec"],"type":"http","x402Version":2},{"accepts":[{"amount":"600000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","outputSchema":{"type":"object"},"payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0x754704Bc059F8C67012fEd69BC8A327a5aafb603","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:143","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0xB97EF9Ef8734C71904D8002F8b6Bc66Dd9c48a6E","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:43114","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0xe15fC38F6D8c56aF07bbCBe3BAf5708A2Bf42392","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:1329","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"601000","asset":"0x0b2C639c533813f4Aa9D7837CAf62653d097Ff85","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:10","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0x5fc5360D0400a0Fd4f2af552ADD042D716F1d168","extra":{"name":"Global Dollar","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:4663","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0xcebA9300f2b948710d2653dD7B07f33A8B32118C","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42220","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"}],"description":"Hand over a Solana SPL mint address and get one cited due-diligence brief: what the token is, whether the mint and freeze authorities are still live, how deep and how locked the liquidity is (pools, lockers, unlock dates, DEX pairs, 24h volume and buy/sell balance), who holds it (top holders with pool and locker accounts told apart from wallets, concentration with and without pools), and every named risk flag the public feeds carry, plus what this data cannot see.","extensions":{"bazaar":{"info":{"input":{"body":{"mint":"JUPyiwrYJFskUPiHa7hkeR8VUtAeFoSYbKedZNsDvCN"},"bodyType":"json","method":"POST","type":"http"},"output":{"example":{"note":"full example in /openapi.json","truncated":true},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"properties":{"format":{"description":"Response shape (default markdown report plus structured evidence).","enum":["markdown","json"],"type":"string"},"mint":{"description":"Base58 Solana SPL token mint address (32-44 chars).","type":"string"}},"required":["mint"],"type":"object"},"bodyType":{"enum":["json","form-data","text"],"type":"string"},"method":{"enum":["POST"],"type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method","bodyType","body"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}},"builder-code":{"info":{"a":"bc_b4aw4uzd"},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false,"properties":{"a":{"description":"App builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"},"s":{"description":"Service builder codes","items":{"pattern":"^[a-z0-9_]{1,32}$","type":"string"},"maxItems":11,"type":"array"},"w":{"description":"Wallet builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"}},"type":"object"}},"payment-identifier":{"info":{"required":false},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"id":{"maxLength":128,"minLength":16,"pattern":"^[a-zA-Z0-9_-]+$","type":"string"},"required":{"type":"boolean"}},"required":["required"],"type":"object"}}},"iconUrl":"https://res.cloudinary.com/bdb-prod/image/upload/c_fill,ar_1:1,w_256,h_256,f_auto,q_auto/v1788138502/bazaar-icons/478aced8e219894c.png","lastUpdated":"2026-09-11T12:07:01.121Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-11T12:07:00.856Z"},"resource":"https://agent402.tools/v1/token-brief","serviceName":"Solana token due-diligence brief","tags":["llm","solana","token","due-diligence","brief"],"type":"http","x402Version":2},{"accepts":[{"amount":"850000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","outputSchema":{"properties":{"address":{"type":"string"},"chain":{"type":"string"},"meta":{"type":"object"},"report":{"type":"string"},"sources":{"type":"array"},"tables":{"type":"array"}},"required":["report","address","chain","sources","tables","meta"],"type":"object"},"payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0x754704Bc059F8C67012fEd69BC8A327a5aafb603","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:143","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0xB97EF9Ef8734C71904D8002F8b6Bc66Dd9c48a6E","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:43114","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0xe15fC38F6D8c56aF07bbCBe3BAf5708A2Bf42392","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:1329","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"851000","asset":"0x0b2C639c533813f4Aa9D7837CAf62653d097Ff85","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:10","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0x5fc5360D0400a0Fd4f2af552ADD042D716F1d168","extra":{"name":"Global Dollar","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:4663","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0xcebA9300f2b948710d2653dD7B07f33A8B32118C","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42220","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"}],"description":"The deeper tier: everything in the standard report plus a deterministic static-pattern scan of the verified source (tx.origin auth, delegatecall, selfdestruct, unchecked calls, reentrancy surface, etc. - heuristic triage, not a formal audit), more holders, and a web reputation check. Still evidence, never a verdict. USDC (x402/MPP). Not cached.","extensions":{"bazaar":{"info":{"input":{"body":{"address":"0x4200000000000000000000000000000000000006","chain":"base"},"bodyType":"json","method":"POST","type":"http"},"output":{"example":{"address":"0x0000000000000000000000000000000000000000","chain":"base","meta":{"address":"0x…","chain":"base","disclaimer":"Evidence-based on-chain risk signals only. Not financial advice.","holder_count":1234,"name":"Example","symbol":"EXMP","synthesis_model":"anthropic/claude-opus-5","tier":"token-risk-pro","top10_share_pct":71.5,"top1_share_pct":42.1,"verified_source":true},"report":"# Token \u0026 Contract Risk Report: EXAMPLE (0x…)\n\n## Snapshot\n...\n\n## Risk summary\n... This is not financial advice and not exhaustive.","sources":[],"tables":[{"columns":["Rank","Address","Share of supply","Type","Label"],"label":"Top holders","name":"holders","rows":[["1","0x…","42.10%","contract","Uniswap V3 Pool"]]}]},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"properties":{"address":{"description":"Token contract address (0x + 40 hex).","type":"string"},"chain":{"description":"Chain: base (default), ethereum, polygon, arbitrum, optimism, bsc, gnosis, or celo.","type":"string"},"format":{"description":"Response shape (default markdown report).","enum":["markdown","json"],"type":"string"}},"required":["address"],"type":"object"},"bodyType":{"enum":["json","form-data","text"],"type":"string"},"method":{"enum":["POST"],"type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method","bodyType","body"],"type":"object"},"output":{"properties":{"example":{"properties":{"address":{"type":"string"},"chain":{"type":"string"},"meta":{"type":"object"},"report":{"type":"string"},"sources":{"type":"array"},"tables":{"type":"array"}},"required":["report","address","chain","sources","tables","meta"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}},"builder-code":{"info":{"a":"bc_b4aw4uzd"},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false,"properties":{"a":{"description":"App builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"},"s":{"description":"Service builder codes","items":{"pattern":"^[a-z0-9_]{1,32}$","type":"string"},"maxItems":11,"type":"array"},"w":{"description":"Wallet builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"}},"type":"object"}},"payment-identifier":{"info":{"required":false},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"id":{"maxLength":128,"minLength":16,"pattern":"^[a-zA-Z0-9_-]+$","type":"string"},"required":{"type":"boolean"}},"required":["required"],"type":"object"}}},"iconUrl":"https://res.cloudinary.com/bdb-prod/image/upload/c_fill,ar_1:1,w_256,h_256,f_auto,q_auto/v1788138502/bazaar-icons/478aced8e219894c.png","lastUpdated":"2026-09-11T12:05:35.878Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-11T12:05:35.631Z"},"resource":"https://agent402.tools/v1/token-risk/pro","serviceName":"Token \u0026 contract risk report -","tags":["llm","crypto","token","risk","rug"],"type":"http","x402Version":2},{"accepts":[{"amount":"600000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","outputSchema":{"properties":{"address":{"type":"string"},"chain":{"type":"string"},"meta":{"type":"object"},"report":{"type":"string"},"sources":{"type":"array"},"tables":{"type":"array"}},"required":["report","address","chain","sources","tables","meta"],"type":"object"},"payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0x754704Bc059F8C67012fEd69BC8A327a5aafb603","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:143","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0xB97EF9Ef8734C71904D8002F8b6Bc66Dd9c48a6E","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:43114","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0xe15fC38F6D8c56aF07bbCBe3BAf5708A2Bf42392","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:1329","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"601000","asset":"0x0b2C639c533813f4Aa9D7837CAf62653d097Ff85","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:10","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0x5fc5360D0400a0Fd4f2af552ADD042D716F1d168","extra":{"name":"Global Dollar","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:4663","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0xcebA9300f2b948710d2653dD7B07f33A8B32118C","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42220","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"}],"description":"Hand over a token contract address (and chain) and get one evidence-based on-chain risk report: whether the source is verified, holder concentration (top-1 / top-10 share of supply, distinguishing pools/contracts from wallets), and supply + market context, with a top-holders appendix. Evidence, never a 'safe' or 'scam' verdict - on-chain checks can't see off-chain rugs, so a clean report is not an endorsement. USDC (x402/MPP). Not cached.","extensions":{"bazaar":{"info":{"input":{"body":{"address":"0x4200000000000000000000000000000000000006","chain":"base"},"bodyType":"json","method":"POST","type":"http"},"output":{"example":{"address":"0x0000000000000000000000000000000000000000","chain":"base","meta":{"address":"0x…","chain":"base","disclaimer":"Evidence-based on-chain risk signals only. Not financial advice.","holder_count":1234,"name":"Example","symbol":"EXMP","synthesis_model":"anthropic/claude-opus-5","tier":"token-risk","top10_share_pct":71.5,"top1_share_pct":42.1,"verified_source":true},"report":"# Token \u0026 Contract Risk Report: EXAMPLE (0x…)\n\n## Snapshot\n...\n\n## Risk summary\n... This is not financial advice and not exhaustive.","sources":[],"tables":[{"columns":["Rank","Address","Share of supply","Type","Label"],"label":"Top holders","name":"holders","rows":[["1","0x…","42.10%","contract","Uniswap V3 Pool"]]}]},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"properties":{"address":{"description":"Token contract address (0x + 40 hex).","type":"string"},"chain":{"description":"Chain: base (default), ethereum, polygon, arbitrum, optimism, bsc, gnosis, or celo.","type":"string"},"format":{"description":"Response shape (default markdown report).","enum":["markdown","json"],"type":"string"}},"required":["address"],"type":"object"},"bodyType":{"enum":["json","form-data","text"],"type":"string"},"method":{"enum":["POST"],"type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method","bodyType","body"],"type":"object"},"output":{"properties":{"example":{"properties":{"address":{"type":"string"},"chain":{"type":"string"},"meta":{"type":"object"},"report":{"type":"string"},"sources":{"type":"array"},"tables":{"type":"array"}},"required":["report","address","chain","sources","tables","meta"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}},"builder-code":{"info":{"a":"bc_b4aw4uzd"},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false,"properties":{"a":{"description":"App builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"},"s":{"description":"Service builder codes","items":{"pattern":"^[a-z0-9_]{1,32}$","type":"string"},"maxItems":11,"type":"array"},"w":{"description":"Wallet builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"}},"type":"object"}},"payment-identifier":{"info":{"required":false},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"id":{"maxLength":128,"minLength":16,"pattern":"^[a-zA-Z0-9_-]+$","type":"string"},"required":{"type":"boolean"}},"required":["required"],"type":"object"}}},"iconUrl":"https://res.cloudinary.com/bdb-prod/image/upload/c_fill,ar_1:1,w_256,h_256,f_auto,q_auto/v1788138502/bazaar-icons/478aced8e219894c.png","lastUpdated":"2026-09-11T12:04:15.794Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-11T12:04:15.541Z"},"resource":"https://agent402.tools/v1/token-risk","serviceName":"Token \u0026 contract risk report","tags":["llm","crypto","token","risk","rug"],"type":"http","x402Version":2},{"accepts":[{"amount":"850000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","outputSchema":{"properties":{"composite":{"type":"integer"},"domain":{"type":"string"},"grade":{"type":"string"},"meta":{"type":"object"},"report":{"type":"string"},"sources":{"type":"array"},"tables":{"type":"array"}},"required":["report","domain","grade","composite","sources","tables","meta"],"type":"object"},"payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0x754704Bc059F8C67012fEd69BC8A327a5aafb603","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:143","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0xB97EF9Ef8734C71904D8002F8b6Bc66Dd9c48a6E","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:43114","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0xe15fC38F6D8c56aF07bbCBe3BAf5708A2Bf42392","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:1329","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"851000","asset":"0x0b2C639c533813f4Aa9D7837CAf62653d097Ff85","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:10","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0x5fc5360D0400a0Fd4f2af552ADD042D716F1d168","extra":{"name":"Global Dollar","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:4663","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0xcebA9300f2b948710d2653dD7B07f33A8B32118C","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42220","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"}],"description":"The deeper tier: everything in the standard audit plus the attack surface from Certificate Transparency logs (subdomains), the detected tech stack, and domain registration, in a longer graded report with a fuller remediation plan. USDC or card (Stripe). Not cached.","extensions":{"bazaar":{"info":{"input":{"body":{"domain":"example.com"},"bodyType":"json","method":"POST","type":"http"},"output":{"example":{"composite":82,"domain":"example.com","grade":"B","meta":{"composite":82,"domain":"example.com","email_score":90,"grade":"B","header_score":70,"synthesis_model":"anthropic/claude-opus-5","tier":"domain-audit-pro","tls_days_remaining":204},"report":"# Domain Security Audit: example.com\n\n**Overall grade: B** (82/100)\n\n## Overall grade\n...","sources":[],"tables":[{"columns":["Check","Status","Detail"],"label":"Email authentication checks","name":"email-checks","rows":[["spf","pass","SPF record present, 1 DNS lookup, ~all qualifier"]]}]},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"properties":{"domain":{"description":"The domain to audit, e.g. example.com (also accepts a URL or host).","type":"string"},"format":{"description":"Response shape (default markdown report).","enum":["markdown","json"],"type":"string"}},"required":["domain"],"type":"object"},"bodyType":{"enum":["json","form-data","text"],"type":"string"},"method":{"enum":["POST"],"type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method","bodyType","body"],"type":"object"},"output":{"properties":{"example":{"properties":{"composite":{"type":"integer"},"domain":{"type":"string"},"grade":{"type":"string"},"meta":{"type":"object"},"report":{"type":"string"},"sources":{"type":"array"},"tables":{"type":"array"}},"required":["report","domain","grade","composite","sources","tables","meta"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}},"builder-code":{"info":{"a":"bc_b4aw4uzd"},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false,"properties":{"a":{"description":"App builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"},"s":{"description":"Service builder codes","items":{"pattern":"^[a-z0-9_]{1,32}$","type":"string"},"maxItems":11,"type":"array"},"w":{"description":"Wallet builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"}},"type":"object"}},"payment-identifier":{"info":{"required":false},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"id":{"maxLength":128,"minLength":16,"pattern":"^[a-zA-Z0-9_-]+$","type":"string"},"required":{"type":"boolean"}},"required":["required"],"type":"object"}}},"iconUrl":"https://res.cloudinary.com/bdb-prod/image/upload/c_fill,ar_1:1,w_256,h_256,f_auto,q_auto/v1788138502/bazaar-icons/478aced8e219894c.png","lastUpdated":"2026-09-11T12:03:03.544Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-11T12:03:03.284Z"},"resource":"https://agent402.tools/v1/domain-audit/pro","serviceName":"Domain security audit - PRO","tags":["llm","security","domain","email","deliverability"],"type":"http","x402Version":2},{"accepts":[{"amount":"600000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","outputSchema":{"properties":{"composite":{"type":"integer"},"domain":{"type":"string"},"grade":{"type":"string"},"meta":{"type":"object"},"report":{"type":"string"},"sources":{"type":"array"},"tables":{"type":"array"}},"required":["report","domain","grade","composite","sources","tables","meta"],"type":"object"},"payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0x754704Bc059F8C67012fEd69BC8A327a5aafb603","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:143","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0xB97EF9Ef8734C71904D8002F8b6Bc66Dd9c48a6E","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:43114","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0xe15fC38F6D8c56aF07bbCBe3BAf5708A2Bf42392","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:1329","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"601000","asset":"0x0b2C639c533813f4Aa9D7837CAf62653d097Ff85","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:10","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0x5fc5360D0400a0Fd4f2af552ADD042D716F1d168","extra":{"name":"Global Dollar","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:4663","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0xcebA9300f2b948710d2653dD7B07f33A8B32118C","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42220","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"}],"description":"Hand over a domain and get one graded security \u0026 email-deliverability audit: SPF, DMARC, DKIM and MX (why your mail lands in spam), the web security headers, and the TLS certificate - every finding from a live probe, with an overall letter grade, a downloadable checks appendix, and a prioritized, specific list of fixes. USDC (x402/MPP) or card (Stripe). Not cached.","extensions":{"bazaar":{"info":{"input":{"body":{"domain":"example.com"},"bodyType":"json","method":"POST","type":"http"},"output":{"example":{"composite":82,"domain":"example.com","grade":"B","meta":{"composite":82,"domain":"example.com","email_score":90,"grade":"B","header_score":70,"synthesis_model":"anthropic/claude-opus-5","tier":"domain-audit","tls_days_remaining":204},"report":"# Domain Security Audit: example.com\n\n**Overall grade: B** (82/100)\n\n## Overall grade\n...","sources":[],"tables":[{"columns":["Check","Status","Detail"],"label":"Email authentication checks","name":"email-checks","rows":[["spf","pass","SPF record present, 1 DNS lookup, ~all qualifier"]]}]},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"properties":{"domain":{"description":"The domain to audit, e.g. example.com (also accepts a URL or host).","type":"string"},"format":{"description":"Response shape (default markdown report).","enum":["markdown","json"],"type":"string"}},"required":["domain"],"type":"object"},"bodyType":{"enum":["json","form-data","text"],"type":"string"},"method":{"enum":["POST"],"type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method","bodyType","body"],"type":"object"},"output":{"properties":{"example":{"properties":{"composite":{"type":"integer"},"domain":{"type":"string"},"grade":{"type":"string"},"meta":{"type":"object"},"report":{"type":"string"},"sources":{"type":"array"},"tables":{"type":"array"}},"required":["report","domain","grade","composite","sources","tables","meta"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}},"builder-code":{"info":{"a":"bc_b4aw4uzd"},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false,"properties":{"a":{"description":"App builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"},"s":{"description":"Service builder codes","items":{"pattern":"^[a-z0-9_]{1,32}$","type":"string"},"maxItems":11,"type":"array"},"w":{"description":"Wallet builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"}},"type":"object"}},"payment-identifier":{"info":{"required":false},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"id":{"maxLength":128,"minLength":16,"pattern":"^[a-zA-Z0-9_-]+$","type":"string"},"required":{"type":"boolean"}},"required":["required"],"type":"object"}}},"iconUrl":"https://res.cloudinary.com/bdb-prod/image/upload/c_fill,ar_1:1,w_256,h_256,f_auto,q_auto/v1788138502/bazaar-icons/478aced8e219894c.png","lastUpdated":"2026-09-11T12:01:50.666Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-11T12:01:50.396Z"},"resource":"https://agent402.tools/v1/domain-audit","serviceName":"Domain security \u0026","tags":["llm","security","domain","email","deliverability"],"type":"http","x402Version":2},{"accepts":[{"amount":"850000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","outputSchema":{"properties":{"cik":{"type":"string"},"manager":{"type":"string"},"meta":{"type":"object"},"report":{"type":"string"},"sources":{"type":"array"},"tables":{"type":"array"}},"required":["report","manager","cik","sources","tables","meta"],"type":"object"},"payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0x754704Bc059F8C67012fEd69BC8A327a5aafb603","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:143","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0xB97EF9Ef8734C71904D8002F8b6Bc66Dd9c48a6E","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:43114","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0xe15fC38F6D8c56aF07bbCBe3BAf5708A2Bf42392","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:1329","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"851000","asset":"0x0b2C639c533813f4Aa9D7837CAf62653d097Ff85","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:10","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0x5fc5360D0400a0Fd4f2af552ADD042D716F1d168","extra":{"name":"Global Dollar","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:4663","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0xcebA9300f2b948710d2653dD7B07f33A8B32118C","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42220","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"}],"description":"The deep tier: the full holdings table, wider quarter-over-quarter change analysis, more grounded web research, and a longer cited report on the manager's positioning. USDC or card (Stripe). Not cached.","extensions":{"bazaar":{"info":{"input":{"body":{"manager":"Scion Asset Management"},"bodyType":"json","method":"POST","type":"http"},"output":{"example":{"cik":"0001234567","manager":"Example Capital Management LLC","meta":{"cik":"0001234567","exited_positions":2,"manager":"Example Capital Management LLC","new_positions":3,"portfolio_value_usd":4200000000,"positions":42,"report_period":"2025-09-30","sources_cited":8,"synthesis_model":"anthropic/claude-opus-5","tier":"fund-report-max"},"report":"# Fund Portfolio Report: Example Capital (CIK 0001234567)\n\n## Snapshot\nExample Capital reported a $4.2B 13F portfolio across 42 positions...\n\n## Sources\n[1] 13F-HR holdings filed ... - https://www.sec.gov/...","sources":[{"n":1,"title":"13F-HR holdings filed 2025-11-14 (period 2025-09-30) - SEC EDGAR","url":"https://www.sec.gov/..."}],"tables":[{"columns":["Issuer","CUSIP","Action","Shares","Prior shares","Shares change","Value (USD)"],"label":"Quarter-over-quarter changes","name":"changes","rows":[["APPLE INC","037833100","ADD","905560000","850000000","55560000","176558000000"]]}]},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"properties":{"cik":{"description":"SEC CIK of the manager (alternative to manager/ticker).","type":"string"},"format":{"description":"Response shape (default markdown report).","enum":["markdown","json"],"type":"string"},"manager":{"description":"Institutional manager: a fund/firm name (e.g. \"Berkshire Hathaway\"), a ticker, or a SEC CIK.","type":"string"},"ticker":{"description":"US ticker of a publicly-traded manager (alternative to manager/cik).","type":"string"}},"type":"object"},"bodyType":{"enum":["json","form-data","text"],"type":"string"},"method":{"enum":["POST"],"type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method","bodyType","body"],"type":"object"},"output":{"properties":{"example":{"properties":{"cik":{"type":"string"},"manager":{"type":"string"},"meta":{"type":"object"},"report":{"type":"string"},"sources":{"type":"array"},"tables":{"type":"array"}},"required":["report","manager","cik","sources","tables","meta"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}},"builder-code":{"info":{"a":"bc_b4aw4uzd"},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false,"properties":{"a":{"description":"App builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"},"s":{"description":"Service builder codes","items":{"pattern":"^[a-z0-9_]{1,32}$","type":"string"},"maxItems":11,"type":"array"},"w":{"description":"Wallet builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"}},"type":"object"}},"payment-identifier":{"info":{"required":false},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"id":{"maxLength":128,"minLength":16,"pattern":"^[a-zA-Z0-9_-]+$","type":"string"},"required":{"type":"boolean"}},"required":["required"],"type":"object"}}},"iconUrl":"https://res.cloudinary.com/bdb-prod/image/upload/c_fill,ar_1:1,w_256,h_256,f_auto,q_auto/v1788138502/bazaar-icons/478aced8e219894c.png","lastUpdated":"2026-09-11T12:00:59.841Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-11T12:00:59.59Z"},"resource":"https://agent402.tools/v1/fund/max","serviceName":"Fund portfolio report - MAX","tags":["llm","research","13f","fund","institutional"],"type":"http","x402Version":2},{"accepts":[{"amount":"600000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","outputSchema":{"properties":{"cik":{"type":"string"},"manager":{"type":"string"},"meta":{"type":"object"},"report":{"type":"string"},"sources":{"type":"array"},"tables":{"type":"array"}},"required":["report","manager","cik","sources","tables","meta"],"type":"object"},"payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0x754704Bc059F8C67012fEd69BC8A327a5aafb603","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:143","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0xB97EF9Ef8734C71904D8002F8b6Bc66Dd9c48a6E","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:43114","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0xe15fC38F6D8c56aF07bbCBe3BAf5708A2Bf42392","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:1329","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"601000","asset":"0x0b2C639c533813f4Aa9D7837CAf62653d097Ff85","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:10","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0x5fc5360D0400a0Fd4f2af552ADD042D716F1d168","extra":{"name":"Global Dollar","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:4663","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"600000","asset":"0xcebA9300f2b948710d2653dD7B07f33A8B32118C","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42220","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"}],"description":"Hand over an institutional manager (a fund name like \"Berkshire Hathaway\", a ticker, or a SEC CIK) and get one cited report on what they hold and what they BOUGHT, ADDED, TRIMMED, and EXITED last quarter - diffed from their two most recent SEC 13F-HR filings, with a downloadable holdings + changes appendix. Data a chatbot can't reach (parsed live off SEC EDGAR). One payment, one report. USDC (x402/MPP) or card (Stripe). Not cached.","extensions":{"bazaar":{"info":{"input":{"body":{"manager":"Berkshire Hathaway"},"bodyType":"json","method":"POST","type":"http"},"output":{"example":{"cik":"0001234567","manager":"Example Capital Management LLC","meta":{"cik":"0001234567","exited_positions":2,"manager":"Example Capital Management LLC","new_positions":3,"portfolio_value_usd":4200000000,"positions":42,"report_period":"2025-09-30","sources_cited":8,"synthesis_model":"anthropic/claude-opus-5","tier":"fund-report"},"report":"# Fund Portfolio Report: Example Capital (CIK 0001234567)\n\n## Snapshot\nExample Capital reported a $4.2B 13F portfolio across 42 positions...\n\n## Sources\n[1] 13F-HR holdings filed ... - https://www.sec.gov/...","sources":[{"n":1,"title":"13F-HR holdings filed 2025-11-14 (period 2025-09-30) - SEC EDGAR","url":"https://www.sec.gov/..."}],"tables":[{"columns":["Issuer","CUSIP","Action","Shares","Prior shares","Shares change","Value (USD)"],"label":"Quarter-over-quarter changes","name":"changes","rows":[["APPLE INC","037833100","ADD","905560000","850000000","55560000","176558000000"]]}]},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"properties":{"cik":{"description":"SEC CIK of the manager (alternative to manager/ticker).","type":"string"},"format":{"description":"Response shape (default markdown report).","enum":["markdown","json"],"type":"string"},"manager":{"description":"Institutional manager: a fund/firm name (e.g. \"Berkshire Hathaway\"), a ticker, or a SEC CIK.","type":"string"},"ticker":{"description":"US ticker of a publicly-traded manager (alternative to manager/cik).","type":"string"}},"type":"object"},"bodyType":{"enum":["json","form-data","text"],"type":"string"},"method":{"enum":["POST"],"type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method","bodyType","body"],"type":"object"},"output":{"properties":{"example":{"properties":{"cik":{"type":"string"},"manager":{"type":"string"},"meta":{"type":"object"},"report":{"type":"string"},"sources":{"type":"array"},"tables":{"type":"array"}},"required":["report","manager","cik","sources","tables","meta"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}},"builder-code":{"info":{"a":"bc_b4aw4uzd"},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false,"properties":{"a":{"description":"App builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"},"s":{"description":"Service builder codes","items":{"pattern":"^[a-z0-9_]{1,32}$","type":"string"},"maxItems":11,"type":"array"},"w":{"description":"Wallet builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"}},"type":"object"}},"payment-identifier":{"info":{"required":false},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"id":{"maxLength":128,"minLength":16,"pattern":"^[a-zA-Z0-9_-]+$","type":"string"},"required":{"type":"boolean"}},"required":["required"],"type":"object"}}},"iconUrl":"https://res.cloudinary.com/bdb-prod/image/upload/c_fill,ar_1:1,w_256,h_256,f_auto,q_auto/v1788138502/bazaar-icons/478aced8e219894c.png","lastUpdated":"2026-09-11T11:59:45.068Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-11T11:59:44.797Z"},"resource":"https://agent402.tools/v1/fund","serviceName":"Fund portfolio report (13F,","tags":["llm","research","13f","fund","institutional"],"type":"http","x402Version":2},{"accepts":[{"amount":"1100000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","outputSchema":{"properties":{"company":{"type":"string"},"dossier":{"type":"string"},"meta":{"type":"object"},"sources":{"type":"array"},"tables":{"type":"array"},"ticker":{"type":"string"}},"required":["dossier","company","ticker","sources","tables","meta"],"type":"object"},"payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"1100000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"1100000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"1100000","asset":"0x754704Bc059F8C67012fEd69BC8A327a5aafb603","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:143","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"1100000","asset":"0xB97EF9Ef8734C71904D8002F8b6Bc66Dd9c48a6E","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:43114","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"1100000","asset":"0xe15fC38F6D8c56aF07bbCBe3BAf5708A2Bf42392","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:1329","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"1101000","asset":"0x0b2C639c533813f4Aa9D7837CAf62653d097Ff85","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:10","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"1100000","asset":"0x5fc5360D0400a0Fd4f2af552ADD042D716F1d168","extra":{"name":"Global Dollar","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:4663","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"1100000","asset":"0xcebA9300f2b948710d2653dD7B07f33A8B32118C","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42220","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"}],"description":"The exhaustive due-diligence tier: more filings, a full year of Form 4 insider activity, wider web research (up to 8 angles), the widest source set, and a ~2,800-word cited dossier with a full source table. For a decision that warrants real diligence. USDC or card (Stripe). Not cached.","extensions":{"bazaar":{"info":{"input":{"body":{"focus":["debt","litigation"],"ticker":"AAPL"},"bodyType":"json","method":"POST","type":"http"},"output":{"example":{"company":"Example Corp","dossier":"# Due-Diligence Dossier: Example Corp (EXMP)\n\n## Snapshot\nExample Corp trades at ... [1]\n\n## Sources\n[1] 10-K filed ... - https://www.sec.gov/...","meta":{"company":"Example Corp","filings_10k":1,"filings_10q":3,"filings_8k":5,"insider_filings":8,"sources_cited":18,"synthesis_model":"anthropic/claude-opus-5","ticker":"EXMP","tier":"dossier-max","web_angles":4},"sources":[{"n":1,"title":"10-K filed 2025-11-01 - SEC EDGAR","url":"https://www.sec.gov/..."}],"tables":[{"columns":["Metric","Latest annual","Annual period","Most recent","Recent period"],"label":"SEC XBRL financials","name":"financials","rows":[["Total revenue","$1.2B","FY 2024 10-K filed 2025-11-01","$0.3B","2025-09-30 (10-Q)"]]}],"ticker":"EXMP"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"properties":{"focus":{"description":"Optional aspects to emphasize (\u003c= 8), e.g. [\"litigation\", \"debt\"].","items":{"type":"string"},"type":"array"},"format":{"description":"Response shape (default markdown dossier).","enum":["markdown","json"],"type":"string"},"ticker":{"description":"US stock ticker to investigate, e.g. AAPL.","type":"string"}},"required":["ticker"],"type":"object"},"bodyType":{"enum":["json","form-data","text"],"type":"string"},"method":{"enum":["POST"],"type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method","bodyType","body"],"type":"object"},"output":{"properties":{"example":{"properties":{"company":{"type":"string"},"dossier":{"type":"string"},"meta":{"type":"object"},"sources":{"type":"array"},"tables":{"type":"array"},"ticker":{"type":"string"}},"required":["dossier","company","ticker","sources","tables","meta"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}},"builder-code":{"info":{"a":"bc_b4aw4uzd"},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false,"properties":{"a":{"description":"App builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"},"s":{"description":"Service builder codes","items":{"pattern":"^[a-z0-9_]{1,32}$","type":"string"},"maxItems":11,"type":"array"},"w":{"description":"Wallet builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"}},"type":"object"}},"payment-identifier":{"info":{"required":false},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"id":{"maxLength":128,"minLength":16,"pattern":"^[a-zA-Z0-9_-]+$","type":"string"},"required":{"type":"boolean"}},"required":["required"],"type":"object"}}},"iconUrl":"https://res.cloudinary.com/bdb-prod/image/upload/c_fill,ar_1:1,w_256,h_256,f_auto,q_auto/v1788138502/bazaar-icons/478aced8e219894c.png","lastUpdated":"2026-09-11T11:58:41.051Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-11T11:58:40.374Z"},"resource":"https://agent402.tools/v1/dossier/max","serviceName":"Company due-diligence dossier -","tags":["llm","research","due-diligence","company","sec"],"type":"http","x402Version":2},{"accepts":[{"amount":"850000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","outputSchema":{"properties":{"company":{"type":"string"},"dossier":{"type":"string"},"meta":{"type":"object"},"sources":{"type":"array"},"tables":{"type":"array"},"ticker":{"type":"string"}},"required":["dossier","company","ticker","sources","tables","meta"],"type":"object"},"payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0x754704Bc059F8C67012fEd69BC8A327a5aafb603","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:143","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0xB97EF9Ef8734C71904D8002F8b6Bc66Dd9c48a6E","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:43114","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0xe15fC38F6D8c56aF07bbCBe3BAf5708A2Bf42392","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:1329","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"851000","asset":"0x0b2C639c533813f4Aa9D7837CAf62653d097Ff85","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:10","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0x5fc5360D0400a0Fd4f2af552ADD042D716F1d168","extra":{"name":"Global Dollar","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:4663","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0xcebA9300f2b948710d2653dD7B07f33A8B32118C","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42220","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"}],"description":"Hand over a ticker and get one due-diligence dossier back. Pulls the company's SEC EDGAR filings (10-K / 10-Q / 8-K) and Form 4 insider trades, a live quote, and grounded web research on recent developments and risks, then synthesizes a ~2,400-word cited dossier - business, financial posture, insider activity, red flags, and a balanced diligence read. Grounded in real SEC data, not a generic web guess. One payment, one report. USDC (x402/MPP) or card (Stripe). Not cached.","extensions":{"bazaar":{"info":{"input":{"body":{"focus":["risks"],"ticker":"AAPL"},"bodyType":"json","method":"POST","type":"http"},"output":{"example":{"company":"Example Corp","dossier":"# Due-Diligence Dossier: Example Corp (EXMP)\n\n## Snapshot\nExample Corp trades at ... [1]\n\n## Sources\n[1] 10-K filed ... - https://www.sec.gov/...","meta":{"company":"Example Corp","filings_10k":1,"filings_10q":3,"filings_8k":5,"insider_filings":8,"sources_cited":18,"synthesis_model":"anthropic/claude-opus-5","ticker":"EXMP","tier":"dossier","web_angles":4},"sources":[{"n":1,"title":"10-K filed 2025-11-01 - SEC EDGAR","url":"https://www.sec.gov/..."}],"tables":[{"columns":["Metric","Latest annual","Annual period","Most recent","Recent period"],"label":"SEC XBRL financials","name":"financials","rows":[["Total revenue","$1.2B","FY 2024 10-K filed 2025-11-01","$0.3B","2025-09-30 (10-Q)"]]}],"ticker":"EXMP"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"properties":{"focus":{"description":"Optional aspects to emphasize (\u003c= 8), e.g. [\"litigation\", \"debt\"].","items":{"type":"string"},"type":"array"},"format":{"description":"Response shape (default markdown dossier).","enum":["markdown","json"],"type":"string"},"ticker":{"description":"US stock ticker to investigate, e.g. AAPL.","type":"string"}},"required":["ticker"],"type":"object"},"bodyType":{"enum":["json","form-data","text"],"type":"string"},"method":{"enum":["POST"],"type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method","bodyType","body"],"type":"object"},"output":{"properties":{"example":{"properties":{"company":{"type":"string"},"dossier":{"type":"string"},"meta":{"type":"object"},"sources":{"type":"array"},"tables":{"type":"array"},"ticker":{"type":"string"}},"required":["dossier","company","ticker","sources","tables","meta"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}},"builder-code":{"info":{"a":"bc_b4aw4uzd"},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false,"properties":{"a":{"description":"App builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"},"s":{"description":"Service builder codes","items":{"pattern":"^[a-z0-9_]{1,32}$","type":"string"},"maxItems":11,"type":"array"},"w":{"description":"Wallet builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"}},"type":"object"}},"payment-identifier":{"info":{"required":false},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"id":{"maxLength":128,"minLength":16,"pattern":"^[a-zA-Z0-9_-]+$","type":"string"},"required":{"type":"boolean"}},"required":["required"],"type":"object"}}},"iconUrl":"https://res.cloudinary.com/bdb-prod/image/upload/c_fill,ar_1:1,w_256,h_256,f_auto,q_auto/v1788138502/bazaar-icons/478aced8e219894c.png","lastUpdated":"2026-09-11T11:56:51.655Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-11T11:56:51.388Z"},"resource":"https://agent402.tools/v1/dossier","serviceName":"Company due-diligence dossier","tags":["llm","research","due-diligence","company","sec"],"type":"http","x402Version":2},{"accepts":[{"amount":"850000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","outputSchema":{"properties":{"meta":{"properties":{"searches_run":{"type":"integer"},"sources_cited":{"type":"integer"},"sources_consulted":{"type":"integer"},"synthesis_model":{"type":"string"},"tier":{"type":"string"}},"type":"object"},"report":{"type":"string"},"sources":{"items":{"type":"object"},"type":"array"},"sub_questions":{"items":{"type":"string"},"type":"array"}},"required":["report","sources","sub_questions","meta"],"type":"object"},"payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0x754704Bc059F8C67012fEd69BC8A327a5aafb603","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:143","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0xB97EF9Ef8734C71904D8002F8b6Bc66Dd9c48a6E","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:43114","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0xe15fC38F6D8c56aF07bbCBe3BAf5708A2Bf42392","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:1329","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"851000","asset":"0x0b2C639c533813f4Aa9D7837CAf62653d097Ff85","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:10","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0x5fc5360D0400a0Fd4f2af552ADD042D716F1d168","extra":{"name":"Global Dollar","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:4663","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0xcebA9300f2b948710d2653dD7B07f33A8B32118C","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42220","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"}],"description":"Name a market, category or company and get one cited MARKET / COMPETITOR BRIEF: how the market is defined and sized, the key players and what each offers, pricing, recent moves, how they differ, risks and a bottom line - every claim from live web research with citations, nothing from memory. The research pipeline with a competitive-intelligence plan. USDC (x402/MPP) or card (Stripe). Not cached.","extensions":{"bazaar":{"info":{"input":{"body":{"query":"What are the leading agentic-payment protocols in 2026 and how do they differ?","recency":"year"},"bodyType":"json","method":"POST","type":"http"},"output":{"example":{"meta":{"searches_run":3,"sources_cited":12,"sources_consulted":14,"synthesis_model":"anthropic/claude-opus-5","tier":"market-brief"},"report":"# Leading agentic-payment protocols (2026)\n\nThe field splits into stablecoin rails and card rails [1]…\n\n## Sources\n[1] … - https://…","sources":[{"n":1,"rank":0.94,"snippet":"…","title":"…","url":"https://…"}],"sub_questions":["What stablecoin agent-payment protocols exist?","…"]},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"properties":{"focus":{"description":"Optional aspects to emphasize (\u003c= 8).","items":{"type":"string"},"type":"array"},"format":{"description":"Response shape (default markdown report).","enum":["markdown","json"],"type":"string"},"query":{"description":"The research question to investigate (\u003c= 2000 chars).","type":"string"},"recency":{"description":"Prefer sources from this window (default any).","enum":["week","month","year","any"],"type":"string"}},"required":["query"],"type":"object"},"bodyType":{"enum":["json","form-data","text"],"type":"string"},"method":{"enum":["POST"],"type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method","bodyType","body"],"type":"object"},"output":{"properties":{"example":{"properties":{"meta":{"properties":{"searches_run":{"type":"integer"},"sources_cited":{"type":"integer"},"sources_consulted":{"type":"integer"},"synthesis_model":{"type":"string"},"tier":{"type":"string"}},"type":"object"},"report":{"type":"string"},"sources":{"items":{"type":"object"},"type":"array"},"sub_questions":{"items":{"type":"string"},"type":"array"}},"required":["report","sources","sub_questions","meta"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}},"builder-code":{"info":{"a":"bc_b4aw4uzd"},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false,"properties":{"a":{"description":"App builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"},"s":{"description":"Service builder codes","items":{"pattern":"^[a-z0-9_]{1,32}$","type":"string"},"maxItems":11,"type":"array"},"w":{"description":"Wallet builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"}},"type":"object"}},"payment-identifier":{"info":{"required":false},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"id":{"maxLength":128,"minLength":16,"pattern":"^[a-zA-Z0-9_-]+$","type":"string"},"required":{"type":"boolean"}},"required":["required"],"type":"object"}}},"iconUrl":"https://res.cloudinary.com/bdb-prod/image/upload/c_fill,ar_1:1,w_256,h_256,f_auto,q_auto/v1788138502/bazaar-icons/478aced8e219894c.png","lastUpdated":"2026-09-11T11:55:10.142Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-11T11:55:09.907Z"},"resource":"https://agent402.tools/v1/research/market-brief","serviceName":"Market / competitor brief","tags":["llm","research","web-search","grounded","citations"],"type":"http","x402Version":2},{"accepts":[{"amount":"1100000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","outputSchema":{"properties":{"meta":{"properties":{"searches_run":{"type":"integer"},"sources_cited":{"type":"integer"},"sources_consulted":{"type":"integer"},"synthesis_model":{"type":"string"},"tier":{"type":"string"}},"type":"object"},"report":{"type":"string"},"sources":{"items":{"type":"object"},"type":"array"},"sub_questions":{"items":{"type":"string"},"type":"array"}},"required":["report","sources","sub_questions","meta"],"type":"object"},"payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"1100000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"1100000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"1100000","asset":"0x754704Bc059F8C67012fEd69BC8A327a5aafb603","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:143","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"1100000","asset":"0xB97EF9Ef8734C71904D8002F8b6Bc66Dd9c48a6E","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:43114","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"1100000","asset":"0xe15fC38F6D8c56aF07bbCBe3BAf5708A2Bf42392","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:1329","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"1101000","asset":"0x0b2C639c533813f4Aa9D7837CAf62653d097Ff85","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:10","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"1100000","asset":"0x5fc5360D0400a0Fd4f2af552ADD042D716F1d168","extra":{"name":"Global Dollar","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:4663","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"1100000","asset":"0xcebA9300f2b948710d2653dD7B07f33A8B32118C","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42220","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"}],"description":"The exhaustive tier: up to a dozen sub-questions and grounded searches, the widest reranked source set, premium synthesis into a ~2,800-word cited report with a full source table. Our most thorough single-call research report. USDC or card (Stripe). Not cached.","extensions":{"bazaar":{"info":{"input":{"body":{"query":"What are the leading agentic-payment protocols in 2026 and how do they differ?","recency":"year"},"bodyType":"json","method":"POST","type":"http"},"output":{"example":{"meta":{"searches_run":3,"sources_cited":12,"sources_consulted":14,"synthesis_model":"anthropic/claude-opus-5","tier":"research-max"},"report":"# Leading agentic-payment protocols (2026)\n\nThe field splits into stablecoin rails and card rails [1]…\n\n## Sources\n[1] … - https://…","sources":[{"n":1,"rank":0.94,"snippet":"…","title":"…","url":"https://…"}],"sub_questions":["What stablecoin agent-payment protocols exist?","…"]},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"properties":{"focus":{"description":"Optional aspects to emphasize (\u003c= 8).","items":{"type":"string"},"type":"array"},"format":{"description":"Response shape (default markdown report).","enum":["markdown","json"],"type":"string"},"query":{"description":"The research question to investigate (\u003c= 2000 chars).","type":"string"},"recency":{"description":"Prefer sources from this window (default any).","enum":["week","month","year","any"],"type":"string"}},"required":["query"],"type":"object"},"bodyType":{"enum":["json","form-data","text"],"type":"string"},"method":{"enum":["POST"],"type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method","bodyType","body"],"type":"object"},"output":{"properties":{"example":{"properties":{"meta":{"properties":{"searches_run":{"type":"integer"},"sources_cited":{"type":"integer"},"sources_consulted":{"type":"integer"},"synthesis_model":{"type":"string"},"tier":{"type":"string"}},"type":"object"},"report":{"type":"string"},"sources":{"items":{"type":"object"},"type":"array"},"sub_questions":{"items":{"type":"string"},"type":"array"}},"required":["report","sources","sub_questions","meta"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}},"builder-code":{"info":{"a":"bc_b4aw4uzd"},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false,"properties":{"a":{"description":"App builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"},"s":{"description":"Service builder codes","items":{"pattern":"^[a-z0-9_]{1,32}$","type":"string"},"maxItems":11,"type":"array"},"w":{"description":"Wallet builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"}},"type":"object"}},"payment-identifier":{"info":{"required":false},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"id":{"maxLength":128,"minLength":16,"pattern":"^[a-zA-Z0-9_-]+$","type":"string"},"required":{"type":"boolean"}},"required":["required"],"type":"object"}}},"iconUrl":"https://res.cloudinary.com/bdb-prod/image/upload/c_fill,ar_1:1,w_256,h_256,f_auto,q_auto/v1788138502/bazaar-icons/478aced8e219894c.png","lastUpdated":"2026-09-11T11:53:25.401Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-11T11:53:25.178Z"},"resource":"https://agent402.tools/v1/research/max","serviceName":"Deep research report - MAX","tags":["llm","research","web-search","grounded","citations"],"type":"http","x402Version":2},{"accepts":[{"amount":"850000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","outputSchema":{"properties":{"meta":{"properties":{"searches_run":{"type":"integer"},"sources_cited":{"type":"integer"},"sources_consulted":{"type":"integer"},"synthesis_model":{"type":"string"},"tier":{"type":"string"}},"type":"object"},"report":{"type":"string"},"sources":{"items":{"type":"object"},"type":"array"},"sub_questions":{"items":{"type":"string"},"type":"array"}},"required":["report","sources","sub_questions","meta"],"type":"object"},"payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:137","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0xaf88d065e77c8cC2239327C5EDb3A432268e5831","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42161","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0x754704Bc059F8C67012fEd69BC8A327a5aafb603","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:143","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0xB97EF9Ef8734C71904D8002F8b6Bc66Dd9c48a6E","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:43114","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0xe15fC38F6D8c56aF07bbCBe3BAf5708A2Bf42392","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:1329","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"851000","asset":"0x0b2C639c533813f4Aa9D7837CAf62653d097Ff85","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:10","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0x5fc5360D0400a0Fd4f2af552ADD042D716F1d168","extra":{"name":"Global Dollar","version":"1"},"maxTimeoutSeconds":300,"network":"eip155:4663","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"},{"amount":"850000","asset":"0xcebA9300f2b948710d2653dD7B07f33A8B32118C","extra":{"name":"USDC","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:42220","payTo":"0xaBF4FAbd7c416fB67202E5f9002389Fc75e2a9D0","scheme":"exact"}],"description":"The deeper research tier: more sub-questions, more grounded searches, wider reranked source set, and a premium (Claude Opus class) synthesis into a ~2,200-word cited report with structured findings. For questions worth a real dossier. USDC or card (Stripe). Not cached.","extensions":{"bazaar":{"info":{"input":{"body":{"query":"What are the leading agentic-payment protocols in 2026 and how do they differ?","recency":"year"},"bodyType":"json","method":"POST","type":"http"},"output":{"example":{"meta":{"searches_run":3,"sources_cited":12,"sources_consulted":14,"synthesis_model":"anthropic/claude-opus-5","tier":"research-pro"},"report":"# Leading agentic-payment protocols (2026)\n\nThe field splits into stablecoin rails and card rails [1]…\n\n## Sources\n[1] … - https://…","sources":[{"n":1,"rank":0.94,"snippet":"…","title":"…","url":"https://…"}],"sub_questions":["What stablecoin agent-payment protocols exist?","…"]},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"properties":{"focus":{"description":"Optional aspects to emphasize (\u003c= 8).","items":{"type":"string"},"type":"array"},"format":{"description":"Response shape (default markdown report).","enum":["markdown","json"],"type":"string"},"query":{"description":"The research question to investigate (\u003c= 2000 chars).","type":"string"},"recency":{"description":"Prefer sources from this window (default any).","enum":["week","month","year","any"],"type":"string"}},"required":["query"],"type":"object"},"bodyType":{"enum":["json","form-data","text"],"type":"string"},"method":{"enum":["POST"],"type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method","bodyType","body"],"type":"object"},"output":{"properties":{"example":{"properties":{"meta":{"properties":{"searches_run":{"type":"integer"},"sources_cited":{"type":"integer"},"sources_consulted":{"type":"integer"},"synthesis_model":{"type":"string"},"tier":{"type":"string"}},"type":"object"},"report":{"type":"string"},"sources":{"items":{"type":"object"},"type":"array"},"sub_questions":{"items":{"type":"string"},"type":"array"}},"required":["report","sources","sub_questions","meta"],"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}},"builder-code":{"info":{"a":"bc_b4aw4uzd"},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","additionalProperties":false,"properties":{"a":{"description":"App builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"},"s":{"description":"Service builder codes","items":{"pattern":"^[a-z0-9_]{1,32}$","type":"string"},"maxItems":11,"type":"array"},"w":{"description":"Wallet builder code","pattern":"^[a-z0-9_]{1,32}$","type":"string"}},"type":"object"}},"payment-identifier":{"info":{"required":false},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"id":{"maxLength":128,"minLength":16,"pattern":"^[a-zA-Z0-9_-]+$","type":"string"},"required":{"type":"boolean"}},"required":["required"],"type":"object"}}},"iconUrl":"https://res.cloudinary.com/bdb-prod/image/upload/c_fill,ar_1:1,w_256,h_256,f_auto,q_auto/v1788138502/bazaar-icons/478aced8e219894c.png","lastUpdated":"2026-09-11T11:51:41.488Z","quality":{"l30DaysTotalCalls":1,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-11T11:51:41.235Z"},"resource":"https://agent402.tools/v1/research/pro","serviceName":"Deep research report - PRO","tags":["llm","research","web-search","grounded","citations"],"type":"http","x402Version":2},{"accepts":[{"amount":"7000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxAmountRequired":"7000","maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0x8D0663BBb967ebF1c047405A888DDf865f3E8854","scheme":"exact"}],"description":"APEX Runner: Altcoin Season Signal","extensions":{"bazaar":{"category":"trading-signals","description":"Altcoin season rotation index 0-100 for crypto markets. Returns current phase (altcoin season vs bitcoin season) and top rotating sector. Shift BTC/altcoin allocation on Kraken, Coinbase, Hyperliquid.","example":{"index":42,"signal":"bitcoin_season","top_sector":"L1"},"info":{"input":{"method":"GET","type":"http"},"output":{"example":{"index":42,"signal":"bitcoin_season","top_sector":"L1"},"index":"integer — altcoin season index 0-100 (\u003e75 = altcoin season, \u003c25 = bitcoin season)","signal":"string — market phase: altcoin_season, bitcoin_season, or neutral","top_sector":"string — strongest rotating sector: L1, DeFi, AI, Meme, or RWA","type":"json"}},"name":"Altcoin Season Index","outputSchema":{"index":"integer 0-100","signal":"string","top_sector":"string"},"schema":{"properties":{"input":{"properties":{"queryParams":{"properties":{},"type":"object"}},"required":["method"],"type":"object"},"output":{"properties":{"example":{"properties":{"_apex":{"properties":{"evolution_runs":{"type":"integer"},"instance":{"type":"string"},"live_capital_deployed":{"type":"boolean"},"live_trading":{"type":"boolean"},"signal":{"type":"string"},"signal_hash":{"type":"string"},"source":{"type":"string"},"trades_backing_signal":{"type":"integer"},"trades_backing_signal_as_of":{"type":"string"},"trading_status":{"type":"string"},"verify_at":{"type":"string"},"version":{"type":"string"}},"type":"object"},"action":{"type":"string"},"altseason_index":{"type":"integer"},"btc_dominance":{"type":"number"},"components":{"properties":{"altcoin_performance_score":{"type":"integer"},"dominance_score":{"type":"integer"},"fear_greed_score":{"type":"integer"}},"type":"object"},"computed_at":{"type":"string"},"data_age_seconds":{"type":"integer"},"fear_greed":{"type":"integer"},"max_age_seconds":{"type":"integer"},"season_label":{"type":"string"},"stale":{"type":"boolean"}},"type":"object"}},"type":"object"}},"type":"object"},"version":"1.0.0"}},"lastUpdated":"2026-10-08T06:25:44.061Z","quality":{"l30DaysTotalCalls":5,"l30DaysUniquePayers":5,"lastCalledAt":"2026-10-08T06:25:43.894Z"},"resource":"https://apexrunner.ai/signals/altcoin-season","type":"http","x402Version":2},{"accepts":[{"amount":"7000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxAmountRequired":"7000","maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0x8D0663BBb967ebF1c047405A888DDf865f3E8854","scheme":"exact"}],"description":"APEX Runner: Apex Pulse Signal","extensions":{"bazaar":{"category":"trading-signals","description":"Ultra-cheap $0.01 heartbeat for AI agents running health checks every few hours. Returns current APEX system status, BTC market regime, Fear \u0026 Greed value, and total active trading pairs across all 3 exchanges in one fast call.","example":{"active_pairs":11,"apex_trading":true,"fg":42,"fg_label":"Fear","market":"OPEN","regime":"RANGING","status":"LIVE","timestamp":"2026-06-17T22:00:00Z","valid_for_seconds":60},"info":{"input":{"method":"GET","type":"http"},"output":{"active_pairs":"integer — total distinct trading pairs with open positions across all 3 exchanges","apex_trading":"boolean — true if APEX grid bots have active positions","example":{"active_pairs":11,"apex_trading":true,"fg":42,"fg_label":"Fear","market":"OPEN","regime":"RANGING","status":"LIVE","valid_for_seconds":60},"fg":"integer — Fear \u0026 Greed index value 0-100","fg_label":"string — Fear \u0026 Greed classification label","market":"string — always OPEN (crypto trades 24/7)","regime":"string — current BTC market regime: RANGING, TRENDING, CRISIS, or CHOPPY","status":"string — LIVE / DEGRADED / DOWN","type":"json"}},"name":"APEX Pulse Heartbeat","outputSchema":{"active_pairs":"integer","apex_trading":"boolean","fg":"integer","fg_label":"string","regime":"string","status":"string LIVE/DEGRADED/DOWN"},"schema":{"properties":{"input":{"properties":{"queryParams":{"properties":{},"type":"object"}},"required":["method"],"type":"object"},"output":{"properties":{"example":{"properties":{"_apex":{"properties":{"evolution_runs":{"type":"integer"},"instance":{"type":"string"},"live_capital_deployed":{"type":"boolean"},"live_trading":{"type":"boolean"},"signal":{"type":"string"},"signal_hash":{"type":"string"},"source":{"type":"string"},"trades_backing_signal":{"type":"integer"},"trades_backing_signal_as_of":{"type":"string"},"trading_status":{"type":"string"},"verify_at":{"type":"string"},"version":{"type":"string"}},"type":"object"},"active_pairs":{"type":"integer"},"apex_trading":{"type":"boolean"},"btc_price":{"type":"number"},"data_age_seconds":{"type":"integer"},"fg":{"type":"integer"},"fg_label":{"type":"string"},"max_age_seconds":{"type":"integer"},"regime":{"type":"string"},"stale":{"type":"boolean"},"status":{"type":"string"},"timestamp":{"type":"string"},"valid_for_seconds":{"type":"integer"}},"type":"object"}},"type":"object"}},"type":"object"},"version":"1.0.0"}},"lastUpdated":"2026-10-08T06:25:41.589Z","quality":{"l30DaysTotalCalls":5,"l30DaysUniquePayers":5,"lastCalledAt":"2026-10-08T06:25:41.429Z"},"resource":"https://apexrunner.ai/signals/apex-pulse","type":"http","x402Version":2},{"accepts":[{"amount":"10000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0x4D7d842536De9Eb491AE2300126B3CDdE7B0aDE3","scheme":"exact"}],"description":"KG-NINJA Agent Error Fix Receipt","extensions":{"bazaar":{"info":{"input":{"body":{"command":"npm run build","environment":"Node.js Cloudflare Worker build","error":"Error: Cannot find module 'hono'"},"bodyType":"json","method":"POST","type":"http"},"output":{"example":{"durable_revenue_log":true,"input_received":true,"mode":"mainnet","network":"eip155:8453","post_payment_retry_path":"Retry POST /fix-error with x402 payment proof.","real_revenue":true,"receipt":{"generated_at":"2026-06-14T00:00:00.000Z","next_command":"npm install","prevention_note":"Store this error pattern in a runbook and add a preflight check before future runs.","retry_plan":["Confirm the exact failing command.","Run the smallest non-destructive diagnostic command relevant to the error.","Check whether required environment variables, packages, files, or services are present.","Retry the original command once after the minimal fix."],"risk_note":"Do not run destructive cleanup, reset, rm, database, credential, or firewall commands without manual review.","root_cause":"The failure appears related to a missing package, missing file, or unresolved module path."},"request_id":"example-request-id","revenue_proof_log":"paid_fix_error_receipt_issued","service":"Agent Error Fix Receipt","status":"paid","version":"2026-05-25-d1-revenue-log"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"command":{"type":"string"},"environment":{"type":"string"},"error":{"type":"string"},"log":{"type":"string"}},"type":"object"},"bodyType":{"enum":["json","form-data","text"],"type":"string"},"method":{"enum":["POST"],"type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method","bodyType","body"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-02T08:35:34Z","quality":{"l30DaysTotalCalls":5,"l30DaysUniquePayers":5,"lastCalledAt":"2026-10-02T08:35:33.576Z"},"resource":"https://api.kgninja.dev/fix-error","type":"http","x402Version":2},{"accepts":[{"amount":"14000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0x02C2fCAfCe36B4AAdB39625866Bc6B1699d83043","scheme":"exact"}],"description":"Get a LinkedIn post or article by URL.","extensions":{"bazaar":{"info":{"input":{"method":"GET","queryParams":{"url":"https://www.linkedin.com/posts/sundarpichai_small-businesses-are-the-engine-of-the-american-share-7449849038398697472-iNtG"},"type":"http"},"output":{"example":{"data":{"author":{"avatarUrl":"https://media.licdn.com/dms/image/v2/C4D0BAQFN0aCscps4rw/company-logo_100_100/company-logo_100_100/0/1631369783777/bubb…","followers":80080,"name":"Bubble","profileUrl":"https://www.linkedin.com/company/bubble"},"comments":[],"lookupStatus":"found","metrics":{"comments":7,"reactions":30},"post":{"contentType":"post","description":"Today Bubble turns fourteen, and to mark it we're introducing fourteen of our coworkers through the projects they finis…","headline":null,"imageUrl":"https://media.licdn.com/dms/image/v2/D4D1FAQERhqagLKA37g/feedshare-document-images_800/B4DZ_cew68KgAk-/1/1786110482890?…","imageUrls":["https://media.licdn.com/dms/image/v2/D4D1FAQERhqagLKA37g/feedshare-document-images_800/B4DZ_cew68KgAk-/1/1786110482890?…"],"publishedAt":"2026-08-07T15:54:01.132Z","thumbnailUrl":null,"title":null,"url":"https://www.linkedin.com/posts/bubble_fourteen-years-fourteen-makers-activity-7491522044476637184-7QTB","videoUrl":null},"relatedArticles":[]},"meta":{"creditsCharged":1,"requestId":"req_e4d7e6a8-bff7-4302-b135-76594f9cc1d1","version":"v1"}},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"method":{"enum":["GET"],"type":"string"},"queryParams":{"properties":{"url":{"description":"Public permalink to the post or article.","maxLength":4096,"minLength":1,"type":"string"}},"required":["url"],"type":"object"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}},"payment-identifier":{"info":{"required":false},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"id":{"maxLength":128,"minLength":16,"pattern":"^[a-zA-Z0-9_-]+$","type":"string"},"required":{"type":"boolean"}},"required":["required"],"type":"object"}}},"lastUpdated":"2026-09-23T11:44:17.61Z","quality":{"l30DaysTotalCalls":31,"l30DaysUniquePayers":1,"lastCalledAt":"2026-09-23T11:44:17.445Z"},"resource":"https://api.socialfetch.dev/v1/linkedin/posts","serviceName":"SocialFetch","tags":["LinkedIn","social-data"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0x217e5Fe265EB78b29067bF8324ef03a7D8e167C4","scheme":"exact"}],"description":"A task marketplace for agents. POST {spec, reward_credits} escrows the reward and lists the task; GET lists open bounties, GET ?id=X reads one task (any state) incl. its full spec. Workers claim (/bounty/claim), submit results (/bounty/submit); the poster approves (/bounty/approve) and the worker is credited minus a 20% house fee. TO POST: hold reward_credits credits first (POST /credits/buy, $0.010 each); short balance answers 409.","extensions":{"bazaar":{"info":{"input":{"method":"GET","queryParams":{"id":"(optional) Xy1…"},"type":"http"},"output":{"example":{"bounties":[{"id":"Xy1…","reward_credits":20,"spec":{"task":"summarize"},"state":"open"}]},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"properties":{"method":{"const":"GET"},"queryParams":{"properties":{"id":{"type":"string"}},"required":["id"],"type":"object"}},"required":["method"],"type":"object"}}}}},"lastUpdated":"2026-10-07T02:52:49.118Z","quality":{"l30DaysTotalCalls":9,"l30DaysUniquePayers":4,"lastCalledAt":"2026-10-07T02:52:48.573Z"},"resource":"https://x402.shizu.me/bounty","serviceName":"Agent Bounty Board","tags":["bounty","marketplace","tasks","labor","agent-commerce"],"type":"http","x402Version":2},{"accepts":[{"amount":"10000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"billing":{"description":"amount is the price and is charged in full when you pay, and is not returned if delivery fails: this rail settles once and cannot give change. (Exact entries appear only on fixed-price requests - ceiling-priced requests are offered the reserve-and-pay-actual entry instead.)","model":"prepaid"},"name":"USD Coin","version":"2","zeroclick":{"agentPaymentId":"apay_8uXbRKc1QRqF1SQemVfvh","kind":"transaction","zcRequestId":"zcreq_nSZ8r_BuGs7_wlqxLVL6k"}},"maxTimeoutSeconds":300,"network":"eip155:8453","payTo":"0x348ac9e3b010ba2300ba9a7bcfe5ae592b9fcfaa","scheme":"exact"}],"description":"Current tournament standings.","extensions":{"bazaar":{"info":{"input":{"body":{},"bodyType":"json","method":"POST","type":"http"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"properties":{"event_urn":{"type":"string"},"league":{"default":"1","type":"string"},"provider_event_id":{"type":"string"},"season":{"default":"2026","type":"string"}},"type":"object"},"bodyType":{"enum":["json","form-data","text"],"type":"string"},"method":{"enum":["POST","PUT","PATCH"],"type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method","bodyType","body"],"type":"object"}},"required":["input"],"type":"object"}},"terms":{"info":{"links":[{"kind":"platform_terms_of_service","url":"https://www.zeroclick.ai/legal/buyer-terms-of-service"}],"note":"By paying this challenge, whether directly or through an agent acting on your behalf, you accept the platform's buyer terms of service; an agent's payment and acceptance are attributed to you and bind you as if you had taken them yourself."},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"links":{"items":{"properties":{"kind":{"enum":["terms_of_service","privacy_policy","additional_terms","platform_terms_of_service"],"type":"string"},"url":{"type":"string"}},"required":["kind","url"],"type":"object"},"type":"array"},"note":{"type":"string"}},"required":["links"],"type":"object"}},"zeroclick":{"info":{"payment":{"amountUsd":"0.010000","id":"apay_8uXbRKc1QRqF1SQemVfvh"},"requestId":"zcreq_nSZ8r_BuGs7_wlqxLVL6k","service":"match-context"},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"agentId":{"type":"string"},"payment":{"properties":{"amountUsd":{"type":"string"},"id":{"type":"string"}},"required":["id","amountUsd"],"type":"object"},"requestId":{"type":"string"},"service":{"type":"string"}},"required":["payment"],"type":"object"}}},"iconUrl":"https://res.cloudinary.com/bdb-prod/image/upload/c_fill,ar_1:1,w_256,h_256,f_auto,q_auto/v1788462366/bazaar-icons/c17701753a1511e2.png","lastUpdated":"2026-10-08T06:26:55.195Z","quality":{"l30DaysTotalCalls":20,"l30DaysUniquePayers":5,"lastCalledAt":"2026-10-08T06:26:54.765Z"},"resource":"https://agents.machina.gg/world-cup/v1/get-standings","serviceName":"Machina Sports","tags":["world-cup","football","sports-data","forecasts","match-content"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/finnegan","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Modified Finnegan NAS from Maguire 2013 Table 1 (operational modified FNAS; not a 31-item website variant; not Maguire's 7-item short form). Exclusive cry, sleep, Moro, tremor, fever, respiratory, and stool bands plus true/false CNS, vasomotor, and GI items. Sum 0-46. at_or_above_8 iff score \u003e= 8. magent does not examine the infant. Not Eat Sleep Console. Not a morphine order, diagnosis, or medical device.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"crying":"none","excessive_sucking":false,"excoriation":false,"fever":"none","frequent_yawning":false,"generalized_convulsions":false,"increased_muscle_tone":false,"moro":"none","mottling":false,"myoclonic_jerk":false,"nasal_flaring":false,"nasal_stuffiness":false,"poor_feeding":false,"projectile_vomiting":false,"regurgitation":false,"respiratory":"none","sleep":"none","sneezing":false,"stools":"none","sweating":false,"tremors":"none"},{"crying":"none","excessive_sucking":false,"excoriation":false,"fever":"none","frequent_yawning":false,"generalized_convulsions":false,"increased_muscle_tone":false,"moro":"none","mottling":false,"myoclonic_jerk":false,"nasal_flaring":false,"nasal_stuffiness":false,"poor_feeding":false,"projectile_vomiting":false,"regurgitation":false,"respiratory":"none","sleep":"none","sneezing":false,"stools":"none","sweating":false,"tremors":"none"}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"at_or_above_8":false,"citation":{"authors":"Finnegan LP, Connaughton JF Jr, Kron RE, Emich JP","id":"finnegan-1975","pmid":"1163358","source":"Addict Dis. 1975;2(1-2):141-158","title":"Neonatal abstinence syndrome: assessment and management"},"components":[{"factor":"crying","points":0,"present":false,"value":"none"},{"factor":"sleep","points":0,"present":false,"value":"none"},{"factor":"moro","points":0,"present":false,"value":"none"},{"factor":"tremors","points":0,"present":false,"value":"none"},{"factor":"increased_muscle_tone","points":0,"present":false},{"factor":"myoclonic_jerk","points":0,"present":false},{"factor":"generalized_convulsions","points":0,"present":false},{"factor":"excoriation","points":0,"present":false},{"factor":"sweating","points":0,"present":false},{"factor":"fever","points":0,"present":false,"value":"none"},{"factor":"frequent_yawning","points":0,"present":false},{"factor":"mottling","points":0,"present":false},{"factor":"nasal_stuffiness","points":0,"present":false},{"factor":"sneezing","points":0,"present":false},{"factor":"nasal_flaring","points":0,"present":false},{"factor":"respiratory","points":0,"present":false,"value":"none"},{"factor":"excessive_sucking","points":0,"present":false},{"factor":"poor_feeding","points":0,"present":false},{"factor":"regurgitation","points":0,"present":false},{"factor":"projectile_vomiting","points":0,"present":false},{"factor":"stools","points":0,"present":false,"value":"none"}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"finnegan","formula_expression":"FNAS = crying + sleep + moro + tremors + increased_muscle_tone + myoclonic_jerk + generalized_convulsions + excoriation + sweating + fever + frequent_yawning + mottling + nasal_stuffiness + sneezing + nasal_flaring + respiratory + excessive_sucking + poor_feeding + regurgitation + projectile_vomiting + stools; Maguire 2013 Table 1 modified Finnegan (exclusive cry/sleep/moro/tremors/fever/respiratory/stools; remaining items true/false); max 46; at_or_above_8 iff total \u003e= 8 (Zimmermann-Baer / Maguire suspicion and pharmacologic-treatment threshold). Not Eat Sleep Console. Not Maguire 7-item short form. magent does not examine the infant. Not a morphine order.","max_score":46,"score":0},{"at_or_above_8":false,"citation":{"authors":"Finnegan LP, Connaughton JF Jr, Kron RE, Emich JP","id":"finnegan-1975","pmid":"1163358","source":"Addict Dis. 1975;2(1-2):141-158","title":"Neonatal abstinence syndrome: assessment and management"},"components":[{"factor":"crying","points":0,"present":false,"value":"none"},{"factor":"sleep","points":0,"present":false,"value":"none"},{"factor":"moro","points":0,"present":false,"value":"none"},{"factor":"tremors","points":0,"present":false,"value":"none"},{"factor":"increased_muscle_tone","points":0,"present":false},{"factor":"myoclonic_jerk","points":0,"present":false},{"factor":"generalized_convulsions","points":0,"present":false},{"factor":"excoriation","points":0,"present":false},{"factor":"sweating","points":0,"present":false},{"factor":"fever","points":0,"present":false,"value":"none"},{"factor":"frequent_yawning","points":0,"present":false},{"factor":"mottling","points":0,"present":false},{"factor":"nasal_stuffiness","points":0,"present":false},{"factor":"sneezing","points":0,"present":false},{"factor":"nasal_flaring","points":0,"present":false},{"factor":"respiratory","points":0,"present":false,"value":"none"},{"factor":"excessive_sucking","points":0,"present":false},{"factor":"poor_feeding","points":0,"present":false},{"factor":"regurgitation","points":0,"present":false},{"factor":"projectile_vomiting","points":0,"present":false},{"factor":"stools","points":0,"present":false,"value":"none"}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"finnegan","formula_expression":"FNAS = crying + sleep + moro + tremors + increased_muscle_tone + myoclonic_jerk + generalized_convulsions + excoriation + sweating + fever + frequent_yawning + mottling + nasal_stuffiness + sneezing + nasal_flaring + respiratory + excessive_sucking + poor_feeding + regurgitation + projectile_vomiting + stools; Maguire 2013 Table 1 modified Finnegan (exclusive cry/sleep/moro/tremors/fever/respiratory/stools; remaining items true/false); max 46; at_or_above_8 iff total \u003e= 8 (Zimmermann-Baer / Maguire suspicion and pharmacologic-treatment threshold). Not Eat Sleep Console. Not Maguire 7-item short form. magent does not examine the infant. Not a morphine order.","max_score":46,"score":0}],"path":"/api/calc/finnegan"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"crying":{"description":"Caller-assigned Maguire 2013 Table 1 crying (none, excessive_high_pitched, or continuous_high_pitched). Exclusive. none 0, excessive_high_pitched 2, continuous_high_pitched 3. magent does not examine the infant.","enum":["none","excessive_high_pitched","continuous_high_pitched"],"type":"string"},"excessive_sucking":{"description":"Caller-assigned Maguire 2013 Table 1 excessive sucking. true scores 1. magent does not observe feeding.","type":"boolean"},"excoriation":{"description":"Caller-assigned Maguire 2013 Table 1 excoriation. Single item (not per-site nose, knees, or toes). true scores 1. magent does not inspect the skin.","type":"boolean"},"fever":{"description":"Caller-assigned Maguire 2013 Table 1 fever (none, lt_101f, or gt_101f). Exclusive. Maguire \u003c101°F scores 1; \u003e101°F scores 2. magent does not take a temperature.","enum":["none","lt_101f","gt_101f"],"type":"string"},"frequent_yawning":{"description":"Caller-assigned Maguire 2013 Table 1 frequent yawning (\u003e3). true scores 1. magent does not observe yawning.","type":"boolean"},"generalized_convulsions":{"description":"Caller-assigned Maguire 2013 Table 1 generalized convulsions. true scores 5. magent does not examine the infant. Not a seizure diagnosis.","type":"boolean"},"increased_muscle_tone":{"description":"Caller-assigned Maguire 2013 Table 1 increased muscle tone. true scores 2. magent does not examine the infant.","type":"boolean"},"moro":{"description":"Caller-assigned Maguire 2013 Table 1 Moro reflex (none, hyperactive, or markedly_hyperactive). Exclusive. hyperactive 2, markedly_hyperactive 3. magent does not examine the infant.","enum":["none","hyperactive","markedly_hyperactive"],"type":"string"},"mottling":{"description":"Caller-assigned Maguire 2013 Table 1 mottling. true scores 1. magent does not examine the infant.","type":"boolean"},"myoclonic_jerk":{"description":"Caller-assigned Maguire 2013 Table 1 myoclonic jerks. true scores 3. magent does not examine the infant.","type":"boolean"},"nasal_flaring":{"description":"Caller-assigned Maguire 2013 Table 1 nasal flaring. true scores 2. magent does not examine the infant.","type":"boolean"},"nasal_stuffiness":{"description":"Caller-assigned Maguire 2013 Table 1 nasal stuffiness. true scores 1. magent does not examine the infant.","type":"boolean"},"poor_feeding":{"description":"Caller-assigned Maguire 2013 Table 1 poor feeding. true scores 2. magent does not observe feeding.","type":"boolean"},"projectile_vomiting":{"description":"Caller-assigned Maguire 2013 Table 1 projectile vomiting. true scores 3. magent does not observe feeding.","type":"boolean"},"regurgitation":{"description":"Caller-assigned Maguire 2013 Table 1 regurgitation. true scores 2. magent does not observe feeding.","type":"boolean"},"respiratory":{"description":"Caller-assigned Maguire 2013 Table 1 respiratory rate (none, gt_60, or gt_60_retractions). Exclusive. Rate \u003e60/min scores 1; \u003e60 with retractions scores 2. magent does not count respirations.","enum":["none","gt_60","gt_60_retractions"],"type":"string"},"sleep":{"description":"Caller-assigned Maguire 2013 Table 1 sleep after feeding (none, lt_3h, lt_2h, or lt_1h). Exclusive. Sleeps less than 3/2/1 h after feeding: lt_3h 1, lt_2h 2, lt_1h 3. magent does not observe sleep.","enum":["none","lt_3h","lt_2h","lt_1h"],"type":"string"},"sneezing":{"description":"Caller-assigned Maguire 2013 Table 1 sneezing (\u003e3). true scores 1. magent does not count sneezes.","type":"boolean"},"stools":{"description":"Caller-assigned Maguire 2013 Table 1 stools (none, loose, or watery). Exclusive. loose 2, watery 3. magent does not inspect stools.","enum":["none","loose","watery"],"type":"string"},"sweating":{"description":"Caller-assigned Maguire 2013 Table 1 sweating. true scores 1. magent does not examine the infant.","type":"boolean"},"tremors":{"description":"Caller-assigned Maguire 2013 Table 1 tremors (none, mild_disturbed, moderate_severe_disturbed, mild_undisturbed, or moderate_severe_undisturbed). Exclusive. mild_disturbed 1, moderate_severe_disturbed 2, mild_undisturbed 3, moderate_severe_undisturbed 4. magent does not examine the infant.","enum":["none","mild_disturbed","moderate_severe_disturbed","mild_undisturbed","moderate_severe_undisturbed"],"type":"string"}},"required":["crying","sleep","moro","tremors","increased_muscle_tone","myoclonic_jerk","generalized_convulsions","excoriation","sweating","fever","frequent_yawning","mottling","nasal_stuffiness","sneezing","nasal_flaring","respiratory","excessive_sucking","poor_feeding","regurgitation","projectile_vomiting","stools"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T15:19:02.342Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T15:19:02.184Z"},"resource":"https://api.magentlab.com/api/calc/finnegan","serviceName":"magent","tags":["finnegan","nas","neonatal","modified-fnas","calculator"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/gir","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Neonatal glucose infusion rate (GIR, mg/kg/min) from the unit conversion used with AAP 2011 postnatal glucose homeostasis: GIR = (dextrose_percent x rate_ml_h) / (6 x weight_kg), or (dextrose_percent x rate_ml_kg_h) / 6. Provide rate_ml_h plus weight_kg, or rate_ml_kg_h, not both rate styles. Dextrose 2.5-25% and weight 0.4-10 kg are magent clamps, not AAP input bands. Reports GIR only. Does not order dextrose or TPN. Not a medical device.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"dextrose_percent":10,"rate_ml_h":7.5,"rate_ml_kg_h":2.5,"weight_kg":3},{"dextrose_percent":10,"rate_ml_h":7.5,"rate_ml_kg_h":2.5,"weight_kg":3}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"citation":{"authors":"Adamkin DH; Committee on Fetus and Newborn, American Academy of Pediatrics","doi":"10.1542/peds.2010-3851","id":"aap-2011-glucose","pmid":"21357346","source":"Pediatrics. 2011;127(3):575-579","title":"Postnatal glucose homeostasis in late-preterm and term infants"},"dextrose_percent":10,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"gir","formula_expression":"gir_mg_kg_min = (dextrose_percent × rate_ml_h) / (6 × weight_kg); equivalently (dextrose_percent × rate_ml_kg_h) / 6","gir_mg_kg_min":4.2,"rate_ml_h":7.5,"rate_ml_kg_h":2.5,"weight_kg":3},{"citation":{"authors":"Adamkin DH; Committee on Fetus and Newborn, American Academy of Pediatrics","doi":"10.1542/peds.2010-3851","id":"aap-2011-glucose","pmid":"21357346","source":"Pediatrics. 2011;127(3):575-579","title":"Postnatal glucose homeostasis in late-preterm and term infants"},"dextrose_percent":10,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"gir","formula_expression":"gir_mg_kg_min = (dextrose_percent × rate_ml_h) / (6 × weight_kg); equivalently (dextrose_percent × rate_ml_kg_h) / 6","gir_mg_kg_min":4.2,"rate_ml_h":7.5,"rate_ml_kg_h":2.5,"weight_kg":3}],"path":"/api/calc/gir"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"dextrose_percent":{"description":"Dextrose concentration as percent (2.5-25, magent clamp; AAP 2011 does not publish an input band). 10 is D10W. magent does not order dextrose.","type":"number"},"rate_ml_h":{"description":"Infusion rate in ml/h (0.5-200, magent clamp; AAP 2011 does not publish an input band). Provide this with weight_kg, or provide rate_ml_kg_h, not both rate styles.","type":"number"},"rate_ml_kg_h":{"description":"Infusion rate in ml/kg/h (0.5-20, magent clamp). GIR = (dextrose_percent × rate_ml_kg_h) / 6. Provide this or rate_ml_h plus weight_kg, not both rate styles.","type":"number"},"weight_kg":{"description":"Weight in kg (0.4-10, magent clamp; AAP 2011 does not publish an input band). Required with rate_ml_h. Not required when rate_ml_kg_h is the only rate. magent does not weigh the infant.","type":"number"}},"required":["dextrose_percent"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T15:18:47.898Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T15:18:47.768Z"},"resource":"https://api.magentlab.com/api/calc/gir","serviceName":"magent","tags":["gir","glucose-infusion","neonatal","dextrose","calculator"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/mrc_icu","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Gwynn 2019 MRC-ICU: 39 printed ICU medication and device items (1, 2, or 3 points). Multiplier classes are weight × the caller-assigned count of qualifying medications. Non-multiplier items add the printed weight when present. Output is the integer sum plus components. Not a pharmacist-staffing order; magent does not read the MAR.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"aminoglycosides":0,"amphotericin_b":false,"antiarrhythmics":0,"anticoagulants":0,"anticonvulsants":0,"antimicrobials":0,"argatroban":false,"azole_antifungals":0,"blood_products":0,"bowel_regimen":false,"chemotherapy":0,"chlorhexidine":false,"clozapine":false,"continuous_infusions":0,"continuous_opioids_sedatives":0,"dialysis":false,"digoxin":false,"ecmo":false,"ganciclovir_valganciclovir":0,"glycemic_control":false,"hyperosmolar_fluids":0,"iabp":false,"immunosuppressants":0,"lidocaine_infusion":false,"lithium":false,"lvad":false,"mechanical_ventilation":false,"neuromuscular_blockade":false,"opioids_sedatives":0,"prostacyclins":0,"restricted_antimicrobials":0,"stress_ulcer_prophylaxis":false,"theophylline":false,"therapeutic_heparins":0,"thromboembolic_prophylaxis":false,"tpn_clinical_pharmacist":false,"tpn_non_pharmacist":false,"vancomycin_iv":false,"warfarin":false},{"aminoglycosides":0,"amphotericin_b":false,"antiarrhythmics":0,"anticoagulants":0,"anticonvulsants":0,"antimicrobials":0,"argatroban":false,"azole_antifungals":0,"blood_products":0,"bowel_regimen":false,"chemotherapy":0,"chlorhexidine":false,"clozapine":false,"continuous_infusions":0,"continuous_opioids_sedatives":0,"dialysis":false,"digoxin":false,"ecmo":false,"ganciclovir_valganciclovir":0,"glycemic_control":false,"hyperosmolar_fluids":0,"iabp":false,"immunosuppressants":0,"lidocaine_infusion":false,"lithium":false,"lvad":false,"mechanical_ventilation":false,"neuromuscular_blockade":false,"opioids_sedatives":0,"prostacyclins":0,"restricted_antimicrobials":0,"stress_ulcer_prophylaxis":false,"theophylline":false,"therapeutic_heparins":0,"thromboembolic_prophylaxis":false,"tpn_clinical_pharmacist":false,"tpn_non_pharmacist":false,"vancomycin_iv":false,"warfarin":false}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"citation":{"authors":"Gwynn ME, Poisson MO, Waller JL, Newsome AS","doi":"10.1093/ajhp/zxy054","id":"gwynn-2019","pmid":"31067298","source":"Am J Health Syst Pharm. 2019;76(Supplement_2):S34-S40","title":"Development and validation of a medication regimen complexity scoring tool for critically ill patients"},"components":[{"factor":"aminoglycosides","points":0,"present":false,"value":0},{"factor":"amphotericin_b","points":0,"present":false},{"factor":"antiarrhythmics","points":0,"present":false,"value":0},{"factor":"anticoagulants","points":0,"present":false,"value":0},{"factor":"anticonvulsants","points":0,"present":false,"value":0},{"factor":"argatroban","points":0,"present":false},{"factor":"azole_antifungals","points":0,"present":false,"value":0},{"factor":"blood_products","points":0,"present":false,"value":0},{"factor":"chemotherapy","points":0,"present":false,"value":0},{"factor":"clozapine","points":0,"present":false},{"factor":"digoxin","points":0,"present":false},{"factor":"ganciclovir_valganciclovir","points":0,"present":false,"value":0},{"factor":"hyperosmolar_fluids","points":0,"present":false,"value":0},{"factor":"immunosuppressants","points":0,"present":false,"value":0},{"factor":"lidocaine_infusion","points":0,"present":false},{"factor":"lithium","points":0,"present":false},{"factor":"prostacyclins","points":0,"present":false,"value":0},{"factor":"theophylline","points":0,"present":false},{"factor":"therapeutic_heparins","points":0,"present":false,"value":0},{"factor":"vancomycin_iv","points":0,"present":false},{"factor":"warfarin","points":0,"present":false},{"factor":"neuromuscular_blockade","points":0,"present":false},{"factor":"continuous_infusions","points":0,"present":false,"value":0},{"factor":"tpn_non_pharmacist","points":0,"present":false},{"factor":"tpn_clinical_pharmacist","points":0,"present":false},{"factor":"thromboembolic_prophylaxis","points":0,"present":false},{"factor":"stress_ulcer_prophylaxis","points":0,"present":false},{"factor":"glycemic_control","points":0,"present":false},{"factor":"bowel_regimen","points":0,"present":false},{"factor":"chlorhexidine","points":0,"present":false},{"factor":"opioids_sedatives","points":0,"present":false,"value":0},{"factor":"continuous_opioids_sedatives","points":0,"present":false,"value":0},{"factor":"antimicrobials","points":0,"present":false,"value":0},{"factor":"restricted_antimicrobials","points":0,"present":false,"value":0},{"factor":"dialysis","points":0,"present":false},{"factor":"ecmo","points":0,"present":false},{"factor":"iabp","points":0,"present":false},{"factor":"lvad","points":0,"present":false},{"factor":"mechanical_ventilation","points":0,"present":false}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"mrc_icu","formula_expression":"MRC-ICU (Gwynn 2019) = sum of 39 printed item weights. Multiplier classes (printed ×) are weight × caller-assigned count of qualifying medications (0-20): aminoglycosides 3, antiarrhythmics 1, anticoagulants 1, anticonvulsants 3, azole_antifungals 2, blood_products 2, chemotherapy 3, ganciclovir_valganciclovir 1, hyperosmolar_fluids 1, immunosuppressants 3, prostacyclins 2, therapeutic_heparins 2, continuous_infusions 1, opioids_sedatives 1, continuous_opioids_sedatives 2, antimicrobials 1, restricted_antimicrobials 2. Flags add the printed weight when present: amphotericin_b 1, argatroban 2, clozapine 3, digoxin 3, lidocaine_infusion 2, lithium 3, theophylline 3, vancomycin_iv 3, warfarin 3, neuromuscular_blockade 2, tpn_non_pharmacist 1, tpn_clinical_pharmacist 3, thromboembolic_prophylaxis 1, stress_ulcer_prophylaxis 1, glycemic_control 1, bowel_regimen 1, chlorhexidine 1, dialysis 2, ecmo 2, iabp 1, lvad 1, mechanical_ventilation 2","score":0},{"citation":{"authors":"Gwynn ME, Poisson MO, Waller JL, Newsome AS","doi":"10.1093/ajhp/zxy054","id":"gwynn-2019","pmid":"31067298","source":"Am J Health Syst Pharm. 2019;76(Supplement_2):S34-S40","title":"Development and validation of a medication regimen complexity scoring tool for critically ill patients"},"components":[{"factor":"aminoglycosides","points":0,"present":false,"value":0},{"factor":"amphotericin_b","points":0,"present":false},{"factor":"antiarrhythmics","points":0,"present":false,"value":0},{"factor":"anticoagulants","points":0,"present":false,"value":0},{"factor":"anticonvulsants","points":0,"present":false,"value":0},{"factor":"argatroban","points":0,"present":false},{"factor":"azole_antifungals","points":0,"present":false,"value":0},{"factor":"blood_products","points":0,"present":false,"value":0},{"factor":"chemotherapy","points":0,"present":false,"value":0},{"factor":"clozapine","points":0,"present":false},{"factor":"digoxin","points":0,"present":false},{"factor":"ganciclovir_valganciclovir","points":0,"present":false,"value":0},{"factor":"hyperosmolar_fluids","points":0,"present":false,"value":0},{"factor":"immunosuppressants","points":0,"present":false,"value":0},{"factor":"lidocaine_infusion","points":0,"present":false},{"factor":"lithium","points":0,"present":false},{"factor":"prostacyclins","points":0,"present":false,"value":0},{"factor":"theophylline","points":0,"present":false},{"factor":"therapeutic_heparins","points":0,"present":false,"value":0},{"factor":"vancomycin_iv","points":0,"present":false},{"factor":"warfarin","points":0,"present":false},{"factor":"neuromuscular_blockade","points":0,"present":false},{"factor":"continuous_infusions","points":0,"present":false,"value":0},{"factor":"tpn_non_pharmacist","points":0,"present":false},{"factor":"tpn_clinical_pharmacist","points":0,"present":false},{"factor":"thromboembolic_prophylaxis","points":0,"present":false},{"factor":"stress_ulcer_prophylaxis","points":0,"present":false},{"factor":"glycemic_control","points":0,"present":false},{"factor":"bowel_regimen","points":0,"present":false},{"factor":"chlorhexidine","points":0,"present":false},{"factor":"opioids_sedatives","points":0,"present":false,"value":0},{"factor":"continuous_opioids_sedatives","points":0,"present":false,"value":0},{"factor":"antimicrobials","points":0,"present":false,"value":0},{"factor":"restricted_antimicrobials","points":0,"present":false,"value":0},{"factor":"dialysis","points":0,"present":false},{"factor":"ecmo","points":0,"present":false},{"factor":"iabp","points":0,"present":false},{"factor":"lvad","points":0,"present":false},{"factor":"mechanical_ventilation","points":0,"present":false}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"mrc_icu","formula_expression":"MRC-ICU (Gwynn 2019) = sum of 39 printed item weights. Multiplier classes (printed ×) are weight × caller-assigned count of qualifying medications (0-20): aminoglycosides 3, antiarrhythmics 1, anticoagulants 1, anticonvulsants 3, azole_antifungals 2, blood_products 2, chemotherapy 3, ganciclovir_valganciclovir 1, hyperosmolar_fluids 1, immunosuppressants 3, prostacyclins 2, therapeutic_heparins 2, continuous_infusions 1, opioids_sedatives 1, continuous_opioids_sedatives 2, antimicrobials 1, restricted_antimicrobials 2. Flags add the printed weight when present: amphotericin_b 1, argatroban 2, clozapine 3, digoxin 3, lidocaine_infusion 2, lithium 3, theophylline 3, vancomycin_iv 3, warfarin 3, neuromuscular_blockade 2, tpn_non_pharmacist 1, tpn_clinical_pharmacist 3, thromboembolic_prophylaxis 1, stress_ulcer_prophylaxis 1, glycemic_control 1, bowel_regimen 1, chlorhexidine 1, dialysis 2, ecmo 2, iabp 1, lvad 1, mechanical_ventilation 2","score":0}],"path":"/api/calc/mrc_icu"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"aminoglycosides":{"description":"Count of aminoglycosides (amikacin, gentamicin, tobramycin) as assigned by the caller (integer 0-20). Gwynn 2019 printed 3×. magent does not read the MAR.","type":"integer"},"amphotericin_b":{"description":"Amphotericin B or liposomal amphotericin B present as assigned by the caller (Gwynn 2019). true adds 1 point.","type":"boolean"},"antiarrhythmics":{"description":"Count of antiarrhythmics (amiodarone, dofetilide, sotalol) as assigned by the caller (integer 0-20). Gwynn 2019 printed 1×.","type":"integer"},"anticoagulants":{"description":"Count of anticoagulants (NOACs/DOACs, fondaparinux) as assigned by the caller (integer 0-20). Gwynn 2019 printed 1×.","type":"integer"},"anticonvulsants":{"description":"Count of anticonvulsants (carbamazepine, phenobarbital, phenytoin, valproic acid) as assigned by the caller (integer 0-20). Gwynn 2019 printed 3×.","type":"integer"},"antimicrobials":{"description":"Count of antimicrobials including HIV medications and excluding agents listed on other Gwynn 2019 rows, as assigned by the caller (integer 0-20). Printed 1×.","type":"integer"},"argatroban":{"description":"Argatroban present as assigned by the caller (Gwynn 2019). true adds 2 points.","type":"boolean"},"azole_antifungals":{"description":"Count of azole antifungals (posaconazole, voriconazole) as assigned by the caller (integer 0-20). Gwynn 2019 printed 2×.","type":"integer"},"blood_products":{"description":"Count of blood products (factor products, antithrombin III) as assigned by the caller (integer 0-20). Gwynn 2019 printed 2×.","type":"integer"},"bowel_regimen":{"description":"Bowel regimen present as assigned by the caller (Gwynn 2019). true adds 1 point.","type":"boolean"},"chemotherapy":{"description":"Count of active inpatient chemotherapy agents as assigned by the caller (integer 0-20). Gwynn 2019 printed 3×.","type":"integer"},"chlorhexidine":{"description":"Chlorhexidine present as assigned by the caller (Gwynn 2019). true adds 1 point.","type":"boolean"},"clozapine":{"description":"Clozapine present as assigned by the caller (Gwynn 2019). true adds 3 points.","type":"boolean"},"continuous_infusions":{"description":"Count of continuous infusions not listed on another Gwynn 2019 row, as assigned by the caller (integer 0-20). Printed 1×.","type":"integer"},"continuous_opioids_sedatives":{"description":"Count of continuous-infusion opioids and sedatives (propofol, fentanyl, dexmedetomidine, ketamine, benzodiazepines) as assigned by the caller (integer 0-20). Gwynn 2019 printed 2×.","type":"integer"},"dialysis":{"description":"Dialysis present as assigned by the caller (Gwynn 2019). true adds 2 points.","type":"boolean"},"digoxin":{"description":"Digoxin present as assigned by the caller (Gwynn 2019). true adds 3 points.","type":"boolean"},"ecmo":{"description":"Extracorporeal membrane oxygenation (ECMO) present as assigned by the caller (Gwynn 2019). true adds 2 points.","type":"boolean"},"ganciclovir_valganciclovir":{"description":"Count of ganciclovir or valganciclovir products as assigned by the caller (integer 0-20). Gwynn 2019 printed 1×.","type":"integer"},"glycemic_control":{"description":"Glycemic control with subcutaneous insulin, excluding intravenous insulin, as assigned by the caller (Gwynn 2019). true adds 1 point.","type":"boolean"},"hyperosmolar_fluids":{"description":"Count of hyperosmolar fluids (hypertonic saline 1.5%, 3%, 23.4%; mannitol) as assigned by the caller (integer 0-20). Gwynn 2019 printed 1×.","type":"integer"},"iabp":{"description":"Intra-aortic balloon pump (IABP) present as assigned by the caller (Gwynn 2019). true adds 1 point.","type":"boolean"},"immunosuppressants":{"description":"Count of immunosuppressants (cyclosporine, sirolimus, tacrolimus) as assigned by the caller (integer 0-20). Gwynn 2019 printed 3×.","type":"integer"},"lidocaine_infusion":{"description":"Lidocaine continuous infusion present as assigned by the caller (Gwynn 2019). true adds 2 points.","type":"boolean"},"lithium":{"description":"Lithium present as assigned by the caller (Gwynn 2019). true adds 3 points.","type":"boolean"},"lvad":{"description":"Left ventricular assist device (LVAD) present as assigned by the caller (Gwynn 2019). true adds 1 point.","type":"boolean"},"mechanical_ventilation":{"description":"Mechanical ventilation present as assigned by the caller (Gwynn 2019). true adds 2 points.","type":"boolean"},"neuromuscular_blockade":{"description":"Neuromuscular blockade present as assigned by the caller (Gwynn 2019). true adds 2 points.","type":"boolean"},"opioids_sedatives":{"description":"Count of scheduled or PRN opioids and sedatives as assigned by the caller (integer 0-20). Gwynn 2019 printed 1×.","type":"integer"},"prostacyclins":{"description":"Count of prostacyclins (epoprostenol, iloprost, treprostinil) as assigned by the caller (integer 0-20). Gwynn 2019 printed 2×.","type":"integer"},"restricted_antimicrobials":{"description":"Count of restricted antimicrobials (4th-5th generation cephalosporins, carbapenems, linezolid, daptomycin, colistin/polymyxins) as assigned by the caller (integer 0-20). Gwynn 2019 printed 2×.","type":"integer"},"stress_ulcer_prophylaxis":{"description":"Stress ulcer prophylaxis present, excluding pantoprazole infusion, as assigned by the caller (Gwynn 2019). true adds 1 point.","type":"boolean"},"theophylline":{"description":"Theophylline present as assigned by the caller (Gwynn 2019). true adds 3 points.","type":"boolean"},"therapeutic_heparins":{"description":"Count of therapeutic heparins (enoxaparin, heparin infusion) as assigned by the caller (integer 0-20). Gwynn 2019 printed 2×.","type":"integer"},"thromboembolic_prophylaxis":{"description":"Thromboembolic prophylaxis present, excluding heparin infusion and therapeutic enoxaparin, as assigned by the caller (Gwynn 2019). true adds 1 point.","type":"boolean"},"tpn_clinical_pharmacist":{"description":"Total parenteral nutrition managed by a clinical specialist pharmacist as assigned by the caller (Gwynn 2019). true adds 3 points.","type":"boolean"},"tpn_non_pharmacist":{"description":"Total parenteral nutrition managed by a non-pharmacist service as assigned by the caller (Gwynn 2019). true adds 1 point.","type":"boolean"},"vancomycin_iv":{"description":"Intravenous vancomycin present as assigned by the caller (Gwynn 2019). true adds 3 points.","type":"boolean"},"warfarin":{"description":"Warfarin present as assigned by the caller (Gwynn 2019). true adds 3 points.","type":"boolean"}},"required":["aminoglycosides","amphotericin_b","antiarrhythmics","anticoagulants","anticonvulsants","argatroban","azole_antifungals","blood_products","chemotherapy","clozapine","digoxin","ganciclovir_valganciclovir","hyperosmolar_fluids","immunosuppressants","lidocaine_infusion","lithium","prostacyclins","theophylline","therapeutic_heparins","vancomycin_iv","warfarin","neuromuscular_blockade","continuous_infusions","tpn_non_pharmacist","tpn_clinical_pharmacist","thromboembolic_prophylaxis","stress_ulcer_prophylaxis","glycemic_control","bowel_regimen","chlorhexidine","opioids_sedatives","continuous_opioids_sedatives","antimicrobials","restricted_antimicrobials","dialysis","ecmo","iabp","lvad","mechanical_ventilation"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T15:17:37.375Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T15:17:37.212Z"},"resource":"https://api.magentlab.com/api/calc/mrc_icu","serviceName":"magent","tags":["mrc-icu","icu","medication-complexity","gwynn-2019"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/periop_doac","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Douketis 2022 ACCP elective perioperative DOAC interruption (PAUSE-style, recommendations 22-25). Returns hold_days_before and resume_days_after from INN (apixaban, rivaroxaban, edoxaban, dabigatran) and bleed_risk. dabigatran also needs caller-assigned CrCl. heparin_bridge is always false (recommendation 26). Not warfarin, not urgent surgery, not a prescription. magent does not assay CrCl.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"bleed_risk":"low_to_moderate","crcl_ml_min":40,"doac":"apixaban"},{"bleed_risk":"low_to_moderate","crcl_ml_min":40,"doac":"apixaban"}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"bleed_risk":"low_to_moderate","citation":{"authors":"Douketis JD, Spyropoulos AC, Murad MH, et al.","doi":"10.1016/j.chest.2022.07.025","id":"douketis-2022","pmid":"35964704","source":"Chest. 2022;162(5):e207-e243","title":"Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline"},"criteria":[{"factor":"doac","met":true,"value":"apixaban"},{"factor":"high_bleed_risk","met":false,"value":"low_to_moderate"},{"factor":"dabigatran","met":false},{"factor":"dabigatran_crcl_lt_50","met":false}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","doac":"apixaban","formula":"periop_doac","formula_expression":"Douketis 2022 PAUSE-style elective DOAC interruption (recommendations 22-25): apixaban/rivaroxaban/edoxaban hold 1 day (low_to_moderate) or 2 days (high); dabigatran CrCl\u003e=50 same 1/2; dabigatran CrCl\u003c50 hold 2 (low_to_moderate) or 4 (high); resume 1 day after low_to_moderate or 2 days after high; heparin_bridge always false (recommendation 26)","heparin_bridge":false,"hold_days_before":1,"resume_days_after":1,"total_pre_post_days":2},{"bleed_risk":"low_to_moderate","citation":{"authors":"Douketis JD, Spyropoulos AC, Murad MH, et al.","doi":"10.1016/j.chest.2022.07.025","id":"douketis-2022","pmid":"35964704","source":"Chest. 2022;162(5):e207-e243","title":"Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline"},"criteria":[{"factor":"doac","met":true,"value":"apixaban"},{"factor":"high_bleed_risk","met":false,"value":"low_to_moderate"},{"factor":"dabigatran","met":false},{"factor":"dabigatran_crcl_lt_50","met":false}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","doac":"apixaban","formula":"periop_doac","formula_expression":"Douketis 2022 PAUSE-style elective DOAC interruption (recommendations 22-25): apixaban/rivaroxaban/edoxaban hold 1 day (low_to_moderate) or 2 days (high); dabigatran CrCl\u003e=50 same 1/2; dabigatran CrCl\u003c50 hold 2 (low_to_moderate) or 4 (high); resume 1 day after low_to_moderate or 2 days after high; heparin_bridge always false (recommendation 26)","heparin_bridge":false,"hold_days_before":1,"resume_days_after":1,"total_pre_post_days":2}],"path":"/api/calc/periop_doac"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"bleed_risk":{"description":"Procedure bleed-risk category from Douketis 2022, case-insensitive: low_to_moderate or high. Caller assigns the category. Not urgent surgery.","enum":["low_to_moderate","high"],"type":"string"},"crcl_ml_min":{"description":"Caller-assigned creatinine clearance in mL/min (15-120). Required only when doac is dabigatran. Must be absent for apixaban, rivaroxaban, and edoxaban. magent does not assay CrCl.","type":"number"},"doac":{"description":"Direct oral anticoagulant INN, case-insensitive: apixaban, rivaroxaban, edoxaban, or dabigatran. Elective procedures only. Not warfarin or a VKA.","enum":["apixaban","rivaroxaban","edoxaban","dabigatran"],"type":"string"}},"required":["doac","bleed_risk"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T15:15:13.852Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T15:15:13.742Z"},"resource":"https://api.magentlab.com/api/calc/periop_doac","serviceName":"magent","tags":["periop-doac","doac","hematology","perioperative","anticoagulation"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/gps","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Forrest 2003 original Glasgow Prognostic Score (GPS) from CRP in mg/L and albumin. Elevated CRP is \u003e10 mg/L; hypoalbuminaemia is albumin \u003c35 g/L. Assign 1 for CRP \u003e10 and 1 for albumin \u003c35, then sum: GPS 0 when CRP ≤10 and albumin ≥35; GPS 1 when CRP ≤10 and albumin \u003c35 (isolated hypoalbuminaemia) or CRP \u003e10 and albumin ≥35; GPS 2 when CRP \u003e10 and albumin \u003c35. Not mGPS, not hs-mGPS, not a cancer diagnosis or treatment order. magent does not assay CRP or albumin.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"albumin_g_dl":4,"albumin_g_l":40,"crp_mg_l":5},{"albumin_g_dl":4,"albumin_g_l":40,"crp_mg_l":5}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"albumin_g_l":40,"citation":{"authors":"Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ","doi":"10.1038/sj.bjc.6601242","id":"forrest-2003","pmid":"12966420","source":"Br J Cancer. 2003;89(6):1028-1030","title":"Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer"},"crp_mg_l":5,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"gps","formula_expression":"GPS 0: CRP ≤ 10 mg/L AND albumin ≥ 35 g/L; GPS 1: CRP ≤ 10 mg/L AND albumin \u003c 35 g/L (isolated hypoalbuminaemia) OR CRP \u003e 10 mg/L AND albumin ≥ 35 g/L; GPS 2: CRP \u003e 10 mg/L AND albumin \u003c 35 g/L (Forrest 2003 original GPS)","gps":0},{"albumin_g_l":40,"citation":{"authors":"Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ","doi":"10.1038/sj.bjc.6601242","id":"forrest-2003","pmid":"12966420","source":"Br J Cancer. 2003;89(6):1028-1030","title":"Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer"},"crp_mg_l":5,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"gps","formula_expression":"GPS 0: CRP ≤ 10 mg/L AND albumin ≥ 35 g/L; GPS 1: CRP ≤ 10 mg/L AND albumin \u003c 35 g/L (isolated hypoalbuminaemia) OR CRP \u003e 10 mg/L AND albumin ≥ 35 g/L; GPS 2: CRP \u003e 10 mg/L AND albumin \u003c 35 g/L (Forrest 2003 original GPS)","gps":0}],"path":"/api/calc/gps"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"albumin_g_dl":{"description":"Serum albumin in g/dL (1-6). Converted as g/L = g/dL × 10. Provide this or albumin_g_l, not both.","type":"number"},"albumin_g_l":{"description":"Serum albumin in g/L (10-60). Provide this or albumin_g_dl, not both. Forrest 2003 hypoalbuminaemia is \u003c35 g/L (35 is not low). Isolated hypoalbuminaemia scores GPS 1. magent does not assay albumin.","type":"number"},"crp_mg_l":{"description":"C-reactive protein in mg/L (0-500), not mg/dL. Forrest 2003 elevated CRP is \u003e10 mg/L. CRP = 10 is not elevated. magent does not assay CRP.","type":"number"}},"required":["crp_mg_l"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T15:13:55.938Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T15:13:55.791Z"},"resource":"https://api.magentlab.com/api/calc/gps","serviceName":"magent","tags":["gps","hematology","crp","albumin","calculator"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/mgps","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"McMillan 2007 modified Glasgow Prognostic Score (mGPS) from CRP in mg/L and albumin. Elevated CRP is \u003e10 mg/L; hypoalbuminaemia is albumin \u003c35 g/L. mGPS 0 when CRP ≤10 (albumin ignored, including isolated hypoalbuminaemia); mGPS 1 when CRP \u003e10 and albumin ≥35; mGPS 2 when CRP \u003e10 and albumin \u003c35. Not original GPS, not hs-mGPS, not a cancer diagnosis or treatment order. magent does not assay CRP or albumin.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"albumin_g_dl":4,"albumin_g_l":40,"crp_mg_l":5},{"albumin_g_dl":4,"albumin_g_l":40,"crp_mg_l":5}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"albumin_g_l":40,"citation":{"authors":"McMillan DC, Crozier JEM, Canna K, Angerson WJ, McArdle CS","doi":"10.1007/s00384-006-0259-6","id":"mcmillan-2007","pmid":"17245566","source":"Int J Colorectal Dis. 2007;22(8):881-886","title":"Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer"},"crp_mg_l":5,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"mgps","formula_expression":"mGPS 0: CRP ≤ 10 mg/L (albumin ignored); mGPS 1: CRP \u003e 10 mg/L AND albumin ≥ 35 g/L; mGPS 2: CRP \u003e 10 mg/L AND albumin \u003c 35 g/L (McMillan 2007 modified GPS)","mgps":0},{"albumin_g_l":40,"citation":{"authors":"McMillan DC, Crozier JEM, Canna K, Angerson WJ, McArdle CS","doi":"10.1007/s00384-006-0259-6","id":"mcmillan-2007","pmid":"17245566","source":"Int J Colorectal Dis. 2007;22(8):881-886","title":"Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer"},"crp_mg_l":5,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"mgps","formula_expression":"mGPS 0: CRP ≤ 10 mg/L (albumin ignored); mGPS 1: CRP \u003e 10 mg/L AND albumin ≥ 35 g/L; mGPS 2: CRP \u003e 10 mg/L AND albumin \u003c 35 g/L (McMillan 2007 modified GPS)","mgps":0}],"path":"/api/calc/mgps"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"albumin_g_dl":{"description":"Serum albumin in g/dL (1-6). Converted as g/L = g/dL × 10. Provide this or albumin_g_l, not both.","type":"number"},"albumin_g_l":{"description":"Serum albumin in g/L (10-60). Provide this or albumin_g_dl, not both. McMillan 2007 hypoalbuminaemia is \u003c35 g/L (35 is not low). Ignored when CRP ≤ 10 mg/L. magent does not assay albumin.","type":"number"},"crp_mg_l":{"description":"C-reactive protein in mg/L (0-500), not mg/dL. McMillan 2007 elevated CRP is \u003e10 mg/L. CRP = 10 is not elevated and scores mGPS 0 regardless of albumin. magent does not assay CRP.","type":"number"}},"required":["crp_mg_l"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T15:13:42.017Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T15:13:41.818Z"},"resource":"https://api.magentlab.com/api/calc/mgps","serviceName":"magent","tags":["mgps","hematology","crp","albumin","calculator"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/isth_dic","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Taylor 2001 ISTH SSC overt DIC (four lab items; max 8). Platelets \u003e=100=0, 50-\u003c100=1, \u003c50=2. fibrin_related_marker none/moderate/strong = 0/2/3 (caller-assigned; magent does not grade D-dimer). PT sec above ULN \u003c3=0, \u003e=3 and \u003c6=1, \u003e=6=2. Fibrinogen \u003e=1.0 g/L=0, \u003c1.0=1 (XOR g/L or mg/dL÷100). Band \u003c5 not compatible with overt DIC; \u003e=5 compatible. Not a diagnosis. Not the non-overt serial score.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"fibrin_related_marker":"none","fibrinogen_g_l":2.5,"fibrinogen_mg_dl":250,"platelets_10e9_l":180,"pt_prolongation_sec":1},{"fibrin_related_marker":"none","fibrinogen_g_l":2.5,"fibrinogen_mg_dl":250,"platelets_10e9_l":180,"pt_prolongation_sec":1}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"citation":{"authors":"Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M","doi":"10.1055/s-0037-1616068","id":"taylor-2001","pmid":"11816725","source":"Thromb Haemost. 2001;86(5):1327-1330","title":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation"},"components":[{"factor":"platelets","points":0,"present":false,"value":180},{"factor":"fibrin_related_marker","points":0,"present":false,"value":"none"},{"factor":"pt_prolongation","points":0,"present":false,"value":1},{"factor":"fibrinogen","points":0,"present":false,"value":2.5}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","fibrin_related_marker":"none","fibrinogen_g_l":2.5,"formula":"isth_dic","formula_expression":"ISTH overt DIC = platelets_10e9_l (\u003e=100 → 0; 50 to \u003c100 → 1; \u003c50 → 2) + fibrin_related_marker (none 0, moderate 2, strong 3) + pt_prolongation_sec (\u003c3 → 0; \u003e=3 and \u003c6 → 1; \u003e=6 → 2) + fibrinogen_g_l (\u003e=1.0 → 0; \u003c1.0 → 1); max 8; bands \u003c5 / \u003e=5","isth_dic_band":"\u003c5","max_score":8,"platelets_10e9_l":180,"pt_prolongation_sec":1,"score":0},{"citation":{"authors":"Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M","doi":"10.1055/s-0037-1616068","id":"taylor-2001","pmid":"11816725","source":"Thromb Haemost. 2001;86(5):1327-1330","title":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation"},"components":[{"factor":"platelets","points":0,"present":false,"value":180},{"factor":"fibrin_related_marker","points":0,"present":false,"value":"none"},{"factor":"pt_prolongation","points":0,"present":false,"value":1},{"factor":"fibrinogen","points":0,"present":false,"value":2.5}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","fibrin_related_marker":"none","fibrinogen_g_l":2.5,"formula":"isth_dic","formula_expression":"ISTH overt DIC = platelets_10e9_l (\u003e=100 → 0; 50 to \u003c100 → 1; \u003c50 → 2) + fibrin_related_marker (none 0, moderate 2, strong 3) + pt_prolongation_sec (\u003c3 → 0; \u003e=3 and \u003c6 → 1; \u003e=6 → 2) + fibrinogen_g_l (\u003e=1.0 → 0; \u003c1.0 → 1); max 8; bands \u003c5 / \u003e=5","isth_dic_band":"\u003c5","max_score":8,"platelets_10e9_l":180,"pt_prolongation_sec":1,"score":0}],"path":"/api/calc/isth_dic"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"fibrin_related_marker":{"description":"Caller-assigned ISTH fibrin-related marker (Taylor 2001). none scores 0; moderate scores 2; strong scores 3. magent does not grade D-dimer assays.","enum":["none","moderate","strong"],"type":"string"},"fibrinogen_g_l":{"description":"Fibrinogen in g/L (0.1-10). Provide this or fibrinogen_mg_dl, not both. \u003e=1.0 scores 0; \u003c1.0 scores 1. 1.0 scores 0 (Taylor 2001).","type":"number"},"fibrinogen_mg_dl":{"description":"Fibrinogen in mg/dL (10-1000). Converted as g/L = mg/dL / 100. Provide this or fibrinogen_g_l, not both.","type":"number"},"platelets_10e9_l":{"description":"Platelet count ×10^9/L (1-2000). \u003e=100 scores 0; 50 to \u003c100 scores 1; \u003c50 scores 2. 100 scores 0; 50 scores 1; 49 scores 2 (Taylor 2001).","type":"number"},"pt_prolongation_sec":{"description":"Prothrombin time prolongation in seconds above the laboratory ULN (0-30). \u003c3 scores 0; \u003e=3 and \u003c6 scores 1; \u003e=6 scores 2. 3.0 and 5.9 score 1; 6.0 scores 2; 2.9 scores 0 (Taylor 2001 table gaps filled at 3 and 6).","type":"number"}},"required":["platelets_10e9_l","fibrin_related_marker","pt_prolongation_sec"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T15:12:59.42Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T15:12:59.291Z"},"resource":"https://api.magentlab.com/api/calc/isth_dic","serviceName":"magent","tags":["isth-dic","dic","hematology","coagulation","calculator"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/r_iss","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Palumbo 2015 R-ISS for multiple myeloma. ISS from beta-2 microglobulin and albumin (Greipp 2005). R-ISS I: ISS I, standard-risk iFISH CA, and normal LDH. R-ISS III: ISS III plus high-risk CA (del(17p) and/or t(4;14) and/or t(14;16)) or LDH \u003e ULN. R-ISS II: all other combinations. Not a myeloma diagnosis or treatment choice; not R2-ISS; not Durie-Salmon. magent does not assay beta-2 microglobulin, albumin, LDH, or cytogenetics.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"albumin_g_dl":4,"albumin_g_l":40,"beta2_microglobulin_mg_l":2,"high_risk_ca":false,"ldh_gt_uln":false},{"albumin_g_dl":4,"albumin_g_l":40,"beta2_microglobulin_mg_l":2,"high_risk_ca":false,"ldh_gt_uln":false}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"albumin_g_dl":4,"beta2_microglobulin_mg_l":2,"citation":{"authors":"Palumbo A, Avet-Loiseau H, Oliva S, et al.","doi":"10.1200/JCO.2015.61.2267","id":"palumbo-2015","pmid":"26240224","source":"J Clin Oncol. 2015;33(26):2863-2869","title":"Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group"},"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"r_iss","formula_expression":"R-ISS I: ISS I AND high_risk_ca false AND ldh_gt_uln false; R-ISS III: ISS III AND (high_risk_ca OR ldh_gt_uln); R-ISS II: all other combinations. ISS I: beta2_microglobulin_mg_l \u003c 3.5 AND albumin_g_dl \u003e= 3.5; ISS III: beta2_microglobulin_mg_l \u003e= 5.5; ISS II: neither I nor III (Palumbo 2015; ISS as Greipp 2005)","high_risk_ca":false,"iss_stage":1,"iss_stage_label":"I","ldh_gt_uln":false,"riss_stage":1,"riss_stage_label":"I"},{"albumin_g_dl":4,"beta2_microglobulin_mg_l":2,"citation":{"authors":"Palumbo A, Avet-Loiseau H, Oliva S, et al.","doi":"10.1200/JCO.2015.61.2267","id":"palumbo-2015","pmid":"26240224","source":"J Clin Oncol. 2015;33(26):2863-2869","title":"Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group"},"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"r_iss","formula_expression":"R-ISS I: ISS I AND high_risk_ca false AND ldh_gt_uln false; R-ISS III: ISS III AND (high_risk_ca OR ldh_gt_uln); R-ISS II: all other combinations. ISS I: beta2_microglobulin_mg_l \u003c 3.5 AND albumin_g_dl \u003e= 3.5; ISS III: beta2_microglobulin_mg_l \u003e= 5.5; ISS II: neither I nor III (Palumbo 2015; ISS as Greipp 2005)","high_risk_ca":false,"iss_stage":1,"iss_stage_label":"I","ldh_gt_uln":false,"riss_stage":1,"riss_stage_label":"I"}],"path":"/api/calc/r_iss"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"albumin_g_dl":{"description":"Serum albumin in g/dL (1-6). Provide this or albumin_g_l, not both. ISS uses g/dL. Stage I requires albumin \u003e= 3.5 when Sβ2M \u003c 3.5. Ignored when Sβ2M \u003e= 5.5.","type":"number"},"albumin_g_l":{"description":"Serum albumin in g/L (10-60). Converted as g/dL = g/L / 10. Provide this or albumin_g_dl, not both.","type":"number"},"beta2_microglobulin_mg_l":{"description":"Serum beta-2 microglobulin in mg/L (0.2-40). Greipp 2005 / Palumbo 2015 ISS. Stage I requires \u003c 3.5; stage III when \u003e= 5.5. magent does not assay beta-2 microglobulin.","type":"number"},"high_risk_ca":{"description":"High-risk cytogenetic abnormalities as assigned by the caller: true iff del(17p) and/or t(4;14) and/or t(14;16) by iFISH (Palumbo 2015). magent does not FISH.","type":"boolean"},"ldh_gt_uln":{"description":"Serum LDH greater than the upper limit of normal as assigned by the caller (Palumbo 2015: high LDH is \u003e ULN). magent does not assay LDH or assign ULN.","type":"boolean"}},"required":["beta2_microglobulin_mg_l","high_risk_ca","ldh_gt_uln"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T15:12:09.814Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T15:12:09.666Z"},"resource":"https://api.magentlab.com/api/calc/r_iss","serviceName":"magent","tags":["r-iss","myeloma","hematology","staging","calculator"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/myeloma_iss","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Greipp 2005 International Staging System for multiple myeloma. Stage I: serum beta-2 microglobulin \u003c3.5 mg/L and albumin \u003e=3.5 g/dL. Stage III: beta-2 microglobulin \u003e=5.5 mg/L. Stage II: neither I nor III. Returns iss_stage 1/2/3. Not a myeloma diagnosis or treatment choice; not R-ISS (no LDH, no cytogenetics); not trauma ISS. magent does not assay beta-2 microglobulin or albumin.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"albumin_g_dl":4,"albumin_g_l":40,"beta2_microglobulin_mg_l":2},{"albumin_g_dl":4,"albumin_g_l":40,"beta2_microglobulin_mg_l":2}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"albumin_g_dl":4,"beta2_microglobulin_mg_l":2,"citation":{"authors":"Greipp PR, San Miguel J, Durie BGM, Crowley JJ, Barlogie B, Bladé J, Boccadoro M, Child JA, Avet-Loiseau H, Kyle RA, Lahuerta JJ, Ludwig H, Morgan G, Powles R, Shimizu K, Shustik C, Sonneveld P, Tosi P, Turesson I, Westin J","doi":"10.1200/JCO.2005.04.242","id":"greipp-2005","pmid":"15809451","source":"J Clin Oncol. 2005;23(15):3412-3420","title":"International staging system for multiple myeloma"},"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"myeloma_iss","formula_expression":"ISS stage I: beta2_microglobulin_mg_l \u003c 3.5 AND albumin_g_dl \u003e= 3.5; stage III: beta2_microglobulin_mg_l \u003e= 5.5; stage II: neither I nor III (Greipp 2005)","iss_stage":1,"iss_stage_label":"I"},{"albumin_g_dl":4,"beta2_microglobulin_mg_l":2,"citation":{"authors":"Greipp PR, San Miguel J, Durie BGM, Crowley JJ, Barlogie B, Bladé J, Boccadoro M, Child JA, Avet-Loiseau H, Kyle RA, Lahuerta JJ, Ludwig H, Morgan G, Powles R, Shimizu K, Shustik C, Sonneveld P, Tosi P, Turesson I, Westin J","doi":"10.1200/JCO.2005.04.242","id":"greipp-2005","pmid":"15809451","source":"J Clin Oncol. 2005;23(15):3412-3420","title":"International staging system for multiple myeloma"},"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"myeloma_iss","formula_expression":"ISS stage I: beta2_microglobulin_mg_l \u003c 3.5 AND albumin_g_dl \u003e= 3.5; stage III: beta2_microglobulin_mg_l \u003e= 5.5; stage II: neither I nor III (Greipp 2005)","iss_stage":1,"iss_stage_label":"I"}],"path":"/api/calc/myeloma_iss"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"albumin_g_dl":{"description":"Serum albumin in g/dL (1-6). Provide this or albumin_g_l, not both. Greipp 2005 stages use g/dL. Stage I requires albumin \u003e= 3.5 when Sβ2M \u003c 3.5. Ignored when Sβ2M \u003e= 5.5.","type":"number"},"albumin_g_l":{"description":"Serum albumin in g/L (10-60). Converted as g/dL = g/L / 10. Provide this or albumin_g_dl, not both.","type":"number"},"beta2_microglobulin_mg_l":{"description":"Serum beta-2 microglobulin in mg/L (0.2-40). Greipp 2005 Sβ2M. Stage I requires \u003c 3.5; stage III when \u003e= 5.5. magent does not assay beta-2 microglobulin.","type":"number"}},"required":["beta2_microglobulin_mg_l"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T15:12:02.777Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T15:12:02.642Z"},"resource":"https://api.magentlab.com/api/calc/myeloma_iss","serviceName":"magent","tags":["myeloma-iss","myeloma","hematology","staging","calculator"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/mars","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Jawhar 2019 mutation-adjusted risk score (MARS) for advanced systemic mastocytosis: age \u003e60 (1), hemoglobin \u003c10 g/dL (1), platelets \u003c100×10^9/L (1), exactly one S/A/R mutation among SRSF2, ASXL1, RUNX1 (1) or two or more (2, not both). Max 5. Low 0–1 (training-set median OS not reached), intermediate 2 (3.9 y), high 3–5 (1.9 y). Not WHO SM criteria. magent does not sequence or assay labs.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"age":50,"hemoglobin_g_dl":12,"hemoglobin_g_l":120,"platelets_10e9_l":200,"sar_mutation_count":0},{"age":50,"hemoglobin_g_dl":12,"hemoglobin_g_l":120,"platelets_10e9_l":200,"sar_mutation_count":0}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"age":50,"citation":{"authors":"Jawhar M, Schwaab J, Álvarez-Twose I, Shoumariyeh K, Naumann N, Lübke J, Perkins C, Muñoz-González JI, Meggendorfer M, Kennedy V, Metzgeroth G, Fabarius A, Pfeifer D, Sotlar K, Horny HP, von Bubnoff N, Haferlach T, Cross NCP, Hofmann WK, Sperr WR, García-Montero AC, Valent P, Gotlib J, Orfao A, Reiter A","doi":"10.1200/JCO.19.00640","id":"jawhar-2019","pmid":"31509472","source":"J Clin Oncol. 2019;37(31):2846-2856","title":"MARS: Mutation-Adjusted Risk Score for Advanced Systemic Mastocytosis"},"components":[{"factor":"age_gt_60","points":0,"present":false,"value":50},{"factor":"hemoglobin_lt_10","points":0,"present":false,"value":12},{"factor":"platelets_lt_100","points":0,"present":false,"value":200},{"factor":"sar_mutations","points":0,"present":false,"value":0}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"mars","formula_expression":"MARS = age_gt_60 1 + hemoglobin_lt_10 1 + platelets_lt_100 1 + sar_mutations (exactly one S/A/R 1, two or more 2; SRSF2, ASXL1, RUNX1); Jawhar 2019; max 5; low 0-1 (training-set median OS not reached), intermediate 2 (3.9 years), high 3-5 (1.9 years)","hemoglobin_g_dl":12,"max_score":5,"platelets_10e9_l":200,"risk_band":"low","sar_mutation_count":0,"score":0},{"age":50,"citation":{"authors":"Jawhar M, Schwaab J, Álvarez-Twose I, Shoumariyeh K, Naumann N, Lübke J, Perkins C, Muñoz-González JI, Meggendorfer M, Kennedy V, Metzgeroth G, Fabarius A, Pfeifer D, Sotlar K, Horny HP, von Bubnoff N, Haferlach T, Cross NCP, Hofmann WK, Sperr WR, García-Montero AC, Valent P, Gotlib J, Orfao A, Reiter A","doi":"10.1200/JCO.19.00640","id":"jawhar-2019","pmid":"31509472","source":"J Clin Oncol. 2019;37(31):2846-2856","title":"MARS: Mutation-Adjusted Risk Score for Advanced Systemic Mastocytosis"},"components":[{"factor":"age_gt_60","points":0,"present":false,"value":50},{"factor":"hemoglobin_lt_10","points":0,"present":false,"value":12},{"factor":"platelets_lt_100","points":0,"present":false,"value":200},{"factor":"sar_mutations","points":0,"present":false,"value":0}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"mars","formula_expression":"MARS = age_gt_60 1 + hemoglobin_lt_10 1 + platelets_lt_100 1 + sar_mutations (exactly one S/A/R 1, two or more 2; SRSF2, ASXL1, RUNX1); Jawhar 2019; max 5; low 0-1 (training-set median OS not reached), intermediate 2 (3.9 years), high 3-5 (1.9 years)","hemoglobin_g_dl":12,"max_score":5,"platelets_10e9_l":200,"risk_band":"low","sar_mutation_count":0,"score":0}],"path":"/api/calc/mars"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"age":{"description":"Age in years (integer 18-120). \u003e60 scores 1 (Jawhar 2019). Age 61 scores; age 60 is the ≤60 arm and scores 0.","type":"integer"},"hemoglobin_g_dl":{"description":"Hemoglobin in g/dL (3-22). Provide this or hemoglobin_g_l, not both. \u003c10 g/dL (\u003c100 g/L) scores 1 (Jawhar 2019). 10.0 is the ≥10 arm and scores 0. magent does not assay hemoglobin.","type":"number"},"hemoglobin_g_l":{"description":"Hemoglobin in g/L (30-220). Converted as hemoglobin_g_dl = hemoglobin_g_l / 10. Provide this or hemoglobin_g_dl, not both. \u003c100 g/L scores 1. 100 is the ≥100 arm and scores 0.","type":"number"},"platelets_10e9_l":{"description":"Platelet count in 10^9/L (1-2000). \u003c100 scores 1 (Jawhar 2019). 100.0 is the ≥100 arm and scores 0. magent does not assay platelets.","type":"number"},"sar_mutation_count":{"description":"Caller-assigned count of S/A/R mutations among SRSF2, ASXL1, and RUNX1 (integer 0, 1, or 2; 2 means two or more). Exactly one scores 1. Two or more scores 2 (not 1 plus 2). Count 0 scores 0. magent does not sequence.","type":"integer"}},"required":["age","platelets_10e9_l","sar_mutation_count"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T15:10:36.625Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T15:10:36.474Z"},"resource":"https://api.magentlab.com/api/calc/mars","serviceName":"magent","tags":["mars","mastocytosis","hematology","prognosis","advsm"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/mipss70","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Guglielmelli 2018 MIPSS70 for transplant-age PMF: Hb \u003c10 g/dL (1), leukocytes \u003e25×10^9/L (2), platelets \u003c100×10^9/L (2), blasts ≥2% (1), fibrosis ≥2 (1), symptoms (1), no type 1/like CALR (1), HMR category (1), ≥2 HMR (2); max 12. Low 0–1, intermediate 2–4, high ≥5. Italian-cohort median (5-year) OS 27.7 y (95%), 7.1 y (70%), 2.3 y (29%). Not MIPSS70-plus or version 2.0. magent does not sequence or grade marrow.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"blasts_percent":0,"calr_type1_like":true,"constitutional_symptoms":false,"fibrosis_grade":1,"hemoglobin_g_dl":12,"hemoglobin_g_l":120,"hmr_mutation_count":0,"leukocytes_10e9_l":10,"platelets_10e9_l":200},{"blasts_percent":0,"calr_type1_like":true,"constitutional_symptoms":false,"fibrosis_grade":1,"hemoglobin_g_dl":12,"hemoglobin_g_l":120,"hmr_mutation_count":0,"leukocytes_10e9_l":10,"platelets_10e9_l":200}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"blasts_percent":0,"calr_type1_like":true,"citation":{"authors":"Guglielmelli P, Lasho TL, Rotunno G, Mudireddy M, Mannarelli C, Nicolosi M, Pacilli A, Pardanani A, Rumi E, Rosti V, Hanson CA, Mannelli F, Ketterling RP, Gangat N, Rambaldi A, Passamonti F, Barosi G, Barbui T, Cazzola M, Vannucchi AM, Tefferi A","doi":"10.1200/JCO.2017.76.4886","id":"guglielmelli-2018","pmid":"29226763","source":"J Clin Oncol. 2018;36(4):310-318","title":"MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis"},"components":[{"factor":"hemoglobin_lt_10","points":0,"present":false,"value":12},{"factor":"leukocytes_gt_25","points":0,"present":false,"value":10},{"factor":"platelets_lt_100","points":0,"present":false,"value":200},{"factor":"blasts_ge_2","points":0,"present":false,"value":0},{"factor":"fibrosis_ge_2","points":0,"present":false,"value":1},{"factor":"constitutional_symptoms","points":0,"present":false},{"factor":"absence_of_calr_type1_like","points":0,"present":false},{"factor":"hmr_category","points":0,"present":false,"value":0},{"factor":"hmr_two_or_more","points":0,"present":false,"value":0}],"constitutional_symptoms":false,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","fibrosis_grade":1,"five_year_survival_percent":95,"formula":"mipss70","formula_expression":"MIPSS70 = hemoglobin_lt_10 1 + leukocytes_gt_25 2 + platelets_lt_100 2 + blasts_ge_2 1 + fibrosis_ge_2 1 + constitutional_symptoms 1 + absence_of_calr_type1_like 1 + hmr_category 1 + hmr_two_or_more 2; Guglielmelli 2018; max 12; low 0-1, intermediate 2-4, high ≥5","hemoglobin_g_dl":12,"hmr_mutation_count":0,"leukocytes_10e9_l":10,"max_score":12,"median_survival_years":27.7,"platelets_10e9_l":200,"risk_band":"low","score":0},{"blasts_percent":0,"calr_type1_like":true,"citation":{"authors":"Guglielmelli P, Lasho TL, Rotunno G, Mudireddy M, Mannarelli C, Nicolosi M, Pacilli A, Pardanani A, Rumi E, Rosti V, Hanson CA, Mannelli F, Ketterling RP, Gangat N, Rambaldi A, Passamonti F, Barosi G, Barbui T, Cazzola M, Vannucchi AM, Tefferi A","doi":"10.1200/JCO.2017.76.4886","id":"guglielmelli-2018","pmid":"29226763","source":"J Clin Oncol. 2018;36(4):310-318","title":"MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis"},"components":[{"factor":"hemoglobin_lt_10","points":0,"present":false,"value":12},{"factor":"leukocytes_gt_25","points":0,"present":false,"value":10},{"factor":"platelets_lt_100","points":0,"present":false,"value":200},{"factor":"blasts_ge_2","points":0,"present":false,"value":0},{"factor":"fibrosis_ge_2","points":0,"present":false,"value":1},{"factor":"constitutional_symptoms","points":0,"present":false},{"factor":"absence_of_calr_type1_like","points":0,"present":false},{"factor":"hmr_category","points":0,"present":false,"value":0},{"factor":"hmr_two_or_more","points":0,"present":false,"value":0}],"constitutional_symptoms":false,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","fibrosis_grade":1,"five_year_survival_percent":95,"formula":"mipss70","formula_expression":"MIPSS70 = hemoglobin_lt_10 1 + leukocytes_gt_25 2 + platelets_lt_100 2 + blasts_ge_2 1 + fibrosis_ge_2 1 + constitutional_symptoms 1 + absence_of_calr_type1_like 1 + hmr_category 1 + hmr_two_or_more 2; Guglielmelli 2018; max 12; low 0-1, intermediate 2-4, high ≥5","hemoglobin_g_dl":12,"hmr_mutation_count":0,"leukocytes_10e9_l":10,"max_score":12,"median_survival_years":27.7,"platelets_10e9_l":200,"risk_band":"low","score":0}],"path":"/api/calc/mipss70"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"blasts_percent":{"description":"Circulating blasts as a percent (0-30). ≥2 scores 1 (Guglielmelli 2018). 2.0 scores; 1.9 is the \u003c2 arm and scores 0. magent does not read a smear.","type":"number"},"calr_type1_like":{"description":"Presence of a type 1/like CALR mutation as assigned by the caller (Guglielmelli 2018). false (absence) scores 1. true scores 0. magent does not sequence.","type":"boolean"},"constitutional_symptoms":{"description":"Constitutional symptoms as assigned by the caller (Guglielmelli 2018). true scores 1. magent does not take a history.","type":"boolean"},"fibrosis_grade":{"description":"WHO bone-marrow fibrosis grade as an integer 0-3, assigned by the caller (Guglielmelli 2018). ≥2 scores 1. Grade 2 scores; grade 1 scores 0. magent does not grade marrow.","type":"integer"},"hemoglobin_g_dl":{"description":"Hemoglobin in g/dL (3-22). Provide this or hemoglobin_g_l, not both. \u003c10 g/dL (\u003c100 g/L) scores 1 (Guglielmelli 2018). 10.0 is the ≥10 arm and scores 0. magent does not assay hemoglobin.","type":"number"},"hemoglobin_g_l":{"description":"Hemoglobin in g/L (30-220). Converted as hemoglobin_g_dl = hemoglobin_g_l / 10. Provide this or hemoglobin_g_dl, not both. \u003c100 g/L scores 1. 100 is the ≥100 arm and scores 0.","type":"number"},"hmr_mutation_count":{"description":"Count of high-molecular-risk mutations among ASXL1, EZH2, SRSF2, IDH1, and IDH2 as assigned by the caller (integer 0-5). ≥1 scores 1 (HMR category). ≥2 scores an additional 2 (two or more HMR mutations), so a count of 2 or more contributes 3. Count 0 scores 0. magent does not sequence.","type":"integer"},"leukocytes_10e9_l":{"description":"Leukocyte count in 10^9/L (0.5-200). \u003e25 scores 2 (Guglielmelli 2018). 25.0 is the ≤25 arm and scores 0. magent does not assay leukocytes.","type":"number"},"platelets_10e9_l":{"description":"Platelet count in 10^9/L (1-2000). \u003c100 scores 2 (Guglielmelli 2018). 100.0 is the ≥100 arm and scores 0. magent does not assay platelets.","type":"number"}},"required":["leukocytes_10e9_l","platelets_10e9_l","blasts_percent","fibrosis_grade","constitutional_symptoms","calr_type1_like","hmr_mutation_count"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T15:09:32.053Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T15:09:31.914Z"},"resource":"https://api.magentlab.com/api/calc/mipss70","serviceName":"magent","tags":["mipss70","myelofibrosis","hematology","prognosis","pmf"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/mysec_pm","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Passamonti 2017 MYSEC-PM for post-PV and post-ET myelofibrosis. Score = 0.15*age + hemoglobin \u003c11 g/dL (2) + circulating blasts ≥3% (2) + CALR-unmutated (2) + platelets \u003c150×10^9/L (1) + constitutional symptoms (1). Low \u003c11, intermediate_1 ≥11 and \u003c14, intermediate_2 ≥14 and \u003c16, high ≥16. Not DIPSS (PMF), not GIPSS, not a transplant listing. magent does not sequence CALR.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"age":40,"blasts_percent":6,"calr_unmutated":false,"constitutional_symptoms":false,"hemoglobin_g_dl":10,"hemoglobin_g_l":100,"platelets_10e9_l":200},{"age":40,"blasts_percent":6,"calr_unmutated":false,"constitutional_symptoms":false,"hemoglobin_g_dl":10,"hemoglobin_g_l":100,"platelets_10e9_l":200}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"age_years":40,"blasts_percent":6,"calr_unmutated":false,"citation":{"authors":"Passamonti F, Giorgino T, Mora B, Guglielmelli P, Rumi E, Maffioli M, Rambaldi A, Caramella M, Komrokji R, Gotlib J, Kiladjian JJ, Cervantes F, Devos T, Palandri F, De Stefano V, Ruggeri M, Silver RT, Benevolo G, Albano F, Caramazza D, Merli M, Pietra D, Casalone R, Rotunno G, Barbui T, Cazzola M, Vannucchi AM","doi":"10.1038/leu.2017.169","id":"passamonti-2017","pmid":"28561069","source":"Leukemia. 2017;31(12):2726-2731","title":"A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis"},"components":[{"factor":"age","points":6,"present":true,"value":40},{"factor":"hemoglobin_lt_11","points":2,"present":true,"value":10},{"factor":"blasts_ge_3","points":2,"present":true,"value":6},{"factor":"calr_unmutated","points":0,"present":false},{"factor":"platelets_lt_150","points":0,"present":false,"value":200},{"factor":"constitutional_symptoms","points":0,"present":false}],"constitutional_symptoms":false,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"mysec_pm","formula_expression":"MYSEC-PM = 0.15*age_years + hemoglobin_lt_11 2 + blasts_ge_3 2 + calr_unmutated 2 + platelets_lt_150 1 + constitutional_symptoms 1; Passamonti 2017; low \u003c11, intermediate_1 ≥11 and \u003c14, intermediate_2 ≥14 and \u003c16, high ≥16","hemoglobin_g_dl":10,"median_os_years":null,"platelets_10e9_l":200,"risk_group":"low","score":10},{"age_years":40,"blasts_percent":6,"calr_unmutated":false,"citation":{"authors":"Passamonti F, Giorgino T, Mora B, Guglielmelli P, Rumi E, Maffioli M, Rambaldi A, Caramella M, Komrokji R, Gotlib J, Kiladjian JJ, Cervantes F, Devos T, Palandri F, De Stefano V, Ruggeri M, Silver RT, Benevolo G, Albano F, Caramazza D, Merli M, Pietra D, Casalone R, Rotunno G, Barbui T, Cazzola M, Vannucchi AM","doi":"10.1038/leu.2017.169","id":"passamonti-2017","pmid":"28561069","source":"Leukemia. 2017;31(12):2726-2731","title":"A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis"},"components":[{"factor":"age","points":6,"present":true,"value":40},{"factor":"hemoglobin_lt_11","points":2,"present":true,"value":10},{"factor":"blasts_ge_3","points":2,"present":true,"value":6},{"factor":"calr_unmutated","points":0,"present":false},{"factor":"platelets_lt_150","points":0,"present":false,"value":200},{"factor":"constitutional_symptoms","points":0,"present":false}],"constitutional_symptoms":false,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"mysec_pm","formula_expression":"MYSEC-PM = 0.15*age_years + hemoglobin_lt_11 2 + blasts_ge_3 2 + calr_unmutated 2 + platelets_lt_150 1 + constitutional_symptoms 1; Passamonti 2017; low \u003c11, intermediate_1 ≥11 and \u003c14, intermediate_2 ≥14 and \u003c16, high ≥16","hemoglobin_g_dl":10,"median_os_years":null,"platelets_10e9_l":200,"risk_group":"low","score":10}],"path":"/api/calc/mysec_pm"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"age":{"description":"Age in years (18-120). Adds 0.15 points per year as published (Passamonti 2017). Age stays continuous; the total score is rounded to 2 decimal places.","type":"integer"},"blasts_percent":{"description":"Circulating blasts as a percent (0-30). ≥3 scores 2 (Passamonti 2017). 2.9 is the \u003c3 arm and scores 0. magent does not read a smear.","type":"number"},"calr_unmutated":{"description":"CALR-unmutated genotype (JAK2, MPL, or triple-negative) as assigned by the caller (Passamonti 2017). true scores 2. magent does not sequence CALR.","type":"boolean"},"constitutional_symptoms":{"description":"Constitutional symptoms as assigned by the caller (Passamonti 2017). true scores 1. magent does not take a history.","type":"boolean"},"hemoglobin_g_dl":{"description":"Hemoglobin in g/dL (3-22). Provide this or hemoglobin_g_l, not both. \u003c11 scores 2 (Passamonti 2017). 11.0 is the ≥11 arm and scores 0. magent does not assay hemoglobin.","type":"number"},"hemoglobin_g_l":{"description":"Hemoglobin in g/L (30-220). Converted as hemoglobin_g_dl = hemoglobin_g_l / 10. Provide this or hemoglobin_g_dl, not both.","type":"number"},"platelets_10e9_l":{"description":"Platelet count in 10^9/L (1-2000). \u003c150 scores 1 (Passamonti 2017). 150.0 is the ≥150 arm and scores 0. magent does not assay platelets.","type":"number"}},"required":["age","platelets_10e9_l","blasts_percent","calr_unmutated","constitutional_symptoms"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T15:09:25.521Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T15:09:25.387Z"},"resource":"https://api.magentlab.com/api/calc/mysec_pm","serviceName":"magent","tags":["mysec-pm","myelofibrosis","hematology","prognosis","calculator"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/mipi","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Hoster 2008 simplified MIPI for advanced-stage mantle cell lymphoma: age (\u003c50 0, 50–59 1, 60–69 2, ≥70 3), ECOG (0–1 0, 2–4 2), LDH/ULN (\u003c0.67 0, 0.67–\u003c1 1, 1–\u003c1.5 2, ≥1.5 3), WBC ×10^9/L (\u003c6.7 0, 6.7–\u003c10 1, 10–\u003c15 2, ≥15 3); max 11. Low 0–3, intermediate 4–5, high 6–11. Deterministic published score with citation; not a lymphoma diagnosis; not continuous MIPI; not MIPI-c. magent does not assay LDH or WBC.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"age":40,"ecog":0,"ldh_uln_ratio":0.5,"wbc_k_ul":5,"wbc_ul":5000},{"age":40,"ecog":0,"ldh_uln_ratio":0.5,"wbc_k_ul":5,"wbc_ul":5000}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"age_years":40,"citation":{"authors":"Hoster E, Dreyling M, Klapper W, et al.","doi":"10.1182/blood-2007-06-095331","id":"hoster-2008","pmid":"17934064","source":"Blood. 2008;111(2):558-565","title":"A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma"},"components":[{"factor":"age","points":0,"present":false,"value":40},{"factor":"ecog","points":0,"present":false,"value":0},{"factor":"ldh_uln_ratio","points":0,"present":false,"value":0.5},{"factor":"wbc","points":0,"present":false,"value":5000}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","ecog":0,"formula":"mipi","formula_expression":"simplified MIPI = age (\u003c50 0, 50–59 1, 60–69 2, ≥70 3) + ECOG (0–1 0, 2–4 2) + LDH/ULN (\u003c0.67 0, 0.67–\u003c1.0 1, 1.0–\u003c1.5 2, ≥1.5 3) + WBC ×10^9/L (\u003c6.7 0, 6.7–\u003c10 1, 10–\u003c15 2, ≥15 3); Hoster 2008; max 11; low 0-3, intermediate 4-5, high 6-11","ldh_uln_ratio":0.5,"max_score":11,"risk_group":"low","score":0,"wbc_10e9_l":5,"wbc_ul":5000},{"age_years":40,"citation":{"authors":"Hoster E, Dreyling M, Klapper W, et al.","doi":"10.1182/blood-2007-06-095331","id":"hoster-2008","pmid":"17934064","source":"Blood. 2008;111(2):558-565","title":"A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma"},"components":[{"factor":"age","points":0,"present":false,"value":40},{"factor":"ecog","points":0,"present":false,"value":0},{"factor":"ldh_uln_ratio","points":0,"present":false,"value":0.5},{"factor":"wbc","points":0,"present":false,"value":5000}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","ecog":0,"formula":"mipi","formula_expression":"simplified MIPI = age (\u003c50 0, 50–59 1, 60–69 2, ≥70 3) + ECOG (0–1 0, 2–4 2) + LDH/ULN (\u003c0.67 0, 0.67–\u003c1.0 1, 1.0–\u003c1.5 2, ≥1.5 3) + WBC ×10^9/L (\u003c6.7 0, 6.7–\u003c10 1, 10–\u003c15 2, ≥15 3); Hoster 2008; max 11; low 0-3, intermediate 4-5, high 6-11","ldh_uln_ratio":0.5,"max_score":11,"risk_group":"low","score":0,"wbc_10e9_l":5,"wbc_ul":5000}],"path":"/api/calc/mipi"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"age":{"description":"Age in years (18-120). \u003c50 scores 0; 50–59 scores 1; 60–69 scores 2; ≥70 scores 3 (Hoster 2008 simplified MIPI). 50 and 59 score 1; 60 and 69 score 2; 70 scores 3.","type":"integer"},"ecog":{"description":"ECOG performance status 0-4 as assigned by the caller (Hoster 2008 simplified MIPI). 0–1 scores 0; 2–4 scores 2. magent does not assign ECOG.","type":"integer"},"ldh_uln_ratio":{"description":"Serum LDH divided by the laboratory ULN (0.1-20). \u003c0.67 scores 0; 0.67–\u003c1.0 scores 1; 1.0–\u003c1.5 scores 2; ≥1.5 scores 3 (0.67 scores 1; 0.99 scores 1; 1.0 scores 2; 1.49 scores 2; 1.5 scores 3). magent does not assay LDH.","type":"number"},"wbc_k_ul":{"description":"WBC in 10^3/µL (same as 10^9/L). Provide wbc_k_ul or wbc_ul, not both. Range 0.01-500. Converted to ×10^9/L: \u003c6.7 scores 0; 6.7–\u003c10 scores 1; 10–\u003c15 scores 2; ≥15 scores 3 (6.7 scores 1; 9.999 scores 1; 10 scores 2; 14.999 scores 2; 15 scores 3).","type":"number"},"wbc_ul":{"description":"WBC in cells/µL (same as cells/mm^3). Provide wbc_k_ul or wbc_ul, not both. Range 10-500000. Converted to ×10^9/L (= wbc_ul/1000): \u003c6.7 scores 0; 6.7–\u003c10 scores 1; 10–\u003c15 scores 2; ≥15 scores 3 (6.7 scores 1; 9.999 scores 1; 10 scores 2; 14.999 scores 2; 15 scores 3).","type":"number"}},"required":["age","ecog","ldh_uln_ratio"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T15:08:06.449Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T15:08:06.303Z"},"resource":"https://api.magentlab.com/api/calc/mipi","serviceName":"magent","tags":["mipi","lymphoma","hematology","prognosis","calculator"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/hat","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"HAT (Lou 2008 Neurology) for sICH after stroke thrombolysis. Diabetes or glucose \u003e200 mg/dL (1; not additive). NIHSS \u003c15 0, 15-20 1, \u003e20 2. CT hypodensity none 0, \u003c1/3 MCA 1, \u003e1/3 MCA 2 (no equals-1/3). Max 5. Collective sICH 2/5/10/15/44% for scores 0/1/2/3/\u003e3. Glucose in mg/dL (mmol × 18). Not a tPA withhold. magent does not assign NIHSS or read CT.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"diabetes":false,"glucose_mg_dl":108,"glucose_mmol_l":6,"hypodensity":"none","nihss":10},{"diabetes":false,"glucose_mg_dl":108,"glucose_mmol_l":6,"hypodensity":"none","nihss":10}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"citation":{"authors":"Lou M, Safdar A, Mehdiratta M, Kumar S, Schlaug G, Caplan L, Searls D, Selim M","doi":"10.1212/01.wnl.0000330297.58334.dd","id":"lou-2008","pmid":"18955684","source":"Neurology. 2008;71(18):1417-1423","title":"The HAT Score: a simple grading scale for predicting hemorrhage after thrombolysis"},"components":[{"diabetes":false,"factor":"diabetes_or_glucose","points":0,"present":false,"value":108},{"factor":"nihss","points":0,"present":false,"value":10},{"factor":"hypodensity","points":0,"present":false,"value":"none"}],"diabetes":false,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"hat","formula_expression":"HAT = (diabetes OR baseline glucose \u003e200 mg/dL) 1 (not additive) + NIHSS (\u003c15 0, 15-20 1, \u003e20 2) + hypodensity (none 0, \u003c1/3 MCA 1, \u003e1/3 MCA 2); Lou 2008; max 5; collective sICH 2/5/10/15/44% for scores 0/1/2/3/\u003e3","glucose_mg_dl":108,"hypodensity":"none","max_score":5,"nihss":10,"score":0,"sich_percent":2},{"citation":{"authors":"Lou M, Safdar A, Mehdiratta M, Kumar S, Schlaug G, Caplan L, Searls D, Selim M","doi":"10.1212/01.wnl.0000330297.58334.dd","id":"lou-2008","pmid":"18955684","source":"Neurology. 2008;71(18):1417-1423","title":"The HAT Score: a simple grading scale for predicting hemorrhage after thrombolysis"},"components":[{"diabetes":false,"factor":"diabetes_or_glucose","points":0,"present":false,"value":108},{"factor":"nihss","points":0,"present":false,"value":10},{"factor":"hypodensity","points":0,"present":false,"value":"none"}],"diabetes":false,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"hat","formula_expression":"HAT = (diabetes OR baseline glucose \u003e200 mg/dL) 1 (not additive) + NIHSS (\u003c15 0, 15-20 1, \u003e20 2) + hypodensity (none 0, \u003c1/3 MCA 1, \u003e1/3 MCA 2); Lou 2008; max 5; collective sICH 2/5/10/15/44% for scores 0/1/2/3/\u003e3","glucose_mg_dl":108,"hypodensity":"none","max_score":5,"nihss":10,"score":0,"sich_percent":2}],"path":"/api/calc/hat"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"diabetes":{"description":"History of diabetes mellitus (Lou 2008). true scores 1 on the diabetes-or-glucose item; not additive with glucose \u003e200 mg/dL.","type":"boolean"},"glucose_mg_dl":{"description":"Baseline glucose in mg/dL (50-1000). Provide this or glucose_mmol_l, not both. \u003e200 scores 1 on the diabetes-or-glucose item if diabetes is false; 200.0 does not (Lou 2008).","type":"number"},"glucose_mmol_l":{"description":"Baseline glucose in mmol/L (2.8-55.5). Provide this or glucose_mg_dl, not both. Converted as mg/dL = mmol/L × 18. Scores 1 on the diabetes-or-glucose item if \u003e200 mg/dL after conversion (200.0 does not).","type":"number"},"hypodensity":{"description":"Easily visible hypodensity on initial CT as assigned by the caller (Lou 2008). none scores 0; less_than_third (\u003c1/3 MCA) scores 1; greater_than_third (\u003e1/3 MCA) scores 2. No published equals-1/3 category. magent does not read the CT.","enum":["none","less_than_third","greater_than_third"],"type":"string"},"nihss":{"description":"Caller-assigned pretreatment NIH Stroke Scale total (integer 0-42). \u003c15 scores 0; 15-20 scores 1; \u003e20 scores 2 (Lou 2008). magent does not compute NIHSS or examine the patient.","type":"integer"}},"required":["diabetes","nihss","hypodensity"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T15:05:51.922Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T15:05:51.791Z"},"resource":"https://api.magentlab.com/api/calc/hat","serviceName":"magent","tags":["hat","stroke","thrombolysis","sich","neurology"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/sedan","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"SEDAN (Strbian 2012 Ann Neurol) for sICH after stroke thrombolysis. Glucose 8.1-12.0 mmol/L (1) or \u003e12.0 (2); early infarct signs (1); hyperdense cerebral artery (1); age \u003e75 (1); admission NIHSS ≥10 (1); max 6. Derivation absolute sICH 1.4%, 2.9%, 8.5%, 12.2%, 21.7%, 33.3% for scores 0-5; no published percent for 6. Not a tPA withhold decision. magent does not assign NIHSS or read CT.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"age":60,"early_infarct_signs":false,"glucose_mg_dl":108,"glucose_mmol_l":6,"hyperdense_artery":false,"nihss":5},{"age":60,"early_infarct_signs":false,"glucose_mg_dl":108,"glucose_mmol_l":6,"hyperdense_artery":false,"nihss":5}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"age_years":60,"citation":{"authors":"Strbian D, Engelter S, Michel P, Meretoja A, Sekoranja L, Ahlhelm FJ, Mustanoja S, Lynch J, Soinne L, Sairanen T, Lyrer P, Tatlisumak T","doi":"10.1002/ana.23546","id":"strbian-2012-sedan","source":"Ann Neurol. 2012;71(5):634-641","title":"Symptomatic intracranial hemorrhage after stroke thrombolysis: the SEDAN score"},"components":[{"factor":"glucose","points":0,"present":false,"value":6},{"factor":"early_infarct_signs","points":0,"present":false},{"factor":"hyperdense_artery","points":0,"present":false},{"factor":"age","points":0,"present":false,"value":60},{"factor":"nihss","points":0,"present":false,"value":5}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","early_infarct_signs":false,"formula":"sedan","formula_expression":"SEDAN = glucose (8.1-12.0 mmol/L 1; \u003e12.0 mmol/L 2) + early_infarct_signs 1 + hyperdense_artery 1 + (age \u003e75) 1 + (NIHSS \u003e=10) 1; max 6; derivation sICH 1.4/2.9/8.5/12.2/21.7/33.3% for scores 0-5 (Strbian 2012); no published percent for 6","glucose_mmol_l":6,"hyperdense_artery":false,"max_score":6,"nihss":5,"score":0,"sich_percent":1.4},{"age_years":60,"citation":{"authors":"Strbian D, Engelter S, Michel P, Meretoja A, Sekoranja L, Ahlhelm FJ, Mustanoja S, Lynch J, Soinne L, Sairanen T, Lyrer P, Tatlisumak T","doi":"10.1002/ana.23546","id":"strbian-2012-sedan","source":"Ann Neurol. 2012;71(5):634-641","title":"Symptomatic intracranial hemorrhage after stroke thrombolysis: the SEDAN score"},"components":[{"factor":"glucose","points":0,"present":false,"value":6},{"factor":"early_infarct_signs","points":0,"present":false},{"factor":"hyperdense_artery","points":0,"present":false},{"factor":"age","points":0,"present":false,"value":60},{"factor":"nihss","points":0,"present":false,"value":5}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","early_infarct_signs":false,"formula":"sedan","formula_expression":"SEDAN = glucose (8.1-12.0 mmol/L 1; \u003e12.0 mmol/L 2) + early_infarct_signs 1 + hyperdense_artery 1 + (age \u003e75) 1 + (NIHSS \u003e=10) 1; max 6; derivation sICH 1.4/2.9/8.5/12.2/21.7/33.3% for scores 0-5 (Strbian 2012); no published percent for 6","glucose_mmol_l":6,"hyperdense_artery":false,"max_score":6,"nihss":5,"score":0,"sich_percent":1.4}],"path":"/api/calc/sedan"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"age":{"description":"Age in years (18-120). \u003e75 scores 1; 75 does not (Strbian 2012). magent does not date the patient.","type":"integer"},"early_infarct_signs":{"description":"Early infarct signs on admission CT as assigned by the caller (Strbian 2012). true scores 1; false scores 0. magent does not read the CT.","type":"boolean"},"glucose_mg_dl":{"description":"Baseline glucose in mg/dL (50-1000). Converted as mmol/L = mg/dL / 18. Provide this or glucose_mmol_l, not both.","type":"number"},"glucose_mmol_l":{"description":"Baseline glucose in mmol/L (2.8-55.5). Provide this or glucose_mg_dl, not both. 8.1-12.0 inclusive scores 1; \u003e12.0 scores 2; else 0 (Strbian 2012).","type":"number"},"hyperdense_artery":{"description":"(Hyper)dense cerebral artery sign on admission CT as assigned by the caller (Strbian 2012). true scores 1; false scores 0. magent does not read the CT.","type":"boolean"},"nihss":{"description":"Caller-assigned NIH Stroke Scale total (integer 0-42). ≥10 scores 1; 9 does not. magent does not compute NIHSS or examine the patient.","type":"integer"}},"required":["age","nihss","early_infarct_signs","hyperdense_artery"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T15:05:44.944Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T15:05:44.815Z"},"resource":"https://api.magentlab.com/api/calc/sedan","serviceName":"magent","tags":["sedan","stroke","thrombolysis","sich","neurology"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/dragon","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"DRAGON (Strbian 2012 Neurology) for 3-month outcome after IV thrombolysis. CT hyperdense artery or early infarct 0/1/2, prestroke mRS \u003e1 (1), age \u003c65/65-79/\u003e=80 (0/1/2), glucose \u003e8 mmol/L (mg/dL /18) (1), onset-to-treatment \u003e90 min (1), NIHSS 0-4/5-9/10-15/\u003e15 (0/1/2/3); max 10. Tabulated mRS 0-2 and mRS 5-6 percents for scores 0-1, 2, 3, 8, and 9-10 only. Not a tPA decision. Not studied in basilar occlusion. magent does not read CT or assign NIHSS.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"age":60,"early_infarct_signs":false,"glucose_mg_dl":108,"glucose_mmol_l":6,"hyperdense_artery":false,"nihss":3,"onset_to_treatment_min":60,"prestroke_mrs_gt_1":false},{"age":60,"early_infarct_signs":false,"glucose_mg_dl":108,"glucose_mmol_l":6,"hyperdense_artery":false,"nihss":3,"onset_to_treatment_min":60,"prestroke_mrs_gt_1":false}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"age_years":60,"citation":{"authors":"Strbian D, Meretoja A, Ahlhelm FJ, Pitkäniemi J, Lyrer P, Kaste M, Tatlisumak T","doi":"10.1212/WNL.0b013e318245d2a9","id":"strbian-2012-dragon","pmid":"22311929","source":"Neurology. 2012;78(6):427-432","title":"Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score"},"components":[{"factor":"hyperdense_artery","points":0,"present":false},{"factor":"early_infarct_signs","points":0,"present":false},{"factor":"prestroke_mrs_gt_1","points":0,"present":false},{"factor":"age","points":0,"present":false,"value":60},{"factor":"glucose","points":0,"present":false,"value":6},{"factor":"onset_to_treatment","points":0,"present":false,"value":60},{"factor":"nihss","points":0,"present":false,"value":3}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","early_infarct_signs":false,"formula":"dragon","formula_expression":"DRAGON = dense_ct (hyperdense_artery 1 + early_infarct_signs 1; none 0, either 1, both 2) + prestroke_mrs_gt_1 (1 if prestroke mRS \u003e1) + age (\u003c65 0, 65-79 1, \u003e=80 2) + glucose \u003e8 mmol/L (1; 8.0 does not; mg/dL /18) + onset_to_treatment \u003e90 min (1; 90 does not) + NIHSS (0-4 0, 5-9 1, 10-15 2, \u003e15 3); Strbian 2012; max 10","glucose_mmol_l":6,"good_outcome_percent":96,"hyperdense_artery":false,"max_score":10,"miserable_outcome_percent":0,"nihss":3,"onset_to_treatment_min":60,"prestroke_mrs_gt_1":false,"score":0},{"age_years":60,"citation":{"authors":"Strbian D, Meretoja A, Ahlhelm FJ, Pitkäniemi J, Lyrer P, Kaste M, Tatlisumak T","doi":"10.1212/WNL.0b013e318245d2a9","id":"strbian-2012-dragon","pmid":"22311929","source":"Neurology. 2012;78(6):427-432","title":"Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score"},"components":[{"factor":"hyperdense_artery","points":0,"present":false},{"factor":"early_infarct_signs","points":0,"present":false},{"factor":"prestroke_mrs_gt_1","points":0,"present":false},{"factor":"age","points":0,"present":false,"value":60},{"factor":"glucose","points":0,"present":false,"value":6},{"factor":"onset_to_treatment","points":0,"present":false,"value":60},{"factor":"nihss","points":0,"present":false,"value":3}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","early_infarct_signs":false,"formula":"dragon","formula_expression":"DRAGON = dense_ct (hyperdense_artery 1 + early_infarct_signs 1; none 0, either 1, both 2) + prestroke_mrs_gt_1 (1 if prestroke mRS \u003e1) + age (\u003c65 0, 65-79 1, \u003e=80 2) + glucose \u003e8 mmol/L (1; 8.0 does not; mg/dL /18) + onset_to_treatment \u003e90 min (1; 90 does not) + NIHSS (0-4 0, 5-9 1, 10-15 2, \u003e15 3); Strbian 2012; max 10","glucose_mmol_l":6,"good_outcome_percent":96,"hyperdense_artery":false,"max_score":10,"miserable_outcome_percent":0,"nihss":3,"onset_to_treatment_min":60,"prestroke_mrs_gt_1":false,"score":0}],"path":"/api/calc/dragon"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"age":{"description":"Age in years (18-120). Strbian 2012: \u003c65 scores 0; 65-79 scores 1; ≥80 scores 2.","type":"integer"},"early_infarct_signs":{"description":"Early infarct signs on admission CT as assigned by the caller (Strbian 2012). true scores 1. Combined with hyperdense_artery: none 0, either 1, both 2. magent does not read CT.","type":"boolean"},"glucose_mg_dl":{"description":"Baseline glucose in mg/dL (50-1000). Converted as mmol/L = mg/dL / 18. Provide this or glucose_mmol_l, not both. \u003e144 mg/dL scores; 144 does not.","type":"number"},"glucose_mmol_l":{"description":"Baseline glucose in mmol/L (2.8-55.5). Provide this or glucose_mg_dl, not both. 1 point if \u003e8.0; 8.0 does not score.","type":"number"},"hyperdense_artery":{"description":"(Hyper)dense cerebral artery sign on admission CT as assigned by the caller (Strbian 2012). true scores 1. Combined with early_infarct_signs: none 0, either 1, both 2. magent does not read CT.","type":"boolean"},"nihss":{"description":"Caller-assigned NIH Stroke Scale total (integer 0-42). 0-4 scores 0; 5-9 scores 1; 10-15 scores 2; \u003e15 (16-42) scores 3. magent does not compute NIHSS or examine the patient.","type":"integer"},"onset_to_treatment_min":{"description":"Onset-to-treatment time in minutes (integer 0-360). \u003e90 scores 1; 90 does not. magent does not clock the delay.","type":"integer"},"prestroke_mrs_gt_1":{"description":"Prestroke modified Rankin Scale \u003e1 as assigned by the caller (Strbian 2012). true scores 1; false scores 0. Do not send a raw mRS integer. magent does not assign mRS.","type":"boolean"}},"required":["age","nihss","onset_to_treatment_min","hyperdense_artery","early_infarct_signs","prestroke_mrs_gt_1"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T15:05:38.119Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T15:05:37.956Z"},"resource":"https://api.magentlab.com/api/calc/dragon","serviceName":"magent","tags":["dragon","stroke","thrombolysis","nihss","neurology"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/cpot","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Gélinas 2006 CPOT from four caller-assigned 0-2 items (facial_expression, body_movements, muscle_tension, plus ventilator_compliance when intubated or vocalization when extubated) using that paper's 0/1/2 descriptors. magent sums only (max 8) and does not observe the patient. No later intensity cutoffs. Not a pain diagnosis or analgesic order. Not PAINAD.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"body_movements":0,"facial_expression":0,"intubated":false,"muscle_tension":0,"ventilator_compliance":0,"vocalization":0},{"body_movements":0,"facial_expression":0,"intubated":false,"muscle_tension":0,"ventilator_compliance":0,"vocalization":0}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"body_movements":0,"citation":{"authors":"Gélinas C, Fillion L, Puntillo KA, Viens C, Fortier M","doi":"10.4037/ajcc2006.15.4.420","id":"gelinas-2006","pmid":"16823021","source":"Am J Crit Care. 2006;15(4):420-427","title":"Validation of the Critical-Care Pain Observation Tool in Adult Patients"},"components":[{"factor":"facial_expression","points":0,"present":true,"value":0},{"factor":"body_movements","points":0,"present":true,"value":0},{"factor":"muscle_tension","points":0,"present":true,"value":0},{"factor":"vocalization","points":0,"present":true,"value":0}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","facial_expression":0,"formula":"cpot","formula_expression":"CPOT = facial_expression + body_movements + muscle_tension + ventilator_compliance (intubated) or vocalization (extubated); each caller-assigned 0-2; max 8","intubated":false,"max_score":8,"muscle_tension":0,"score":0,"vocalization":0},{"body_movements":0,"citation":{"authors":"Gélinas C, Fillion L, Puntillo KA, Viens C, Fortier M","doi":"10.4037/ajcc2006.15.4.420","id":"gelinas-2006","pmid":"16823021","source":"Am J Crit Care. 2006;15(4):420-427","title":"Validation of the Critical-Care Pain Observation Tool in Adult Patients"},"components":[{"factor":"facial_expression","points":0,"present":true,"value":0},{"factor":"body_movements","points":0,"present":true,"value":0},{"factor":"muscle_tension","points":0,"present":true,"value":0},{"factor":"vocalization","points":0,"present":true,"value":0}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","facial_expression":0,"formula":"cpot","formula_expression":"CPOT = facial_expression + body_movements + muscle_tension + ventilator_compliance (intubated) or vocalization (extubated); each caller-assigned 0-2; max 8","intubated":false,"max_score":8,"muscle_tension":0,"score":0,"vocalization":0}],"path":"/api/calc/cpot"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"body_movements":{"description":"Caller-assigned Gélinas 2006 CPOT body movements (integer 0-2): 0 absence of movements or normal position; 1 protection; 2 restlessness. magent does not observe the patient.","type":"integer"},"facial_expression":{"description":"Caller-assigned Gélinas 2006 CPOT facial expression (integer 0-2): 0 relaxed, no muscle tension; 1 tense (brow lowering, orbit tightening, levator contraction); 2 grimacing. magent does not observe the patient.","type":"integer"},"intubated":{"description":"true when intubated: provide ventilator_compliance and omit vocalization. false when extubated: provide vocalization and omit ventilator_compliance. magent does not observe the patient.","type":"boolean"},"muscle_tension":{"description":"Caller-assigned Gélinas 2006 CPOT muscle tension on passive flexion/extension of upper limbs (integer 0-2): 0 relaxed; 1 tense/rigid; 2 very tense or rigid. magent does not observe the patient.","type":"integer"},"ventilator_compliance":{"description":"Caller-assigned Gélinas 2006 CPOT ventilator compliance when intubated=true (integer 0-2): 0 tolerating ventilator or movement; 1 coughing but still tolerating; 2 fighting ventilator. Omit when intubated=false. magent does not observe the patient.","type":"integer"},"vocalization":{"description":"Caller-assigned Gélinas 2006 CPOT vocalization when intubated=false (integer 0-2): 0 talking in normal tone or no sound; 1 sighing, moaning; 2 crying out, sobbing. Omit when intubated=true. magent does not observe the patient.","type":"integer"}},"required":["facial_expression","body_movements","muscle_tension","intubated"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T15:05:02.834Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T15:05:02.711Z"},"resource":"https://api.magentlab.com/api/calc/cpot","serviceName":"magent","tags":["cpot","pain","icu","neurology","calculator"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/bush_francis","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Bush 1996 23-item catatonia rating scale from caller-assigned integers. Items 1-16 and 22-23 are 0-3; mitgehen, gegenhalten, ambitendency, grasp_reflex, and perseveration are 0 or 3 only. Severity is the sum of items 1-23 (max 69). The 14-item screen is positive iff at least two of items 1-14 score above 0. magent does not perform the standardized examination. Not a diagnosis, not DSM catatonia criteria, not a medical device.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"ambitendency":0,"automatic_obedience":0,"autonomic_abnormality":0,"combativeness":0,"echopraxia_echolalia":0,"excitement":1,"gegenhalten":0,"grasp_reflex":0,"grimacing":0,"immobility_stupor":1,"impulsivity":0,"mannerisms":0,"mitgehen":0,"mutism":0,"negativism":0,"perseveration":0,"posturing_catalepsy":0,"rigidity":0,"staring":0,"stereotypy":0,"verbigeration":0,"waxy_flexibility":0,"withdrawal":0},{"ambitendency":0,"automatic_obedience":0,"autonomic_abnormality":0,"combativeness":0,"echopraxia_echolalia":0,"excitement":1,"gegenhalten":0,"grasp_reflex":0,"grimacing":0,"immobility_stupor":1,"impulsivity":0,"mannerisms":0,"mitgehen":0,"mutism":0,"negativism":0,"perseveration":0,"posturing_catalepsy":0,"rigidity":0,"staring":0,"stereotypy":0,"verbigeration":0,"waxy_flexibility":0,"withdrawal":0}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"citation":{"authors":"Bush G, Fink M, Petrides G, Dowling F, Francis A","doi":"10.1111/j.1600-0447.1996.tb09814.x","id":"bush-1996","pmid":"8686483","source":"Acta Psychiatr Scand. 1996;93(2):129-136","title":"Catatonia. I. Rating scale and standardized examination"},"components":[{"factor":"excitement","points":1,"present":true,"value":1},{"factor":"immobility_stupor","points":1,"present":true,"value":1},{"factor":"mutism","points":0,"present":true,"value":0},{"factor":"staring","points":0,"present":true,"value":0},{"factor":"posturing_catalepsy","points":0,"present":true,"value":0},{"factor":"grimacing","points":0,"present":true,"value":0},{"factor":"echopraxia_echolalia","points":0,"present":true,"value":0},{"factor":"stereotypy","points":0,"present":true,"value":0},{"factor":"mannerisms","points":0,"present":true,"value":0},{"factor":"verbigeration","points":0,"present":true,"value":0},{"factor":"rigidity","points":0,"present":true,"value":0},{"factor":"negativism","points":0,"present":true,"value":0},{"factor":"waxy_flexibility","points":0,"present":true,"value":0},{"factor":"withdrawal","points":0,"present":true,"value":0},{"factor":"impulsivity","points":0,"present":true,"value":0},{"factor":"automatic_obedience","points":0,"present":true,"value":0},{"factor":"mitgehen","points":0,"present":true,"value":0},{"factor":"gegenhalten","points":0,"present":true,"value":0},{"factor":"ambitendency","points":0,"present":true,"value":0},{"factor":"grasp_reflex","points":0,"present":true,"value":0},{"factor":"perseveration","points":0,"present":true,"value":0},{"factor":"combativeness","points":0,"present":true,"value":0},{"factor":"autonomic_abnormality","points":0,"present":true,"value":0}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"bush_francis","formula_expression":"Bush-Francis CRS = excitement + immobility_stupor + mutism + staring + posturing_catalepsy + grimacing + echopraxia_echolalia + stereotypy + mannerisms + verbigeration + rigidity + negativism + waxy_flexibility + withdrawal + impulsivity + automatic_obedience + mitgehen + gegenhalten + ambitendency + grasp_reflex + perseveration + combativeness + autonomic_abnormality; Bush 1996 23-item catatonia rating scale; items 1-16 and 22-23 integers 0-3; items 17-21 (mitgehen, gegenhalten, ambitendency, grasp_reflex, perseveration) 0 or 3 only; severity score = sum of items 1-23; screening instrument = first 14 items; screen_positive iff count of items 1-14 with score \u003e 0 is \u003e= 2; max 69; not a diagnosis","max_score":69,"score":2,"screen_positive":true,"screen_signs_met":2},{"citation":{"authors":"Bush G, Fink M, Petrides G, Dowling F, Francis A","doi":"10.1111/j.1600-0447.1996.tb09814.x","id":"bush-1996","pmid":"8686483","source":"Acta Psychiatr Scand. 1996;93(2):129-136","title":"Catatonia. I. Rating scale and standardized examination"},"components":[{"factor":"excitement","points":1,"present":true,"value":1},{"factor":"immobility_stupor","points":1,"present":true,"value":1},{"factor":"mutism","points":0,"present":true,"value":0},{"factor":"staring","points":0,"present":true,"value":0},{"factor":"posturing_catalepsy","points":0,"present":true,"value":0},{"factor":"grimacing","points":0,"present":true,"value":0},{"factor":"echopraxia_echolalia","points":0,"present":true,"value":0},{"factor":"stereotypy","points":0,"present":true,"value":0},{"factor":"mannerisms","points":0,"present":true,"value":0},{"factor":"verbigeration","points":0,"present":true,"value":0},{"factor":"rigidity","points":0,"present":true,"value":0},{"factor":"negativism","points":0,"present":true,"value":0},{"factor":"waxy_flexibility","points":0,"present":true,"value":0},{"factor":"withdrawal","points":0,"present":true,"value":0},{"factor":"impulsivity","points":0,"present":true,"value":0},{"factor":"automatic_obedience","points":0,"present":true,"value":0},{"factor":"mitgehen","points":0,"present":true,"value":0},{"factor":"gegenhalten","points":0,"present":true,"value":0},{"factor":"ambitendency","points":0,"present":true,"value":0},{"factor":"grasp_reflex","points":0,"present":true,"value":0},{"factor":"perseveration","points":0,"present":true,"value":0},{"factor":"combativeness","points":0,"present":true,"value":0},{"factor":"autonomic_abnormality","points":0,"present":true,"value":0}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"bush_francis","formula_expression":"Bush-Francis CRS = excitement + immobility_stupor + mutism + staring + posturing_catalepsy + grimacing + echopraxia_echolalia + stereotypy + mannerisms + verbigeration + rigidity + negativism + waxy_flexibility + withdrawal + impulsivity + automatic_obedience + mitgehen + gegenhalten + ambitendency + grasp_reflex + perseveration + combativeness + autonomic_abnormality; Bush 1996 23-item catatonia rating scale; items 1-16 and 22-23 integers 0-3; items 17-21 (mitgehen, gegenhalten, ambitendency, grasp_reflex, perseveration) 0 or 3 only; severity score = sum of items 1-23; screening instrument = first 14 items; screen_positive iff count of items 1-14 with score \u003e 0 is \u003e= 2; max 69; not a diagnosis","max_score":69,"score":2,"screen_positive":true,"screen_signs_met":2}],"path":"/api/calc/bush_francis"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"ambitendency":{"description":"Caller-assigned Bush 1996 ambitendency (item 19; 0 absent or 3 present only). magent does not examine the patient.","enum":[0,3],"type":"integer"},"automatic_obedience":{"description":"Caller-assigned Bush 1996 automatic obedience (item 16; integer 0-3). magent does not examine the patient.","enum":[0,1,2,3],"type":"integer"},"autonomic_abnormality":{"description":"Caller-assigned Bush 1996 autonomic abnormality (item 23; integer 0-3). magent does not examine the patient.","enum":[0,1,2,3],"type":"integer"},"combativeness":{"description":"Caller-assigned Bush 1996 combativeness (item 22; integer 0-3). magent does not examine the patient.","enum":[0,1,2,3],"type":"integer"},"echopraxia_echolalia":{"description":"Caller-assigned Bush 1996 echopraxia/echolalia (item 7; integer 0-3). magent does not examine the patient.","enum":[0,1,2,3],"type":"integer"},"excitement":{"description":"Caller-assigned Bush 1996 excitement (item 1; integer 0-3). magent does not examine the patient.","enum":[0,1,2,3],"type":"integer"},"gegenhalten":{"description":"Caller-assigned Bush 1996 gegenhalten (item 18; 0 absent or 3 present only). magent does not examine the patient.","enum":[0,3],"type":"integer"},"grasp_reflex":{"description":"Caller-assigned Bush 1996 grasp reflex (item 20; 0 absent or 3 present only). magent does not examine the patient.","enum":[0,3],"type":"integer"},"grimacing":{"description":"Caller-assigned Bush 1996 grimacing (item 6; integer 0-3). magent does not examine the patient.","enum":[0,1,2,3],"type":"integer"},"immobility_stupor":{"description":"Caller-assigned Bush 1996 immobility/stupor (item 2; integer 0-3). magent does not examine the patient.","enum":[0,1,2,3],"type":"integer"},"impulsivity":{"description":"Caller-assigned Bush 1996 impulsivity (item 15; integer 0-3). magent does not examine the patient.","enum":[0,1,2,3],"type":"integer"},"mannerisms":{"description":"Caller-assigned Bush 1996 mannerisms (item 9; integer 0-3). magent does not examine the patient.","enum":[0,1,2,3],"type":"integer"},"mitgehen":{"description":"Caller-assigned Bush 1996 mitgehen (item 17; 0 absent or 3 present only). magent does not examine the patient.","enum":[0,3],"type":"integer"},"mutism":{"description":"Caller-assigned Bush 1996 mutism (item 3; integer 0-3). magent does not examine the patient.","enum":[0,1,2,3],"type":"integer"},"negativism":{"description":"Caller-assigned Bush 1996 negativism (item 12; integer 0-3). magent does not examine the patient.","enum":[0,1,2,3],"type":"integer"},"perseveration":{"description":"Caller-assigned Bush 1996 perseveration (item 21; 0 absent or 3 present only). magent does not examine the patient.","enum":[0,3],"type":"integer"},"posturing_catalepsy":{"description":"Caller-assigned Bush 1996 posturing/catalepsy (item 5; integer 0-3). magent does not examine the patient.","enum":[0,1,2,3],"type":"integer"},"rigidity":{"description":"Caller-assigned Bush 1996 rigidity (item 11; integer 0-3). magent does not examine the patient.","enum":[0,1,2,3],"type":"integer"},"staring":{"description":"Caller-assigned Bush 1996 staring (item 4; integer 0-3). magent does not examine the patient.","enum":[0,1,2,3],"type":"integer"},"stereotypy":{"description":"Caller-assigned Bush 1996 stereotypy (item 8; integer 0-3). magent does not examine the patient.","enum":[0,1,2,3],"type":"integer"},"verbigeration":{"description":"Caller-assigned Bush 1996 verbigeration (item 10; integer 0-3). magent does not examine the patient.","enum":[0,1,2,3],"type":"integer"},"waxy_flexibility":{"description":"Caller-assigned Bush 1996 waxy flexibility (item 13; integer 0-3). magent does not examine the patient.","enum":[0,1,2,3],"type":"integer"},"withdrawal":{"description":"Caller-assigned Bush 1996 withdrawal (item 14; integer 0-3). magent does not examine the patient.","enum":[0,1,2,3],"type":"integer"}},"required":["excitement","immobility_stupor","mutism","staring","posturing_catalepsy","grimacing","echopraxia_echolalia","stereotypy","mannerisms","verbigeration","rigidity","negativism","waxy_flexibility","withdrawal","impulsivity","automatic_obedience","mitgehen","gegenhalten","ambitendency","grasp_reflex","perseveration","combativeness","autonomic_abnormality"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T15:03:36.974Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T15:03:36.815Z"},"resource":"https://api.magentlab.com/api/calc/bush_francis","serviceName":"magent","tags":["bush-francis","catatonia","neurology","bfcrs","calculator"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/astral","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Ntaios 2012 ASTRAL integer score for 3-month mRS \u003e2 in acute ischemic stroke. Age 1/5 years + NIHSS (caller 0-42) + 2 if onset-to-admission \u003e180 min + 2 if visual field defect + 1 if glucose \u003c3.7 or \u003e7.3 mmol/L (mg/dL /18) + 3 if impaired consciousness. Score 31 is 50% unfavorable. Not a tPA decision. magent does not compute NIHSS.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"age":40,"delay_gt_180":false,"glucose_mg_dl":108,"glucose_mmol_l":6,"loc_impaired":false,"nihss":0,"visual_field_defect":false},{"age":40,"delay_gt_180":false,"glucose_mg_dl":108,"glucose_mmol_l":6,"loc_impaired":false,"nihss":0,"visual_field_defect":false}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"age_years":40,"citation":{"authors":"Ntaios G, Faouzi M, Ferrari J, Lang W, Vemmos K, Michel P","doi":"10.1212/WNL.0b013e318259e221","id":"ntaios-2012","pmid":"22649218","source":"Neurology. 2012;78(24):1916-1922","title":"An integer-based score to predict functional outcome in acute ischemic stroke: the ASTRAL score"},"components":[{"factor":"age","points":8,"present":true,"value":40},{"factor":"nihss","points":0,"present":false,"value":0},{"factor":"delay_gt_180","points":0,"present":false},{"factor":"visual_field_defect","points":0,"present":false},{"factor":"glucose","points":0,"present":false,"value":6},{"factor":"loc_impaired","points":0,"present":false}],"delay_gt_180":false,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"astral","formula_expression":"ASTRAL = age (1 per 5 years) + NIHSS + 2 if onset-to-admission \u003e180 min + 2 if visual field defect + 1 if glucose \u003c3.7 or \u003e7.3 mmol/L + 3 if impaired consciousness; Ntaios 2012; 3-month mRS \u003e2 is 50% at score 31","glucose_abnormal":false,"glucose_mmol_l":6,"loc_impaired":false,"max_score":74,"nihss":0,"score":8,"unfavorable_ge_31":false,"visual_field_defect":false},{"age_years":40,"citation":{"authors":"Ntaios G, Faouzi M, Ferrari J, Lang W, Vemmos K, Michel P","doi":"10.1212/WNL.0b013e318259e221","id":"ntaios-2012","pmid":"22649218","source":"Neurology. 2012;78(24):1916-1922","title":"An integer-based score to predict functional outcome in acute ischemic stroke: the ASTRAL score"},"components":[{"factor":"age","points":8,"present":true,"value":40},{"factor":"nihss","points":0,"present":false,"value":0},{"factor":"delay_gt_180","points":0,"present":false},{"factor":"visual_field_defect","points":0,"present":false},{"factor":"glucose","points":0,"present":false,"value":6},{"factor":"loc_impaired","points":0,"present":false}],"delay_gt_180":false,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"astral","formula_expression":"ASTRAL = age (1 per 5 years) + NIHSS + 2 if onset-to-admission \u003e180 min + 2 if visual field defect + 1 if glucose \u003c3.7 or \u003e7.3 mmol/L + 3 if impaired consciousness; Ntaios 2012; 3-month mRS \u003e2 is 50% at score 31","glucose_abnormal":false,"glucose_mmol_l":6,"loc_impaired":false,"max_score":74,"nihss":0,"score":8,"unfavorable_ge_31":false,"visual_field_defect":false}],"path":"/api/calc/astral"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"age":{"description":"Age in years (18-120). Ntaios 2012 integer weight is 1 point per 5 years (integer division). magent does not date the patient.","type":"integer"},"delay_gt_180":{"description":"Onset-to-admission delay \u003e180 minutes (Ntaios 2012 time item). true scores 2; false (including 180 min) scores 0. magent does not clock the delay.","type":"boolean"},"glucose_mg_dl":{"description":"Admission glucose in mg/dL (50-1000). Converted as mmol/L = mg/dL / 18. Provide this or glucose_mmol_l, not both.","type":"number"},"glucose_mmol_l":{"description":"Admission glucose in mmol/L (2.8-55.5). Provide this or glucose_mg_dl, not both. 1 point if \u003c3.7 or \u003e7.3; 3.7 and 7.3 do not score.","type":"number"},"loc_impaired":{"description":"Impaired consciousness as assigned by the caller (Ntaios 2012; NIHSS item 1a \u003e0). true scores 3; false scores 0. magent does not compute NIHSS.","type":"boolean"},"nihss":{"description":"Caller-assigned NIH Stroke Scale total (integer 0-42). 1 point per NIHSS point. magent does not compute NIHSS or examine the patient.","type":"integer"},"visual_field_defect":{"description":"Any stroke-related visual field defect as assigned by the caller (Ntaios 2012 range of visual fields). true scores 2; false scores 0. magent does not examine the patient.","type":"boolean"}},"required":["age","nihss","delay_gt_180","visual_field_defect","loc_impaired"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T15:03:01.628Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T15:03:01.465Z"},"resource":"https://api.magentlab.com/api/calc/astral","serviceName":"magent","tags":["astral","stroke","neurology","nihss","calculator"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/berg_balance","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Berg 1992 Berg Balance Scale (BBS): fourteen caller-assigned integers 0-4 (sitting to standing through standing on one foot). Sum 0-56. magent does not observe. Berg 1992 printed no 0-20 wheelchair / 21-40 walking-with-assistance / 41-56 independent website bands. Not Timed Up and Go, not a diagnosis, and not a medical device.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"alternate_foot_on_stool":0,"reaching_forward":0,"retrieving_object_from_floor":0,"sitting_to_standing":0,"sitting_unsupported":0,"standing_eyes_closed":0,"standing_feet_together":0,"standing_on_one_foot":0,"standing_to_sitting":0,"standing_unsupported":0,"tandem_stance":0,"transfers":0,"turning_360":0,"turning_to_look_behind":0},{"alternate_foot_on_stool":0,"reaching_forward":0,"retrieving_object_from_floor":0,"sitting_to_standing":0,"sitting_unsupported":0,"standing_eyes_closed":0,"standing_feet_together":0,"standing_on_one_foot":0,"standing_to_sitting":0,"standing_unsupported":0,"tandem_stance":0,"transfers":0,"turning_360":0,"turning_to_look_behind":0}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"citation":{"authors":"Berg KO, Wood-Dauphinee SL, Williams JI, Maki B","id":"berg-1992","pmid":"1468055","source":"Can J Public Health. 1992;83 Suppl 2:S7-S11","title":"Measuring balance in the elderly: validation of an instrument"},"components":[{"factor":"sitting_to_standing","points":0,"present":true,"value":0},{"factor":"standing_unsupported","points":0,"present":true,"value":0},{"factor":"sitting_unsupported","points":0,"present":true,"value":0},{"factor":"standing_to_sitting","points":0,"present":true,"value":0},{"factor":"transfers","points":0,"present":true,"value":0},{"factor":"standing_eyes_closed","points":0,"present":true,"value":0},{"factor":"standing_feet_together","points":0,"present":true,"value":0},{"factor":"reaching_forward","points":0,"present":true,"value":0},{"factor":"retrieving_object_from_floor","points":0,"present":true,"value":0},{"factor":"turning_to_look_behind","points":0,"present":true,"value":0},{"factor":"turning_360","points":0,"present":true,"value":0},{"factor":"alternate_foot_on_stool","points":0,"present":true,"value":0},{"factor":"tandem_stance","points":0,"present":true,"value":0},{"factor":"standing_on_one_foot","points":0,"present":true,"value":0}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"berg_balance","formula_expression":"Berg Balance Scale = sitting_to_standing + standing_unsupported + sitting_unsupported + standing_to_sitting + transfers + standing_eyes_closed + standing_feet_together + reaching_forward + retrieving_object_from_floor + turning_to_look_behind + turning_360 + alternate_foot_on_stool + tandem_stance + standing_on_one_foot; each caller-assigned 0-4; Berg 1992 fourteen items; max 56; no 0-20 / 21-40 / 41-56 wheelchair/assist/independent website bands","max_score":56,"score":0},{"citation":{"authors":"Berg KO, Wood-Dauphinee SL, Williams JI, Maki B","id":"berg-1992","pmid":"1468055","source":"Can J Public Health. 1992;83 Suppl 2:S7-S11","title":"Measuring balance in the elderly: validation of an instrument"},"components":[{"factor":"sitting_to_standing","points":0,"present":true,"value":0},{"factor":"standing_unsupported","points":0,"present":true,"value":0},{"factor":"sitting_unsupported","points":0,"present":true,"value":0},{"factor":"standing_to_sitting","points":0,"present":true,"value":0},{"factor":"transfers","points":0,"present":true,"value":0},{"factor":"standing_eyes_closed","points":0,"present":true,"value":0},{"factor":"standing_feet_together","points":0,"present":true,"value":0},{"factor":"reaching_forward","points":0,"present":true,"value":0},{"factor":"retrieving_object_from_floor","points":0,"present":true,"value":0},{"factor":"turning_to_look_behind","points":0,"present":true,"value":0},{"factor":"turning_360","points":0,"present":true,"value":0},{"factor":"alternate_foot_on_stool","points":0,"present":true,"value":0},{"factor":"tandem_stance","points":0,"present":true,"value":0},{"factor":"standing_on_one_foot","points":0,"present":true,"value":0}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"berg_balance","formula_expression":"Berg Balance Scale = sitting_to_standing + standing_unsupported + sitting_unsupported + standing_to_sitting + transfers + standing_eyes_closed + standing_feet_together + reaching_forward + retrieving_object_from_floor + turning_to_look_behind + turning_360 + alternate_foot_on_stool + tandem_stance + standing_on_one_foot; each caller-assigned 0-4; Berg 1992 fourteen items; max 56; no 0-20 / 21-40 / 41-56 wheelchair/assist/independent website bands","max_score":56,"score":0}],"path":"/api/calc/berg_balance"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"alternate_foot_on_stool":{"description":"Caller-assigned Berg 1992 placing alternate foot on step or stool while standing unsupported (integer 0-4): 4 able to stand independently and safely and complete 8 steps in 20 seconds; 3 able to stand independently and complete 8 steps in more than 20 seconds; 2 able to complete 4 steps without aid with supervision; 1 able to complete more than 2 steps needs minimal assist; 0 needs assistance to keep from falling or unable to try. magent does not observe the patient.","type":"integer"},"reaching_forward":{"description":"Caller-assigned Berg 1992 reaching forward with outstretched arm while standing (integer 0-4): 4 can reach forward confidently more than 25 cm (10 inches); 3 can reach forward more than 12 cm (5 inches) safely; 2 can reach forward more than 5 cm (2 inches) safely; 1 reaches forward but needs supervision; 0 loses balance while trying or requires external support. magent does not observe the patient.","type":"integer"},"retrieving_object_from_floor":{"description":"Caller-assigned Berg 1992 retrieving object from floor from a standing position (integer 0-4): 4 able to pick up slipper safely and easily; 3 able to pick up slipper but needs supervision; 2 unable to pick up but reaches 2-5 cm from slipper and keeps balance independently; 1 unable to pick up and needs supervision while trying; 0 unable to try or needs assist to keep from losing balance. magent does not observe the patient.","type":"integer"},"sitting_to_standing":{"description":"Caller-assigned Berg 1992 sitting to standing (integer 0-4): 4 able to stand without using hands and stabilize independently; 3 able to stand independently using hands; 2 able to stand using hands after several tries; 1 needs minimal aid to stand or stabilize; 0 needs moderate or maximal assist to stand. magent does not observe the patient.","type":"integer"},"sitting_unsupported":{"description":"Caller-assigned Berg 1992 sitting unsupported, feet supported (integer 0-4): 4 able to sit safely and securely for 2 minutes; 3 able to sit 2 minutes under supervision; 2 able to sit 30 seconds; 1 able to sit 10 seconds; 0 unable to sit without support 10 seconds. magent does not observe the patient.","type":"integer"},"standing_eyes_closed":{"description":"Caller-assigned Berg 1992 standing unsupported with eyes closed (integer 0-4): 4 able to stand 10 seconds safely; 3 able to stand 10 seconds with supervision; 2 able to stand 3 seconds; 1 unable to keep eyes closed 3 seconds but stays standing; 0 needs help to keep from falling. magent does not observe the patient.","type":"integer"},"standing_feet_together":{"description":"Caller-assigned Berg 1992 standing unsupported with feet together (integer 0-4): 4 able to place feet together independently and stand 1 minute safely; 3 able to place feet together independently and stand 1 minute with supervision; 2 able to place feet together independently but unable to hold 30 seconds; 1 needs help to attain position but able to stand 15 seconds; 0 needs help to attain position and unable to hold 15 seconds. magent does not observe the patient.","type":"integer"},"standing_on_one_foot":{"description":"Caller-assigned Berg 1992 standing on one foot (integer 0-4): 4 able to lift leg independently and hold more than 10 seconds; 3 able to lift leg independently and hold 5-10 seconds; 2 able to lift leg independently and hold at least 3 seconds; 1 tries to lift leg unable to hold 3 seconds but remains standing independently; 0 unable to try or needs assist to prevent fall. magent does not observe the patient.","type":"integer"},"standing_to_sitting":{"description":"Caller-assigned Berg 1992 standing to sitting (integer 0-4): 4 sits safely with minimal use of hands; 3 controls descent by using hands; 2 uses back of legs against chair to control descent; 1 sits independently but has uncontrolled descent; 0 needs assistance to sit. magent does not observe the patient.","type":"integer"},"standing_unsupported":{"description":"Caller-assigned Berg 1992 standing unsupported (integer 0-4): 4 able to stand safely for 2 minutes; 3 able to stand 2 minutes with supervision; 2 able to stand 30 seconds unsupported; 1 needs several tries to stand 30 seconds unsupported; 0 unable to stand 30 seconds unassisted. magent does not observe the patient.","type":"integer"},"tandem_stance":{"description":"Caller-assigned Berg 1992 standing unsupported one foot in front (integer 0-4): 4 able to place foot tandem independently and hold 30 seconds; 3 able to place foot ahead of other independently and hold 30 seconds; 2 able to take small step independently and hold 30 seconds; 1 needs help to step but can hold 15 seconds; 0 loses balance while stepping or standing. magent does not observe the patient.","type":"integer"},"transfers":{"description":"Caller-assigned Berg 1992 transfers (integer 0-4): 4 able to transfer safely with minor use of hands; 3 able to transfer safely definite need of hands; 2 able to transfer with verbal cuing and/or supervision; 1 needs one person to assist; 0 needs two people to assist or supervise to be safe. magent does not observe the patient.","type":"integer"},"turning_360":{"description":"Caller-assigned Berg 1992 turning 360 degrees (integer 0-4): 4 able to turn 360 degrees safely in 4 seconds or less; 3 able to turn 360 degrees safely one side only in 4 seconds or less; 2 able to turn 360 degrees safely but slowly; 1 needs close supervision or verbal cuing; 0 needs assistance while turning. magent does not observe the patient.","type":"integer"},"turning_to_look_behind":{"description":"Caller-assigned Berg 1992 turning to look behind over left and right shoulders while standing (integer 0-4): 4 looks behind from both sides with weight shift; 3 looks behind one side only other side shows less weight shift; 2 turns sideways only but maintains balance; 1 needs supervision when turning; 0 needs assist to keep from losing balance or falling. magent does not observe the patient.","type":"integer"}},"required":["sitting_to_standing","standing_unsupported","sitting_unsupported","standing_to_sitting","transfers","standing_eyes_closed","standing_feet_together","reaching_forward","retrieving_object_from_floor","turning_to_look_behind","turning_360","alternate_foot_on_stool","tandem_stance","standing_on_one_foot"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T14:59:39.364Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T14:59:39.211Z"},"resource":"https://api.magentlab.com/api/calc/berg_balance","serviceName":"magent","tags":["bbs","berg","balance","neurology","calculator"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/canadian_tia","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Perry 2021 Canadian TIA Score (Table 1) for 7-day stroke or carotid revascularization after TIA. Clinical: first TIA 2, symptoms \u003e=10 min 2, past carotid stenosis 2, antiplatelet 3, gait 1, unilateral weakness 1, vertigo -3, diastolic \u003e=110 3, dysarthria/aphasia 1. Investigations: AF on ECG 2, infarct on CT 1, platelets \u003e=400 2, glucose \u003e=15 mmol/L 3. Age required, 0 points. Total -3 to 23. Bands \u003c=3 low (0.5%), 4-8 medium (2.3%), \u003e=9 high (5.9%). Not ABCD2. Not a diagnosis or admit order.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"af_on_ecg":false,"age":70,"carotid_stenosis":false,"diastolic_mm_hg":80,"dysarthria_or_aphasia":false,"first_tia":false,"gait_disturbance":false,"glucose_mg_dl":90,"glucose_mmol_l":5,"infarct_on_ct":false,"on_antiplatelet":false,"platelets_10e9_l":200,"symptoms_ge_10_min":false,"unilateral_weakness":false,"vertigo":false},{"af_on_ecg":false,"age":70,"carotid_stenosis":false,"diastolic_mm_hg":80,"dysarthria_or_aphasia":false,"first_tia":false,"gait_disturbance":false,"glucose_mg_dl":90,"glucose_mmol_l":5,"infarct_on_ct":false,"on_antiplatelet":false,"platelets_10e9_l":200,"symptoms_ge_10_min":false,"unilateral_weakness":false,"vertigo":false}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"age_years":70,"citation":{"authors":"Perry JJ, Sivilotti MLA, Émond M, Stiell IG, Stotts G, Lee J, Worster A, Morris J, Cheung KW, Jin AY, Oczkowski WJ, Sahlas DJ, Murray HE, Mackey A, Verreault S, Camden MC, Yip S, Teal P, Gladstone DJ, Boulos MI, Chagnon N, Shouldice E, Atzema C, Slaoui T, Teitlebaum J, Abdulaziz K, Nemnom MJ, Wells GA, Sharma M","doi":"10.1136/bmj.n49","id":"perry-2021","pmid":"33541890","source":"BMJ. 2021;372:n49","title":"Prospective validation of Canadian TIA Score and comparison with ABCD2 and ABCD2i for subsequent stroke risk after transient ischaemic attack: multicentre prospective cohort study"},"components":[{"factor":"first_tia","points":0,"present":false},{"factor":"symptoms_ge_10_min","points":0,"present":false},{"factor":"carotid_stenosis","points":0,"present":false},{"factor":"on_antiplatelet","points":0,"present":false},{"factor":"gait_disturbance","points":0,"present":false},{"factor":"unilateral_weakness","points":0,"present":false},{"factor":"vertigo","points":0,"present":false},{"factor":"diastolic_mm_hg","points":0,"present":false,"value":80},{"factor":"dysarthria_or_aphasia","points":0,"present":false},{"factor":"af_on_ecg","points":0,"present":false},{"factor":"infarct_on_ct","points":0,"present":false},{"factor":"platelets_10e9_l","points":0,"present":false,"value":200},{"factor":"glucose","points":0,"present":false,"value":5}],"diastolic_mm_hg":80,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"canadian_tia","formula_expression":"Canadian TIA Score = first_tia 2 + symptoms_ge_10_min 2 + carotid_stenosis 2 + on_antiplatelet 3 + gait_disturbance 1 + unilateral_weakness 1 + vertigo -3 + (diastolic_mm_hg \u003e= 110) 3 + dysarthria_or_aphasia 1 + af_on_ecg 2 + infarct_on_ct 1 + (platelets_10e9_l \u003e= 400) 2 + (glucose \u003e= 15 mmol/L) 3; age 18-120 required, 0 points; total -3 to 23; tia_risk low \u003c=3 (0.5%), medium 4-8 (2.3%), high \u003e=9 (5.9%) 7-day stroke or carotid revascularization (Perry 2021 Table 1 / Table 4); max 23","glucose_mmol_l":5,"max_score":23,"platelets_10e9_l":200,"score":0,"tia_risk":"low"},{"age_years":70,"citation":{"authors":"Perry JJ, Sivilotti MLA, Émond M, Stiell IG, Stotts G, Lee J, Worster A, Morris J, Cheung KW, Jin AY, Oczkowski WJ, Sahlas DJ, Murray HE, Mackey A, Verreault S, Camden MC, Yip S, Teal P, Gladstone DJ, Boulos MI, Chagnon N, Shouldice E, Atzema C, Slaoui T, Teitlebaum J, Abdulaziz K, Nemnom MJ, Wells GA, Sharma M","doi":"10.1136/bmj.n49","id":"perry-2021","pmid":"33541890","source":"BMJ. 2021;372:n49","title":"Prospective validation of Canadian TIA Score and comparison with ABCD2 and ABCD2i for subsequent stroke risk after transient ischaemic attack: multicentre prospective cohort study"},"components":[{"factor":"first_tia","points":0,"present":false},{"factor":"symptoms_ge_10_min","points":0,"present":false},{"factor":"carotid_stenosis","points":0,"present":false},{"factor":"on_antiplatelet","points":0,"present":false},{"factor":"gait_disturbance","points":0,"present":false},{"factor":"unilateral_weakness","points":0,"present":false},{"factor":"vertigo","points":0,"present":false},{"factor":"diastolic_mm_hg","points":0,"present":false,"value":80},{"factor":"dysarthria_or_aphasia","points":0,"present":false},{"factor":"af_on_ecg","points":0,"present":false},{"factor":"infarct_on_ct","points":0,"present":false},{"factor":"platelets_10e9_l","points":0,"present":false,"value":200},{"factor":"glucose","points":0,"present":false,"value":5}],"diastolic_mm_hg":80,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"canadian_tia","formula_expression":"Canadian TIA Score = first_tia 2 + symptoms_ge_10_min 2 + carotid_stenosis 2 + on_antiplatelet 3 + gait_disturbance 1 + unilateral_weakness 1 + vertigo -3 + (diastolic_mm_hg \u003e= 110) 3 + dysarthria_or_aphasia 1 + af_on_ecg 2 + infarct_on_ct 1 + (platelets_10e9_l \u003e= 400) 2 + (glucose \u003e= 15 mmol/L) 3; age 18-120 required, 0 points; total -3 to 23; tia_risk low \u003c=3 (0.5%), medium 4-8 (2.3%), high \u003e=9 (5.9%) 7-day stroke or carotid revascularization (Perry 2021 Table 1 / Table 4); max 23","glucose_mmol_l":5,"max_score":23,"platelets_10e9_l":200,"score":0,"tia_risk":"low"}],"path":"/api/calc/canadian_tia"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"af_on_ecg":{"description":"Atrial fibrillation on ECG (Perry 2021 Table 1). true scores 2; false scores 0. magent does not read the ECG.","type":"boolean"},"age":{"description":"Age in years (18-120). Required for the adult ED cohort. Does not add points (Perry 2021 Table 1 has no age item).","type":"integer"},"carotid_stenosis":{"description":"Past history of carotid stenosis (Perry 2021 Table 1). true scores 2; false scores 0. magent does not read imaging.","type":"boolean"},"diastolic_mm_hg":{"description":"Initial triage diastolic blood pressure in mm Hg (20-160). ≥110 scores 3; 109 scores 0 (Perry 2021 Table 1).","type":"number"},"dysarthria_or_aphasia":{"description":"Dysarthria or aphasia on history or examination (Perry 2021 Table 1). true scores 1; false scores 0. Not 3. magent does not examine the patient.","type":"boolean"},"first_tia":{"description":"Lifetime first TIA (Perry 2021 Table 1). true scores 2; false scores 0. Caller-assigned; magent does not take a history.","type":"boolean"},"gait_disturbance":{"description":"Gait disturbance (Perry 2021 Table 1). true scores 1; false scores 0. magent does not examine the patient.","type":"boolean"},"glucose_mg_dl":{"description":"Glucose in mg/dL (50-1000). Converted as mmol/L = mg/dL / 18. Provide this or glucose_mmol_l, not both. ≥15 mmol/L after conversion scores 3.","type":"number"},"glucose_mmol_l":{"description":"Glucose in mmol/L (2.8-55.5). Provide this or glucose_mg_dl, not both. ≥15.0 scores 3; 14.9 scores 0 (Perry 2021 Table 1).","type":"number"},"infarct_on_ct":{"description":"New or old infarction on CT (Perry 2021 Table 1). true scores 1; false scores 0. magent does not read the CT.","type":"boolean"},"on_antiplatelet":{"description":"Already on antiplatelet therapy (Perry 2021 Table 1). true scores 3; false scores 0.","type":"boolean"},"platelets_10e9_l":{"description":"Platelet count ×10^9/L (1-2000). ≥400 scores 2; 399 scores 0 (Perry 2021 Table 1).","type":"number"},"symptoms_ge_10_min":{"description":"Symptoms lasting 10 minutes or longer (Perry 2021 Table 1). true scores 2; false scores 0. magent does not time the episode.","type":"boolean"},"unilateral_weakness":{"description":"Unilateral weakness (Perry 2021 Table 1). true scores 1; false scores 0. magent does not examine the patient.","type":"boolean"},"vertigo":{"description":"Vertigo (Perry 2021 Table 1). true scores -3; false scores 0. magent does not examine the patient.","type":"boolean"}},"required":["age","first_tia","symptoms_ge_10_min","carotid_stenosis","on_antiplatelet","gait_disturbance","unilateral_weakness","vertigo","diastolic_mm_hg","dysarthria_or_aphasia","af_on_ecg","infarct_on_ct","platelets_10e9_l"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T14:58:19.854Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T14:58:19.708Z"},"resource":"https://api.magentlab.com/api/calc/canadian_tia","serviceName":"magent","tags":["canadian-tia","tia","stroke","neurology","calculator"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/nhfs","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Maxwell 2008 Nottingham hip fracture score: age \u003c=65 0, 66-85 3, \u003e=86 4; male 1; hemoglobin \u003c=10 g/dL 1 (g/L / 10); caller-assigned AMTS \u003c=6, lives in institution, \u003e=2 comorbidities, and malignancy 1 each. Max 10. Integer score only; no predicted 30-day mortality percent. magent does not administer AMTS or clear a patient for surgery. Not the 2012 or 2015 recalibrations.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"age":70,"amts_le_6":false,"comorbidities_ge_2":false,"hemoglobin_g_dl":12,"hemoglobin_g_l":120,"lives_in_institution":false,"malignancy":false,"sex":"female"},{"age":70,"amts_le_6":false,"comorbidities_ge_2":false,"hemoglobin_g_dl":12,"hemoglobin_g_l":120,"lives_in_institution":false,"malignancy":false,"sex":"female"}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"age_years":70,"amts_le_6":false,"citation":{"authors":"Maxwell MJ, Moran CG, Moppett IK","doi":"10.1093/bja/aen236","id":"maxwell-2008","pmid":"18723517","source":"Br J Anaesth. 2008;101(4):511-517","title":"Development and validation of a preoperative scoring system to predict 30 day mortality in patients undergoing hip fracture surgery"},"comorbidities_ge_2":false,"components":[{"factor":"age","points":3,"present":true,"value":70},{"factor":"sex","points":0,"present":false,"value":"female"},{"factor":"hemoglobin","points":0,"present":false,"value":12},{"factor":"amts_le_6","points":0,"present":false},{"factor":"lives_in_institution","points":0,"present":false},{"factor":"comorbidities_ge_2","points":0,"present":false},{"factor":"malignancy","points":0,"present":false}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"nhfs","formula_expression":"NHFS = age (≤65 0, 66-85 3, ≥86 4) + male 1 + (hemoglobin ≤10 g/dL) 1 + amts_le_6 1 + lives_in_institution 1 + comorbidities_ge_2 1 + malignancy 1; Maxwell 2008 integer score; max 10","hemoglobin_g_dl":12,"lives_in_institution":false,"malignancy":false,"max_score":10,"score":3,"sex":"female"},{"age_years":70,"amts_le_6":false,"citation":{"authors":"Maxwell MJ, Moran CG, Moppett IK","doi":"10.1093/bja/aen236","id":"maxwell-2008","pmid":"18723517","source":"Br J Anaesth. 2008;101(4):511-517","title":"Development and validation of a preoperative scoring system to predict 30 day mortality in patients undergoing hip fracture surgery"},"comorbidities_ge_2":false,"components":[{"factor":"age","points":3,"present":true,"value":70},{"factor":"sex","points":0,"present":false,"value":"female"},{"factor":"hemoglobin","points":0,"present":false,"value":12},{"factor":"amts_le_6","points":0,"present":false},{"factor":"lives_in_institution","points":0,"present":false},{"factor":"comorbidities_ge_2","points":0,"present":false},{"factor":"malignancy","points":0,"present":false}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"nhfs","formula_expression":"NHFS = age (≤65 0, 66-85 3, ≥86 4) + male 1 + (hemoglobin ≤10 g/dL) 1 + amts_le_6 1 + lives_in_institution 1 + comorbidities_ge_2 1 + malignancy 1; Maxwell 2008 integer score; max 10","hemoglobin_g_dl":12,"lives_in_institution":false,"malignancy":false,"max_score":10,"score":3,"sex":"female"}],"path":"/api/calc/nhfs"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"age":{"description":"Age in years (18-120). ≤65 scores 0; 66-85 scores 3; ≥86 scores 4 (Maxwell 2008).","type":"integer"},"amts_le_6":{"description":"Abbreviated Mental Test Score ≤6/10 as assigned by the caller (Maxwell 2008). true or false. magent does not administer AMTS. 1 point if true.","type":"boolean"},"comorbidities_ge_2":{"description":"Two or more comorbidities as defined in Maxwell 2008, as assigned by the caller. true or false. magent does not enumerate comorbidities. 1 point if true.","type":"boolean"},"hemoglobin_g_dl":{"description":"Hemoglobin in g/dL (3-22). Provide this or hemoglobin_g_l, not both. ≤10 g/dL scores 1 (10.0 scores; 10.1 does not).","type":"number"},"hemoglobin_g_l":{"description":"Hemoglobin in g/L (30-220). Converted as hemoglobin_g_dl = hemoglobin_g_l / 10. Provide this or hemoglobin_g_dl, not both.","type":"number"},"lives_in_institution":{"description":"Lives in an institution as assigned by the caller (Maxwell 2008). true or false. 1 point if true.","type":"boolean"},"malignancy":{"description":"Active malignancy (Maxwell 2008: within 20 years) as assigned by the caller. true or false. magent does not take a cancer history. 1 point if true.","type":"boolean"},"sex":{"description":"female or male. Male scores 1; female scores 0.","enum":["female","male"],"type":"string"}},"required":["age","sex","amts_le_6","lives_in_institution","comorbidities_ge_2","malignancy"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T14:54:23.805Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T14:54:23.621Z"},"resource":"https://api.magentlab.com/api/calc/nhfs","serviceName":"magent","tags":["nhfs","hip-fracture","preoperative","score","calculator"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/easi","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Hanifin 2001 EASI from four regions. Each region: area 0-6 and erythema, edema/papulation, excoriation, and lichenification 0-3. Region score = (sum of signs) × area × adult weight (head/neck 0.1, upper extremities 0.2, trunk 0.3, lower extremities 0.4). Total max 72. Adult weights only. magent does not examine the skin. No IGA or later severity bands. Not a diagnosis.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"head_neck_area":0,"head_neck_edema_papulation":0,"head_neck_erythema":0,"head_neck_excoriation":0,"head_neck_lichenification":0,"lower_extremities_area":0,"lower_extremities_edema_papulation":0,"lower_extremities_erythema":0,"lower_extremities_excoriation":0,"lower_extremities_lichenification":0,"trunk_area":0,"trunk_edema_papulation":0,"trunk_erythema":0,"trunk_excoriation":0,"trunk_lichenification":0,"upper_extremities_area":0,"upper_extremities_edema_papulation":0,"upper_extremities_erythema":0,"upper_extremities_excoriation":0,"upper_extremities_lichenification":0},{"head_neck_area":0,"head_neck_edema_papulation":0,"head_neck_erythema":0,"head_neck_excoriation":0,"head_neck_lichenification":0,"lower_extremities_area":0,"lower_extremities_edema_papulation":0,"lower_extremities_erythema":0,"lower_extremities_excoriation":0,"lower_extremities_lichenification":0,"trunk_area":0,"trunk_edema_papulation":0,"trunk_erythema":0,"trunk_excoriation":0,"trunk_lichenification":0,"upper_extremities_area":0,"upper_extremities_edema_papulation":0,"upper_extremities_erythema":0,"upper_extremities_excoriation":0,"upper_extremities_lichenification":0}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"citation":{"authors":"Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M","doi":"10.1034/j.1600-0625.2001.100102.x","id":"hanifin-2001","pmid":"11168575","source":"Exp Dermatol. 2001;10(1):11-18","title":"The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis"},"components":[{"area":0,"factor":"head_neck","points":0,"present":true,"value":0,"weight":0.1},{"area":0,"factor":"upper_extremities","points":0,"present":true,"value":0,"weight":0.2},{"area":0,"factor":"trunk","points":0,"present":true,"value":0,"weight":0.3},{"area":0,"factor":"lower_extremities","points":0,"present":true,"value":0,"weight":0.4}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"easi","formula_expression":"EASI = 0.1*(head_neck_erythema + head_neck_edema_papulation + head_neck_excoriation + head_neck_lichenification)*head_neck_area + 0.2*(upper_extremities_erythema + upper_extremities_edema_papulation + upper_extremities_excoriation + upper_extremities_lichenification)*upper_extremities_area + 0.3*(trunk_erythema + trunk_edema_papulation + trunk_excoriation + trunk_lichenification)*trunk_area + 0.4*(lower_extremities_erythema + lower_extremities_edema_papulation + lower_extremities_excoriation + lower_extremities_lichenification)*lower_extremities_area; each area integer 0-6 (0 none, 1 \u003c10%, 2 10-29%, 3 30-49%, 4 50-69%, 5 70-89%, 6 90-100%); each sign integer 0-3 (0 none, 1 mild, 2 moderate, 3 severe); adult region weights head/neck 0.1, upper extremities 0.2, trunk 0.3, lower extremities 0.4; max 72; magent uses these adult weights only; this paper published no Investigator Global Assessment or mild-moderate-severe EASI cutoffs","head_neck_score":0,"lower_extremities_score":0,"max_score":72,"score":0,"trunk_score":0,"upper_extremities_score":0},{"citation":{"authors":"Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M","doi":"10.1034/j.1600-0625.2001.100102.x","id":"hanifin-2001","pmid":"11168575","source":"Exp Dermatol. 2001;10(1):11-18","title":"The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis"},"components":[{"area":0,"factor":"head_neck","points":0,"present":true,"value":0,"weight":0.1},{"area":0,"factor":"upper_extremities","points":0,"present":true,"value":0,"weight":0.2},{"area":0,"factor":"trunk","points":0,"present":true,"value":0,"weight":0.3},{"area":0,"factor":"lower_extremities","points":0,"present":true,"value":0,"weight":0.4}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"easi","formula_expression":"EASI = 0.1*(head_neck_erythema + head_neck_edema_papulation + head_neck_excoriation + head_neck_lichenification)*head_neck_area + 0.2*(upper_extremities_erythema + upper_extremities_edema_papulation + upper_extremities_excoriation + upper_extremities_lichenification)*upper_extremities_area + 0.3*(trunk_erythema + trunk_edema_papulation + trunk_excoriation + trunk_lichenification)*trunk_area + 0.4*(lower_extremities_erythema + lower_extremities_edema_papulation + lower_extremities_excoriation + lower_extremities_lichenification)*lower_extremities_area; each area integer 0-6 (0 none, 1 \u003c10%, 2 10-29%, 3 30-49%, 4 50-69%, 5 70-89%, 6 90-100%); each sign integer 0-3 (0 none, 1 mild, 2 moderate, 3 severe); adult region weights head/neck 0.1, upper extremities 0.2, trunk 0.3, lower extremities 0.4; max 72; magent uses these adult weights only; this paper published no Investigator Global Assessment or mild-moderate-severe EASI cutoffs","head_neck_score":0,"lower_extremities_score":0,"max_score":72,"score":0,"trunk_score":0,"upper_extremities_score":0}],"path":"/api/calc/easi"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"head_neck_area":{"description":"Caller-assigned Hanifin 2001 EASI area of involvement for this body region (integer 0-6): 0 none, 1 \u003c10%, 2 10-29%, 3 30-49%, 4 50-69%, 5 70-89%, 6 90-100%. magent does not examine the skin.","enum":[0,1,2,3,4,5,6],"type":"integer"},"head_neck_edema_papulation":{"description":"Caller-assigned Hanifin 2001 EASI edema/papulation for this region (integer 0-3): 0 none, 1 mild, 2 moderate, 3 severe. magent does not examine the skin.","enum":[0,1,2,3],"type":"integer"},"head_neck_erythema":{"description":"Caller-assigned Hanifin 2001 EASI erythema for this region (integer 0-3): 0 none, 1 mild, 2 moderate, 3 severe. magent does not examine the skin.","enum":[0,1,2,3],"type":"integer"},"head_neck_excoriation":{"description":"Caller-assigned Hanifin 2001 EASI excoriation for this region (integer 0-3): 0 none, 1 mild, 2 moderate, 3 severe. magent does not examine the skin.","enum":[0,1,2,3],"type":"integer"},"head_neck_lichenification":{"description":"Caller-assigned Hanifin 2001 EASI lichenification for this region (integer 0-3): 0 none, 1 mild, 2 moderate, 3 severe. magent does not examine the skin.","enum":[0,1,2,3],"type":"integer"},"lower_extremities_area":{"description":"Caller-assigned Hanifin 2001 EASI area of involvement for this body region (integer 0-6): 0 none, 1 \u003c10%, 2 10-29%, 3 30-49%, 4 50-69%, 5 70-89%, 6 90-100%. magent does not examine the skin.","enum":[0,1,2,3,4,5,6],"type":"integer"},"lower_extremities_edema_papulation":{"description":"Caller-assigned Hanifin 2001 EASI edema/papulation for this region (integer 0-3): 0 none, 1 mild, 2 moderate, 3 severe. magent does not examine the skin.","enum":[0,1,2,3],"type":"integer"},"lower_extremities_erythema":{"description":"Caller-assigned Hanifin 2001 EASI erythema for this region (integer 0-3): 0 none, 1 mild, 2 moderate, 3 severe. magent does not examine the skin.","enum":[0,1,2,3],"type":"integer"},"lower_extremities_excoriation":{"description":"Caller-assigned Hanifin 2001 EASI excoriation for this region (integer 0-3): 0 none, 1 mild, 2 moderate, 3 severe. magent does not examine the skin.","enum":[0,1,2,3],"type":"integer"},"lower_extremities_lichenification":{"description":"Caller-assigned Hanifin 2001 EASI lichenification for this region (integer 0-3): 0 none, 1 mild, 2 moderate, 3 severe. magent does not examine the skin.","enum":[0,1,2,3],"type":"integer"},"trunk_area":{"description":"Caller-assigned Hanifin 2001 EASI area of involvement for this body region (integer 0-6): 0 none, 1 \u003c10%, 2 10-29%, 3 30-49%, 4 50-69%, 5 70-89%, 6 90-100%. magent does not examine the skin.","enum":[0,1,2,3,4,5,6],"type":"integer"},"trunk_edema_papulation":{"description":"Caller-assigned Hanifin 2001 EASI edema/papulation for this region (integer 0-3): 0 none, 1 mild, 2 moderate, 3 severe. magent does not examine the skin.","enum":[0,1,2,3],"type":"integer"},"trunk_erythema":{"description":"Caller-assigned Hanifin 2001 EASI erythema for this region (integer 0-3): 0 none, 1 mild, 2 moderate, 3 severe. magent does not examine the skin.","enum":[0,1,2,3],"type":"integer"},"trunk_excoriation":{"description":"Caller-assigned Hanifin 2001 EASI excoriation for this region (integer 0-3): 0 none, 1 mild, 2 moderate, 3 severe. magent does not examine the skin.","enum":[0,1,2,3],"type":"integer"},"trunk_lichenification":{"description":"Caller-assigned Hanifin 2001 EASI lichenification for this region (integer 0-3): 0 none, 1 mild, 2 moderate, 3 severe. magent does not examine the skin.","enum":[0,1,2,3],"type":"integer"},"upper_extremities_area":{"description":"Caller-assigned Hanifin 2001 EASI area of involvement for this body region (integer 0-6): 0 none, 1 \u003c10%, 2 10-29%, 3 30-49%, 4 50-69%, 5 70-89%, 6 90-100%. magent does not examine the skin.","enum":[0,1,2,3,4,5,6],"type":"integer"},"upper_extremities_edema_papulation":{"description":"Caller-assigned Hanifin 2001 EASI edema/papulation for this region (integer 0-3): 0 none, 1 mild, 2 moderate, 3 severe. magent does not examine the skin.","enum":[0,1,2,3],"type":"integer"},"upper_extremities_erythema":{"description":"Caller-assigned Hanifin 2001 EASI erythema for this region (integer 0-3): 0 none, 1 mild, 2 moderate, 3 severe. magent does not examine the skin.","enum":[0,1,2,3],"type":"integer"},"upper_extremities_excoriation":{"description":"Caller-assigned Hanifin 2001 EASI excoriation for this region (integer 0-3): 0 none, 1 mild, 2 moderate, 3 severe. magent does not examine the skin.","enum":[0,1,2,3],"type":"integer"},"upper_extremities_lichenification":{"description":"Caller-assigned Hanifin 2001 EASI lichenification for this region (integer 0-3): 0 none, 1 mild, 2 moderate, 3 severe. magent does not examine the skin.","enum":[0,1,2,3],"type":"integer"}},"required":["head_neck_area","head_neck_erythema","head_neck_edema_papulation","head_neck_excoriation","head_neck_lichenification","upper_extremities_area","upper_extremities_erythema","upper_extremities_edema_papulation","upper_extremities_excoriation","upper_extremities_lichenification","trunk_area","trunk_erythema","trunk_edema_papulation","trunk_excoriation","trunk_lichenification","lower_extremities_area","lower_extremities_erythema","lower_extremities_edema_papulation","lower_extremities_excoriation","lower_extremities_lichenification"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T14:54:09.656Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T14:54:09.508Z"},"resource":"https://api.magentlab.com/api/calc/easi","serviceName":"magent","tags":["easi","atopic-dermatitis","emergency","hanifin-2001","calculator"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/burch_wartofsky","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Burch 1993 points: °F (\u003c99→0, 99.0–99.9→5, 100.0–100.9→10, 101.0–101.9→15, 102.0–102.9→20, 103.0–103.9→25, ≥104→30); CNS 0/10/20/30; GI-hepatic 0/10/20; HR (\u003c90→0, 90–109→5, 110–119→10, 120–129→15, 130–139→20, ≥140→25); HF 0/5/10/15; AF 10; precipitant 10. Max 140. \u003c25 unlikely, 25–44 impending, ≥45 highly suggestive. temperature_f or temperature_c, not both. Not a diagnosis or ICU order. magent does not measure temperature or an ECG.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"atrial_fibrillation":false,"cns_effects":"none","gi_hepatic":"none","heart_failure":"none","heart_rate_bpm":80,"precipitating_event":false,"temperature_c":37,"temperature_f":98.6},{"atrial_fibrillation":false,"cns_effects":"none","gi_hepatic":"none","heart_failure":"none","heart_rate_bpm":80,"precipitating_event":false,"temperature_c":37,"temperature_f":98.6}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"atrial_fibrillation":false,"bwps_band":"unlikely","citation":{"authors":"Burch HB, Wartofsky L","doi":"10.1016/S0889-8529(18)30165-8","id":"burch-1993","pmid":"8325286","source":"Endocrinol Metab Clin North Am. 1993;22(2):263-277","title":"Life-threatening thyrotoxicosis. Thyroid storm"},"cns_effects":"none","components":[{"factor":"temperature_f","points":0,"present":false,"value":98.6},{"factor":"cns_effects","points":0,"present":false,"value":"none"},{"factor":"gi_hepatic","points":0,"present":false,"value":"none"},{"factor":"heart_rate_bpm","points":0,"present":false,"value":80},{"factor":"heart_failure","points":0,"present":false,"value":"none"},{"factor":"atrial_fibrillation","points":0,"present":false,"value":false},{"factor":"precipitating_event","points":0,"present":false,"value":false}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"burch_wartofsky","formula_expression":"BWPS = temp_F(\u003c99.0→0, 99.0–99.9→5, 100.0–100.9→10, 101.0–101.9→15, 102.0–102.9→20, 103.0–103.9→25, ≥104.0→30) + CNS(none→0, mild→10, moderate→20, severe→30) + GI-hepatic(none→0, moderate→10, severe→20) + HR(\u003c90→0, 90–109→5, 110–119→10, 120–129→15, 130–139→20, ≥140→25) + HF(none→0, mild→5, moderate→10, severe→15) + 10*AF + 10*precipitant; Burch 1993; max 140; \u003c25 unlikely, 25–44 impending, ≥45 highly_suggestive","gi_hepatic":"none","heart_failure":"none","heart_rate_bpm":80,"max_score":140,"precipitating_event":false,"score":0,"temperature_f":98.6},{"atrial_fibrillation":false,"bwps_band":"unlikely","citation":{"authors":"Burch HB, Wartofsky L","doi":"10.1016/S0889-8529(18)30165-8","id":"burch-1993","pmid":"8325286","source":"Endocrinol Metab Clin North Am. 1993;22(2):263-277","title":"Life-threatening thyrotoxicosis. Thyroid storm"},"cns_effects":"none","components":[{"factor":"temperature_f","points":0,"present":false,"value":98.6},{"factor":"cns_effects","points":0,"present":false,"value":"none"},{"factor":"gi_hepatic","points":0,"present":false,"value":"none"},{"factor":"heart_rate_bpm","points":0,"present":false,"value":80},{"factor":"heart_failure","points":0,"present":false,"value":"none"},{"factor":"atrial_fibrillation","points":0,"present":false,"value":false},{"factor":"precipitating_event","points":0,"present":false,"value":false}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"burch_wartofsky","formula_expression":"BWPS = temp_F(\u003c99.0→0, 99.0–99.9→5, 100.0–100.9→10, 101.0–101.9→15, 102.0–102.9→20, 103.0–103.9→25, ≥104.0→30) + CNS(none→0, mild→10, moderate→20, severe→30) + GI-hepatic(none→0, moderate→10, severe→20) + HR(\u003c90→0, 90–109→5, 110–119→10, 120–129→15, 130–139→20, ≥140→25) + HF(none→0, mild→5, moderate→10, severe→15) + 10*AF + 10*precipitant; Burch 1993; max 140; \u003c25 unlikely, 25–44 impending, ≥45 highly_suggestive","gi_hepatic":"none","heart_failure":"none","heart_rate_bpm":80,"max_score":140,"precipitating_event":false,"score":0,"temperature_f":98.6}],"path":"/api/calc/burch_wartofsky"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"atrial_fibrillation":{"description":"Atrial fibrillation as assigned by the caller (true or false). Burch 1993: true → 10. magent does not read an ECG.","type":"boolean"},"cns_effects":{"description":"Caller-assigned CNS effects (Burch 1993). none → 0; mild (agitation) → 10; moderate (delirium, psychosis, extreme lethargy) → 20; severe (seizure or coma) → 30. magent does not examine the patient.","enum":["none","mild","moderate","severe"],"type":"string"},"gi_hepatic":{"description":"Caller-assigned GI-hepatic dysfunction (Burch 1993). none → 0; moderate (diarrhea, nausea/vomiting, abdominal pain) → 10; severe (unexplained jaundice) → 20. magent does not examine the patient.","enum":["none","moderate","severe"],"type":"string"},"heart_failure":{"description":"Caller-assigned heart-failure grade (Burch 1993). none → 0; mild (pedal edema) → 5; moderate (bibasilar rales) → 10; severe (pulmonary edema) → 15. magent does not examine the patient.","enum":["none","mild","moderate","severe"],"type":"string"},"heart_rate_bpm":{"description":"Heart rate in beats/min (integer 30-220). Burch 1993: \u003c90 → 0, 90-109 → 5, 110-119 → 10, 120-129 → 15, 130-139 → 20, ≥140 → 25. Bins start at 90, not 99. magent does not read an ECG.","type":"integer"},"precipitating_event":{"description":"Precipitating event as assigned by the caller (true or false). Burch 1993: true → 10. magent does not take a history.","type":"boolean"},"temperature_c":{"description":"Temperature in °C (32.2-43.3). Converted as F = C×9/5+32, then scored on the Burch 1993 Fahrenheit table. Provide this or temperature_f, not both. magent does not measure temperature.","type":"number"},"temperature_f":{"description":"Temperature in °F (90-110). Provide this or temperature_c, not both. Burch 1993: \u003c99.0 → 0, 99.0-99.9 → 5, 100.0-100.9 → 10, 101.0-101.9 → 15, 102.0-102.9 → 20, 103.0-103.9 → 25, ≥104.0 → 30. magent does not measure temperature.","type":"number"}},"required":["cns_effects","gi_hepatic","heart_rate_bpm","heart_failure","atrial_fibrillation","precipitating_event"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T14:49:48.024Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T14:49:47.888Z"},"resource":"https://api.magentlab.com/api/calc/burch_wartofsky","serviceName":"magent","tags":["thyroid-storm","thyrotoxicosis","emergency","burch-wartofsky","calculator"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/itas2010","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Misra 2013 ITAS2010: weighted sum of 44 caller-assigned Takayasu clinical-activity items that are new or worsening within 3 months and ascribed to active vasculitis. Seven items score 2 (diastolic hypertension, stroke, bruits, pulse inequality, pulse loss, claudication, carotidodynia); the other 37 score 1. Max 51. active_disease iff score ≥ 2. magent does not examine the patient. Not ITAS-A, not a diagnosis, and not a medical device.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"abortions":false,"aortic_incompetence":false,"bp_inequality":false,"bruit_left_carotid":false,"bruit_left_renal":false,"bruit_left_subclavian":false,"bruit_right_carotid":false,"bruit_right_renal":false,"bruit_right_subclavian":false,"bruits":false,"cardiomyopathy_cardiac_failure":false,"carotidodynia":false,"claudication":false,"claudication_arm":false,"claudication_leg":false,"diastolic_hypertension":false,"headache":false,"malaise_weight_loss":false,"myalgia_arthralgia_arthritis":false,"myocardial_infarct_angina":false,"pulse_inequality":false,"pulse_loss":false,"pulse_loss_left_brachial":false,"pulse_loss_left_carotid":false,"pulse_loss_left_dorsalis_pedis":false,"pulse_loss_left_femoral":false,"pulse_loss_left_popliteal":false,"pulse_loss_left_posterior_tibial":false,"pulse_loss_left_radial":false,"pulse_loss_left_subclavian":false,"pulse_loss_right_brachial":false,"pulse_loss_right_carotid":false,"pulse_loss_right_dorsalis_pedis":false,"pulse_loss_right_femoral":false,"pulse_loss_right_popliteal":false,"pulse_loss_right_posterior_tibial":false,"pulse_loss_right_radial":false,"pulse_loss_right_subclavian":false,"seizures":false,"severe_abdominal_pain":false,"stroke":false,"syncope":false,"systolic_hypertension":false,"vertigo_dizziness":false},{"abortions":false,"aortic_incompetence":false,"bp_inequality":false,"bruit_left_carotid":false,"bruit_left_renal":false,"bruit_left_subclavian":false,"bruit_right_carotid":false,"bruit_right_renal":false,"bruit_right_subclavian":false,"bruits":false,"cardiomyopathy_cardiac_failure":false,"carotidodynia":false,"claudication":false,"claudication_arm":false,"claudication_leg":false,"diastolic_hypertension":false,"headache":false,"malaise_weight_loss":false,"myalgia_arthralgia_arthritis":false,"myocardial_infarct_angina":false,"pulse_inequality":false,"pulse_loss":false,"pulse_loss_left_brachial":false,"pulse_loss_left_carotid":false,"pulse_loss_left_dorsalis_pedis":false,"pulse_loss_left_femoral":false,"pulse_loss_left_popliteal":false,"pulse_loss_left_posterior_tibial":false,"pulse_loss_left_radial":false,"pulse_loss_left_subclavian":false,"pulse_loss_right_brachial":false,"pulse_loss_right_carotid":false,"pulse_loss_right_dorsalis_pedis":false,"pulse_loss_right_femoral":false,"pulse_loss_right_popliteal":false,"pulse_loss_right_posterior_tibial":false,"pulse_loss_right_radial":false,"pulse_loss_right_subclavian":false,"seizures":false,"severe_abdominal_pain":false,"stroke":false,"syncope":false,"systolic_hypertension":false,"vertigo_dizziness":false}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"active_disease":false,"citation":{"authors":"Misra R, Danda D, Rajappa SM, et al; Indian Rheumatology Vasculitis (IRAVAS) group","doi":"10.1093/rheumatology/ket128","id":"misra-2013","pmid":"23594468","source":"Rheumatology (Oxford). 2013;52(10):1795-1801","title":"Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010)"},"components":[{"factor":"malaise_weight_loss","points":0,"present":false},{"factor":"myalgia_arthralgia_arthritis","points":0,"present":false},{"factor":"headache","points":0,"present":false},{"factor":"severe_abdominal_pain","points":0,"present":false},{"factor":"abortions","points":0,"present":false},{"factor":"diastolic_hypertension","points":0,"present":false},{"factor":"systolic_hypertension","points":0,"present":false},{"factor":"stroke","points":0,"present":false},{"factor":"seizures","points":0,"present":false},{"factor":"syncope","points":0,"present":false},{"factor":"vertigo_dizziness","points":0,"present":false},{"factor":"bruits","points":0,"present":false},{"factor":"bruit_right_carotid","points":0,"present":false},{"factor":"bruit_left_carotid","points":0,"present":false},{"factor":"bruit_right_subclavian","points":0,"present":false},{"factor":"bruit_left_subclavian","points":0,"present":false},{"factor":"bruit_right_renal","points":0,"present":false},{"factor":"bruit_left_renal","points":0,"present":false},{"factor":"pulse_inequality","points":0,"present":false},{"factor":"bp_inequality","points":0,"present":false},{"factor":"pulse_loss","points":0,"present":false},{"factor":"pulse_loss_right_carotid","points":0,"present":false},{"factor":"pulse_loss_left_carotid","points":0,"present":false},{"factor":"pulse_loss_right_subclavian","points":0,"present":false},{"factor":"pulse_loss_left_subclavian","points":0,"present":false},{"factor":"pulse_loss_right_brachial","points":0,"present":false},{"factor":"pulse_loss_left_brachial","points":0,"present":false},{"factor":"pulse_loss_right_radial","points":0,"present":false},{"factor":"pulse_loss_left_radial","points":0,"present":false},{"factor":"pulse_loss_right_femoral","points":0,"present":false},{"factor":"pulse_loss_left_femoral","points":0,"present":false},{"factor":"pulse_loss_right_popliteal","points":0,"present":false},{"factor":"pulse_loss_left_popliteal","points":0,"present":false},{"factor":"pulse_loss_right_posterior_tibial","points":0,"present":false},{"factor":"pulse_loss_left_posterior_tibial","points":0,"present":false},{"factor":"pulse_loss_right_dorsalis_pedis","points":0,"present":false},{"factor":"pulse_loss_left_dorsalis_pedis","points":0,"present":false},{"factor":"claudication","points":0,"present":false},{"factor":"claudication_arm","points":0,"present":false},{"factor":"claudication_leg","points":0,"present":false},{"factor":"carotidodynia","points":0,"present":false},{"factor":"aortic_incompetence","points":0,"present":false},{"factor":"myocardial_infarct_angina","points":0,"present":false},{"factor":"cardiomyopathy_cardiac_failure","points":0,"present":false}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"itas2010","formula_expression":"ITAS2010 = 2*(diastolic_hypertension + stroke + bruits + pulse_inequality + pulse_loss + claudication + carotidodynia) + malaise_weight_loss + myalgia_arthralgia_arthritis + headache + severe_abdominal_pain + abortions + systolic_hypertension + seizures + syncope + vertigo_dizziness + bruit_right_carotid + bruit_left_carotid + bruit_right_subclavian + bruit_left_subclavian + bruit_right_renal + bruit_left_renal + bp_inequality + pulse_loss_right_carotid + pulse_loss_left_carotid + pulse_loss_right_subclavian + pulse_loss_left_subclavian + pulse_loss_right_brachial + pulse_loss_left_brachial + pulse_loss_right_radial + pulse_loss_left_radial + pulse_loss_right_femoral + pulse_loss_left_femoral + pulse_loss_right_popliteal + pulse_loss_left_popliteal + pulse_loss_right_posterior_tibial + pulse_loss_left_posterior_tibial + pulse_loss_right_dorsalis_pedis + pulse_loss_left_dorsalis_pedis + claudication_arm + claudication_leg + aortic_incompetence + myocardial_infarct_angina + cardiomyopathy_cardiac_failure; Misra 2013; each item true only if new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller; magent does not examine the patient; active_disease iff score ≥ 2; max 51; not ITAS-A; not a diagnosis","max_score":51,"score":0},{"active_disease":false,"citation":{"authors":"Misra R, Danda D, Rajappa SM, et al; Indian Rheumatology Vasculitis (IRAVAS) group","doi":"10.1093/rheumatology/ket128","id":"misra-2013","pmid":"23594468","source":"Rheumatology (Oxford). 2013;52(10):1795-1801","title":"Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010)"},"components":[{"factor":"malaise_weight_loss","points":0,"present":false},{"factor":"myalgia_arthralgia_arthritis","points":0,"present":false},{"factor":"headache","points":0,"present":false},{"factor":"severe_abdominal_pain","points":0,"present":false},{"factor":"abortions","points":0,"present":false},{"factor":"diastolic_hypertension","points":0,"present":false},{"factor":"systolic_hypertension","points":0,"present":false},{"factor":"stroke","points":0,"present":false},{"factor":"seizures","points":0,"present":false},{"factor":"syncope","points":0,"present":false},{"factor":"vertigo_dizziness","points":0,"present":false},{"factor":"bruits","points":0,"present":false},{"factor":"bruit_right_carotid","points":0,"present":false},{"factor":"bruit_left_carotid","points":0,"present":false},{"factor":"bruit_right_subclavian","points":0,"present":false},{"factor":"bruit_left_subclavian","points":0,"present":false},{"factor":"bruit_right_renal","points":0,"present":false},{"factor":"bruit_left_renal","points":0,"present":false},{"factor":"pulse_inequality","points":0,"present":false},{"factor":"bp_inequality","points":0,"present":false},{"factor":"pulse_loss","points":0,"present":false},{"factor":"pulse_loss_right_carotid","points":0,"present":false},{"factor":"pulse_loss_left_carotid","points":0,"present":false},{"factor":"pulse_loss_right_subclavian","points":0,"present":false},{"factor":"pulse_loss_left_subclavian","points":0,"present":false},{"factor":"pulse_loss_right_brachial","points":0,"present":false},{"factor":"pulse_loss_left_brachial","points":0,"present":false},{"factor":"pulse_loss_right_radial","points":0,"present":false},{"factor":"pulse_loss_left_radial","points":0,"present":false},{"factor":"pulse_loss_right_femoral","points":0,"present":false},{"factor":"pulse_loss_left_femoral","points":0,"present":false},{"factor":"pulse_loss_right_popliteal","points":0,"present":false},{"factor":"pulse_loss_left_popliteal","points":0,"present":false},{"factor":"pulse_loss_right_posterior_tibial","points":0,"present":false},{"factor":"pulse_loss_left_posterior_tibial","points":0,"present":false},{"factor":"pulse_loss_right_dorsalis_pedis","points":0,"present":false},{"factor":"pulse_loss_left_dorsalis_pedis","points":0,"present":false},{"factor":"claudication","points":0,"present":false},{"factor":"claudication_arm","points":0,"present":false},{"factor":"claudication_leg","points":0,"present":false},{"factor":"carotidodynia","points":0,"present":false},{"factor":"aortic_incompetence","points":0,"present":false},{"factor":"myocardial_infarct_angina","points":0,"present":false},{"factor":"cardiomyopathy_cardiac_failure","points":0,"present":false}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"itas2010","formula_expression":"ITAS2010 = 2*(diastolic_hypertension + stroke + bruits + pulse_inequality + pulse_loss + claudication + carotidodynia) + malaise_weight_loss + myalgia_arthralgia_arthritis + headache + severe_abdominal_pain + abortions + systolic_hypertension + seizures + syncope + vertigo_dizziness + bruit_right_carotid + bruit_left_carotid + bruit_right_subclavian + bruit_left_subclavian + bruit_right_renal + bruit_left_renal + bp_inequality + pulse_loss_right_carotid + pulse_loss_left_carotid + pulse_loss_right_subclavian + pulse_loss_left_subclavian + pulse_loss_right_brachial + pulse_loss_left_brachial + pulse_loss_right_radial + pulse_loss_left_radial + pulse_loss_right_femoral + pulse_loss_left_femoral + pulse_loss_right_popliteal + pulse_loss_left_popliteal + pulse_loss_right_posterior_tibial + pulse_loss_left_posterior_tibial + pulse_loss_right_dorsalis_pedis + pulse_loss_left_dorsalis_pedis + claudication_arm + claudication_leg + aortic_incompetence + myocardial_infarct_angina + cardiomyopathy_cardiac_failure; Misra 2013; each item true only if new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller; magent does not examine the patient; active_disease iff score ≥ 2; max 51; not ITAS-A; not a diagnosis","max_score":51,"score":0}],"path":"/api/calc/itas2010"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"abortions":{"description":"Misra 2013 ITAS2010: abortion (genitourinary item), new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"aortic_incompetence":{"description":"Misra 2013 ITAS2010: aortic incompetence, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"bp_inequality":{"description":"Misra 2013 ITAS2010: blood-pressure inequality, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"bruit_left_carotid":{"description":"Misra 2013 ITAS2010: left carotid bruit, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"bruit_left_renal":{"description":"Misra 2013 ITAS2010: left renal bruit, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"bruit_left_subclavian":{"description":"Misra 2013 ITAS2010: left subclavian bruit, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"bruit_right_carotid":{"description":"Misra 2013 ITAS2010: right carotid bruit, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"bruit_right_renal":{"description":"Misra 2013 ITAS2010: right renal bruit, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"bruit_right_subclavian":{"description":"Misra 2013 ITAS2010: right subclavian bruit, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"bruits":{"description":"Misra 2013 ITAS2010: bruits (weighted parent item), new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. Weighted item (scores 2). true scores 2. magent does not examine the patient.","type":"boolean"},"cardiomyopathy_cardiac_failure":{"description":"Misra 2013 ITAS2010: cardiomyopathy or cardiac failure, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"carotidodynia":{"description":"Misra 2013 ITAS2010: carotidodynia, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. Weighted item (scores 2). true scores 2. magent does not examine the patient.","type":"boolean"},"claudication":{"description":"Misra 2013 ITAS2010: claudication (weighted parent item), new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. Weighted item (scores 2). true scores 2. magent does not examine the patient.","type":"boolean"},"claudication_arm":{"description":"Misra 2013 ITAS2010: arm claudication, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"claudication_leg":{"description":"Misra 2013 ITAS2010: leg claudication, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"diastolic_hypertension":{"description":"Misra 2013 ITAS2010: diastolic blood pressure \u003e90 mmHg, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. Weighted item (scores 2). true scores 2. magent does not examine the patient.","type":"boolean"},"headache":{"description":"Misra 2013 ITAS2010: headache, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"malaise_weight_loss":{"description":"Misra 2013 ITAS2010: malaise or weight loss \u003e2 kg, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"myalgia_arthralgia_arthritis":{"description":"Misra 2013 ITAS2010: myalgia, arthralgia, or arthritis, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"myocardial_infarct_angina":{"description":"Misra 2013 ITAS2010: myocardial infarction or angina, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"pulse_inequality":{"description":"Misra 2013 ITAS2010: pulse inequality, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. Weighted item (scores 2). true scores 2. magent does not examine the patient.","type":"boolean"},"pulse_loss":{"description":"Misra 2013 ITAS2010: new loss of pulses (weighted parent item), new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. Weighted item (scores 2). true scores 2. magent does not examine the patient.","type":"boolean"},"pulse_loss_left_brachial":{"description":"Misra 2013 ITAS2010: new loss of the left brachial pulse, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"pulse_loss_left_carotid":{"description":"Misra 2013 ITAS2010: new loss of the left carotid pulse, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"pulse_loss_left_dorsalis_pedis":{"description":"Misra 2013 ITAS2010: new loss of the left dorsalis pedis pulse, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"pulse_loss_left_femoral":{"description":"Misra 2013 ITAS2010: new loss of the left femoral pulse, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"pulse_loss_left_popliteal":{"description":"Misra 2013 ITAS2010: new loss of the left popliteal pulse, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"pulse_loss_left_posterior_tibial":{"description":"Misra 2013 ITAS2010: new loss of the left posterior tibial pulse, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"pulse_loss_left_radial":{"description":"Misra 2013 ITAS2010: new loss of the left radial pulse, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"pulse_loss_left_subclavian":{"description":"Misra 2013 ITAS2010: new loss of the left subclavian pulse, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"pulse_loss_right_brachial":{"description":"Misra 2013 ITAS2010: new loss of the right brachial pulse, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"pulse_loss_right_carotid":{"description":"Misra 2013 ITAS2010: new loss of the right carotid pulse, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"pulse_loss_right_dorsalis_pedis":{"description":"Misra 2013 ITAS2010: new loss of the right dorsalis pedis pulse, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"pulse_loss_right_femoral":{"description":"Misra 2013 ITAS2010: new loss of the right femoral pulse, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"pulse_loss_right_popliteal":{"description":"Misra 2013 ITAS2010: new loss of the right popliteal pulse, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"pulse_loss_right_posterior_tibial":{"description":"Misra 2013 ITAS2010: new loss of the right posterior tibial pulse, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"pulse_loss_right_radial":{"description":"Misra 2013 ITAS2010: new loss of the right radial pulse, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"pulse_loss_right_subclavian":{"description":"Misra 2013 ITAS2010: new loss of the right subclavian pulse, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"seizures":{"description":"Misra 2013 ITAS2010: seizures (not hypertensive), new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"severe_abdominal_pain":{"description":"Misra 2013 ITAS2010: severe abdominal pain, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"stroke":{"description":"Misra 2013 ITAS2010: stroke, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. Weighted item (scores 2). true scores 2. magent does not examine the patient.","type":"boolean"},"syncope":{"description":"Misra 2013 ITAS2010: syncope, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"systolic_hypertension":{"description":"Misra 2013 ITAS2010: systolic blood pressure \u003e140 mmHg, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"},"vertigo_dizziness":{"description":"Misra 2013 ITAS2010: vertigo or dizziness, new or worsening within 3 months and ascribed to active vasculitis as assigned by the caller. true scores 1. magent does not examine the patient.","type":"boolean"}},"required":["malaise_weight_loss","myalgia_arthralgia_arthritis","headache","severe_abdominal_pain","abortions","diastolic_hypertension","systolic_hypertension","stroke","seizures","syncope","vertigo_dizziness","bruits","bruit_right_carotid","bruit_left_carotid","bruit_right_subclavian","bruit_left_subclavian","bruit_right_renal","bruit_left_renal","pulse_inequality","bp_inequality","pulse_loss","pulse_loss_right_carotid","pulse_loss_left_carotid","pulse_loss_right_subclavian","pulse_loss_left_subclavian","pulse_loss_right_brachial","pulse_loss_left_brachial","pulse_loss_right_radial","pulse_loss_left_radial","pulse_loss_right_femoral","pulse_loss_left_femoral","pulse_loss_right_popliteal","pulse_loss_left_popliteal","pulse_loss_right_posterior_tibial","pulse_loss_left_posterior_tibial","pulse_loss_right_dorsalis_pedis","pulse_loss_left_dorsalis_pedis","claudication","claudication_arm","claudication_leg","carotidodynia","aortic_incompetence","myocardial_infarct_angina","cardiomyopathy_cardiac_failure"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T14:48:51.381Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T14:48:51.202Z"},"resource":"https://api.magentlab.com/api/calc/itas2010","serviceName":"magent","tags":["itas2010","takayasu","vasculitis","disease-activity","calculator"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/sledai_2k","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Gladman 2002 SLEDAI-2K: weighted sum of 24 caller-assigned descriptors present in the last 10 days (max 105). magent does not examine the patient. Proteinuria scores if \u003e0.5 g/24 h (not original SLEDAI \u003e3.5 g/24 h only). Rash, alopecia, and mucosal ulcers score if new or persistent (not new only). Not a diagnosis, not SLICC damage, not SELENA-SLEDAI flare rules, and not a medical device.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"alopecia":false,"arthritis":true,"cranial_nerve_disorder":false,"cva":false,"fever":false,"hematuria":false,"increased_dna_binding":false,"leukopenia":false,"low_complement":false,"lupus_headache":false,"mucosal_ulcers":false,"myositis":false,"organic_brain_syndrome":false,"pericarditis":false,"pleurisy":false,"proteinuria":false,"psychosis":false,"pyuria":false,"rash":true,"seizure":false,"thrombocytopenia":false,"urinary_casts":false,"vasculitis":false,"visual_disturbance":false},{"alopecia":false,"arthritis":true,"cranial_nerve_disorder":false,"cva":false,"fever":false,"hematuria":false,"increased_dna_binding":false,"leukopenia":false,"low_complement":false,"lupus_headache":false,"mucosal_ulcers":false,"myositis":false,"organic_brain_syndrome":false,"pericarditis":false,"pleurisy":false,"proteinuria":false,"psychosis":false,"pyuria":false,"rash":true,"seizure":false,"thrombocytopenia":false,"urinary_casts":false,"vasculitis":false,"visual_disturbance":false}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"citation":{"authors":"Gladman DD, Ibañez D, Urowitz MB","id":"gladman-2002","pmid":"11838846","source":"J Rheumatol. 2002;29(2):288-291","title":"Systemic lupus erythematosus disease activity index 2000"},"components":[{"factor":"seizure","points":0,"present":false},{"factor":"psychosis","points":0,"present":false},{"factor":"organic_brain_syndrome","points":0,"present":false},{"factor":"visual_disturbance","points":0,"present":false},{"factor":"cranial_nerve_disorder","points":0,"present":false},{"factor":"lupus_headache","points":0,"present":false},{"factor":"cva","points":0,"present":false},{"factor":"vasculitis","points":0,"present":false},{"factor":"arthritis","points":4,"present":true},{"factor":"myositis","points":0,"present":false},{"factor":"urinary_casts","points":0,"present":false},{"factor":"hematuria","points":0,"present":false},{"factor":"proteinuria","points":0,"present":false},{"factor":"pyuria","points":0,"present":false},{"factor":"rash","points":2,"present":true},{"factor":"alopecia","points":0,"present":false},{"factor":"mucosal_ulcers","points":0,"present":false},{"factor":"pleurisy","points":0,"present":false},{"factor":"pericarditis","points":0,"present":false},{"factor":"low_complement","points":0,"present":false},{"factor":"increased_dna_binding","points":0,"present":false},{"factor":"fever","points":0,"present":false},{"factor":"thrombocytopenia","points":0,"present":false},{"factor":"leukopenia","points":0,"present":false}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"sledai_2k","formula_expression":"SLEDAI-2K = 8*(seizure + psychosis + organic_brain_syndrome + visual_disturbance + cranial_nerve_disorder + lupus_headache + cva + vasculitis) + 4*(arthritis + myositis + urinary_casts + hematuria + proteinuria + pyuria) + 2*(rash + alopecia + mucosal_ulcers + pleurisy + pericarditis + low_complement + increased_dna_binding) + (fever + thrombocytopenia + leukopenia); Gladman 2002; each descriptor present in the last 10 days as assigned by the caller; proteinuria scores if \u003e0.5 g/24 h (not original SLEDAI \u003e3.5 g/24 h only); rash, alopecia, and mucosal ulcers score if new or persistent (not new only); max 105; not a diagnosis","max_score":105,"score":6},{"citation":{"authors":"Gladman DD, Ibañez D, Urowitz MB","id":"gladman-2002","pmid":"11838846","source":"J Rheumatol. 2002;29(2):288-291","title":"Systemic lupus erythematosus disease activity index 2000"},"components":[{"factor":"seizure","points":0,"present":false},{"factor":"psychosis","points":0,"present":false},{"factor":"organic_brain_syndrome","points":0,"present":false},{"factor":"visual_disturbance","points":0,"present":false},{"factor":"cranial_nerve_disorder","points":0,"present":false},{"factor":"lupus_headache","points":0,"present":false},{"factor":"cva","points":0,"present":false},{"factor":"vasculitis","points":0,"present":false},{"factor":"arthritis","points":4,"present":true},{"factor":"myositis","points":0,"present":false},{"factor":"urinary_casts","points":0,"present":false},{"factor":"hematuria","points":0,"present":false},{"factor":"proteinuria","points":0,"present":false},{"factor":"pyuria","points":0,"present":false},{"factor":"rash","points":2,"present":true},{"factor":"alopecia","points":0,"present":false},{"factor":"mucosal_ulcers","points":0,"present":false},{"factor":"pleurisy","points":0,"present":false},{"factor":"pericarditis","points":0,"present":false},{"factor":"low_complement","points":0,"present":false},{"factor":"increased_dna_binding","points":0,"present":false},{"factor":"fever","points":0,"present":false},{"factor":"thrombocytopenia","points":0,"present":false},{"factor":"leukopenia","points":0,"present":false}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"sledai_2k","formula_expression":"SLEDAI-2K = 8*(seizure + psychosis + organic_brain_syndrome + visual_disturbance + cranial_nerve_disorder + lupus_headache + cva + vasculitis) + 4*(arthritis + myositis + urinary_casts + hematuria + proteinuria + pyuria) + 2*(rash + alopecia + mucosal_ulcers + pleurisy + pericarditis + low_complement + increased_dna_binding) + (fever + thrombocytopenia + leukopenia); Gladman 2002; each descriptor present in the last 10 days as assigned by the caller; proteinuria scores if \u003e0.5 g/24 h (not original SLEDAI \u003e3.5 g/24 h only); rash, alopecia, and mucosal ulcers score if new or persistent (not new only); max 105; not a diagnosis","max_score":105,"score":6}],"path":"/api/calc/sledai_2k"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"alopecia":{"description":"Alopecia in the last 10 days as assigned by the caller (Gladman 2002 SLEDAI-2K): abnormal, patchy or diffuse loss of hair. Scores if new or persistent (not original SLEDAI new only). true scores 2. magent does not examine the scalp.","type":"boolean"},"arthritis":{"description":"Arthritis in the last 10 days as assigned by the caller (Gladman 2002 SLEDAI-2K): more than 2 joints with pain and signs of inflammation (tenderness, swelling, or effusion). true scores 4. magent does not examine joints.","type":"boolean"},"cranial_nerve_disorder":{"description":"Cranial nerve disorder in the last 10 days as assigned by the caller (Gladman 2002 SLEDAI-2K): new onset of sensory or motor neuropathy involving cranial nerves. true scores 8. magent does not examine cranial nerves.","type":"boolean"},"cva":{"description":"Cerebrovascular accident in the last 10 days as assigned by the caller (Gladman 2002 SLEDAI-2K): new onset of CVA(s). Exclude arteriosclerosis. true scores 8. magent does not read imaging.","type":"boolean"},"fever":{"description":"Fever in the last 10 days as assigned by the caller (Gladman 2002 SLEDAI-2K): \u003e38°C. Exclude infectious cause. true scores 1. magent does not measure temperature.","type":"boolean"},"hematuria":{"description":"Hematuria in the last 10 days as assigned by the caller (Gladman 2002 SLEDAI-2K): \u003e5 red blood cells/high power field. Exclude stone, infection, or other cause. true scores 4. magent does not assay urine.","type":"boolean"},"increased_dna_binding":{"description":"Increased DNA binding in the last 10 days as assigned by the caller (Gladman 2002 SLEDAI-2K): DNA binding by Farr assay above the normal range for the testing laboratory. true scores 2. magent does not assay anti-dsDNA.","type":"boolean"},"leukopenia":{"description":"Leukopenia in the last 10 days as assigned by the caller (Gladman 2002 SLEDAI-2K): \u003c3,000 white blood cells/mm³. Exclude drug causes. true scores 1. magent does not assay blood counts.","type":"boolean"},"low_complement":{"description":"Low complement in the last 10 days as assigned by the caller (Gladman 2002 SLEDAI-2K): CH50, C3, or C4 below the lower limit of normal for the testing laboratory. true scores 2. magent does not assay complement.","type":"boolean"},"lupus_headache":{"description":"Lupus headache in the last 10 days as assigned by the caller (Gladman 2002 SLEDAI-2K): severe persistent headache; may be migrainous, but must be nonresponsive to narcotic analgesia. true scores 8. magent does not examine the patient.","type":"boolean"},"mucosal_ulcers":{"description":"Mucosal ulcers in the last 10 days as assigned by the caller (Gladman 2002 SLEDAI-2K): oral or nasal ulcerations. Scores if new or persistent (not original SLEDAI new only). true scores 2. magent does not examine mucosa.","type":"boolean"},"myositis":{"description":"Myositis in the last 10 days as assigned by the caller (Gladman 2002 SLEDAI-2K): proximal muscle aching/weakness with elevated creatine phosphokinase/aldolase, EMG changes, or a biopsy showing myositis. true scores 4. magent does not assay muscle enzymes.","type":"boolean"},"organic_brain_syndrome":{"description":"Organic brain syndrome in the last 10 days as assigned by the caller (Gladman 2002 SLEDAI-2K): altered mental function with impaired orientation, memory, or other intellectual function, rapid onset and fluctuating features. Exclude metabolic, infectious, or drug causes. true scores 8. magent does not examine the patient.","type":"boolean"},"pericarditis":{"description":"Pericarditis in the last 10 days as assigned by the caller (Gladman 2002 SLEDAI-2K): pericardial pain with at least one of rub, effusion, or electrocardiogram or echocardiogram confirmation. true scores 2. magent does not examine the heart.","type":"boolean"},"pleurisy":{"description":"Pleurisy in the last 10 days as assigned by the caller (Gladman 2002 SLEDAI-2K): pleuritic chest pain with pleural rub or effusion, or pleural thickening. true scores 2. magent does not examine the chest.","type":"boolean"},"proteinuria":{"description":"Proteinuria in the last 10 days as assigned by the caller (Gladman 2002 SLEDAI-2K): \u003e0.5 g/24 h (not original SLEDAI \u003e3.5 g/24 h only). true scores 4. magent does not assay urine.","type":"boolean"},"psychosis":{"description":"Psychosis in the last 10 days as assigned by the caller (Gladman 2002 SLEDAI-2K): altered ability to function in normal activity due to severe disturbance in the perception of reality. Exclude uremia and drug causes. true scores 8. magent does not examine the patient.","type":"boolean"},"pyuria":{"description":"Pyuria in the last 10 days as assigned by the caller (Gladman 2002 SLEDAI-2K): \u003e5 white blood cells/high power field. Exclude infection. true scores 4. magent does not assay urine.","type":"boolean"},"rash":{"description":"Rash in the last 10 days as assigned by the caller (Gladman 2002 SLEDAI-2K): inflammatory type rash. Scores if new or persistent (not original SLEDAI new only). true scores 2. magent does not examine skin.","type":"boolean"},"seizure":{"description":"Seizure in the last 10 days as assigned by the caller (Gladman 2002 SLEDAI-2K). Recent onset. Exclude metabolic, infectious, or drug cause. true scores 8. magent does not examine the patient.","type":"boolean"},"thrombocytopenia":{"description":"Thrombocytopenia in the last 10 days as assigned by the caller (Gladman 2002 SLEDAI-2K): \u003c100,000 platelets/mm³. Exclude drug causes. true scores 1. magent does not assay platelets.","type":"boolean"},"urinary_casts":{"description":"Urinary casts in the last 10 days as assigned by the caller (Gladman 2002 SLEDAI-2K): heme-granular or red blood cell casts. true scores 4. magent does not assay urine.","type":"boolean"},"vasculitis":{"description":"Vasculitis in the last 10 days as assigned by the caller (Gladman 2002 SLEDAI-2K): ulceration, gangrene, tender finger nodules, periungual infarction, splinter hemorrhages, or biopsy or angiogram proof of vasculitis. true scores 8. magent does not examine skin or read a biopsy.","type":"boolean"},"visual_disturbance":{"description":"Visual disturbance in the last 10 days as assigned by the caller (Gladman 2002 SLEDAI-2K): retinal changes of SLE (cytoid bodies, retinal hemorrhages, serous exudate or hemorrhages in the choroid, or optic neuritis). Exclude hypertension, infection, or drug causes. true scores 8. magent does not examine the fundus.","type":"boolean"}},"required":["seizure","psychosis","organic_brain_syndrome","visual_disturbance","cranial_nerve_disorder","lupus_headache","cva","vasculitis","arthritis","myositis","urinary_casts","hematuria","proteinuria","pyuria","rash","alopecia","mucosal_ulcers","pleurisy","pericarditis","low_complement","increased_dna_binding","fever","thrombocytopenia","leukopenia"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T14:48:44.362Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T14:48:44.217Z"},"resource":"https://api.magentlab.com/api/calc/sledai_2k","serviceName":"magent","tags":["sledai-2k","lupus","sle","disease-activity","calculator"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/slicc_sle","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"SLICC 2012 SLE classification (Petri Table 3). classified iff biopsy-proven lupus nephritis plus ANA or anti-dsDNA, or at least four criteria including at least one clinical and one immunologic. 11 clinical and 6 immunologic caller flags. Direct Coombs counts only in the absence of hemolytic anemia. Criteria need not be concurrent. Not a diagnosis. Not 1997 ACR. Not 2019 EULAR/ACR. magent does not examine skin, assay serologies, or read a biopsy.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"acute_cutaneous_lupus":true,"ana":true,"anti_dsdna":true,"anti_sm":false,"antiphospholipid":false,"biopsy_lupus_nephritis":false,"chronic_cutaneous_lupus":false,"direct_coombs":false,"hemolytic_anemia":false,"leukopenia_or_lymphopenia":false,"low_complement":false,"neurologic":false,"nonscarring_alopecia":false,"oral_or_nasal_ulcers":true,"renal":false,"serositis":false,"synovitis":true,"thrombocytopenia":false},{"acute_cutaneous_lupus":true,"ana":true,"anti_dsdna":true,"anti_sm":false,"antiphospholipid":false,"biopsy_lupus_nephritis":false,"chronic_cutaneous_lupus":false,"direct_coombs":false,"hemolytic_anemia":false,"leukopenia_or_lymphopenia":false,"low_complement":false,"neurologic":false,"nonscarring_alopecia":false,"oral_or_nasal_ulcers":true,"renal":false,"serositis":false,"synovitis":true,"thrombocytopenia":false}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"citation":{"authors":"Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O, Sturfelt G, Ramsey-Goldman R, Bae SC, Hanly JG, Sánchez-Guerrero J, Clarke A, Aranow C, Manzi S, Urowitz M, Gladman D, Kalunian K, Costner M, Werth VP, Zoma A, Bernatsky S, Ruiz-Irastorza G, Khamashta MA, Jacobsen S, Buyon JP, Maddison P, Dooley MA, van Vollenhoven RF, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim SS, Fessler BJ, Inanc M, Kamen DL, Rahman A, Steinsson K, Franks AG, Sigler L, Hameed S, Fang H, Pham N, Brey R, Weisman MH, McGwin G, Magder LS","doi":"10.1002/art.34473","id":"petri-2012","pmid":"22553077","source":"Arthritis Rheum. 2012;64(8):2677-2686","title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus"},"classified":true,"clinical_count":3,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"slicc_sle","formula_expression":"SLICC 2012 SLE classification (Petri Table 3 + classification rule): 11 clinical flags (acute_cutaneous_lupus, chronic_cutaneous_lupus, oral_or_nasal_ulcers, nonscarring_alopecia, synovitis, serositis, renal, neurologic, hemolytic_anemia, leukopenia_or_lymphopenia, thrombocytopenia) and 6 immunologic flags (ana, anti_dsdna, anti_sm, antiphospholipid, low_complement, direct_coombs). clinical_count = count of clinical flags that are true. immunologic_count = count of immunologic flags that are true, except direct_coombs counts only when hemolytic_anemia is false. nephritis_shortcut iff biopsy_lupus_nephritis and (ana or anti_dsdna). classified iff nephritis_shortcut or (clinical_count ≥1 and immunologic_count ≥1 and clinical_count + immunologic_count ≥4). Criteria need not be concurrent. Not a diagnosis. Not 1997 ACR. Not 2019 EULAR/ACR","immunologic_count":2,"nephritis_shortcut":false},{"citation":{"authors":"Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O, Sturfelt G, Ramsey-Goldman R, Bae SC, Hanly JG, Sánchez-Guerrero J, Clarke A, Aranow C, Manzi S, Urowitz M, Gladman D, Kalunian K, Costner M, Werth VP, Zoma A, Bernatsky S, Ruiz-Irastorza G, Khamashta MA, Jacobsen S, Buyon JP, Maddison P, Dooley MA, van Vollenhoven RF, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim SS, Fessler BJ, Inanc M, Kamen DL, Rahman A, Steinsson K, Franks AG, Sigler L, Hameed S, Fang H, Pham N, Brey R, Weisman MH, McGwin G, Magder LS","doi":"10.1002/art.34473","id":"petri-2012","pmid":"22553077","source":"Arthritis Rheum. 2012;64(8):2677-2686","title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus"},"classified":true,"clinical_count":3,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"slicc_sle","formula_expression":"SLICC 2012 SLE classification (Petri Table 3 + classification rule): 11 clinical flags (acute_cutaneous_lupus, chronic_cutaneous_lupus, oral_or_nasal_ulcers, nonscarring_alopecia, synovitis, serositis, renal, neurologic, hemolytic_anemia, leukopenia_or_lymphopenia, thrombocytopenia) and 6 immunologic flags (ana, anti_dsdna, anti_sm, antiphospholipid, low_complement, direct_coombs). clinical_count = count of clinical flags that are true. immunologic_count = count of immunologic flags that are true, except direct_coombs counts only when hemolytic_anemia is false. nephritis_shortcut iff biopsy_lupus_nephritis and (ana or anti_dsdna). classified iff nephritis_shortcut or (clinical_count ≥1 and immunologic_count ≥1 and clinical_count + immunologic_count ≥4). Criteria need not be concurrent. Not a diagnosis. Not 1997 ACR. Not 2019 EULAR/ACR","immunologic_count":2,"nephritis_shortcut":false}],"path":"/api/calc/slicc_sle"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"acute_cutaneous_lupus":{"description":"Acute cutaneous lupus as assigned by the caller (Petri 2012 Table 3): lupus malar rash (do not count if malar discoid), bullous lupus, toxic epidermal necrolysis variant of SLE, maculopapular lupus rash, photosensitive lupus rash in the absence of dermatomyositis, or subacute cutaneous lupus. true or false. magent does not examine skin.","type":"boolean"},"ana":{"description":"ANA above laboratory reference range as assigned by the caller (Petri 2012 Table 3). With biopsy_lupus_nephritis (or anti_dsdna), fulfills the nephritis shortcut. true or false. magent does not assay ANA.","type":"boolean"},"anti_dsdna":{"description":"Anti-dsDNA above laboratory reference range (or \u003e2-fold the reference range if tested by ELISA), as assigned by the caller (Petri 2012 Table 3). true or false. magent does not assay anti-dsDNA.","type":"boolean"},"anti_sm":{"description":"Antibody to Sm nuclear antigen as assigned by the caller (Petri 2012 Table 3). true or false. magent does not assay anti-Sm.","type":"boolean"},"antiphospholipid":{"description":"Antiphospholipid antibody positivity as assigned by the caller (Petri 2012 Table 3): lupus anticoagulant, false-positive rapid plasma reagin, medium- or high-titer anticardiolipin (IgA, IgG, or IgM), or anti-β2-glycoprotein I (IgA, IgG, or IgM). true or false. magent does not assay antiphospholipid antibodies.","type":"boolean"},"biopsy_lupus_nephritis":{"description":"Biopsy-proven nephritis compatible with SLE as assigned by the caller (Petri 2012 classification rule). With ANA or anti-dsDNA, classifies without four criteria. Distinct from the renal clinical item. true or false. magent does not read a biopsy.","type":"boolean"},"chronic_cutaneous_lupus":{"description":"Chronic cutaneous lupus as assigned by the caller (Petri 2012 Table 3): classic discoid (localized or generalized), hypertrophic (verrucous) lupus, lupus panniculitis (profundus), mucosal lupus, lupus erythematosus tumidus, chilblains lupus, or discoid lupus/lichen planus overlap. true or false. magent does not examine skin.","type":"boolean"},"direct_coombs":{"description":"Direct Coombs’ test as assigned by the caller (Petri 2012 Table 3). Counts toward immunologic_count only when hemolytic_anemia is false. true or false. magent does not run a Coombs test.","type":"boolean"},"hemolytic_anemia":{"description":"Hemolytic anemia as assigned by the caller (Petri 2012 Table 3). When true, direct_coombs does not count toward immunologic_count. true or false. magent does not assay hemolysis.","type":"boolean"},"leukopenia_or_lymphopenia":{"description":"Leukopenia (\u003c4,000/mm³ at least once) in the absence of other known causes, or lymphopenia (\u003c1,000/mm³ at least once) in the absence of other known causes, as assigned by the caller (Petri 2012 Table 3). true or false. magent does not assay blood counts.","type":"boolean"},"low_complement":{"description":"Low C3, low C4, or low CH50 as assigned by the caller (Petri 2012 Table 3). true or false. magent does not assay complement.","type":"boolean"},"neurologic":{"description":"Neurologic criterion as assigned by the caller (Petri 2012 Table 3): seizures, psychosis, mononeuritis multiplex, myelitis, peripheral or cranial neuropathy, or acute confusional state, in the absence of other known causes. true or false. magent does not examine the nervous system.","type":"boolean"},"nonscarring_alopecia":{"description":"Nonscarring alopecia: diffuse thinning or hair fragility with visible broken hairs, in the absence of other causes, as assigned by the caller (Petri 2012 Table 3). true or false. magent does not examine the scalp.","type":"boolean"},"oral_or_nasal_ulcers":{"description":"Oral ulcers (palate, buccal, tongue) or nasal ulcers, in the absence of other causes, as assigned by the caller (Petri 2012 Table 3). true or false. magent does not examine mucosa.","type":"boolean"},"renal":{"description":"Renal clinical criterion as assigned by the caller (Petri 2012 Table 3): urine protein-to-creatinine ratio (or 24-hour urine protein) representing 500 mg protein/24 hours, or red blood cell casts. Distinct from biopsy_lupus_nephritis. true or false. magent does not assay urine.","type":"boolean"},"serositis":{"description":"Serositis as assigned by the caller (Petri 2012 Table 3): typical pleurisy \u003e1 day or pleural effusion or pleural rub, or typical pericardial pain \u003e1 day or pericardial effusion or pericardial rub or pericarditis by electrocardiography, in the absence of other causes. true or false. magent does not examine the chest.","type":"boolean"},"synovitis":{"description":"Synovitis involving 2 or more joints, characterized by swelling or effusion, or tenderness in 2 or more joints and at least 30 minutes of morning stiffness, as assigned by the caller (Petri 2012 Table 3). true or false. magent does not examine joints.","type":"boolean"},"thrombocytopenia":{"description":"Thrombocytopenia (\u003c100,000/mm³) at least once in the absence of other known causes, as assigned by the caller (Petri 2012 Table 3). true or false. magent does not assay platelets.","type":"boolean"}},"required":["acute_cutaneous_lupus","chronic_cutaneous_lupus","oral_or_nasal_ulcers","nonscarring_alopecia","synovitis","serositis","renal","neurologic","hemolytic_anemia","leukopenia_or_lymphopenia","thrombocytopenia","ana","anti_dsdna","anti_sm","antiphospholipid","low_complement","direct_coombs","biopsy_lupus_nephritis"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T14:48:37.665Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T14:48:37.527Z"},"resource":"https://api.magentlab.com/api/calc/slicc_sle","serviceName":"magent","tags":["slicc","sle","lupus","classification","emergency"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/acr_eular_gout","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"ACR/EULAR 2015 gout classification (Neogi). MSU crystals classify without score ≥8; else score ≥8 (max 23). Pattern 0/1/2, characteristics 0–3, time course 0/1/2, tophus 4, urate −4 to 4, MSU-negative −2, imaging 4+4. Not a diagnosis. Not Janssens 2010. magent does not examine joints or polarizing microscopy.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"characteristics":0,"entry_criterion":true,"imaging_erosion":"absent_or_not_done","imaging_urate":"absent_or_not_done","pattern":"other","sufficient_msu":false,"synovial":"not_done","time_course":"none","tophus":false,"uric_acid_mg_dl":5,"uric_acid_umol_l":300},{"characteristics":0,"entry_criterion":true,"imaging_erosion":"absent_or_not_done","imaging_urate":"absent_or_not_done","pattern":"other","sufficient_msu":false,"synovial":"not_done","time_course":"none","tophus":false,"uric_acid_mg_dl":5,"uric_acid_umol_l":300}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"citation":{"authors":"Neogi T, Jansen TLTA, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, Brown M, Choi H, Edwards NL, Janssens HJEM, Lioté F, Naden RP, Nuki G, Ogdie A, Perez-Ruiz F, Saag K, Singh JA, Sundy JS, Tausche AK, Vazquez-Mellado J, Yarows SA, Taylor WJ","doi":"10.1002/art.39254","id":"neogi-2015","pmid":"26352873","source":"Arthritis Rheumatol. 2015;67(10):2557-2568","title":"2015 Gout Classification Criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative"},"classified_gout":false,"components":[{"factor":"pattern","points":0,"present":true,"value":"other"},{"factor":"characteristics","points":0,"present":true,"value":0},{"factor":"time_course","points":0,"present":true,"value":"none"},{"factor":"tophus","points":0,"present":true,"value":false},{"factor":"serum_urate","points":0,"present":true,"value":5},{"factor":"synovial","points":0,"present":true,"value":"not_done"},{"factor":"imaging_urate","points":0,"present":true,"value":"absent_or_not_done"},{"factor":"imaging_erosion","points":0,"present":true,"value":"absent_or_not_done"}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"acr_eular_gout","formula_expression":"ACR/EULAR 2015 gout classification (Neogi Table 2): entry (episode of swelling, pain, or tenderness in a peripheral joint or bursa) required; sufficient MSU in a symptomatic joint/bursa or tophus classifies without score ≥8; else score ≥8 classifies. Score = pattern (other 0, ankle_midfoot 1, mtp1 2) + characteristics 0-3 + time_course (none 0, one_typical 1, recurrent 2) + tophus true 4 + serum urate (\u003c4 mg/dL or \u003c0.24 mmol/L −4; ≥4–\u003c6 or ≥0.24–\u003c0.36 0; 6–\u003c8 or 0.36–\u003c0.48 2; 8–\u003c10 or 0.48–\u003c0.60 3; ≥10 or ≥0.60 4) + synovial (not_done 0, msu_negative −2) + imaging_urate present 4 + imaging_erosion present 4; max 23. Not a diagnosis. Not Janssens 2010","gout_band":"not_classified","max_score":23,"score":0,"sufficient_criterion":false},{"citation":{"authors":"Neogi T, Jansen TLTA, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, Brown M, Choi H, Edwards NL, Janssens HJEM, Lioté F, Naden RP, Nuki G, Ogdie A, Perez-Ruiz F, Saag K, Singh JA, Sundy JS, Tausche AK, Vazquez-Mellado J, Yarows SA, Taylor WJ","doi":"10.1002/art.39254","id":"neogi-2015","pmid":"26352873","source":"Arthritis Rheumatol. 2015;67(10):2557-2568","title":"2015 Gout Classification Criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative"},"classified_gout":false,"components":[{"factor":"pattern","points":0,"present":true,"value":"other"},{"factor":"characteristics","points":0,"present":true,"value":0},{"factor":"time_course","points":0,"present":true,"value":"none"},{"factor":"tophus","points":0,"present":true,"value":false},{"factor":"serum_urate","points":0,"present":true,"value":5},{"factor":"synovial","points":0,"present":true,"value":"not_done"},{"factor":"imaging_urate","points":0,"present":true,"value":"absent_or_not_done"},{"factor":"imaging_erosion","points":0,"present":true,"value":"absent_or_not_done"}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"acr_eular_gout","formula_expression":"ACR/EULAR 2015 gout classification (Neogi Table 2): entry (episode of swelling, pain, or tenderness in a peripheral joint or bursa) required; sufficient MSU in a symptomatic joint/bursa or tophus classifies without score ≥8; else score ≥8 classifies. Score = pattern (other 0, ankle_midfoot 1, mtp1 2) + characteristics 0-3 + time_course (none 0, one_typical 1, recurrent 2) + tophus true 4 + serum urate (\u003c4 mg/dL or \u003c0.24 mmol/L −4; ≥4–\u003c6 or ≥0.24–\u003c0.36 0; 6–\u003c8 or 0.36–\u003c0.48 2; 8–\u003c10 or 0.48–\u003c0.60 3; ≥10 or ≥0.60 4) + synovial (not_done 0, msu_negative −2) + imaging_urate present 4 + imaging_erosion present 4; max 23. Not a diagnosis. Not Janssens 2010","gout_band":"not_classified","max_score":23,"score":0,"sufficient_criterion":false}],"path":"/api/calc/acr_eular_gout"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"characteristics":{"description":"Count (0-3) of symptomatic-episode characteristics ever: erythema overlying the affected joint; cannot bear touch or pressure; great difficulty walking or inability to use the affected joint (Neogi 2015). Points equal the count. magent does not examine joints.","enum":[0,1,2,3],"type":"integer"},"entry_criterion":{"description":"Must be true. ACR/EULAR 2015 entry: at least one episode of swelling, pain, or tenderness in a peripheral joint or bursa. false is invalid. magent does not examine joints.","type":"boolean"},"imaging_erosion":{"description":"Conventional radiograph of hands and/or feet with ≥1 gout-related erosion (cortical break with sclerotic margin and overhanging edge; excludes DIP joints and gull-wing) (Neogi 2015). present scores 4; absent_or_not_done scores 0. magent does not read radiographs.","enum":["absent_or_not_done","present"],"type":"string"},"imaging_urate":{"description":"Imaging evidence of urate deposition (ultrasound double-contour or DECT urate) in a symptomatic (ever) joint/bursa (Neogi 2015). present scores 4. If imaging is not available, absent_or_not_done scores 0. magent does not read imaging.","enum":["absent_or_not_done","present"],"type":"string"},"pattern":{"description":"Pattern of joint/bursa involvement ever, monoarticular or oligoarticular unless other (Neogi 2015). other (joints/bursa other than ankle, midfoot, or 1st MTP, or only as part of a polyarticular presentation) scores 0. ankle_midfoot (ankle or midfoot without 1st MTP) scores 1. mtp1 (1st MTP) scores 2. magent does not examine joints.","enum":["other","ankle_midfoot","mtp1"],"type":"string"},"sufficient_msu":{"description":"Presence of MSU crystals in a symptomatic joint or bursa (synovial fluid) or tophus (Neogi 2015 Step 2). true classifies gout without requiring score ≥8. magent does not perform polarizing microscopy.","type":"boolean"},"synovial":{"description":"Synovial fluid of a symptomatic (ever) joint/bursa, trained observer (Neogi 2015). not_done scores 0; msu_negative scores −2. MSU-positive is sufficient_msu, not this field. magent does not perform polarizing microscopy.","enum":["not_done","msu_negative"],"type":"string"},"time_course":{"description":"Time course of episode(s) ever (Neogi 2015). A typical episode has ≥2 of: time to maximum pain \u003c24 h; resolution ≤14 days; complete resolution between episodes. none scores 0; one_typical scores 1; recurrent scores 2. magent does not take a history.","enum":["none","one_typical","recurrent"],"type":"string"},"tophus":{"description":"Clinical evidence of tophus: draining or chalk-like subcutaneous nodule under transparent skin, often with overlying vascularity, in typical locations (joints, ears, olecranon bursae, finger pads, tendons e.g. Achilles) (Neogi 2015). true scores 4; false scores 0. magent does not examine joints.","type":"boolean"},"uric_acid_mg_dl":{"description":"Highest serum urate in mg/dL (uricase method; 1-20). Provide this or uric_acid_umol_l, not both. \u003c4 scores −4; ≥4 and \u003c6 scores 0; 6–\u003c8 scores 2; 8–\u003c10 scores 3; ≥10 scores 4. magent does not assay uric acid.","type":"number"},"uric_acid_umol_l":{"description":"Highest serum urate in µmol/L (uricase method; 60-1190). Provide this or uric_acid_mg_dl, not both. mmol/L = µmol/L / 1000. \u003c0.24 scores −4; ≥0.24 and \u003c0.36 scores 0; 0.36–\u003c0.48 scores 2; 0.48–\u003c0.60 scores 3; ≥0.60 scores 4. magent does not assay uric acid.","type":"number"}},"required":["entry_criterion","sufficient_msu","pattern","characteristics","time_course","tophus","synovial","imaging_urate","imaging_erosion"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T14:47:46.913Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T14:47:46.779Z"},"resource":"https://api.magentlab.com/api/calc/acr_eular_gout","serviceName":"magent","tags":["gout","acr-eular","classification","emergency","calculator"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/gout_rule","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Janssens 2010 diagnostic rule for acute gouty arthritis without joint fluid: male 2, previous arthritis attack 2, onset within 1 day 0.5, joint redness 1, MTP1 2.5, hypertension or CVD 1.5, uric acid \u003e5.88 mg/dL or \u003e350 µmol/L 3.5; max 13. Low ≤4, intermediate 4.5–7.5, high ≥8. uric_acid_mg_dl or uric_acid_umol_l, not both. Deterministic published score; not a gout diagnosis; magent does not examine joints or replace synovial crystal analysis.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"hypertension_or_cvd":false,"joint_redness":false,"mtp1_involvement":false,"onset_within_1_day":false,"previous_arthritis_attack":false,"sex":"female","uric_acid_mg_dl":5,"uric_acid_umol_l":300},{"hypertension_or_cvd":false,"joint_redness":false,"mtp1_involvement":false,"onset_within_1_day":false,"previous_arthritis_attack":false,"sex":"female","uric_acid_mg_dl":5,"uric_acid_umol_l":300}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"citation":{"authors":"Janssens HJEM, Fransen J, van de Lisdonk EH, van Riel PLCM, van Weel C, Janssen M","doi":"10.1001/archinternmed.2010.196","id":"janssens-2010","pmid":"20625017","source":"Arch Intern Med. 2010;170(13):1120-1126","title":"A diagnostic rule for acute gouty arthritis in primary care without joint fluid analysis"},"components":[{"factor":"male","points":0,"present":false},{"factor":"previous_arthritis_attack","points":0,"present":false},{"factor":"onset_within_1_day","points":0,"present":false},{"factor":"joint_redness","points":0,"present":false},{"factor":"mtp1_involvement","points":0,"present":false},{"factor":"hypertension_or_cvd","points":0,"present":false},{"factor":"uric_acid","points":0,"present":false,"value":5}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"gout_rule","formula_expression":"gout_rule = 2*male + 2*previous_arthritis_attack + 0.5*onset_within_1_day + 1*joint_redness + 2.5*mtp1_involvement + 1.5*hypertension_or_cvd + 3.5*(uric_acid_mg_dl\u003e5.88 | uric_acid_umol_l\u003e350); Janssens 2010; max 13; low ≤4, intermediate 4.5-7.5, high ≥8","gout_band":"low","max_score":13,"score":0},{"citation":{"authors":"Janssens HJEM, Fransen J, van de Lisdonk EH, van Riel PLCM, van Weel C, Janssen M","doi":"10.1001/archinternmed.2010.196","id":"janssens-2010","pmid":"20625017","source":"Arch Intern Med. 2010;170(13):1120-1126","title":"A diagnostic rule for acute gouty arthritis in primary care without joint fluid analysis"},"components":[{"factor":"male","points":0,"present":false},{"factor":"previous_arthritis_attack","points":0,"present":false},{"factor":"onset_within_1_day","points":0,"present":false},{"factor":"joint_redness","points":0,"present":false},{"factor":"mtp1_involvement","points":0,"present":false},{"factor":"hypertension_or_cvd","points":0,"present":false},{"factor":"uric_acid","points":0,"present":false,"value":5}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"gout_rule","formula_expression":"gout_rule = 2*male + 2*previous_arthritis_attack + 0.5*onset_within_1_day + 1*joint_redness + 2.5*mtp1_involvement + 1.5*hypertension_or_cvd + 3.5*(uric_acid_mg_dl\u003e5.88 | uric_acid_umol_l\u003e350); Janssens 2010; max 13; low ≤4, intermediate 4.5-7.5, high ≥8","gout_band":"low","max_score":13,"score":0}],"path":"/api/calc/gout_rule"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"hypertension_or_cvd":{"description":"Hypertension or one or more cardiovascular diseases (Janssens 2010). true scores 1.5. magent does not diagnose hypertension or cardiovascular disease.","type":"boolean"},"joint_redness":{"description":"Joint redness as assigned by the caller (Janssens 2010). true scores 1.0. magent does not examine joints.","type":"boolean"},"mtp1_involvement":{"description":"Involvement of the first metatarsophalangeal joint (Janssens 2010). true scores 2.5. magent does not examine joints.","type":"boolean"},"onset_within_1_day":{"description":"Onset within 1 day (Janssens 2010). true scores 0.5. magent does not timestamp onset.","type":"boolean"},"previous_arthritis_attack":{"description":"Previous patient-reported arthritis attack (Janssens 2010). true scores 2.0. magent does not take a history.","type":"boolean"},"sex":{"description":"Caller-assigned sex (Janssens 2010). male scores 2.0; female scores 0. magent does not assign sex.","enum":["female","male"],"type":"string"},"uric_acid_mg_dl":{"description":"Serum uric acid in mg/dL (1-20). Provide this or uric_acid_umol_l, not both. Scores 3.5 when \u003e5.88; 5.88 does not score. magent does not assay uric acid.","type":"number"},"uric_acid_umol_l":{"description":"Serum uric acid in µmol/L (60-1190). Provide this or uric_acid_mg_dl, not both. Scores 3.5 when \u003e350; 350 does not score. magent does not assay uric acid.","type":"number"}},"required":["sex","previous_arthritis_attack","onset_within_1_day","joint_redness","mtp1_involvement","hypertension_or_cvd"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T14:47:39.939Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T14:47:39.788Z"},"resource":"https://api.magentlab.com/api/calc/gout_rule","serviceName":"magent","tags":["gout","arthritis","emergency","uric-acid","calculator"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/tash","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Yücel 2006 TASH (Trauma Associated Severe Hemorrhage): seven independent nested less-than point bands for arrival SBP, hemoglobin, intra-abdominal fluid, complex long-bone/pelvic fracture AIS, heart rate, base excess, and male sex; max 28. Highest matching band only (do not stack). Deterministic published arithmetic with citation; not a transfusion or MTP order; not ABC (assessment of blood consumption). Caller assigns FAST and AIS; magent does not read imaging.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"base_excess_mmol_l":-4,"fracture_ais":3,"heart_rate_bpm":110,"hemoglobin_g_dl":10.5,"hemoglobin_g_l":105,"intra_abdominal_fluid":false,"sex":"male","systolic_mm_hg":110},{"base_excess_mmol_l":-4,"fracture_ais":3,"heart_rate_bpm":110,"hemoglobin_g_dl":10.5,"hemoglobin_g_l":105,"intra_abdominal_fluid":false,"sex":"male","systolic_mm_hg":110}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"base_excess_mmol_l":-4,"citation":{"authors":"Yücel N, Lefering R, Maegele M, et al.","doi":"10.1097/01.ta.0000220386.84012.bf","id":"yucel-2006","pmid":"16766965","source":"J Trauma. 2006;60(6):1228-1236","title":"Trauma Associated Severe Hemorrhage (TASH)-Score: probability of mass transfusion as surrogate for life threatening hemorrhage after multiple trauma"},"components":[{"factor":"systolic","points":1,"present":true,"value":110},{"factor":"hemoglobin","points":3,"present":true,"value":10.5},{"factor":"intra_abdominal_fluid","points":0,"present":false},{"factor":"fracture_ais","points":3,"present":true,"value":3},{"factor":"heart_rate","points":0,"present":false,"value":110},{"factor":"base_excess","points":1,"present":true,"value":-4},{"factor":"male","points":1,"present":true,"value":"male"}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"tash","formula_expression":"TASH = SBP (\u003c100:4, \u003c120:1) + Hb g/dL (\u003c7:8, \u003c9:6, \u003c10:4, \u003c11:3, \u003c12:2) + intra-abdominal fluid 3 + fracture AIS (3-4:3, 5:6) + HR\u003e120:2 + BE mmol/L (\u003c-10:4, \u003c-6:3, \u003c-2:1) + male 1; nested less-than highest band only; max 28","fracture_ais":3,"heart_rate_bpm":110,"hemoglobin_g_dl":10.5,"intra_abdominal_fluid":false,"max_score":28,"score":9,"sex":"male","systolic_mm_hg":110},{"base_excess_mmol_l":-4,"citation":{"authors":"Yücel N, Lefering R, Maegele M, et al.","doi":"10.1097/01.ta.0000220386.84012.bf","id":"yucel-2006","pmid":"16766965","source":"J Trauma. 2006;60(6):1228-1236","title":"Trauma Associated Severe Hemorrhage (TASH)-Score: probability of mass transfusion as surrogate for life threatening hemorrhage after multiple trauma"},"components":[{"factor":"systolic","points":1,"present":true,"value":110},{"factor":"hemoglobin","points":3,"present":true,"value":10.5},{"factor":"intra_abdominal_fluid","points":0,"present":false},{"factor":"fracture_ais","points":3,"present":true,"value":3},{"factor":"heart_rate","points":0,"present":false,"value":110},{"factor":"base_excess","points":1,"present":true,"value":-4},{"factor":"male","points":1,"present":true,"value":"male"}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"tash","formula_expression":"TASH = SBP (\u003c100:4, \u003c120:1) + Hb g/dL (\u003c7:8, \u003c9:6, \u003c10:4, \u003c11:3, \u003c12:2) + intra-abdominal fluid 3 + fracture AIS (3-4:3, 5:6) + HR\u003e120:2 + BE mmol/L (\u003c-10:4, \u003c-6:3, \u003c-2:1) + male 1; nested less-than highest band only; max 28","fracture_ais":3,"heart_rate_bpm":110,"hemoglobin_g_dl":10.5,"intra_abdominal_fluid":false,"max_score":28,"score":9,"sex":"male","systolic_mm_hg":110}],"path":"/api/calc/tash"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"base_excess_mmol_l":{"description":"Admission base excess in mmol/L (−30 to 20). Nested less-than: \u003c −10 scores 4; \u003c −6 scores 3; \u003c −2 scores 1; ≥ −2 scores 0. Highest matching band only.","type":"number"},"fracture_ais":{"description":"Caller-assigned AIS for complex long bone and/or pelvic fractures. Must be 0 (none), 3, 4, or 5. 3 or 4 scores 3; 5 scores 6. magent does not assign AIS from imaging.","type":"integer"},"heart_rate_bpm":{"description":"Arrival heart rate in beats per minute (integer 30-220). \u003e120 scores 2; 120 does not.","type":"integer"},"hemoglobin_g_dl":{"description":"Hemoglobin in g/dL (3-22). Provide this or hemoglobin_g_l, not both. Nested less-than: \u003c7 scores 8; \u003c9 scores 6; \u003c10 scores 4; \u003c11 scores 3; \u003c12 scores 2; ≥12 scores 0. Highest matching band only.","type":"number"},"hemoglobin_g_l":{"description":"Hemoglobin in g/L (30-220). Converted as hemoglobin_g_dl = hemoglobin_g_l / 10. Provide this or hemoglobin_g_dl, not both.","type":"number"},"intra_abdominal_fluid":{"description":"Intra-abdominal fluid (FAST) as assigned by the caller (Yücel 2006). true or false. true scores 3. magent does not interpret FAST images.","type":"boolean"},"sex":{"description":"Sex as assigned by the caller. male scores 1; female scores 0.","type":"string"},"systolic_mm_hg":{"description":"Arrival systolic blood pressure in mm Hg (integer 0-300). Nested less-than: \u003c100 scores 4; \u003c120 (and not \u003c100) scores 1; ≥120 scores 0. Highest matching band only.","type":"integer"}},"required":["systolic_mm_hg","intra_abdominal_fluid","fracture_ais","heart_rate_bpm","base_excess_mmol_l","sex"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T14:45:53.704Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T14:45:53.574Z"},"resource":"https://api.magentlab.com/api/calc/tash","serviceName":"magent","tags":["tash","trauma","hemorrhage","transfusion"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/bam","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Cacciola 2013 Brief Addiction Monitor (BAM; public-domain VA instrument). Three subscales only: Use (items 4+5+6, 0-90), Risk (items 1+2+3+8+11+15, 0-102 on Table 1 0-4 Likert plus 0-30 days), Protective (items 9+10+12+13+14+16, 0-98; income No=0 Yes=30). Items 7a-g and 17 collected, not summed. No total BAM score. magent does not interview the patient. Not a diagnosis, level-of-care order, or medical device.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"abstinence_confidence":0,"adequate_income":false,"craving":0,"days_alcohol":0,"days_drug":0,"days_heavy_alcohol":0,"days_psychological":0,"days_risky":0,"days_self_help":0,"days_sleep":0,"days_structured":0,"days_supportive":0,"drug_cocaine":false,"drug_inhalants":false,"drug_marijuana":false,"drug_opiates":false,"drug_other":false,"drug_sedatives":false,"drug_stimulants":false,"family_arguments":0,"physical_health":0,"recovery_satisfaction":0,"religion_support":0},{"abstinence_confidence":0,"adequate_income":false,"craving":0,"days_alcohol":0,"days_drug":0,"days_heavy_alcohol":0,"days_psychological":0,"days_risky":0,"days_self_help":0,"days_sleep":0,"days_structured":0,"days_supportive":0,"drug_cocaine":false,"drug_inhalants":false,"drug_marijuana":false,"drug_opiates":false,"drug_other":false,"drug_sedatives":false,"drug_stimulants":false,"family_arguments":0,"physical_health":0,"recovery_satisfaction":0,"religion_support":0}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"citation":{"authors":"Cacciola JS, Alterman AI, DePhilippis D, et al.","doi":"10.1016/j.jsat.2012.07.013","id":"cacciola-2013","pmid":"22898042","source":"J Subst Abuse Treat. 2013;44(5):492-499","title":"Development and initial evaluation of the Brief Addiction Monitor (BAM)"},"components":[{"factor":"physical_health","points":0,"present":true,"subscale":"risk","value":0},{"factor":"days_sleep","points":0,"present":true,"subscale":"risk","value":0},{"factor":"days_psychological","points":0,"present":true,"subscale":"risk","value":0},{"factor":"days_alcohol","points":0,"present":true,"subscale":"use","value":0},{"factor":"days_heavy_alcohol","points":0,"present":true,"subscale":"use","value":0},{"factor":"days_drug","points":0,"present":true,"subscale":"use","value":0},{"factor":"drug_marijuana","points":0,"present":false,"subscale":"collected","value":false},{"factor":"drug_sedatives","points":0,"present":false,"subscale":"collected","value":false},{"factor":"drug_cocaine","points":0,"present":false,"subscale":"collected","value":false},{"factor":"drug_stimulants","points":0,"present":false,"subscale":"collected","value":false},{"factor":"drug_opiates","points":0,"present":false,"subscale":"collected","value":false},{"factor":"drug_inhalants","points":0,"present":false,"subscale":"collected","value":false},{"factor":"drug_other","points":0,"present":false,"subscale":"collected","value":false},{"factor":"craving","points":0,"present":true,"subscale":"risk","value":0},{"factor":"abstinence_confidence","points":0,"present":true,"subscale":"protective","value":0},{"factor":"days_self_help","points":0,"present":true,"subscale":"protective","value":0},{"factor":"days_risky","points":0,"present":true,"subscale":"risk","value":0},{"factor":"religion_support","points":0,"present":true,"subscale":"protective","value":0},{"factor":"days_structured","points":0,"present":true,"subscale":"protective","value":0},{"factor":"adequate_income","points":0,"present":false,"subscale":"protective","value":false},{"factor":"family_arguments","points":0,"present":true,"subscale":"risk","value":0},{"factor":"days_supportive","points":0,"present":true,"subscale":"protective","value":0},{"factor":"recovery_satisfaction","points":0,"present":true,"subscale":"collected","value":0}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"bam","formula_expression":"Use = days_alcohol + days_heavy_alcohol + days_drug (Cacciola 2013 Table 1 items 4+5+6; each 0-30; max 90); Risk = physical_health + days_sleep + days_psychological + craving + days_risky + family_arguments (items 1+2+3+8+11+15; Table 1 Likert 0-4 kept on Table 1's own scale, day-counts 0-30; max 102); Protective = abstinence_confidence + days_self_help + religion_support + days_structured + adequate_income + days_supportive (items 9+10+12+13+14+16; Table 1 Likert 0-4, day-counts 0-30, income No=0 Yes=30; max 98); items 7a-g and 17 collected and not summed. No single total BAM score. magent does not interview the patient. Not a diagnosis or level-of-care order.","protective":0,"protective_max":98,"risk":0,"risk_max":102,"use":0,"use_max":90},{"citation":{"authors":"Cacciola JS, Alterman AI, DePhilippis D, et al.","doi":"10.1016/j.jsat.2012.07.013","id":"cacciola-2013","pmid":"22898042","source":"J Subst Abuse Treat. 2013;44(5):492-499","title":"Development and initial evaluation of the Brief Addiction Monitor (BAM)"},"components":[{"factor":"physical_health","points":0,"present":true,"subscale":"risk","value":0},{"factor":"days_sleep","points":0,"present":true,"subscale":"risk","value":0},{"factor":"days_psychological","points":0,"present":true,"subscale":"risk","value":0},{"factor":"days_alcohol","points":0,"present":true,"subscale":"use","value":0},{"factor":"days_heavy_alcohol","points":0,"present":true,"subscale":"use","value":0},{"factor":"days_drug","points":0,"present":true,"subscale":"use","value":0},{"factor":"drug_marijuana","points":0,"present":false,"subscale":"collected","value":false},{"factor":"drug_sedatives","points":0,"present":false,"subscale":"collected","value":false},{"factor":"drug_cocaine","points":0,"present":false,"subscale":"collected","value":false},{"factor":"drug_stimulants","points":0,"present":false,"subscale":"collected","value":false},{"factor":"drug_opiates","points":0,"present":false,"subscale":"collected","value":false},{"factor":"drug_inhalants","points":0,"present":false,"subscale":"collected","value":false},{"factor":"drug_other","points":0,"present":false,"subscale":"collected","value":false},{"factor":"craving","points":0,"present":true,"subscale":"risk","value":0},{"factor":"abstinence_confidence","points":0,"present":true,"subscale":"protective","value":0},{"factor":"days_self_help","points":0,"present":true,"subscale":"protective","value":0},{"factor":"days_risky","points":0,"present":true,"subscale":"risk","value":0},{"factor":"religion_support","points":0,"present":true,"subscale":"protective","value":0},{"factor":"days_structured","points":0,"present":true,"subscale":"protective","value":0},{"factor":"adequate_income","points":0,"present":false,"subscale":"protective","value":false},{"factor":"family_arguments","points":0,"present":true,"subscale":"risk","value":0},{"factor":"days_supportive","points":0,"present":true,"subscale":"protective","value":0},{"factor":"recovery_satisfaction","points":0,"present":true,"subscale":"collected","value":0}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"bam","formula_expression":"Use = days_alcohol + days_heavy_alcohol + days_drug (Cacciola 2013 Table 1 items 4+5+6; each 0-30; max 90); Risk = physical_health + days_sleep + days_psychological + craving + days_risky + family_arguments (items 1+2+3+8+11+15; Table 1 Likert 0-4 kept on Table 1's own scale, day-counts 0-30; max 102); Protective = abstinence_confidence + days_self_help + religion_support + days_structured + adequate_income + days_supportive (items 9+10+12+13+14+16; Table 1 Likert 0-4, day-counts 0-30, income No=0 Yes=30; max 98); items 7a-g and 17 collected and not summed. No single total BAM score. magent does not interview the patient. Not a diagnosis or level-of-care order.","protective":0,"protective_max":98,"risk":0,"risk_max":102,"use":0,"use_max":90}],"path":"/api/calc/bam"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"abstinence_confidence":{"description":"Caller-assigned Cacciola 2013 Table 1 item 9 abstinence-confidence rating (integer 0-4; 0 not at all, 4 extremely). Kept on Table 1's 0-4 scale. magent does not interview the patient.","type":"integer"},"adequate_income":{"description":"Caller-assigned Cacciola 2013 Table 1 item 14 adequate income (true or false). No scores 0; Yes scores 30 (VA public-domain BAM-R item-14 map). magent does not interview the patient.","type":"boolean"},"craving":{"description":"Caller-assigned Cacciola 2013 Table 1 item 8 craving rating (integer 0-4; 0 not at all, 4 extremely). Kept on Table 1's 0-4 scale. magent does not interview the patient.","type":"integer"},"days_alcohol":{"description":"Caller-assigned Cacciola 2013 Table 1 item 4 days of alcohol use in the prior 30 days (integer 0-30). magent does not interview the patient.","type":"integer"},"days_drug":{"description":"Caller-assigned Cacciola 2013 Table 1 item 6 days of drug use in the prior 30 days (integer 0-30). magent does not interview the patient.","type":"integer"},"days_heavy_alcohol":{"description":"Caller-assigned Cacciola 2013 Table 1 item 5 days of heavy alcohol use in the prior 30 days (integer 0-30). Contingent on item 4 in that paper; this tool accepts 0-30 independently. magent does not interview the patient.","type":"integer"},"days_psychological":{"description":"Caller-assigned Cacciola 2013 Table 1 item 3 days of psychological problems in the prior 30 days (integer 0-30). magent does not interview the patient.","type":"integer"},"days_risky":{"description":"Caller-assigned Cacciola 2013 Table 1 item 11 days in risky situations in the prior 30 days (integer 0-30). magent does not interview the patient.","type":"integer"},"days_self_help":{"description":"Caller-assigned Cacciola 2013 Table 1 item 10 days of self-help group attendance in the prior 30 days (integer 0-30). magent does not interview the patient.","type":"integer"},"days_sleep":{"description":"Caller-assigned Cacciola 2013 Table 1 item 2 days of trouble sleeping in the prior 30 days (integer 0-30). magent does not interview the patient.","type":"integer"},"days_structured":{"description":"Caller-assigned Cacciola 2013 Table 1 item 13 days of structured activities in the prior 30 days (integer 0-30). magent does not interview the patient.","type":"integer"},"days_supportive":{"description":"Caller-assigned Cacciola 2013 Table 1 item 16 days with supportive family/friends in the prior 30 days (integer 0-30). magent does not interview the patient.","type":"integer"},"drug_cocaine":{"description":"Caller-assigned Cacciola 2013 item 7 checklist slot 7c (cocaine/crack). Collected and not summed. magent does not interview the patient.","type":"boolean"},"drug_inhalants":{"description":"Caller-assigned Cacciola 2013 item 7 checklist slot 7f (inhalants). Collected and not summed. magent does not interview the patient.","type":"boolean"},"drug_marijuana":{"description":"Caller-assigned Cacciola 2013 item 7 checklist slot 7a (marijuana). Collected and not summed. Table 1 names a 6-category checklist without listing categories; 7a-g follow the VA public-domain slots. magent does not interview the patient.","type":"boolean"},"drug_opiates":{"description":"Caller-assigned Cacciola 2013 item 7 checklist slot 7e (opiates). Collected and not summed. magent does not interview the patient.","type":"boolean"},"drug_other":{"description":"Caller-assigned Cacciola 2013 item 7 checklist slot 7g (other drugs). Collected and not summed. magent does not interview the patient.","type":"boolean"},"drug_sedatives":{"description":"Caller-assigned Cacciola 2013 item 7 checklist slot 7b (sedatives/tranquilizers). Collected and not summed. magent does not interview the patient.","type":"boolean"},"drug_stimulants":{"description":"Caller-assigned Cacciola 2013 item 7 checklist slot 7d (other stimulants). Collected and not summed. magent does not interview the patient.","type":"boolean"},"family_arguments":{"description":"Caller-assigned Cacciola 2013 Table 1 item 15 arguments with family/friends rating (integer 0-4; 0 not at all, 4 extremely). Kept on Table 1's 0-4 scale. magent does not interview the patient.","type":"integer"},"physical_health":{"description":"Caller-assigned Cacciola 2013 Table 1 item 1 physical-health rating (integer 0-4; 0 excellent, 4 poor). Healthiest published anchor is 0. Kept on Table 1's 0-4 scale (not a 0/8/15/22/30 recode). magent does not interview the patient.","type":"integer"},"recovery_satisfaction":{"description":"Caller-assigned Cacciola 2013 Table 1 item 17 recovery-satisfaction rating (integer 0-4; 0 not at all, 4 extremely). Collected and not summed. magent does not interview the patient.","type":"integer"},"religion_support":{"description":"Caller-assigned Cacciola 2013 Table 1 item 12 religion/spirituality support rating (integer 0-4; 0 not at all, 4 extremely). Kept on Table 1's 0-4 scale. magent does not interview the patient.","type":"integer"}},"required":["physical_health","days_sleep","days_psychological","days_alcohol","days_heavy_alcohol","days_drug","drug_marijuana","drug_sedatives","drug_cocaine","drug_stimulants","drug_opiates","drug_inhalants","drug_other","craving","abstinence_confidence","days_self_help","days_risky","religion_support","days_structured","adequate_income","family_arguments","days_supportive","recovery_satisfaction"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T14:41:53.349Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T14:41:53.193Z"},"resource":"https://api.magentlab.com/api/calc/bam","serviceName":"magent","tags":["bam","addiction","emergency","substance-use","calculator"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/ehmrg","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Lee 2012 EHMRG 7-day ED model (Table 3 integer score): 2*age + 60 if EMS transport - min(SBP,160) + clamp(HR,80-120) - 2*min(SpO2,92) + 20*creatinine_mg_dl + K (\u003c=3.9: +5; 4.0-4.5: 0; \u003e=4.6: +30) + 60 if troponin\u003eULN + 45 if active cancer + 60 if home metolazone + 12. Groups 1/2/3/4/5a/5b. Dialysis-dependent excluded. Not EHMRG30-ST, not ADHERE CART, not a discharge or admission order.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"active_cancer":false,"age":70,"creatinine_mg_dl":1,"creatinine_umol_l":88.4,"dialysis_dependent":false,"ems_transport":false,"heart_rate_bpm":80,"metolazone":false,"potassium_mmol_l":4.2,"spo2_percent":92,"systolic_mm_hg":160,"troponin_gt_uln":false},{"active_cancer":false,"age":70,"creatinine_mg_dl":1,"creatinine_umol_l":88.4,"dialysis_dependent":false,"ems_transport":false,"heart_rate_bpm":80,"metolazone":false,"potassium_mmol_l":4.2,"spo2_percent":92,"systolic_mm_hg":160,"troponin_gt_uln":false}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"active_cancer":false,"age_years":70,"citation":{"authors":"Lee DS, Stitt A, Austin PC, Stukel TA, Schull MJ, Chong A, Newton GE, Lee JS, Tu JV","doi":"10.7326/0003-4819-156-11-201206050-00003","id":"lee-2012","pmid":"22665814","source":"Ann Intern Med. 2012;156(11):767-775","title":"Prediction of heart failure mortality in emergent care: a cohort study"},"creatinine_mg_dl":1,"dialysis_dependent":false,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","ehmrg_score":-92,"ems_transport":false,"formula":"ehmrg","formula_expression":"ehmrg_score = 2*age_years + 60*(ems_transport) - min(systolic_mm_hg, 160) + clamp(heart_rate_bpm, 80, 120) - 2*min(spo2_percent, 92) + 20*creatinine_mg_dl + K(\u003c=3.9:5, 4.0-4.5:0, \u003e=4.6:30) + 60*(troponin_gt_uln) + 45*(active_cancer) + 60*(metolazone) + 12; Lee 2012 Table 3 7-day ED model; dialysis-dependent excluded; risk_group 1 (score \u003c= -49.1), 2 (-49.0 to -15.9), 3 (-15.8 to 17.9), 4 (18.0 to 56.5), 5a (56.6 to 89.3), 5b (\u003e= 89.4)","heart_rate_bpm":80,"metolazone":false,"potassium_mmol_l":4.2,"risk_group":"1","spo2_percent":92,"systolic_mm_hg":160,"troponin_gt_uln":false},{"active_cancer":false,"age_years":70,"citation":{"authors":"Lee DS, Stitt A, Austin PC, Stukel TA, Schull MJ, Chong A, Newton GE, Lee JS, Tu JV","doi":"10.7326/0003-4819-156-11-201206050-00003","id":"lee-2012","pmid":"22665814","source":"Ann Intern Med. 2012;156(11):767-775","title":"Prediction of heart failure mortality in emergent care: a cohort study"},"creatinine_mg_dl":1,"dialysis_dependent":false,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","ehmrg_score":-92,"ems_transport":false,"formula":"ehmrg","formula_expression":"ehmrg_score = 2*age_years + 60*(ems_transport) - min(systolic_mm_hg, 160) + clamp(heart_rate_bpm, 80, 120) - 2*min(spo2_percent, 92) + 20*creatinine_mg_dl + K(\u003c=3.9:5, 4.0-4.5:0, \u003e=4.6:30) + 60*(troponin_gt_uln) + 45*(active_cancer) + 60*(metolazone) + 12; Lee 2012 Table 3 7-day ED model; dialysis-dependent excluded; risk_group 1 (score \u003c= -49.1), 2 (-49.0 to -15.9), 3 (-15.8 to 17.9), 4 (18.0 to 56.5), 5a (56.6 to 89.3), 5b (\u003e= 89.4)","heart_rate_bpm":80,"metolazone":false,"potassium_mmol_l":4.2,"risk_group":"1","spo2_percent":92,"systolic_mm_hg":160,"troponin_gt_uln":false}],"path":"/api/calc/ehmrg"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"active_cancer":{"description":"Active cancer as assigned by the caller (true or false). Lee 2012 Table 3: +45 if true.","type":"boolean"},"age":{"description":"Age in years (integer 18-120). Lee 2012 Table 3 adds +2 per year. magent does not assign age.","type":"integer"},"creatinine_mg_dl":{"description":"Serum creatinine in mg/dL (0.1-20). Provide this or creatinine_umol_l, not both. Lee 2012 Table 3 adds +20 per mg/dL. magent does not measure creatinine.","type":"number"},"creatinine_umol_l":{"description":"Serum creatinine in µmol/L (9-1768). Converted as mg/dL = µmol/L / 88.42. Provide this or creatinine_mg_dl, not both.","type":"number"},"dialysis_dependent":{"description":"Dialysis dependence as assigned by the caller (true or false). Lee 2012 excludes dialysis-dependent patients; true returns HTTP 400. magent does not determine dialysis status.","type":"boolean"},"ems_transport":{"description":"Transported by EMS as assigned by the caller (true or false). Lee 2012 Table 3: +60 if true.","type":"boolean"},"heart_rate_bpm":{"description":"Heart rate in beats/min (integer 30-220). Lee 2012 Table 3 scores +1 * clamp(HR, 80, 120): floor 80, ceiling 120. magent does not measure heart rate.","type":"integer"},"metolazone":{"description":"Metolazone at home as assigned by the caller (true or false). Lee 2012 Table 3: +60 if true.","type":"boolean"},"potassium_mmol_l":{"description":"Serum potassium in mmol/L (1.5-8.0). Lee 2012 Table 3: 4.0-4.5 inclusive → 0; \u003e=4.6 → +30; \u003c=3.9 → +5. Unpublished 3.91-3.99 pin with \u003c=3.9; 4.51-4.59 pin with \u003e=4.6. magent does not measure potassium.","type":"number"},"spo2_percent":{"description":"Lowest initial/triage oxygen saturation percent (50-100). Lee 2012 Table 3 scores -2 * min(SpO2, 92); values above 92% are capped. magent does not measure saturation.","type":"number"},"systolic_mm_hg":{"description":"Initial/triage systolic blood pressure in mm Hg (integer 50-250). Lee 2012 Table 3 scores -1 * min(SBP, 160); values above 160 mm Hg are capped. magent does not measure blood pressure.","type":"integer"},"troponin_gt_uln":{"description":"Troponin above the local upper limit of normal as assigned by the caller (true or false). Lee 2012 Table 3: +60 if true.","type":"boolean"}},"required":["age","ems_transport","systolic_mm_hg","heart_rate_bpm","spo2_percent","potassium_mmol_l","troponin_gt_uln","active_cancer","metolazone","dialysis_dependent"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T14:39:44.006Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T14:39:43.853Z"},"resource":"https://api.magentlab.com/api/calc/ehmrg","serviceName":"magent","tags":["ehmrg","heart-failure","emergency","mortality","calculator"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/saps_3","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Moreno 2005 SAPS 3 admission score from caller-assigned ICU-hour boxes (age, comorbidities, stay, location, vasoactive drugs, admission circumstances, and ten physiology items) plus the published 16-point offset. Converts the integer to hospital-mortality percent with the Part 2 global logit. Not SAPS II. Not APACHE. magent does not measure vitals.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"acute_abdomen":false,"age":35,"aids":false,"anaphylactic_or_mixed_shock":false,"arterial_ph":7.4,"bilirubin_mg_dl":0.8,"bilirubin_umol_l":14,"cancer_therapy":false,"chronic_hf_nyha_iv":false,"cirrhosis":false,"coma_stupor_agitation":false,"creatinine_mg_dl":1,"creatinine_umol_l":88,"focal_neurologic_deficit":false,"gcs":15,"heart_rate":80,"hematologic_cancer":false,"hypovolemic_shock":false,"icu_admission":"planned","intracranial_mass_effect":false,"leukocytes_g_l":8,"liver_failure":false,"location":"operating_room","los_days":1,"mechanical_ventilation":false,"metastatic_cancer":false,"nosocomial_infection":false,"pao2_fio2":250,"pao2_mm_hg":90,"platelets_g_l":250,"respiratory_infection":false,"rhythm_disturbances":false,"seizures":false,"septic_shock":false,"severe_pancreatitis":false,"surgery_site":"all_others","surgical_status":"scheduled_surgery","systolic_bp_mm_hg":120,"temperature_c":37,"vasoactive_drugs":false},{"acute_abdomen":false,"age":35,"aids":false,"anaphylactic_or_mixed_shock":false,"arterial_ph":7.4,"bilirubin_mg_dl":0.8,"bilirubin_umol_l":14,"cancer_therapy":false,"chronic_hf_nyha_iv":false,"cirrhosis":false,"coma_stupor_agitation":false,"creatinine_mg_dl":1,"creatinine_umol_l":88,"focal_neurologic_deficit":false,"gcs":15,"heart_rate":80,"hematologic_cancer":false,"hypovolemic_shock":false,"icu_admission":"planned","intracranial_mass_effect":false,"leukocytes_g_l":8,"liver_failure":false,"location":"operating_room","los_days":1,"mechanical_ventilation":false,"metastatic_cancer":false,"nosocomial_infection":false,"pao2_fio2":250,"pao2_mm_hg":90,"platelets_g_l":250,"respiratory_infection":false,"rhythm_disturbances":false,"seizures":false,"septic_shock":false,"severe_pancreatitis":false,"surgery_site":"all_others","surgical_status":"scheduled_surgery","systolic_bp_mm_hg":120,"temperature_c":37,"vasoactive_drugs":false}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"citation":{"authors":"Moreno RP, Metnitz PGH, Almeida E, et al; SAPS 3 Investigators","doi":"10.1007/s00134-005-2763-5","id":"moreno-2005","pmid":"16132893","source":"Intensive Care Med. 2005;31(10):1345-1355","title":"SAPS 3—From evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admission"},"components":[{"factor":"admission_offset","points":16,"present":true,"value":16},{"factor":"age","points":0,"present":false,"value":35},{"factor":"los_days","points":0,"present":false,"value":1},{"factor":"location","points":0,"present":false,"value":"operating_room"},{"aids":false,"cancer_therapy":false,"chronic_hf_nyha_iv":false,"cirrhosis":false,"factor":"comorbidities","hematologic_cancer":false,"metastatic_cancer":false,"points":0,"present":false},{"factor":"vasoactive_drugs","points":0,"present":false,"value":false},{"factor":"icu_admission","points":0,"present":false,"value":"planned"},{"acute_abdomen":false,"anaphylactic_or_mixed_shock":false,"coma_stupor_agitation":false,"factor":"reasons_for_admission","focal_neurologic_deficit":false,"hypovolemic_shock":false,"intracranial_mass_effect":false,"liver_failure":false,"points":0,"present":false,"rhythm_disturbances":false,"seizures":false,"septic_shock":false,"severe_pancreatitis":false},{"factor":"surgical_status","points":0,"present":false,"value":"scheduled_surgery"},{"factor":"surgery_site","points":0,"present":false,"value":"all_others"},{"factor":"infection","nosocomial_infection":false,"points":0,"present":false,"respiratory_infection":false},{"factor":"gcs","points":0,"present":false,"value":15},{"branch":"bilirubin_mg_dl","factor":"bilirubin","points":0,"present":false,"value":0.8},{"factor":"temperature_c","points":0,"present":false,"value":37},{"branch":"creatinine_mg_dl","factor":"creatinine","points":0,"present":false,"value":1},{"factor":"heart_rate","points":0,"present":false,"value":80},{"factor":"leukocytes_g_l","points":0,"present":false,"value":8},{"factor":"arterial_ph","points":0,"present":false,"value":7.4},{"factor":"platelets_g_l","points":0,"present":false,"value":250},{"factor":"systolic_bp_mm_hg","points":0,"present":false,"value":120},{"branch":"pao2_no_mv","factor":"oxygenation","mechanical_ventilation":false,"points":0,"present":false,"value":90}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","estimated_probability_percent":0.17,"formula":"saps_3","formula_expression":"SAPS 3 = 16 (admission offset) + Box I + Box II + Box III (Moreno 2005 Part 2 scoresheet). Box I: age (\u003c40 → 0, 40-59 → 5, 60-69 → 9, 70-74 → 13, 75-79 → 15, ≥80 → 18); los_days (\u003c14 → 0, 14-27 → 6, ≥28 → 7); location (operating_room → 0, emergency_room → 5, other_icu → 7, other → 8); comorbidities additive (cancer_therapy → 3, metastatic_cancer → 11, hematologic_cancer → 6, chronic_hf_nyha_iv → 6, cirrhosis → 8, aids → 8); vasoactive_drugs → 3. Box II: unplanned ICU admission → 3; reasons additive (rhythm_disturbances → -5, hypovolemic_shock → 3, septic_shock → 5, anaphylactic_or_mixed_shock → 5, liver_failure → 6, severe_pancreatitis → 9, acute_abdomen → 3, intracranial_mass_effect → 10, focal_neurologic_deficit → 7, seizures → -4, coma_stupor_agitation → 4; if rhythm and seizures both, only -4; hypovolemic_shock plus acute_abdomen scores both); surgical_status (scheduled_surgery → 0, emergency_surgery → 6, no_surgery → 5); surgery_site (transplantation → -11, trauma_isolated or trauma_multiple → -8, cabg_no_valve → -6, neurosurgery_cva → 5, all_others → 0); nosocomial_infection → 4, respiratory_infection → 5. Box III within ±1 h as assigned: GCS (3-4 → 15, 5 → 10, 6 → 7, 7-12 → 2, ≥13 → 0); bilirubin_mg_dl (\u003c2 → 0, 2-\u003c6 → 4, ≥6 → 5) or bilirubin_umol_l (\u003c34.2 → 0, 34.2-\u003c102.6 → 4, ≥102.6 → 5); temperature_c (\u003c35 → 7, ≥35 → 0); creatinine_mg_dl (\u003c1.2 → 0, 1.2-\u003c2 → 2, 2-\u003c3.5 → 7, ≥3.5 → 8) or creatinine_umol_l (\u003c106.1 → 0, 106.1-\u003c176.8 → 2, 176.8-\u003c309.4 → 7, ≥309.4 → 8); heart_rate (\u003c120 → 0, 120-159 → 5, ≥160 → 7); leukocytes_g_l (\u003c15 → 0, ≥15 → 2); arterial_ph (≤7.25 → 3, \u003e7.25 → 0); platelets_g_l (\u003c20 → 13, 20-\u003c50 → 8, 50-\u003c100 → 5, ≥100 → 0); systolic_bp_mm_hg (\u003c40 → 11, 40-\u003c70 → 8, 70-\u003c120 → 3, ≥120 → 0); oxygenation (PaO2/FiO2 \u003c100 and MV → 11, PaO2/FiO2 ≥100 and MV → 7, PaO2 \u003c60 and no MV → 5, else 0). logit = -32.6659 + ln(SAPS_3 + 20.5958) × 7.3068; estimated_probability_percent = 100 × exp(logit)/(1+exp(logit)); max 217","logit":-6.3619,"max_score":217,"score":16},{"citation":{"authors":"Moreno RP, Metnitz PGH, Almeida E, et al; SAPS 3 Investigators","doi":"10.1007/s00134-005-2763-5","id":"moreno-2005","pmid":"16132893","source":"Intensive Care Med. 2005;31(10):1345-1355","title":"SAPS 3—From evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admission"},"components":[{"factor":"admission_offset","points":16,"present":true,"value":16},{"factor":"age","points":0,"present":false,"value":35},{"factor":"los_days","points":0,"present":false,"value":1},{"factor":"location","points":0,"present":false,"value":"operating_room"},{"aids":false,"cancer_therapy":false,"chronic_hf_nyha_iv":false,"cirrhosis":false,"factor":"comorbidities","hematologic_cancer":false,"metastatic_cancer":false,"points":0,"present":false},{"factor":"vasoactive_drugs","points":0,"present":false,"value":false},{"factor":"icu_admission","points":0,"present":false,"value":"planned"},{"acute_abdomen":false,"anaphylactic_or_mixed_shock":false,"coma_stupor_agitation":false,"factor":"reasons_for_admission","focal_neurologic_deficit":false,"hypovolemic_shock":false,"intracranial_mass_effect":false,"liver_failure":false,"points":0,"present":false,"rhythm_disturbances":false,"seizures":false,"septic_shock":false,"severe_pancreatitis":false},{"factor":"surgical_status","points":0,"present":false,"value":"scheduled_surgery"},{"factor":"surgery_site","points":0,"present":false,"value":"all_others"},{"factor":"infection","nosocomial_infection":false,"points":0,"present":false,"respiratory_infection":false},{"factor":"gcs","points":0,"present":false,"value":15},{"branch":"bilirubin_mg_dl","factor":"bilirubin","points":0,"present":false,"value":0.8},{"factor":"temperature_c","points":0,"present":false,"value":37},{"branch":"creatinine_mg_dl","factor":"creatinine","points":0,"present":false,"value":1},{"factor":"heart_rate","points":0,"present":false,"value":80},{"factor":"leukocytes_g_l","points":0,"present":false,"value":8},{"factor":"arterial_ph","points":0,"present":false,"value":7.4},{"factor":"platelets_g_l","points":0,"present":false,"value":250},{"factor":"systolic_bp_mm_hg","points":0,"present":false,"value":120},{"branch":"pao2_no_mv","factor":"oxygenation","mechanical_ventilation":false,"points":0,"present":false,"value":90}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","estimated_probability_percent":0.17,"formula":"saps_3","formula_expression":"SAPS 3 = 16 (admission offset) + Box I + Box II + Box III (Moreno 2005 Part 2 scoresheet). Box I: age (\u003c40 → 0, 40-59 → 5, 60-69 → 9, 70-74 → 13, 75-79 → 15, ≥80 → 18); los_days (\u003c14 → 0, 14-27 → 6, ≥28 → 7); location (operating_room → 0, emergency_room → 5, other_icu → 7, other → 8); comorbidities additive (cancer_therapy → 3, metastatic_cancer → 11, hematologic_cancer → 6, chronic_hf_nyha_iv → 6, cirrhosis → 8, aids → 8); vasoactive_drugs → 3. Box II: unplanned ICU admission → 3; reasons additive (rhythm_disturbances → -5, hypovolemic_shock → 3, septic_shock → 5, anaphylactic_or_mixed_shock → 5, liver_failure → 6, severe_pancreatitis → 9, acute_abdomen → 3, intracranial_mass_effect → 10, focal_neurologic_deficit → 7, seizures → -4, coma_stupor_agitation → 4; if rhythm and seizures both, only -4; hypovolemic_shock plus acute_abdomen scores both); surgical_status (scheduled_surgery → 0, emergency_surgery → 6, no_surgery → 5); surgery_site (transplantation → -11, trauma_isolated or trauma_multiple → -8, cabg_no_valve → -6, neurosurgery_cva → 5, all_others → 0); nosocomial_infection → 4, respiratory_infection → 5. Box III within ±1 h as assigned: GCS (3-4 → 15, 5 → 10, 6 → 7, 7-12 → 2, ≥13 → 0); bilirubin_mg_dl (\u003c2 → 0, 2-\u003c6 → 4, ≥6 → 5) or bilirubin_umol_l (\u003c34.2 → 0, 34.2-\u003c102.6 → 4, ≥102.6 → 5); temperature_c (\u003c35 → 7, ≥35 → 0); creatinine_mg_dl (\u003c1.2 → 0, 1.2-\u003c2 → 2, 2-\u003c3.5 → 7, ≥3.5 → 8) or creatinine_umol_l (\u003c106.1 → 0, 106.1-\u003c176.8 → 2, 176.8-\u003c309.4 → 7, ≥309.4 → 8); heart_rate (\u003c120 → 0, 120-159 → 5, ≥160 → 7); leukocytes_g_l (\u003c15 → 0, ≥15 → 2); arterial_ph (≤7.25 → 3, \u003e7.25 → 0); platelets_g_l (\u003c20 → 13, 20-\u003c50 → 8, 50-\u003c100 → 5, ≥100 → 0); systolic_bp_mm_hg (\u003c40 → 11, 40-\u003c70 → 8, 70-\u003c120 → 3, ≥120 → 0); oxygenation (PaO2/FiO2 \u003c100 and MV → 11, PaO2/FiO2 ≥100 and MV → 7, PaO2 \u003c60 and no MV → 5, else 0). logit = -32.6659 + ln(SAPS_3 + 20.5958) × 7.3068; estimated_probability_percent = 100 × exp(logit)/(1+exp(logit)); max 217","logit":-6.3619,"max_score":217,"score":16}],"path":"/api/calc/saps_3"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"acute_abdomen":{"description":"Digestive acute abdomen or other digestive (not pancreatitis) as one Box II row (+3). Additive with hypovolemic_shock. Omit or false → 0.","type":"boolean"},"age":{"description":"Age in years, integer 18-120, as assigned at ICU admission. \u003c40 → 0; 40-59 → 5; 60-69 → 9; 70-74 → 13; 75-79 → 15; ≥80 → 18.","type":"integer"},"aids":{"description":"AIDS as assigned (+8). Additive with cirrhosis. Omit or false → 0.","type":"boolean"},"anaphylactic_or_mixed_shock":{"description":"Anaphylactic, mixed, or undefined shock (+5). Additive. Omit or false → 0.","type":"boolean"},"arterial_ph":{"description":"Lowest arterial pH (6.5-8.0). ≤7.25 → 3; \u003e7.25 → 0.","type":"number"},"bilirubin_mg_dl":{"description":"Highest total bilirubin in mg/dL (0-40). One of bilirubin_mg_dl or bilirubin_umol_l is required. If both are sent, bilirubin_mg_dl is scored. \u003c2 → 0; 2-\u003c6 → 4; ≥6 → 5.","type":"number"},"bilirubin_umol_l":{"description":"Highest total bilirubin in µmol/L (0-684). Alternate to bilirubin_mg_dl. Ignored when bilirubin_mg_dl is present. \u003c34.2 → 0; 34.2-\u003c102.6 → 4; ≥102.6 → 5. magent does not convert units.","type":"number"},"cancer_therapy":{"description":"Chemotherapy, other immunosuppression, radiotherapy, or steroid treatment as assigned (+3). Additive with other comorbidity flags. Omit or false → 0.","type":"boolean"},"chronic_hf_nyha_iv":{"description":"Chronic heart failure NYHA class IV as assigned (+6). Additive. Omit or false → 0.","type":"boolean"},"cirrhosis":{"description":"Cirrhosis as assigned (+8). Additive with aids. Omit or false → 0.","type":"boolean"},"coma_stupor_agitation":{"description":"Coma, stupor, obtunded, agitation, vigilance disturbance, confusion, or delirium (+4). Omit or false → 0.","type":"boolean"},"creatinine_mg_dl":{"description":"Highest creatinine in mg/dL (0.1-20). One of creatinine_mg_dl or creatinine_umol_l is required. If both are sent, creatinine_mg_dl is scored. \u003c1.2 → 0; 1.2-\u003c2 → 2; 2-\u003c3.5 → 7; ≥3.5 → 8.","type":"number"},"creatinine_umol_l":{"description":"Highest creatinine in µmol/L (9-1768). Alternate to creatinine_mg_dl. Ignored when creatinine_mg_dl is present. \u003c106.1 → 0; 106.1-\u003c176.8 → 2; 176.8-\u003c309.4 → 7; ≥309.4 → 8. magent does not convert units.","type":"number"},"focal_neurologic_deficit":{"description":"Focal neurologic deficit (+7). Additive. Omit or false → 0.","type":"boolean"},"gcs":{"description":"Lowest estimated Glasgow Coma Scale, integer 3-15, within ±1 h of ICU admission as assigned by the caller. 3-4 → 15; 5 → 10; 6 → 7; 7-12 → 2; ≥13 → 0. magent does not examine the patient.","type":"integer"},"heart_rate":{"description":"Highest heart rate in beats/min, integer 20-250. \u003c120 → 0; 120-159 → 5; ≥160 → 7. magent does not measure pulse.","type":"integer"},"hematologic_cancer":{"description":"Haematological cancer as assigned (+6). Additive. Omit or false → 0.","type":"boolean"},"hypovolemic_shock":{"description":"Hypovolemic hemorrhagic or non-hemorrhagic shock as one Box II row (+3). Additive with acute_abdomen. Omit or false → 0.","type":"boolean"},"icu_admission":{"description":"Planned (0) or unplanned (3) ICU admission as assigned by the caller. magent does not classify the admission.","enum":["planned","unplanned"],"type":"string"},"intracranial_mass_effect":{"description":"Neurologic intracranial mass effect (+10). Additive. Omit or false → 0.","type":"boolean"},"leukocytes_g_l":{"description":"Lowest leukocytes in G/L (0.1-200), numerically equal to 10^9/L. \u003c15 → 0; ≥15 → 2. magent does not count cells.","type":"number"},"liver_failure":{"description":"Hepatic liver failure as a reason for ICU admission (+6). Omit or false → 0.","type":"boolean"},"location":{"description":"Intra-hospital location before ICU admission: operating_room (0), emergency_room (5), other_icu (7; intermediate/high-dependency, other ICU, or recovery), or other (8; ward or other). magent does not classify the bed.","enum":["operating_room","emergency_room","other_icu","other"],"type":"string"},"los_days":{"description":"Hospital stay in days before ICU admission as assigned by the caller (integer 0-365). \u003c14 → 0; 14-27 → 6; ≥28 → 7. magent does not subtract timestamps.","type":"integer"},"mechanical_ventilation":{"description":"true if the caller assigns mechanical ventilation at ICU admission. true scores PaO2/FiO2 (pao2_fio2 required). false scores PaO2 (pao2_mm_hg required) and pao2_fio2 is ignored.","type":"boolean"},"metastatic_cancer":{"description":"Metastatic cancer as assigned (+11). Additive. Omit or false → 0. magent does not diagnose.","type":"boolean"},"nosocomial_infection":{"description":"Hospital-acquired infection at ICU admission (+4). Additive with respiratory_infection. Omit or false → 0.","type":"boolean"},"pao2_fio2":{"description":"PaO2/FiO2 ratio in mm Hg (10-800). Required when mechanical_ventilation is true. \u003c100 → 11; ≥100 → 7. Ignored when mechanical_ventilation is false. magent does not compute the ratio.","type":"number"},"pao2_mm_hg":{"description":"Lowest PaO2 in mm Hg (20-700). Required when mechanical_ventilation is false. \u003c60 → 5; ≥60 → 0. Ignored when mechanical_ventilation is true.","type":"number"},"platelets_g_l":{"description":"Lowest platelets in G/L (0-2000). \u003c20 → 13; 20-\u003c50 → 8; 50-\u003c100 → 5; ≥100 → 0.","type":"number"},"respiratory_infection":{"description":"Lower respiratory tract infection at ICU admission (+5). Additive with nosocomial_infection. Omit or false → 0.","type":"boolean"},"rhythm_disturbances":{"description":"Cardiovascular reason: rhythm disturbances (-5). If seizures is also true, only -4 is scored. Omit or false → 0.","type":"boolean"},"seizures":{"description":"Seizures (-4). If rhythm_disturbances is also true, only -4 is scored. Omit or false → 0.","type":"boolean"},"septic_shock":{"description":"Septic shock as a reason for ICU admission (+5). Additive. Omit or false → 0.","type":"boolean"},"severe_pancreatitis":{"description":"Severe pancreatitis (+9). Omit or false → 0.","type":"boolean"},"surgery_site":{"description":"Anatomical site of surgery as assigned: all_others (0), transplantation (-11), trauma_isolated or trauma_multiple (-8), cabg_no_valve (-6), or neurosurgery_cva (5). One token. magent does not classify a procedure.","enum":["all_others","transplantation","trauma_isolated","trauma_multiple","cabg_no_valve","neurosurgery_cva"],"type":"string"},"surgical_status":{"description":"Surgical status at ICU admission: scheduled_surgery (0), emergency_surgery (6), or no_surgery (5).","enum":["scheduled_surgery","emergency_surgery","no_surgery"],"type":"string"},"systolic_bp_mm_hg":{"description":"Lowest systolic blood pressure in mm Hg (20-300). \u003c40 → 11; 40-\u003c70 → 8; 70-\u003c120 → 3; ≥120 → 0. magent does not measure blood pressure.","type":"number"},"temperature_c":{"description":"Highest body temperature in °C (20-46) within ±1 h as assigned. \u003c35 → 7; ≥35 → 0. The scoresheet has no hyperthermia points. magent does not measure temperature or convert Fahrenheit.","type":"number"},"vasoactive_drugs":{"description":"true if the caller assigns vasoactive drugs before ICU admission (+3). false → 0. magent does not inspect the medication list.","type":"boolean"}},"required":["age","los_days","location","vasoactive_drugs","icu_admission","surgical_status","surgery_site","gcs","temperature_c","heart_rate","leukocytes_g_l","arterial_ph","platelets_g_l","systolic_bp_mm_hg","mechanical_ventilation"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T14:39:29.854Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T14:39:29.7Z"},"resource":"https://api.magentlab.com/api/calc/saps_3","serviceName":"magent","tags":["saps-3","icu","severity","physiology","mortality"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/saps_ii","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Le Gall 1993 Simplified Acute Physiology Score II from 12 physiology variables (worst values in the first 24 hours as assigned by the caller), age, type of admission, and one chronic disease (AIDS, metastatic cancer, or hematologic malignancy). Max 163. Converts the integer to hospital-mortality probability with the paper's logit. PaO2/FiO2 is scored only if ventilated or CPAP. Not SAPS 3. Not APACHE. magent does not measure vitals.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"admission_type":"scheduled_surgical","age":35,"bicarbonate_meq_l":24,"bilirubin_mg_dl":0.8,"bilirubin_umol_l":14,"bun_mg_dl":15,"chronic_disease":"none","gcs":15,"heart_rate":80,"pao2_fio2":250,"potassium_mmol_l":4,"sodium_mmol_l":140,"systolic_bp_mm_hg":120,"temperature_c":37,"urea_mmol_l":5,"urine_output_l_day":1.5,"ventilated":false,"wbc_k_ul":8},{"admission_type":"scheduled_surgical","age":35,"bicarbonate_meq_l":24,"bilirubin_mg_dl":0.8,"bilirubin_umol_l":14,"bun_mg_dl":15,"chronic_disease":"none","gcs":15,"heart_rate":80,"pao2_fio2":250,"potassium_mmol_l":4,"sodium_mmol_l":140,"systolic_bp_mm_hg":120,"temperature_c":37,"urea_mmol_l":5,"urine_output_l_day":1.5,"ventilated":false,"wbc_k_ul":8}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"citation":{"authors":"Le Gall JR, Lemeshow S, Saulnier F","doi":"10.1001/jama.270.24.2957","id":"le-gall-1993","pmid":"8254858","source":"JAMA. 1993;270(24):2957-2963","title":"A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study"},"components":[{"factor":"age","points":0,"present":false,"value":35},{"factor":"heart_rate","points":0,"present":false,"value":80},{"factor":"systolic_bp_mm_hg","points":0,"present":false,"value":120},{"factor":"temperature_c","points":0,"present":false,"value":37},{"branch":"not_ventilated","factor":"oxygenation","points":0,"present":false,"value":null,"ventilated":false},{"factor":"urine_output_l_day","points":0,"present":false,"value":1.5},{"branch":"urea_mmol_l","factor":"urea","points":0,"present":false,"value":5},{"factor":"wbc_k_ul","points":0,"present":false,"value":8},{"factor":"potassium_mmol_l","points":0,"present":false,"value":4},{"factor":"sodium_mmol_l","points":0,"present":false,"value":140},{"factor":"bicarbonate_meq_l","points":0,"present":false,"value":24},{"branch":"bilirubin_mg_dl","factor":"bilirubin","points":0,"present":false,"value":0.8},{"factor":"gcs","points":0,"present":false,"value":15},{"factor":"admission_type","points":0,"present":false,"value":"scheduled_surgical"},{"factor":"chronic_disease","points":0,"present":false,"value":"none"}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"saps_ii","formula_expression":"SAPS II = sum of 17 Le Gall 1993 variables (worst values in 24h as assigned by the caller): heart_rate (\u003c40 → 11, 40-69 → 2, 70-119 → 0, 120-159 → 4, ≥160 → 7), systolic_bp_mm_hg (\u003c70 → 13, 70-99 → 5, 100-199 → 0, ≥200 → 2), temperature_c (\u003c39 → 0, ≥39 → 3), PaO2/FiO2 mm Hg if ventilated or CPAP (\u003c100 → 11, 100-199 → 9, ≥200 → 6) else 0, urine_output_l_day (\u003c0.500 → 11, 0.500-0.999 → 4, ≥1.000 → 0), urea_mmol_l (\u003c10.0 → 0, 10.0-29.9 → 6, ≥30.0 → 10) or bun_mg_dl (\u003c28 → 0, 28-83 → 6, ≥84 → 10), wbc_k_ul (\u003c1.0 → 12, 1.0-19.9 → 0, ≥20.0 → 3), potassium_mmol_l (\u003c3.0 or ≥5.0 → 3, 3.0-4.9 → 0), sodium_mmol_l (\u003c125 → 5, 125-144 → 0, ≥145 → 1), bicarbonate_meq_l (\u003c15 → 6, 15-19 → 3, ≥20 → 0), bilirubin_mg_dl (\u003c4.0 → 0, 4.0-5.9 → 4, ≥6.0 → 9) or bilirubin_umol_l (\u003c68.4 → 0, 68.4-102.5 → 4, ≥102.6 → 9), gcs (\u003c6 → 26, 6-8 → 13, 9-10 → 7, 11-13 → 5, 14-15 → 0), age (\u003c40 → 0, 40-59 → 7, 60-69 → 12, 70-74 → 15, 75-79 → 16, ≥80 → 18), admission_type (scheduled_surgical → 0, medical → 6, unscheduled_surgical → 8), chronic_disease (none → 0, metastatic_cancer → 9, hematologic_malignancy → 10, aids → 17, one row not additive); logit = -7.7631 + 0.0737*SAPS_II + 0.9971*ln(SAPS_II+1); hospital_mortality_probability = exp(logit)/(1+exp(logit)); max 163","hospital_mortality_probability":0.000425,"logit":-7.7631,"max_score":163,"score":0},{"citation":{"authors":"Le Gall JR, Lemeshow S, Saulnier F","doi":"10.1001/jama.270.24.2957","id":"le-gall-1993","pmid":"8254858","source":"JAMA. 1993;270(24):2957-2963","title":"A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study"},"components":[{"factor":"age","points":0,"present":false,"value":35},{"factor":"heart_rate","points":0,"present":false,"value":80},{"factor":"systolic_bp_mm_hg","points":0,"present":false,"value":120},{"factor":"temperature_c","points":0,"present":false,"value":37},{"branch":"not_ventilated","factor":"oxygenation","points":0,"present":false,"value":null,"ventilated":false},{"factor":"urine_output_l_day","points":0,"present":false,"value":1.5},{"branch":"urea_mmol_l","factor":"urea","points":0,"present":false,"value":5},{"factor":"wbc_k_ul","points":0,"present":false,"value":8},{"factor":"potassium_mmol_l","points":0,"present":false,"value":4},{"factor":"sodium_mmol_l","points":0,"present":false,"value":140},{"factor":"bicarbonate_meq_l","points":0,"present":false,"value":24},{"branch":"bilirubin_mg_dl","factor":"bilirubin","points":0,"present":false,"value":0.8},{"factor":"gcs","points":0,"present":false,"value":15},{"factor":"admission_type","points":0,"present":false,"value":"scheduled_surgical"},{"factor":"chronic_disease","points":0,"present":false,"value":"none"}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"saps_ii","formula_expression":"SAPS II = sum of 17 Le Gall 1993 variables (worst values in 24h as assigned by the caller): heart_rate (\u003c40 → 11, 40-69 → 2, 70-119 → 0, 120-159 → 4, ≥160 → 7), systolic_bp_mm_hg (\u003c70 → 13, 70-99 → 5, 100-199 → 0, ≥200 → 2), temperature_c (\u003c39 → 0, ≥39 → 3), PaO2/FiO2 mm Hg if ventilated or CPAP (\u003c100 → 11, 100-199 → 9, ≥200 → 6) else 0, urine_output_l_day (\u003c0.500 → 11, 0.500-0.999 → 4, ≥1.000 → 0), urea_mmol_l (\u003c10.0 → 0, 10.0-29.9 → 6, ≥30.0 → 10) or bun_mg_dl (\u003c28 → 0, 28-83 → 6, ≥84 → 10), wbc_k_ul (\u003c1.0 → 12, 1.0-19.9 → 0, ≥20.0 → 3), potassium_mmol_l (\u003c3.0 or ≥5.0 → 3, 3.0-4.9 → 0), sodium_mmol_l (\u003c125 → 5, 125-144 → 0, ≥145 → 1), bicarbonate_meq_l (\u003c15 → 6, 15-19 → 3, ≥20 → 0), bilirubin_mg_dl (\u003c4.0 → 0, 4.0-5.9 → 4, ≥6.0 → 9) or bilirubin_umol_l (\u003c68.4 → 0, 68.4-102.5 → 4, ≥102.6 → 9), gcs (\u003c6 → 26, 6-8 → 13, 9-10 → 7, 11-13 → 5, 14-15 → 0), age (\u003c40 → 0, 40-59 → 7, 60-69 → 12, 70-74 → 15, 75-79 → 16, ≥80 → 18), admission_type (scheduled_surgical → 0, medical → 6, unscheduled_surgical → 8), chronic_disease (none → 0, metastatic_cancer → 9, hematologic_malignancy → 10, aids → 17, one row not additive); logit = -7.7631 + 0.0737*SAPS_II + 0.9971*ln(SAPS_II+1); hospital_mortality_probability = exp(logit)/(1+exp(logit)); max 163","hospital_mortality_probability":0.000425,"logit":-7.7631,"max_score":163,"score":0}],"path":"/api/calc/saps_ii"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"admission_type":{"description":"Le Gall 1993 type of admission as assigned by the caller: scheduled_surgical (0), medical (6), or unscheduled_surgical (8). magent does not classify the admission.","enum":["scheduled_surgical","medical","unscheduled_surgical"],"type":"string"},"age":{"description":"Age in years, integer 18-120 (Le Gall 1993 excluded patients younger than 18). \u003c40 → 0; 40-59 → 7; 60-69 → 12; 70-74 → 15; 75-79 → 16; ≥80 → 18.","type":"integer"},"bicarbonate_meq_l":{"description":"Serum bicarbonate in mEq/L (2-60). \u003c15 → 6; 15-19 → 3; ≥20 → 0. Arterial pH is not a SAPS II variable.","type":"number"},"bilirubin_mg_dl":{"description":"Serum bilirubin in mg/dL (0-40). One of bilirubin_mg_dl or bilirubin_umol_l is required. If both are sent, bilirubin_mg_dl is scored and bilirubin_umol_l is ignored. \u003c4.0 → 0; 4.0-5.9 → 4; ≥6.0 → 9.","type":"number"},"bilirubin_umol_l":{"description":"Serum bilirubin in µmol/L (0-684). Alternate to bilirubin_mg_dl (Le Gall 1993 SI column). Ignored when bilirubin_mg_dl is present. \u003c68.4 → 0; 68.4-102.5 → 4; ≥102.6 → 9. magent does not convert units.","type":"number"},"bun_mg_dl":{"description":"Blood urea nitrogen in mg/dL (1-250). Alternate to urea_mmol_l (Le Gall 1993 US column). Ignored when urea_mmol_l is present. \u003c28 → 0; 28-83 → 6; ≥84 → 10. magent does not convert BUN to urea.","type":"number"},"chronic_disease":{"description":"Le Gall 1993 chronic-disease row as assigned by the caller: none (0), metastatic_cancer (9), hematologic_malignancy (10), or aids (17). One token; the paper's table is not additive. magent does not diagnose.","enum":["none","metastatic_cancer","hematologic_malignancy","aids"],"type":"string"},"gcs":{"description":"Glasgow Coma Scale total as assigned by the caller (integer 3-15). \u003c6 → 26; 6-8 → 13; 9-10 → 7; 11-13 → 5; 14-15 → 0. magent does not examine the patient.","type":"integer"},"heart_rate":{"description":"Heart rate in beats/min, integer 20-250, worst in 24h as assigned by the caller. \u003c40 → 11; 40-69 → 2; 70-119 → 0; 120-159 → 4; ≥160 → 7. magent does not measure pulse.","type":"integer"},"pao2_fio2":{"description":"PaO2/FiO2 ratio in mm Hg (10-800). Required when ventilated is true. \u003c100 → 11; 100-199 → 9; ≥200 → 6. Ignored when ventilated is false. magent does not compute the ratio from PaO2 and FiO2.","type":"number"},"potassium_mmol_l":{"description":"Serum potassium in mmol/L (1-12). \u003c3.0 → 3; 3.0-4.9 → 0; ≥5.0 → 3.","type":"number"},"sodium_mmol_l":{"description":"Serum sodium in mmol/L (90-200). \u003c125 → 5; 125-144 → 0; ≥145 → 1.","type":"number"},"systolic_bp_mm_hg":{"description":"Systolic blood pressure in mm Hg (20-300), worst in 24h as assigned by the caller. \u003c70 → 13; 70-99 → 5; 100-199 → 0; ≥200 → 2. magent does not measure blood pressure.","type":"number"},"temperature_c":{"description":"Body temperature in °C (20-46). \u003c39 → 0; ≥39 → 3. The 1993 table has no hypothermia points. magent does not measure temperature or convert Fahrenheit.","type":"number"},"urea_mmol_l":{"description":"Serum urea in mmol/L (0.1-80). One of urea_mmol_l or bun_mg_dl is required. If both are sent, urea_mmol_l is scored and bun_mg_dl is ignored. \u003c10.0 → 0; 10.0-29.9 → 6; ≥30.0 → 10.","type":"number"},"urine_output_l_day":{"description":"Urine output in L/24h (0-20) as assigned by the caller. \u003c0.500 → 11; 0.500-0.999 → 4; ≥1.000 → 0. magent does not measure urine.","type":"number"},"ventilated":{"description":"true if the caller assigns mechanical ventilation or CPAP in the first 24h (Le Gall 1993 PaO2/FiO2 row). false → 0 oxygenation points and pao2_fio2 is ignored. Ventilated or CPAP scores at least 6 even when PaO2/FiO2 is ≥200.","type":"boolean"},"wbc_k_ul":{"description":"White blood count in thousands per mm^3 (0-100). \u003c1.0 → 12; 1.0-19.9 → 0; ≥20.0 → 3.","type":"number"}},"required":["age","heart_rate","systolic_bp_mm_hg","temperature_c","ventilated","urine_output_l_day","wbc_k_ul","potassium_mmol_l","sodium_mmol_l","bicarbonate_meq_l","gcs","admission_type","chronic_disease"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T14:39:22.786Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T14:39:22.646Z"},"resource":"https://api.magentlab.com/api/calc/saps_ii","serviceName":"magent","tags":["saps-ii","icu","severity","physiology","mortality"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/nri","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"VA TPN 1991 Nutritional Risk Index (NEJM): NRI = 1.519*albumin_g_l + 41.7*(current/usual weight). Malnourished if NRI \u003c= 100. Strata: not_malnourished if NRI \u003e 100; borderline_malnourished if 97.5 \u003c NRI \u003c= 100; mildly_malnourished if 83.5 \u003c= NRI \u003c= 97.5; severely_malnourished if NRI \u003c 83.5. Does not cap current/usual at 1. Not a malnutrition diagnosis or TPN order. magent does not assay albumin or weigh the patient. Not GNRI or PNI.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"albumin_g_dl":4,"albumin_g_l":40,"current_weight_kg":70,"usual_weight_kg":70},{"albumin_g_dl":4,"albumin_g_l":40,"current_weight_kg":70,"usual_weight_kg":70}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"albumin_g_l":40,"citation":{"authors":"The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group","doi":"10.1056/NEJM199108223250801","id":"va-tpn-1991","pmid":"1906163","source":"N Engl J Med. 1991;325(8):525-532","title":"Perioperative total parenteral nutrition in surgical patients"},"current_weight_kg":70,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"nri","formula_expression":"NRI = 1.519 × albumin_g_l + 0.417 × (current_weight_kg / usual_weight_kg) × 100","nri":102.5,"screening":"not_malnourished","stratification":"not_malnourished","usual_weight_kg":70},{"albumin_g_l":40,"citation":{"authors":"The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group","doi":"10.1056/NEJM199108223250801","id":"va-tpn-1991","pmid":"1906163","source":"N Engl J Med. 1991;325(8):525-532","title":"Perioperative total parenteral nutrition in surgical patients"},"current_weight_kg":70,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"nri","formula_expression":"NRI = 1.519 × albumin_g_l + 0.417 × (current_weight_kg / usual_weight_kg) × 100","nri":102.5,"screening":"not_malnourished","stratification":"not_malnourished","usual_weight_kg":70}],"path":"/api/calc/nri"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"albumin_g_dl":{"description":"Serum albumin in g/dL (1-6). Converted as g/L = g/dL × 10. Provide this or albumin_g_l, not both.","type":"number"},"albumin_g_l":{"description":"Serum albumin in g/L (10-60). Provide this or albumin_g_dl, not both. VA TPN 1991 NRI uses g/L. magent does not assay albumin.","type":"number"},"current_weight_kg":{"description":"Current weight in kg (1-500). Not capped at usual weight. magent does not weigh the patient.","type":"number"},"usual_weight_kg":{"description":"Usual weight in kg (1-500). Must be greater than 0. magent does not weigh the patient.","type":"number"}},"required":["current_weight_kg","usual_weight_kg"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T14:38:47.443Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T14:38:47.309Z"},"resource":"https://api.magentlab.com/api/calc/nri","serviceName":"magent","tags":["nri","nutrition","emergency","albumin","calculator"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/vacs_cci","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"McGinnis 2024 VACS-CCI Table 2 Model 7 linear predictor from sex, age, hemoglobin, FIB-4, eGFR, albumin, WBC, BMI, hepatitis C, and caller-assigned Charlson groupings. CCI group is those weights (0/1/2/3+) times age band. The 0-100 score needs unpublished development min/max Xbeta; magent does not invent it. Paper prints score 30 to 1/3/8/18% and 45 to 6/14/35/61% at 1/2/5/10 years. Not a diagnosis or individual prognosis. magent does not code the chart.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"age":55,"albumin_g_dl":4,"any_malignancy":false,"bmi_kg_m2":25,"cerebrovascular_disease":false,"chronic_pulmonary_disease":false,"congestive_heart_failure":false,"dementia":false,"diabetes_with_complications":false,"diabetes_without_complications":false,"egfr_ml_min_1_73m2":90,"fib4":1,"hemiplegia_or_paraplegia":false,"hemoglobin_g_dl":14,"hepatitis_c":false,"kidney_mild_to_moderate":false,"kidney_severe":false,"liver_mild":false,"liver_moderate_to_severe":false,"metastatic_solid_tumor":false,"myocardial_infarction":false,"peptic_ulcer_disease":false,"peripheral_vascular_disease":false,"rheumatic_disease":false,"sex":"male","wbc_10e9_l":4},{"age":55,"albumin_g_dl":4,"any_malignancy":false,"bmi_kg_m2":25,"cerebrovascular_disease":false,"chronic_pulmonary_disease":false,"congestive_heart_failure":false,"dementia":false,"diabetes_with_complications":false,"diabetes_without_complications":false,"egfr_ml_min_1_73m2":90,"fib4":1,"hemiplegia_or_paraplegia":false,"hemoglobin_g_dl":14,"hepatitis_c":false,"kidney_mild_to_moderate":false,"kidney_severe":false,"liver_mild":false,"liver_moderate_to_severe":false,"metastatic_solid_tumor":false,"myocardial_infarction":false,"peptic_ulcer_disease":false,"peripheral_vascular_disease":false,"rheumatic_disease":false,"sex":"male","wbc_10e9_l":4}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"age":55,"age_band":"50_64","albumin_g_dl":4,"any_malignancy":false,"bmi_kg_m2":25,"cci_group":"0","cci_score":0,"cerebrovascular_disease":false,"chronic_pulmonary_disease":false,"citation":{"authors":"McGinnis KA, Justice AC, Marconi VC, et al.","doi":"10.3389/fmed.2023.1342466","id":"mcginnis-2024-vacs-cci","pmid":"38356736","source":"Front Med (Lausanne). 2024;10:1342466","title":"Combining Charlson comorbidity and VACS indices improves prognostic accuracy for all-cause mortality for patients with and without HIV in the Veterans Health Administration"},"congestive_heart_failure":false,"dementia":false,"diabetes_with_complications":false,"diabetes_without_complications":false,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","egfr_ml_min_1_73m2":90,"fib4":1,"formula":"vacs_cci","formula_expression":"lp = sex_female -0.513 + age_poly(X=age-50, 0.278/0.006/-0.001) + hb_poly(X=hemoglobin-14, -0.115/0.024/0.004) + fib4_poly(X, 0.205/-0.006) + egfr_poly(X=egfr-90, 0.071/0.036/0.002) + alb_poly(X=albumin-4, -0.405/0.326/0.156) + wbc_poly(X=WBC-4, -0.011/0.053/-0.008/0.000) + bmi_poly(X=BMI-25, -0.061/0.005/0.000) + hepatitis_c 0.273 + Table 2 Charlson condition coefficients + CCI-group x age-band interaction (CCI 0/1/2/3+ by \u003c50, 50-64, 65-79, 80+; CCI 1 x 50-64 is reference 0); cci_group from caller-assigned condition weights (MI 1, CHF 1, PVD 1, CVD 1, dementia 1, pulmonary 1, rheumatic 1, PUD 1, DM without 1, DM with 2, hemiplegia 2, kidney mild-to-moderate 2, kidney severe 2, any malignancy 2, metastatic 6, liver mild 1, liver moderate-to-severe 3); McGinnis 2024 Table 2 Model 7; 1st/99th percentile winsorizing not published; 0-100 score uses unpublished development min/max Xbeta so magent does not scale; paper prints 0-100 score 30 → 1-year 1%, 2-year 3%, 5-year 8%, 10-year 18% and score 45 → 6%, 14%, 35%, 61%; no published S0; 2025 corrigendum PMID 39845833 does not change Table 2 coefficients; caller-assigned comorbidities, FIB-4, and eGFR","hemiplegia_or_paraplegia":false,"hemoglobin_g_dl":14,"hepatitis_c":false,"kidney_mild_to_moderate":false,"kidney_severe":false,"linear_predictor":1.228,"liver_mild":false,"liver_moderate_to_severe":false,"metastatic_solid_tumor":false,"myocardial_infarction":false,"peptic_ulcer_disease":false,"peripheral_vascular_disease":false,"rheumatic_disease":false,"sex":"male","wbc_10e9_l":4},{"age":55,"age_band":"50_64","albumin_g_dl":4,"any_malignancy":false,"bmi_kg_m2":25,"cci_group":"0","cci_score":0,"cerebrovascular_disease":false,"chronic_pulmonary_disease":false,"citation":{"authors":"McGinnis KA, Justice AC, Marconi VC, et al.","doi":"10.3389/fmed.2023.1342466","id":"mcginnis-2024-vacs-cci","pmid":"38356736","source":"Front Med (Lausanne). 2024;10:1342466","title":"Combining Charlson comorbidity and VACS indices improves prognostic accuracy for all-cause mortality for patients with and without HIV in the Veterans Health Administration"},"congestive_heart_failure":false,"dementia":false,"diabetes_with_complications":false,"diabetes_without_complications":false,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","egfr_ml_min_1_73m2":90,"fib4":1,"formula":"vacs_cci","formula_expression":"lp = sex_female -0.513 + age_poly(X=age-50, 0.278/0.006/-0.001) + hb_poly(X=hemoglobin-14, -0.115/0.024/0.004) + fib4_poly(X, 0.205/-0.006) + egfr_poly(X=egfr-90, 0.071/0.036/0.002) + alb_poly(X=albumin-4, -0.405/0.326/0.156) + wbc_poly(X=WBC-4, -0.011/0.053/-0.008/0.000) + bmi_poly(X=BMI-25, -0.061/0.005/0.000) + hepatitis_c 0.273 + Table 2 Charlson condition coefficients + CCI-group x age-band interaction (CCI 0/1/2/3+ by \u003c50, 50-64, 65-79, 80+; CCI 1 x 50-64 is reference 0); cci_group from caller-assigned condition weights (MI 1, CHF 1, PVD 1, CVD 1, dementia 1, pulmonary 1, rheumatic 1, PUD 1, DM without 1, DM with 2, hemiplegia 2, kidney mild-to-moderate 2, kidney severe 2, any malignancy 2, metastatic 6, liver mild 1, liver moderate-to-severe 3); McGinnis 2024 Table 2 Model 7; 1st/99th percentile winsorizing not published; 0-100 score uses unpublished development min/max Xbeta so magent does not scale; paper prints 0-100 score 30 → 1-year 1%, 2-year 3%, 5-year 8%, 10-year 18% and score 45 → 6%, 14%, 35%, 61%; no published S0; 2025 corrigendum PMID 39845833 does not change Table 2 coefficients; caller-assigned comorbidities, FIB-4, and eGFR","hemiplegia_or_paraplegia":false,"hemoglobin_g_dl":14,"hepatitis_c":false,"kidney_mild_to_moderate":false,"kidney_severe":false,"linear_predictor":1.228,"liver_mild":false,"liver_moderate_to_severe":false,"metastatic_solid_tumor":false,"myocardial_infarction":false,"peptic_ulcer_disease":false,"peripheral_vascular_disease":false,"rheumatic_disease":false,"sex":"male","wbc_10e9_l":4}],"path":"/api/calc/vacs_cci"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"age":{"description":"Age in years (integer 18-120). Table 2 uses the cubic polynomial of (age-50) and CCI x age-band interaction (\u003c50, 50-64, 65-79, 80+). magent does not assign age.","type":"integer"},"albumin_g_dl":{"description":"Serum albumin in g/dL (1-6.5). Table 2 centers at (albumin-4). magent does not assay albumin.","type":"number"},"any_malignancy":{"description":"Caller-assigned any malignancy (McGinnis 2024 Table 2). true adds 0.090 to lp and 2 to the CCI grouping. magent does not diagnose cancer.","type":"boolean"},"bmi_kg_m2":{"description":"Body mass index in kg/m² (10-60). Table 2 centers at (BMI-25). magent does not compute BMI from height and weight.","type":"number"},"cerebrovascular_disease":{"description":"Caller-assigned cerebrovascular disease (McGinnis 2024 Table 2). true adds 0.114 to lp and 1 to the CCI grouping. magent does not diagnose stroke.","type":"boolean"},"chronic_pulmonary_disease":{"description":"Caller-assigned chronic pulmonary disease (McGinnis 2024 Table 2). true adds 0.279 to lp and 1 to the CCI grouping. magent does not diagnose lung disease.","type":"boolean"},"congestive_heart_failure":{"description":"Caller-assigned congestive heart failure (McGinnis 2024 Table 2). true adds 0.420 to lp and 1 to the CCI grouping. magent does not diagnose heart failure.","type":"boolean"},"dementia":{"description":"Caller-assigned dementia (McGinnis 2024 Table 2). true adds 0.489 to lp and 1 to the CCI grouping. magent does not diagnose dementia.","type":"boolean"},"diabetes_with_complications":{"description":"Caller-assigned diabetes with chronic complications (McGinnis 2024 Table 2). true adds 0.075 to lp and 2 to the CCI grouping. magent does not diagnose diabetes.","type":"boolean"},"diabetes_without_complications":{"description":"Caller-assigned diabetes without chronic complications (McGinnis 2024 Table 2). true adds 0.053 to lp and 1 to the CCI grouping. magent does not diagnose diabetes.","type":"boolean"},"egfr_ml_min_1_73m2":{"description":"Caller-assigned eGFR in mL/min/1.73m² (0-200). Table 2 centers at (egfr-90). magent does not compute CKD-EPI.","type":"number"},"fib4":{"description":"Caller-assigned FIB-4 (0.1-20). Table 2 uses X and X2 of FIB-4. magent does not recompute FIB-4.","type":"number"},"hemiplegia_or_paraplegia":{"description":"Caller-assigned hemiplegia or paraplegia (McGinnis 2024 Table 2). true adds -0.049 to lp and 2 to the CCI grouping. magent does not diagnose paralysis.","type":"boolean"},"hemoglobin_g_dl":{"description":"Hemoglobin in g/dL (3-22). Table 2 centers at (hemoglobin-14). magent does not assay hemoglobin.","type":"number"},"hepatitis_c":{"description":"Caller-assigned hepatitis C (McGinnis 2024). true adds 0.273 to the linear predictor. magent does not diagnose hepatitis C.","type":"boolean"},"kidney_mild_to_moderate":{"description":"Caller-assigned mild-to-moderate kidney disease (McGinnis 2024 Table 2). true adds -0.199 to lp and 2 to the CCI grouping. magent does not grade kidney disease.","type":"boolean"},"kidney_severe":{"description":"Caller-assigned severe kidney disease (McGinnis 2024 Table 2). true adds -0.098 to lp and 2 to the CCI grouping. magent does not grade kidney disease.","type":"boolean"},"liver_mild":{"description":"Caller-assigned mild liver disease (McGinnis 2024 Table 2). true adds -0.045 to lp and 1 to the CCI grouping. magent does not grade liver disease.","type":"boolean"},"liver_moderate_to_severe":{"description":"Caller-assigned moderate-to-severe liver disease (McGinnis 2024 Table 2). true adds 0.226 to lp and 3 to the CCI grouping. magent does not grade liver disease.","type":"boolean"},"metastatic_solid_tumor":{"description":"Caller-assigned metastatic solid tumor (McGinnis 2024 Table 2). true adds 1.184 to lp and 6 to the CCI grouping. magent does not diagnose cancer.","type":"boolean"},"myocardial_infarction":{"description":"Caller-assigned myocardial infarction (McGinnis 2024 Table 2). true adds 0.008 to lp and 1 to the CCI grouping. magent does not diagnose infarction.","type":"boolean"},"peptic_ulcer_disease":{"description":"Caller-assigned peptic ulcer disease (McGinnis 2024 Table 2). true adds -0.074 to lp and 1 to the CCI grouping. magent does not diagnose ulcer disease.","type":"boolean"},"peripheral_vascular_disease":{"description":"Caller-assigned peripheral vascular disease (McGinnis 2024 Table 2). true adds 0.141 to lp and 1 to the CCI grouping. magent does not diagnose vascular disease.","type":"boolean"},"rheumatic_disease":{"description":"Caller-assigned rheumatic disease (McGinnis 2024 Table 2). true adds -0.034 to lp and 1 to the CCI grouping. magent does not diagnose rheumatic disease.","type":"boolean"},"sex":{"description":"Caller-assigned sex (female or male). Female vs male adds -0.513 to the Table 2 linear predictor. magent does not assign sex.","enum":["female","male"],"type":"string"},"wbc_10e9_l":{"description":"White blood count in 10^9/L (0.5-50), equal to k/µL. Table 2 centers at (WBC-4). magent does not assay WBC.","type":"number"}},"required":["sex","age","hemoglobin_g_dl","fib4","egfr_ml_min_1_73m2","albumin_g_dl","wbc_10e9_l","bmi_kg_m2","hepatitis_c","myocardial_infarction","congestive_heart_failure","peripheral_vascular_disease","cerebrovascular_disease","dementia","chronic_pulmonary_disease","rheumatic_disease","peptic_ulcer_disease","diabetes_without_complications","diabetes_with_complications","hemiplegia_or_paraplegia","kidney_mild_to_moderate","kidney_severe","any_malignancy","metastatic_solid_tumor","liver_mild","liver_moderate_to_severe"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T14:31:43.492Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T14:31:43.336Z"},"resource":"https://api.magentlab.com/api/calc/vacs_cci","serviceName":"magent","tags":["vacs-cci","charlson","mortality","comorbidity","calculator"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/atlas","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Miller 2013 ATLAS for Clostridioides difficile: age (\u003c60 0, 60–79 1, ≥80 2), systemic antibiotics during CDI therapy (0 or 2), WBC (\u003c16 0, 16–25 1, \u003e25 ×10^9/L 2), albumin (\u003e35 0, 26–35 1, ≤25 g/L 2), creatinine (≤120 0, 121–179 1, ≥180 µmol/L 2); max 10. Predicted cure percent = 100 − 5.08 × score (1 decimal). Not a CDI diagnosis, stool culture, or metronidazole/vancomycin/fidaxomicin order.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"age":40,"albumin_g_dl":4,"albumin_g_l":40,"creatinine_mg_dl":0.9,"creatinine_umol_l":80,"systemic_antibiotics":false,"wbc_k_ul":8,"wbc_ul":8000},{"age":40,"albumin_g_dl":4,"albumin_g_l":40,"creatinine_mg_dl":0.9,"creatinine_umol_l":80,"systemic_antibiotics":false,"wbc_k_ul":8,"wbc_ul":8000}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"age_years":40,"albumin_g_l":40,"atlas_score":0,"citation":{"authors":"Miller MA, Louie T, Mullane K, Weiss K, Lentnek A, Golan Y, Kean Y, Sears P","doi":"10.1186/1471-2334-13-148","id":"miller-2013","pmid":"23530807","source":"BMC Infect Dis. 2013;13:148","title":"Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy"},"components":[{"factor":"age","points":0,"present":false,"value":40},{"factor":"systemic_antibiotics","points":0,"present":false},{"factor":"leukocyte","points":0,"present":false,"value":8000},{"factor":"albumin","points":0,"present":false,"value":40},{"factor":"creatinine","points":0,"present":false,"value":80}],"creatinine_umol_l":80,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"atlas","formula_expression":"ATLAS = age (\u003c60 0, 60–79 1, ≥80 2) + systemic_antibiotics (false 0, true 2) + leukocyte (\u003c16 ×10^9/L 0, 16–25 1, \u003e25 2) + albumin (\u003e35 g/L 0, 26–35 1, ≤25 2) + creatinine (≤120 µmol/L 0, 121–179 1, ≥180 2); Miller 2013 Table 1 five-component ATLAS; max 10; predicted_cure_percent = 100 − 5.08 × score (1 decimal)","max_score":10,"predicted_cure_percent":100,"score":0,"systemic_antibiotics":false,"wbc_per_ul":8000},{"age_years":40,"albumin_g_l":40,"atlas_score":0,"citation":{"authors":"Miller MA, Louie T, Mullane K, Weiss K, Lentnek A, Golan Y, Kean Y, Sears P","doi":"10.1186/1471-2334-13-148","id":"miller-2013","pmid":"23530807","source":"BMC Infect Dis. 2013;13:148","title":"Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy"},"components":[{"factor":"age","points":0,"present":false,"value":40},{"factor":"systemic_antibiotics","points":0,"present":false},{"factor":"leukocyte","points":0,"present":false,"value":8000},{"factor":"albumin","points":0,"present":false,"value":40},{"factor":"creatinine","points":0,"present":false,"value":80}],"creatinine_umol_l":80,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"atlas","formula_expression":"ATLAS = age (\u003c60 0, 60–79 1, ≥80 2) + systemic_antibiotics (false 0, true 2) + leukocyte (\u003c16 ×10^9/L 0, 16–25 1, \u003e25 2) + albumin (\u003e35 g/L 0, 26–35 1, ≤25 2) + creatinine (≤120 µmol/L 0, 121–179 1, ≥180 2); Miller 2013 Table 1 five-component ATLAS; max 10; predicted_cure_percent = 100 − 5.08 × score (1 decimal)","max_score":10,"predicted_cure_percent":100,"score":0,"systemic_antibiotics":false,"wbc_per_ul":8000}],"path":"/api/calc/atlas"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"age":{"description":"Age in years (18-120). Miller 2013 Table 1: \u003c60 scores 0; 60–79 inclusive scores 1; ≥80 scores 2.","type":"integer"},"albumin_g_dl":{"description":"Serum albumin in g/dL (1-6). Converted as g/L = g/dL × 10. Provide this or albumin_g_l, not both.","type":"number"},"albumin_g_l":{"description":"Serum albumin in g/L (10-60). Provide this or albumin_g_dl, not both. Miller 2013: \u003e35 scores 0; 26–35 inclusive scores 1; ≤25 scores 2. magent does not assay albumin.","type":"number"},"creatinine_mg_dl":{"description":"Serum creatinine in mg/dL (0.1-20). Converted as µmol/L = mg/dL × 88.42. Provide this or creatinine_umol_l, not both.","type":"number"},"creatinine_umol_l":{"description":"Serum creatinine in µmol/L (9-1768). Provide this or creatinine_mg_dl, not both. Miller 2013: ≤120 scores 0; 121–179 inclusive scores 1; ≥180 scores 2. magent does not assay creatinine.","type":"number"},"systemic_antibiotics":{"description":"Systemic antibiotics on one or more days of CDI therapy (Miller 2013). true scores 2; false scores 0. There is no 1-point cell. magent does not review the medication list.","type":"boolean"},"wbc_k_ul":{"description":"Total leukocyte count in 10^3/µL (same as ×10^9/L). Provide wbc_k_ul or wbc_ul, not both. Range 0.01-500. Miller 2013: \u003c16 scores 0; 16–25 inclusive scores 1; \u003e25 scores 2.","type":"number"},"wbc_ul":{"description":"Total leukocyte count in cells/µL. Provide wbc_k_ul or wbc_ul, not both. Range 10-500000. Miller 2013: \u003c16000 scores 0; 16000–25000 inclusive scores 1; \u003e25000 scores 2.","type":"number"}},"required":["age","systemic_antibiotics"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T14:29:34.059Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T14:29:33.931Z"},"resource":"https://api.magentlab.com/api/calc/atlas","serviceName":"magent","tags":["atlas","cdi","c-difficile","infection","calculator"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/lrinec","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"LRINEC (Wong 2004): CRP ≥150 mg/L (4), WBC k/µL (\u003c15 0, 15–25 1, \u003e25 2), hemoglobin g/dL (\u003e13.5 0, 11–13.5 1, \u003c11 2), sodium \u003c135 mmol/L (2), creatinine \u003e141 µmol/L (2), glucose \u003e10 mmol/L (1); max 13; cutoff ≥6. Deterministic published laboratory score with citation; not a diagnosis of necrotizing fasciitis and not an operative decision. A score below cutoff does not exclude disease.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"creatinine_mg_dl":1,"creatinine_umol_l":88.42,"crp_mg_l":20,"glucose_mg_dl":90,"glucose_mmol_l":5,"hemoglobin_g_dl":14,"sodium_mmol_l":140,"wbc_k_ul":8,"wbc_ul":8000},{"creatinine_mg_dl":1,"creatinine_umol_l":88.42,"crp_mg_l":20,"glucose_mg_dl":90,"glucose_mmol_l":5,"hemoglobin_g_dl":14,"sodium_mmol_l":140,"wbc_k_ul":8,"wbc_ul":8000}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"at_or_above_cutoff":false,"citation":{"authors":"Wong CH, Khin LW, Heng KS, Tan KC, Low CO","doi":"10.1097/01.ccm.0000131218.22741.d4","id":"wong-2004","source":"Crit Care Med. 2004;32(7):1535-1541","title":"The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections"},"components":[{"factor":"crp","points":0,"present":false,"value":20},{"factor":"wbc","points":0,"present":false,"value":8},{"factor":"hemoglobin","points":0,"present":false,"value":14},{"factor":"sodium","points":0,"present":false,"value":140},{"factor":"creatinine","points":0,"present":false,"value":88.42},{"factor":"glucose","points":0,"present":false,"value":4.994949551009535}],"creatinine_umol_l":88.42,"crp_mg_l":20,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"lrinec","formula_expression":"LRINEC = CRP (\u003e=150 mg/L → 4) + WBC 10^3/mm^3 (\u003c15 → 0; 15-25 → 1; \u003e25 → 2) + hemoglobin g/dL (\u003e13.5 → 0; 11-13.5 → 1; \u003c11 → 2) + sodium (\u003c135 mmol/L → 2) + creatinine (\u003e141 µmol/L → 2) + glucose (\u003e10 mmol/L → 1); max 13; cutoff \u003e=6","glucose_mmol_l":4.994949551009535,"hemoglobin_g_dl":14,"max_score":13,"score":0,"sodium_mmol_l":140,"wbc_k_ul":8},{"at_or_above_cutoff":false,"citation":{"authors":"Wong CH, Khin LW, Heng KS, Tan KC, Low CO","doi":"10.1097/01.ccm.0000131218.22741.d4","id":"wong-2004","source":"Crit Care Med. 2004;32(7):1535-1541","title":"The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections"},"components":[{"factor":"crp","points":0,"present":false,"value":20},{"factor":"wbc","points":0,"present":false,"value":8},{"factor":"hemoglobin","points":0,"present":false,"value":14},{"factor":"sodium","points":0,"present":false,"value":140},{"factor":"creatinine","points":0,"present":false,"value":88.42},{"factor":"glucose","points":0,"present":false,"value":4.994949551009535}],"creatinine_umol_l":88.42,"crp_mg_l":20,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"lrinec","formula_expression":"LRINEC = CRP (\u003e=150 mg/L → 4) + WBC 10^3/mm^3 (\u003c15 → 0; 15-25 → 1; \u003e25 → 2) + hemoglobin g/dL (\u003e13.5 → 0; 11-13.5 → 1; \u003c11 → 2) + sodium (\u003c135 mmol/L → 2) + creatinine (\u003e141 µmol/L → 2) + glucose (\u003e10 mmol/L → 1); max 13; cutoff \u003e=6","glucose_mmol_l":4.994949551009535,"hemoglobin_g_dl":14,"max_score":13,"score":0,"sodium_mmol_l":140,"wbc_k_ul":8}],"path":"/api/calc/lrinec"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"creatinine_mg_dl":{"description":"Creatinine in mg/dL (0.1-20). Provide this or creatinine_umol_l. Converted as µmol/L = mg/dL × 88.42. \u003e141 µmol/L scores 2.","type":"number"},"creatinine_umol_l":{"description":"Creatinine in µmol/L (9-1768). Provide this or creatinine_mg_dl. \u003e141 scores 2.","type":"number"},"crp_mg_l":{"description":"C-reactive protein in mg/L (0-500). ≥150 scores 4; otherwise 0.","type":"number"},"glucose_mg_dl":{"description":"Plasma glucose in mg/dL (50-1000). Provide this or glucose_mmol_l, not both. Converted as mmol/L = mg/dL / 18.0182. \u003e10 mmol/L scores 1.","type":"number"},"glucose_mmol_l":{"description":"Plasma glucose in mmol/L (2.8-55.5). Provide this or glucose_mg_dl, not both. \u003e10 scores 1.","type":"number"},"hemoglobin_g_dl":{"description":"Hemoglobin in g/dL (3-22). \u003e13.5 scores 0; 11-13.5 scores 1; \u003c11 scores 2.","type":"number"},"sodium_mmol_l":{"description":"Serum sodium in mmol/L (110-160). \u003c135 scores 2; otherwise 0.","type":"number"},"wbc_k_ul":{"description":"WBC in 10^3/mm^3 (same as k/µL or 10^9/L). Provide wbc_k_ul or wbc_ul. Range 0.01-500. \u003c15 scores 0; 15-25 scores 1; \u003e25 scores 2.","type":"number"},"wbc_ul":{"description":"WBC in cells/µL (same as cells/mm^3). Provide wbc_k_ul or wbc_ul. Range 10-500000. Converted as k/µL = cells/µL / 1000.","type":"number"}},"required":["crp_mg_l","hemoglobin_g_dl","sodium_mmol_l"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T14:28:13.556Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T14:28:13.433Z"},"resource":"https://api.magentlab.com/api/calc/lrinec","serviceName":"magent","tags":["lrinec","necrotizing-fasciitis","infection","calculator"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/khorana","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Khorana 2008 Blood predictive model for chemotherapy-associated thrombosis: very_high site (stomach or pancreas) 2, high (lung, lymphoma, gynecologic, bladder, testicular) 1, other 0; platelets \u003e=350 1; hemoglobin \u003c10 g/dL or ESA 1 (once); WBC \u003e11 x10^9/L 1; BMI\u003e=35 caller flag 1. Max 6. 0 low; 1-2 intermediate; \u003e=3 high. Not a diagnosis. Not Padua or Caprini. Caller assigns cancer site; magent does not compute BMI.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"bmi_ge_35":false,"cancer_site":"other","erythropoiesis_stimulating_agent":false,"hemoglobin_g_dl":12,"hemoglobin_g_l":120,"platelets_10e9_l":200,"wbc_k_ul":8,"wbc_ul":8000},{"bmi_ge_35":false,"cancer_site":"other","erythropoiesis_stimulating_agent":false,"hemoglobin_g_dl":12,"hemoglobin_g_l":120,"platelets_10e9_l":200,"wbc_k_ul":8,"wbc_ul":8000}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"bmi_ge_35":false,"cancer_site":"other","citation":{"authors":"Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW","doi":"10.1182/blood-2007-10-116327","id":"khorana-2008","source":"Blood. 2008;111(10):4902-4907","title":"Development and validation of a predictive model for chemotherapy-associated thrombosis"},"components":[{"factor":"cancer_site","points":0,"present":false,"value":"other"},{"factor":"platelets","points":0,"present":false,"value":200},{"factor":"hemoglobin_or_esa","points":0,"present":false,"value":{"erythropoiesis_stimulating_agent":false,"hemoglobin_g_dl":12}},{"factor":"wbc","points":0,"present":false,"value":8000},{"factor":"bmi_ge_35","points":0,"present":false}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","erythropoiesis_stimulating_agent":false,"formula":"khorana","formula_expression":"Khorana = cancer_site (very_high 2, high 1, other 0) + (platelets\u003e=350) + (hemoglobin\u003c10 g/dL or ESA) + (wbc\u003e11 x10^9/L) + (BMI\u003e=35); max 6; 0 low, 1-2 intermediate, \u003e=3 high","hemoglobin_g_dl":12,"khorana_risk":"low","max_score":6,"platelets_10e9_l":200,"score":0,"wbc_ul":8000},{"bmi_ge_35":false,"cancer_site":"other","citation":{"authors":"Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW","doi":"10.1182/blood-2007-10-116327","id":"khorana-2008","source":"Blood. 2008;111(10):4902-4907","title":"Development and validation of a predictive model for chemotherapy-associated thrombosis"},"components":[{"factor":"cancer_site","points":0,"present":false,"value":"other"},{"factor":"platelets","points":0,"present":false,"value":200},{"factor":"hemoglobin_or_esa","points":0,"present":false,"value":{"erythropoiesis_stimulating_agent":false,"hemoglobin_g_dl":12}},{"factor":"wbc","points":0,"present":false,"value":8000},{"factor":"bmi_ge_35","points":0,"present":false}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","erythropoiesis_stimulating_agent":false,"formula":"khorana","formula_expression":"Khorana = cancer_site (very_high 2, high 1, other 0) + (platelets\u003e=350) + (hemoglobin\u003c10 g/dL or ESA) + (wbc\u003e11 x10^9/L) + (BMI\u003e=35); max 6; 0 low, 1-2 intermediate, \u003e=3 high","hemoglobin_g_dl":12,"khorana_risk":"low","max_score":6,"platelets_10e9_l":200,"score":0,"wbc_ul":8000}],"path":"/api/calc/khorana"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"bmi_ge_35":{"description":"BMI ≥35 as assigned by the caller. true or false. magent does not take height or weight. 1 point if true.","type":"boolean"},"cancer_site":{"description":"Caller-assigned Khorana site class. very_high (stomach or pancreas) scores 2; high (lung, lymphoma, gynecologic, bladder, or testicular) scores 1; other scores 0. magent does not assign cancer site from histology text.","type":"string"},"erythropoiesis_stimulating_agent":{"description":"Use of an erythropoiesis-stimulating agent as assigned by the caller. true or false. Scores 1 with hemoglobin \u003c10 g/dL (once, not twice).","type":"boolean"},"hemoglobin_g_dl":{"description":"Hemoglobin in g/dL (3-22). Provide this or hemoglobin_g_l, not both. \u003c10 scores 1 with ESA (once, not twice). 10.0 does not score unless ESA is true.","type":"number"},"hemoglobin_g_l":{"description":"Hemoglobin in g/L (30-220). Converted as hemoglobin_g_dl = hemoglobin_g_l / 10. Provide this or hemoglobin_g_dl, not both.","type":"number"},"platelets_10e9_l":{"description":"Pre-chemotherapy platelet count ×10^9/L (1-2000). ≥350 scores 1 (350 scores; 349 does not).","type":"number"},"wbc_k_ul":{"description":"WBC in 10^3/µL (same as 10^9/L). Provide wbc_k_ul or wbc_ul. Range 0.01-500. \u003e11 scores 1 (11.0 does not).","type":"number"},"wbc_ul":{"description":"WBC in cells/µL (same as cells/mm^3). Provide wbc_k_ul or wbc_ul. Range 10-500000. \u003e11000 scores 1 (11000 does not).","type":"number"}},"required":["cancer_site","platelets_10e9_l","erythropoiesis_stimulating_agent","bmi_ge_35"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T14:27:30.842Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T14:27:30.696Z"},"resource":"https://api.magentlab.com/api/calc/khorana","serviceName":"magent","tags":["khorana","vte","thrombosis","cancer","score"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/caprini","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Caprini 2005 thrombosis risk assessment (Table 3): exclusive age (41-60=1, 61-74=2, \u003e=75=3) and exclusive surgery (minor=1; arthroscopic/major/laparoscopic=2; arthroplasty=5) plus caller-assigned 1-, 2-, 3-, and 5-point flags. Max 78. Bands: 0-1 low, 2 moderate, 3-4 high, \u003e=5 highest. Not a diagnosis. Not Caprini 2009/2013. Not a prophylaxis order.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"abnormal_pulmonary_function":false,"acute_myocardial_infarction":false,"adverse_pregnancy_history":false,"age":50,"anticardiolipin_antibodies":false,"central_venous_access":false,"confined_to_bed_gt_72h":false,"congestive_heart_failure":false,"elevated_homocysteine":false,"factor_v_leiden":false,"family_history_thrombosis":false,"heparin_induced_thrombocytopenia":false,"hip_pelvis_leg_fracture":false,"history_dvt_pe":false,"immobilizing_plaster_cast":false,"inflammatory_bowel_disease":false,"lupus_anticoagulant":false,"malignancy":false,"medical_bed_rest":false,"multiple_trauma":false,"obesity":false,"oral_contraceptives_or_hrt":false,"other_risk_factor":false,"other_thrombophilia":false,"pregnancy_or_postpartum":false,"prior_major_surgery":false,"prothrombin_20210a":false,"sepsis":false,"serious_lung_disease":false,"spinal_cord_injury":false,"stroke":false,"surgery":"none","swollen_legs":false,"varicose_veins":false},{"abnormal_pulmonary_function":false,"acute_myocardial_infarction":false,"adverse_pregnancy_history":false,"age":50,"anticardiolipin_antibodies":false,"central_venous_access":false,"confined_to_bed_gt_72h":false,"congestive_heart_failure":false,"elevated_homocysteine":false,"factor_v_leiden":false,"family_history_thrombosis":false,"heparin_induced_thrombocytopenia":false,"hip_pelvis_leg_fracture":false,"history_dvt_pe":false,"immobilizing_plaster_cast":false,"inflammatory_bowel_disease":false,"lupus_anticoagulant":false,"malignancy":false,"medical_bed_rest":false,"multiple_trauma":false,"obesity":false,"oral_contraceptives_or_hrt":false,"other_risk_factor":false,"other_thrombophilia":false,"pregnancy_or_postpartum":false,"prior_major_surgery":false,"prothrombin_20210a":false,"sepsis":false,"serious_lung_disease":false,"spinal_cord_injury":false,"stroke":false,"surgery":"none","swollen_legs":false,"varicose_veins":false}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"age_years":50,"citation":{"authors":"Caprini JA","doi":"10.1016/j.disamonth.2005.02.003","id":"caprini-2005","pmid":"15900257","source":"Dis Mon. 2005;51(2-3):70-78","title":"Thrombosis risk assessment as a guide to quality patient care"},"components":[{"factor":"age","points":1,"present":true,"value":50},{"factor":"surgery","points":0,"present":false,"value":"none"},{"factor":"prior_major_surgery","points":0,"present":false},{"factor":"varicose_veins","points":0,"present":false},{"factor":"inflammatory_bowel_disease","points":0,"present":false},{"factor":"swollen_legs","points":0,"present":false},{"factor":"obesity","points":0,"present":false},{"factor":"acute_myocardial_infarction","points":0,"present":false},{"factor":"congestive_heart_failure","points":0,"present":false},{"factor":"sepsis","points":0,"present":false},{"factor":"serious_lung_disease","points":0,"present":false},{"factor":"abnormal_pulmonary_function","points":0,"present":false},{"factor":"medical_bed_rest","points":0,"present":false},{"factor":"other_risk_factor","points":0,"present":false},{"factor":"oral_contraceptives_or_hrt","points":0,"present":false},{"factor":"pregnancy_or_postpartum","points":0,"present":false},{"factor":"adverse_pregnancy_history","points":0,"present":false},{"factor":"malignancy","points":0,"present":false},{"factor":"confined_to_bed_gt_72h","points":0,"present":false},{"factor":"immobilizing_plaster_cast","points":0,"present":false},{"factor":"central_venous_access","points":0,"present":false},{"factor":"history_dvt_pe","points":0,"present":false},{"factor":"family_history_thrombosis","points":0,"present":false},{"factor":"factor_v_leiden","points":0,"present":false},{"factor":"prothrombin_20210a","points":0,"present":false},{"factor":"elevated_homocysteine","points":0,"present":false},{"factor":"lupus_anticoagulant","points":0,"present":false},{"factor":"anticardiolipin_antibodies","points":0,"present":false},{"factor":"heparin_induced_thrombocytopenia","points":0,"present":false},{"factor":"other_thrombophilia","points":0,"present":false},{"factor":"hip_pelvis_leg_fracture","points":0,"present":false},{"factor":"stroke","points":0,"present":false},{"factor":"multiple_trauma","points":0,"present":false},{"factor":"spinal_cord_injury","points":0,"present":false}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"caprini","formula_expression":"Caprini 2005 = exclusive age (\u003c=40: 0, 41-60: 1, 61-74: 2, \u003e=75: 3) + exclusive surgery (none 0, minor 1, arthroscopic 2, major \u003e45 min 2, laparoscopic \u003e45 min 2, elective arthroplasty 5) + Table 3 flags (1, 2, 3, or 5); max 78; 0-1 low, 2 moderate, 3-4 high, \u003e=5 highest","max_score":78,"risk_band":"low","score":1,"surgery":"none"},{"age_years":50,"citation":{"authors":"Caprini JA","doi":"10.1016/j.disamonth.2005.02.003","id":"caprini-2005","pmid":"15900257","source":"Dis Mon. 2005;51(2-3):70-78","title":"Thrombosis risk assessment as a guide to quality patient care"},"components":[{"factor":"age","points":1,"present":true,"value":50},{"factor":"surgery","points":0,"present":false,"value":"none"},{"factor":"prior_major_surgery","points":0,"present":false},{"factor":"varicose_veins","points":0,"present":false},{"factor":"inflammatory_bowel_disease","points":0,"present":false},{"factor":"swollen_legs","points":0,"present":false},{"factor":"obesity","points":0,"present":false},{"factor":"acute_myocardial_infarction","points":0,"present":false},{"factor":"congestive_heart_failure","points":0,"present":false},{"factor":"sepsis","points":0,"present":false},{"factor":"serious_lung_disease","points":0,"present":false},{"factor":"abnormal_pulmonary_function","points":0,"present":false},{"factor":"medical_bed_rest","points":0,"present":false},{"factor":"other_risk_factor","points":0,"present":false},{"factor":"oral_contraceptives_or_hrt","points":0,"present":false},{"factor":"pregnancy_or_postpartum","points":0,"present":false},{"factor":"adverse_pregnancy_history","points":0,"present":false},{"factor":"malignancy","points":0,"present":false},{"factor":"confined_to_bed_gt_72h","points":0,"present":false},{"factor":"immobilizing_plaster_cast","points":0,"present":false},{"factor":"central_venous_access","points":0,"present":false},{"factor":"history_dvt_pe","points":0,"present":false},{"factor":"family_history_thrombosis","points":0,"present":false},{"factor":"factor_v_leiden","points":0,"present":false},{"factor":"prothrombin_20210a","points":0,"present":false},{"factor":"elevated_homocysteine","points":0,"present":false},{"factor":"lupus_anticoagulant","points":0,"present":false},{"factor":"anticardiolipin_antibodies","points":0,"present":false},{"factor":"heparin_induced_thrombocytopenia","points":0,"present":false},{"factor":"other_thrombophilia","points":0,"present":false},{"factor":"hip_pelvis_leg_fracture","points":0,"present":false},{"factor":"stroke","points":0,"present":false},{"factor":"multiple_trauma","points":0,"present":false},{"factor":"spinal_cord_injury","points":0,"present":false}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"caprini","formula_expression":"Caprini 2005 = exclusive age (\u003c=40: 0, 41-60: 1, 61-74: 2, \u003e=75: 3) + exclusive surgery (none 0, minor 1, arthroscopic 2, major \u003e45 min 2, laparoscopic \u003e45 min 2, elective arthroplasty 5) + Table 3 flags (1, 2, 3, or 5); max 78; 0-1 low, 2 moderate, 3-4 high, \u003e=5 highest","max_score":78,"risk_band":"low","score":1,"surgery":"none"}],"path":"/api/calc/caprini"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"abnormal_pulmonary_function":{"description":"Abnormal pulmonary function (COPD) as assigned by the caller (Caprini 2005 Table 3). true scores 1.","type":"boolean"},"acute_myocardial_infarction":{"description":"Acute myocardial infarction as assigned by the caller (Caprini 2005 Table 3). true scores 1.","type":"boolean"},"adverse_pregnancy_history":{"description":"History of unexplained stillborn infant, recurrent spontaneous abortion (\u003e=3), premature birth with toxemia, or growth-restricted infant as assigned by the caller (Caprini 2005 Table 3, listed for women). true scores 1.","type":"boolean"},"age":{"description":"Age in years (18-120). Caprini 2005 exclusive bands: 41-60 scores 1; 61-74 scores 2; 75 or older scores 3. Age 40 or younger scores 0 for age.","type":"integer"},"anticardiolipin_antibodies":{"description":"Elevated anticardiolipin antibodies as assigned by the caller (Caprini 2005 Table 3). true scores 3.","type":"boolean"},"central_venous_access":{"description":"Central venous access as assigned by the caller (Caprini 2005 Table 3). true scores 2.","type":"boolean"},"confined_to_bed_gt_72h":{"description":"Patient confined to bed (\u003e72 hours) as assigned by the caller (Caprini 2005 Table 3). true scores 2. Independent of medical_bed_rest.","type":"boolean"},"congestive_heart_failure":{"description":"Congestive heart failure (\u003c1 month) as assigned by the caller (Caprini 2005 Table 3). true scores 1.","type":"boolean"},"elevated_homocysteine":{"description":"Elevated serum homocysteine as assigned by the caller (Caprini 2005 Table 3). true scores 3.","type":"boolean"},"factor_v_leiden":{"description":"Positive Factor V Leiden as assigned by the caller (Caprini 2005 Table 3). true scores 3.","type":"boolean"},"family_history_thrombosis":{"description":"Family history of thrombosis as assigned by the caller (Caprini 2005 Table 3). true scores 3.","type":"boolean"},"heparin_induced_thrombocytopenia":{"description":"Heparin-induced thrombocytopenia (HIT) as assigned by the caller (Caprini 2005 Table 3). true scores 3. magent does not diagnose HIT.","type":"boolean"},"hip_pelvis_leg_fracture":{"description":"Hip, pelvis, or leg fracture (\u003c1 month) as assigned by the caller (Caprini 2005 Table 3). true scores 5. Independent of exclusive surgery.","type":"boolean"},"history_dvt_pe":{"description":"History of DVT or PE as assigned by the caller (Caprini 2005 Table 3). true scores 3. magent does not diagnose VTE.","type":"boolean"},"immobilizing_plaster_cast":{"description":"Immobilizing plaster cast (\u003c1 month) as assigned by the caller (Caprini 2005 Table 3). true scores 2.","type":"boolean"},"inflammatory_bowel_disease":{"description":"History of inflammatory bowel disease as assigned by the caller (Caprini 2005 Table 3). true scores 1.","type":"boolean"},"lupus_anticoagulant":{"description":"Positive lupus anticoagulant as assigned by the caller (Caprini 2005 Table 3). true scores 3.","type":"boolean"},"malignancy":{"description":"Malignancy (present or previous) as assigned by the caller (Caprini 2005 Table 3). true scores 2.","type":"boolean"},"medical_bed_rest":{"description":"Medical patient currently at bed rest as assigned by the caller (Caprini 2005 Table 3). true scores 1. Independent of confined_to_bed_gt_72h.","type":"boolean"},"multiple_trauma":{"description":"Multiple trauma (\u003c1 month) as assigned by the caller (Caprini 2005 Table 3). true scores 5.","type":"boolean"},"obesity":{"description":"Obesity as assigned by the caller (Caprini 2005 BMI \u003e25). true scores 1. magent does not take height or weight.","type":"boolean"},"oral_contraceptives_or_hrt":{"description":"Oral contraceptives or hormone replacement therapy as assigned by the caller (Caprini 2005 Table 3, listed for women). true scores 1.","type":"boolean"},"other_risk_factor":{"description":"Other Caprini 2005 Table 3 1-point risk factor as assigned by the caller. true scores 1. magent does not invent a factor from prose.","type":"boolean"},"other_thrombophilia":{"description":"Other congenital or acquired thrombophilia as assigned by the caller (Caprini 2005 Table 3). true scores 3.","type":"boolean"},"pregnancy_or_postpartum":{"description":"Pregnancy or postpartum (\u003c1 month) as assigned by the caller (Caprini 2005 Table 3, listed for women). true scores 1.","type":"boolean"},"prior_major_surgery":{"description":"History of prior major surgery (\u003c1 month) as assigned by the caller (Caprini 2005 Table 3). Independent of the exclusive surgery category. true scores 1.","type":"boolean"},"prothrombin_20210a":{"description":"Positive Prothrombin 20210A as assigned by the caller (Caprini 2005 Table 3). true scores 3.","type":"boolean"},"sepsis":{"description":"Sepsis (\u003c1 month) as assigned by the caller (Caprini 2005 Table 3). true scores 1.","type":"boolean"},"serious_lung_disease":{"description":"Serious lung disease including pneumonia (\u003c1 month) as assigned by the caller (Caprini 2005 Table 3). true scores 1.","type":"boolean"},"spinal_cord_injury":{"description":"Acute spinal cord injury (paralysis) (\u003c1 month) as assigned by the caller (Caprini 2005 Table 3). true scores 5.","type":"boolean"},"stroke":{"description":"Stroke (\u003c1 month) as assigned by the caller (Caprini 2005 Table 3). true scores 5.","type":"boolean"},"surgery":{"description":"Mutually exclusive Caprini 2005 Table 3 surgery category as assigned by the caller. none scores 0. minor (minor surgery planned) scores 1. arthroscopic, major (major surgery \u003e45 minutes), and laparoscopic (laparoscopic surgery \u003e45 minutes) score 2. arthroplasty (elective major lower extremity arthroplasty) scores 5. One category only. History of prior major surgery is a separate 1-point flag.","enum":["none","minor","arthroscopic","major","laparoscopic","arthroplasty"],"type":"string"},"swollen_legs":{"description":"Swollen legs (current) as assigned by the caller (Caprini 2005 Table 3). true scores 1. magent does not examine the patient.","type":"boolean"},"varicose_veins":{"description":"Varicose veins as assigned by the caller (Caprini 2005 Table 3). true scores 1. magent does not examine the patient.","type":"boolean"}},"required":["age","surgery","prior_major_surgery","varicose_veins","inflammatory_bowel_disease","swollen_legs","obesity","acute_myocardial_infarction","congestive_heart_failure","sepsis","serious_lung_disease","abnormal_pulmonary_function","medical_bed_rest","other_risk_factor","oral_contraceptives_or_hrt","pregnancy_or_postpartum","adverse_pregnancy_history","malignancy","confined_to_bed_gt_72h","immobilizing_plaster_cast","central_venous_access","history_dvt_pe","family_history_thrombosis","factor_v_leiden","prothrombin_20210a","elevated_homocysteine","lupus_anticoagulant","anticardiolipin_antibodies","heparin_induced_thrombocytopenia","other_thrombophilia","hip_pelvis_leg_fracture","stroke","multiple_trauma","spinal_cord_injury"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T14:27:09.493Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T14:27:09.347Z"},"resource":"https://api.magentlab.com/api/calc/caprini","serviceName":"magent","tags":["caprini","vte","thrombosis","score","calculator"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/4c","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Knight 2020 ISARIC 4C Mortality Score: age (\u003c50→0, 50–59→2, 60–69→4, 70–79→6, ≥80→7) + male 1 + comorbidity_count (0/1/≥2 → 0/1/2; caller-assigned Charlson-plus-obesity count) + RR (\u003c20→0, 20–29→1, ≥30→2) + room-air SpO2 (\u003c92→2) + GCS (\u003c15→2) + urea (\u003c7→0, 7–14→1, \u003e14→3 mmol/L; or BUN/2.8) + CRP (\u003c50→0, 50–99→1, ≥100→2). Max 21. Table 5: low 0–3, intermediate 4–8, high 9–14, very high ≥15. Not a COVID-19 diagnosis or treatment order.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"age":40,"bun_mg_dl":14,"comorbidity_count":0,"crp_mg_l":10,"gcs":15,"respiratory_rate":16,"sex":"female","spo2_percent":98,"urea_mmol_l":5},{"age":40,"bun_mg_dl":14,"comorbidity_count":0,"crp_mg_l":10,"gcs":15,"respiratory_rate":16,"sex":"female","spo2_percent":98,"urea_mmol_l":5}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"age_years":40,"citation":{"authors":"Knight SR, Ho A, Pius R, Buchan I, Carson G, Drake TM, Dunning J, Fairfield CJ, Gamble C, Green CA, Gupta R, Halpin S, Hardwick HE, Holden KA, Horby PW, Jackson C, Mclean KA, Merson L, Nguyen-Van-Tam JS, Norman L, Noursadeghi M, Olliaro PL, Pritchard MG, Russell CD, Shaw CA, Sheikh A, Solomon T, Sudlow C, Swann OV, Turtle LCW, Openshaw PJM, Baillie JK, Semple MG, Docherty AB, Harrison EM; ISARIC4C investigators","doi":"10.1136/bmj.m3339","id":"knight-2020","pmid":"32907855","source":"BMJ. 2020;370:m3339","title":"Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score"},"comorbidity_count":0,"components":[{"factor":"age","points":0,"present":false,"value":40},{"factor":"sex","points":0,"present":false,"value":"female"},{"factor":"comorbidity_count","points":0,"present":false,"value":0},{"factor":"respiratory_rate","points":0,"present":false,"value":16},{"factor":"spo2_percent","points":0,"present":false,"value":98},{"factor":"gcs","points":0,"present":false,"value":15},{"factor":"urea","points":0,"present":false,"value":5},{"factor":"crp_mg_l","points":0,"present":false,"value":10}],"crp_mg_l":10,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"4c","formula_expression":"4C = age (\u003c50 0, 50–59 2, 60–69 4, 70–79 6, ≥80 7) + sex (female 0, male 1) + comorbidity_count (0→0, 1→1, ≥2→2) + respiratory_rate (\u003c20 0, 20–29 1, ≥30 2) + spo2_percent (≥92 0, \u003c92 2) + gcs (15 0, \u003c15 2) + urea_mmol_l (\u003c7 0, 7–14 1, \u003e14 3) + crp_mg_l (\u003c50 0, 50–99 1, ≥100 2); Knight 2020 Table 2; max 21; Table 5 bands low 0–3, intermediate 4–8, high 9–14, very_high ≥15","four_c_band":"low","gcs":15,"max_score":21,"respiratory_rate":16,"score":0,"sex":"female","spo2_percent":98,"urea_mmol_l":5},{"age_years":40,"citation":{"authors":"Knight SR, Ho A, Pius R, Buchan I, Carson G, Drake TM, Dunning J, Fairfield CJ, Gamble C, Green CA, Gupta R, Halpin S, Hardwick HE, Holden KA, Horby PW, Jackson C, Mclean KA, Merson L, Nguyen-Van-Tam JS, Norman L, Noursadeghi M, Olliaro PL, Pritchard MG, Russell CD, Shaw CA, Sheikh A, Solomon T, Sudlow C, Swann OV, Turtle LCW, Openshaw PJM, Baillie JK, Semple MG, Docherty AB, Harrison EM; ISARIC4C investigators","doi":"10.1136/bmj.m3339","id":"knight-2020","pmid":"32907855","source":"BMJ. 2020;370:m3339","title":"Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score"},"comorbidity_count":0,"components":[{"factor":"age","points":0,"present":false,"value":40},{"factor":"sex","points":0,"present":false,"value":"female"},{"factor":"comorbidity_count","points":0,"present":false,"value":0},{"factor":"respiratory_rate","points":0,"present":false,"value":16},{"factor":"spo2_percent","points":0,"present":false,"value":98},{"factor":"gcs","points":0,"present":false,"value":15},{"factor":"urea","points":0,"present":false,"value":5},{"factor":"crp_mg_l","points":0,"present":false,"value":10}],"crp_mg_l":10,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"4c","formula_expression":"4C = age (\u003c50 0, 50–59 2, 60–69 4, 70–79 6, ≥80 7) + sex (female 0, male 1) + comorbidity_count (0→0, 1→1, ≥2→2) + respiratory_rate (\u003c20 0, 20–29 1, ≥30 2) + spo2_percent (≥92 0, \u003c92 2) + gcs (15 0, \u003c15 2) + urea_mmol_l (\u003c7 0, 7–14 1, \u003e14 3) + crp_mg_l (\u003c50 0, 50–99 1, ≥100 2); Knight 2020 Table 2; max 21; Table 5 bands low 0–3, intermediate 4–8, high 9–14, very_high ≥15","four_c_band":"low","gcs":15,"max_score":21,"respiratory_rate":16,"score":0,"sex":"female","spo2_percent":98,"urea_mmol_l":5}],"path":"/api/calc/4c"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"age":{"description":"Age in years (18-120). Knight 2020 Table 2: \u003c50 scores 0; 50–59 scores 2; 60–69 scores 4; 70–79 scores 6; ≥80 scores 7.","type":"integer"},"bun_mg_dl":{"description":"BUN in mg/dL (3–140). Converted as urea_mmol_l = bun_mg_dl / 2.8.","type":"number"},"comorbidity_count":{"description":"Caller-assigned count of Charlson-plus-obesity comorbidities from Knight 2020 (integer 0–20). 0 scores 0; 1 scores 1; ≥2 scores 2. magent does not compute Charlson.","type":"integer"},"crp_mg_l":{"description":"C-reactive protein in mg/L (0–500). Knight 2020: \u003c50 scores 0; 50–99 scores 1; ≥100 scores 2.","type":"number"},"gcs":{"description":"Caller-assigned total GCS as an integer 3–15. 15 scores 0; \u003c15 scores 2 (Knight 2020). This API does not collect eye, verbal, or motor components.","type":"integer"},"respiratory_rate":{"description":"Respiratory rate in breaths/min (integer 4–80). Knight 2020: \u003c20 scores 0; 20–29 scores 1; ≥30 scores 2. magent does not measure vitals.","type":"integer"},"sex":{"description":"Sex at birth (Knight 2020). female scores 0; male scores 1.","enum":["female","male"],"type":"string"},"spo2_percent":{"description":"Room-air SpO2 percent (50–100). Knight 2020: ≥92 scores 0; \u003c92 scores 2. magent does not measure saturation.","type":"number"},"urea_mmol_l":{"description":"Serum urea in mmol/L (1–50). Provide this or bun_mg_dl, not both. Knight 2020: \u003c7 scores 0; 7–14 inclusive scores 1; \u003e14 scores 3.","type":"number"}},"required":["age","sex","comorbidity_count","respiratory_rate","spo2_percent","gcs","crp_mg_l"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T14:24:54.201Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T14:24:54.064Z"},"resource":"https://api.magentlab.com/api/calc/4c","serviceName":"magent","tags":["4c","covid-19","mortality","isaric","calculator"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/sofa_2","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Ranzani 2025 SOFA-2 from six organs 0-4 (brain, respiratory, cardiovascular, liver, kidney, hemostasis), max 24. Maps PaO2/FiO2 or SpO2/FiO2 with NIV/ECMO, MAP and vasopressor dose bands, caller-assigned GCS and delirium-drug flag, bilirubin, platelets, creatinine or urine rate, and RRT. Not Vincent 1996 SOFA and not a diagnosis.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"advanced_ventilatory_support":false,"bilirubin_mg_dl":0.8,"bilirubin_umol_l":13.7,"creatinine_mg_dl":1,"creatinine_umol_l":88,"delirium_drugs":false,"dopamine_ug_kg_min":0,"ecmo":false,"epinephrine_ug_kg_min":0,"fio2":0.21,"gcs":15,"map_mm_hg":80,"mechanical_circulatory_support":false,"norepinephrine_ug_kg_min":0,"oliguria_hours":8,"other_vasopressor_or_inotrope":false,"pao2_mm_hg":96,"platelets_10e9_l":200,"rrt":false,"spo2":96,"urine_output_ml_kg_h":1,"vasoactive_unavailable":false,"ventilatory_support_unavailable":false},{"advanced_ventilatory_support":false,"bilirubin_mg_dl":0.8,"bilirubin_umol_l":13.7,"creatinine_mg_dl":1,"creatinine_umol_l":88,"delirium_drugs":false,"dopamine_ug_kg_min":0,"ecmo":false,"epinephrine_ug_kg_min":0,"fio2":0.21,"gcs":15,"map_mm_hg":80,"mechanical_circulatory_support":false,"norepinephrine_ug_kg_min":0,"oliguria_hours":8,"other_vasopressor_or_inotrope":false,"pao2_mm_hg":96,"platelets_10e9_l":200,"rrt":false,"spo2":96,"urine_output_ml_kg_h":1,"vasoactive_unavailable":false,"ventilatory_support_unavailable":false}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"citation":{"authors":"Ranzani OT, Singer M, Salluh JIF, Shankar-Hari M, Pilcher D, Berger-Estilita J, Coopersmith CM, Juffermans NP, Laffey J, Reinikainen M, Serpa Neto A, Tavares M, Timsit JF, Arias Lopez MDP, Arulkumaran N, Aryal D, Azoulay E, Celi LA, Chaudhuri D, De Lange D, De Waele J, Dos Santos CC, Du B, Einav S, Engelbrecht T, Fazla F, Ferrer R, Finazzi S, Fujii T, Gershengorn HB, Greene JD, Haniffa R, Hao S, Hasan MS, Hollenberg S, Ippolito M, Jung C, Kirov M, Kobari S, Lakbar I, Lipman J, Liu V, Liu X, Lobo SM, Magatti D, Martin GS, Metnitz B, Metnitz P, Myatra SN, Oczkowski S, Paiva JA, Paruk F, Pekkarinen PT, Piquilloud L, Pölkki A, Prescott HC, Reintam Blaser A, Rezende E, Robba C, Rochwerg B, Ruckly S, Samei R, Schenck EJ, Secombe P, Sendagire C, Siaw-Frimpong M, Simpkin AJ, Soares M, Summers C, Szczeklik W, Takala J, Tanaka S, Tricella G, Vincent JL, Wendon J, Zampieri FG, Rhodes A, Moreno R","doi":"10.1001/jama.2025.20516","id":"ranzani-2025","pmid":"41159833","source":"JAMA. 2025 (SOFA-2)","title":"Development and Validation of the Sequential Organ Failure Assessment (SOFA)-2 Score"},"components":[{"factor":"brain","points":0,"present":false,"value":15},{"factor":"respiratory","points":0,"present":false,"value":457.14285714285717},{"factor":"cardiovascular","points":0,"present":false,"value":80},{"factor":"liver","points":0,"present":false,"value":0.8},{"factor":"kidney","points":0,"present":false,"value":{"creatinine":{"mg_dl":1},"rrt":false,"urine":null}},{"factor":"hemostasis","points":0,"present":false,"value":200}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"sofa_2","formula_expression":"SOFA-2 = brain + respiratory + cardiovascular + liver + kidney + hemostasis; each 0-4; max 24","max_score":24,"score":0},{"citation":{"authors":"Ranzani OT, Singer M, Salluh JIF, Shankar-Hari M, Pilcher D, Berger-Estilita J, Coopersmith CM, Juffermans NP, Laffey J, Reinikainen M, Serpa Neto A, Tavares M, Timsit JF, Arias Lopez MDP, Arulkumaran N, Aryal D, Azoulay E, Celi LA, Chaudhuri D, De Lange D, De Waele J, Dos Santos CC, Du B, Einav S, Engelbrecht T, Fazla F, Ferrer R, Finazzi S, Fujii T, Gershengorn HB, Greene JD, Haniffa R, Hao S, Hasan MS, Hollenberg S, Ippolito M, Jung C, Kirov M, Kobari S, Lakbar I, Lipman J, Liu V, Liu X, Lobo SM, Magatti D, Martin GS, Metnitz B, Metnitz P, Myatra SN, Oczkowski S, Paiva JA, Paruk F, Pekkarinen PT, Piquilloud L, Pölkki A, Prescott HC, Reintam Blaser A, Rezende E, Robba C, Rochwerg B, Ruckly S, Samei R, Schenck EJ, Secombe P, Sendagire C, Siaw-Frimpong M, Simpkin AJ, Soares M, Summers C, Szczeklik W, Takala J, Tanaka S, Tricella G, Vincent JL, Wendon J, Zampieri FG, Rhodes A, Moreno R","doi":"10.1001/jama.2025.20516","id":"ranzani-2025","pmid":"41159833","source":"JAMA. 2025 (SOFA-2)","title":"Development and Validation of the Sequential Organ Failure Assessment (SOFA)-2 Score"},"components":[{"factor":"brain","points":0,"present":false,"value":15},{"factor":"respiratory","points":0,"present":false,"value":457.14285714285717},{"factor":"cardiovascular","points":0,"present":false,"value":80},{"factor":"liver","points":0,"present":false,"value":0.8},{"factor":"kidney","points":0,"present":false,"value":{"creatinine":{"mg_dl":1},"rrt":false,"urine":null}},{"factor":"hemostasis","points":0,"present":false,"value":200}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"sofa_2","formula_expression":"SOFA-2 = brain + respiratory + cardiovascular + liver + kidney + hemostasis; each 0-4; max 24","max_score":24,"score":0}],"path":"/api/calc/sofa_2"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"advanced_ventilatory_support":{"description":"High-flow nasal cannula, CPAP, bilevel positive airway pressure, noninvasive ventilation, invasive mechanical ventilation, or long-term home ventilation (Ranzani 2025). true or false. Respiratory scores 3 and 4 require this, ventilatory_support_unavailable, or respiratory ECMO.","type":"boolean"},"bilirubin_mg_dl":{"description":"Total bilirubin in mg/dL (0.1-40). Provide this or bilirubin_umol_l. ≤1.20 scores 0; ≤3.0 scores 1; ≤6.0 scores 2; ≤12.0 scores 3; \u003e12.0 scores 4.","type":"number"},"bilirubin_umol_l":{"description":"Total bilirubin in µmol/L (2-684). ≤20.6 scores 0; ≤51.3 scores 1; ≤102.6 scores 2; ≤205 scores 3; \u003e205 scores 4.","type":"number"},"creatinine_mg_dl":{"description":"Creatinine in mg/dL (0.1-20). Provide this, creatinine_umol_l, or rrt=true. ≤1.20 scores 0; ≤2.0 scores 1; ≤3.50 scores 2; \u003e3.50 scores 3. Kidney is the max of creatinine, urine, and RRT.","type":"number"},"creatinine_umol_l":{"description":"Creatinine in µmol/L (9-1768). ≤110 scores 0; ≤170 scores 1; ≤300 scores 2; \u003e300 scores 3.","type":"number"},"delirium_drugs":{"description":"Drugs given to treat delirium (Ranzani 2025). true or false when provided; absent is false. true scores brain at least 1 even if GCS is 15.","type":"boolean"},"dopamine_ug_kg_min":{"description":"Dopamine in µg/kg·min (0-80) when provided. Absent is 0. As a single vasopressor: ≤20 scores 2; \u003e20 to 40 scores 3; \u003e40 scores 4. With norepinephrine, epinephrine, or another agent it counts as an other vasopressor or inotrope.","type":"number"},"ecmo":{"description":"Respiratory ECMO of any form. true or false when provided; absent is false. true scores respiratory 4 regardless of PaO2/FiO2 or SpO2/FiO2 and does not by itself score cardiovascular points.","type":"boolean"},"epinephrine_ug_kg_min":{"description":"Epinephrine in µg/kg·min (0-10) when provided. Absent is 0. Added to norepinephrine for the published dose bands.","type":"number"},"fio2":{"description":"Inspired oxygen as a fraction (0.21-1.0), not a percent.","type":"number"},"gcs":{"description":"Glasgow Coma Scale total as assigned by the caller (integer 3-15), including last pre-sedation GCS or the motor scale when the three-domain GCS cannot be evaluated. 15 scores 0; 13-14 scores 1; 9-12 scores 2; 6-8 scores 3; 3-5 scores 4. magent does not examine the patient.","type":"integer"},"map_mm_hg":{"description":"Mean arterial pressure in mm Hg (20-180). MAP \u003c70 with no vasopressor or inotrope scores 1 unless a higher cardiovascular band applies. When vasoactive_unavailable is true, MAP ≥70 scores 0; 60-69 scores 1; 50-59 scores 2; 40-49 scores 3; \u003c40 scores 4.","type":"number"},"mechanical_circulatory_support":{"description":"Mechanical circulatory support (veno-arterial ECMO, intra-aortic balloon pump, left ventricular assist device, or microaxial flow pump). true or false when provided; absent is false. true scores cardiovascular 4.","type":"boolean"},"norepinephrine_ug_kg_min":{"description":"Norepinephrine as the base in µg/kg·min (0-10) when provided. Absent is 0. Summed with epinephrine: \u003e0 to ≤0.2 scores 2; \u003e0.2 to ≤0.4 scores 3; \u003e0.4 scores 4. Low-dose plus any other vasopressor or inotrope scores 3; medium-dose plus any other, or mechanical circulatory support, scores 4.","type":"number"},"oliguria_hours":{"description":"Hours at the reported urine_output_ml_kg_h (0-72). Required when urine_output_ml_kg_h is provided.","type":"number"},"other_vasopressor_or_inotrope":{"description":"Any other vasopressor or inotrope (Ranzani 2025). true or false when provided; absent is false. Any dose scores cardiovascular 2 unless a higher norepinephrine/epinephrine or mechanical band applies.","type":"boolean"},"pao2_mm_hg":{"description":"Arterial PaO2 in mm Hg (20-700). Provide this with fio2, or spo2 with fio2 when PaO2 is unavailable. PaO2/FiO2 \u003e300 scores 0; ≤300 scores 1; ≤225 scores 2; ≤150 with advanced ventilatory support scores 3; ≤75 with advanced ventilatory support scores 4. Respiratory ECMO scores 4 regardless of the ratio.","type":"number"},"platelets_10e9_l":{"description":"Platelets ×10^9/L, same as ×10^3/μL (1-2000). \u003e150 scores 0; ≤150 scores 1; ≤100 scores 2; ≤80 scores 3; ≤50 scores 4.","type":"number"},"rrt":{"description":"Receiving renal replacement therapy or fulfilling published RRT criteria, including chronic use (Ranzani 2025). true or false when provided; absent is false. true scores kidney 4. Non-renal RRT is not scored; the caller assigns this flag.","type":"boolean"},"spo2":{"description":"Pulse-oximetry SpO2 as a percent (50-97.9). Used with fio2 only when pao2_mm_hg is absent and SpO2 is \u003c98 (Ranzani 2025). SpO2/FiO2 \u003e300 scores 0; ≤300 scores 1; ≤250 scores 2; ≤200 with advanced ventilatory support scores 3; ≤120 with advanced ventilatory support or ECMO scores 4.","type":"number"},"urine_output_ml_kg_h":{"description":"Urine output in mL/kg/h (0-20) when provided. Provide oliguria_hours with this. \u003c0.5 for 6-12 h scores 1; \u003c0.5 for ≥12 h scores 2; \u003c0.3 for ≥24 h or anuria (0 mL) for ≥12 h scores 3.","type":"number"},"vasoactive_unavailable":{"description":"Vasoactive drugs unavailable or precluded by a ceiling of treatment (Ranzani 2025). true or false when provided; absent is false. When true, cardiovascular points use the MAP-only cutoffs unless mechanical_circulatory_support is true.","type":"boolean"},"ventilatory_support_unavailable":{"description":"Advanced ventilatory support not available or precluded by a ceiling of treatment (Ranzani 2025). true or false when provided; absent is false. When true, oxygenation ratios may score 3 or 4 without advanced_ventilatory_support.","type":"boolean"}},"required":["fio2","advanced_ventilatory_support","platelets_10e9_l","map_mm_hg","gcs"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T14:24:32.869Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T14:24:32.707Z"},"resource":"https://api.magentlab.com/api/calc/sofa_2","serviceName":"magent","tags":["sofa-2","sepsis","organ-failure","calculator"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/smart_cop","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Charles 2008 SMART-COP for intensive respiratory or vasopressor support in community-acquired pneumonia: SBP \u003c90 (2), multilobar CXR (1), albumin \u003c3.5 g/dL (1), age-adjusted RR (1), HR \u003e=125 (1), new confusion (1), age-adjusted low oxygen (2), arterial pH \u003c7.35 (2; omitted pH scores 0). Max 11. IRVS 0-2 low, 3-4 moderate, 5-6 high, \u003e=7 very high. Not a site-of-care protocol. Albumin g/dL or g/L. Exactly one of PaO2, SpO2, or P/F.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"age":40,"albumin_g_dl":4,"albumin_g_l":40,"arterial_ph":7.4,"confusion":false,"heart_rate_bpm":80,"multilobar_cxr":false,"pao2_mm_hg":90,"pf_ratio":400,"respiratory_rate":16,"spo2_percent":98,"systolic_mm_hg":120},{"age":40,"albumin_g_dl":4,"albumin_g_l":40,"arterial_ph":7.4,"confusion":false,"heart_rate_bpm":80,"multilobar_cxr":false,"pao2_mm_hg":90,"pf_ratio":400,"respiratory_rate":16,"spo2_percent":98,"systolic_mm_hg":120}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"age_years":40,"albumin_g_dl":4,"arterial_ph":7.4,"citation":{"authors":"Charles PGP, Wolfe R, Whitby M, et al.","doi":"10.1086/589754","id":"charles-2008","pmid":"18558884","source":"Clin Infect Dis. 2008;47(3):375-384","title":"SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia"},"components":[{"factor":"systolic_lt_90","points":0,"present":false,"value":120},{"factor":"multilobar_cxr","points":0,"present":false},{"factor":"albumin_lt_3_5","points":0,"present":false,"value":4},{"factor":"respiratory_rate","points":0,"present":false,"value":16},{"factor":"heart_rate_ge_125","points":0,"present":false,"value":80},{"factor":"confusion","points":0,"present":false},{"factor":"oxygen_low","input":"spo2_percent","points":0,"present":false,"value":98},{"factor":"arterial_ph_lt_7_35","points":0,"present":false,"value":7.4}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"smart_cop","formula_expression":"SMART-COP (Charles 2008) = SBP\u003c90 (2) + multilobar_cxr (1) + albumin\u003c3.5 g/dL (1) + age-adjusted RR (1; age\u003c=50 RR\u003e=25, age\u003e50 RR\u003e=30) + HR\u003e=125 (1) + confusion (1) + age-adjusted low oxygen (2; age\u003c=50 PaO2\u003c70 or SpO2\u003c=93 or P/F\u003c333; age\u003e50 PaO2\u003c60 or SpO2\u003c=90 or P/F\u003c250) + arterial_pH\u003c7.35 (2; omitted pH scores 0); max 11; IRVS 0-2 low, 3-4 moderate, 5-6 high, \u003e=7 very high","heart_rate_bpm":80,"irvs_risk":"low","max_score":11,"respiratory_rate":16,"score":0,"spo2_percent":98,"systolic_mm_hg":120},{"age_years":40,"albumin_g_dl":4,"arterial_ph":7.4,"citation":{"authors":"Charles PGP, Wolfe R, Whitby M, et al.","doi":"10.1086/589754","id":"charles-2008","pmid":"18558884","source":"Clin Infect Dis. 2008;47(3):375-384","title":"SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia"},"components":[{"factor":"systolic_lt_90","points":0,"present":false,"value":120},{"factor":"multilobar_cxr","points":0,"present":false},{"factor":"albumin_lt_3_5","points":0,"present":false,"value":4},{"factor":"respiratory_rate","points":0,"present":false,"value":16},{"factor":"heart_rate_ge_125","points":0,"present":false,"value":80},{"factor":"confusion","points":0,"present":false},{"factor":"oxygen_low","input":"spo2_percent","points":0,"present":false,"value":98},{"factor":"arterial_ph_lt_7_35","points":0,"present":false,"value":7.4}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"smart_cop","formula_expression":"SMART-COP (Charles 2008) = SBP\u003c90 (2) + multilobar_cxr (1) + albumin\u003c3.5 g/dL (1) + age-adjusted RR (1; age\u003c=50 RR\u003e=25, age\u003e50 RR\u003e=30) + HR\u003e=125 (1) + confusion (1) + age-adjusted low oxygen (2; age\u003c=50 PaO2\u003c70 or SpO2\u003c=93 or P/F\u003c333; age\u003e50 PaO2\u003c60 or SpO2\u003c=90 or P/F\u003c250) + arterial_pH\u003c7.35 (2; omitted pH scores 0); max 11; IRVS 0-2 low, 3-4 moderate, 5-6 high, \u003e=7 very high","heart_rate_bpm":80,"irvs_risk":"low","max_score":11,"respiratory_rate":16,"score":0,"spo2_percent":98,"systolic_mm_hg":120}],"path":"/api/calc/smart_cop"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"age":{"description":"Age in years (18-120). Age ≤50 uses RR ≥25, PaO2 \u003c70, SpO2 ≤93%, P/F \u003c333. Age \u003e50 uses RR ≥30, PaO2 \u003c60, SpO2 ≤90%, P/F \u003c250.","type":"integer"},"albumin_g_dl":{"description":"Albumin in g/dL (1-6). Provide this or albumin_g_l, not both. Scores 1 when \u003c3.5; 3.5 does not score (Charles 2008 A).","type":"number"},"albumin_g_l":{"description":"Albumin in g/L (10-60). Converted as g/dL = g/L / 10. Provide this or albumin_g_dl, not both. Scores 1 when \u003c35 g/L.","type":"number"},"arterial_ph":{"description":"Arterial pH (6.80-7.80). Optional. Scores 2 when \u003c7.35; 7.35 does not score. Omitted pH scores 0 (Charles 2008 missing-pH assumption).","type":"number"},"confusion":{"description":"New or acute confusion as assigned by the caller (Charles 2008 C). true or false. 1 point if true. magent does not assess mental status.","type":"boolean"},"heart_rate_bpm":{"description":"Heart rate in beats per minute (integer 30-220). Scores 1 when ≥125; 124 does not score (Charles 2008 T).","type":"integer"},"multilobar_cxr":{"description":"Multilobar involvement on chest radiograph as assigned by the caller (Charles 2008 M). true or false. 1 point if true. magent does not interpret radiographs.","type":"boolean"},"pao2_mm_hg":{"description":"Arterial PaO2 in mm Hg (20-700). Provide exactly one of pao2_mm_hg, spo2_percent, or pf_ratio. Age ≤50: \u003c70 scores 2. Age \u003e50: \u003c60 scores 2.","type":"number"},"pf_ratio":{"description":"PaO2/FiO2 ratio (20-800). Provide exactly one of pao2_mm_hg, spo2_percent, or pf_ratio. Age ≤50: \u003c333 scores 2. Age \u003e50: \u003c250 scores 2.","type":"number"},"respiratory_rate":{"description":"Respiratory rate in breaths/min (integer 4-80). Age ≤50: ≥25 scores 1 (24 does not). Age \u003e50: ≥30 scores 1 (29 does not). Charles 2008 R.","type":"integer"},"spo2_percent":{"description":"Oxygen saturation percent (50-100). Provide exactly one of pao2_mm_hg, spo2_percent, or pf_ratio. Age ≤50: ≤93 scores 2. Age \u003e50: ≤90 scores 2.","type":"number"},"systolic_mm_hg":{"description":"Systolic blood pressure in mm Hg (50-250). Scores 2 when \u003c90; 90 does not score (Charles 2008 S).","type":"number"}},"required":["age","systolic_mm_hg","multilobar_cxr","respiratory_rate","heart_rate_bpm","confusion"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T14:22:54.975Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T14:22:54.842Z"},"resource":"https://api.magentlab.com/api/calc/smart_cop","serviceName":"magent","tags":["smart-cop","pneumonia","cap","irvs","calculator"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/nafcs","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Hegele 2025 NAFCS. Table 3 points from age or early HTG onset, BMI, abdominal pain or pancreatitis, secondary factors, fasting TG \u003e880 mg/dL or \u003e10 mmol/L, TG/TC \u003e8 (mg/dL) or \u003e3.5 (mmol/L), and apo B \u003c1.0 g/L, plus published interactions. Max 100. ≥60 definite classical FCS; ≥45 very likely. Not a diagnosis or genetic test. Not Simon Broome or Dutch FH. magent does not examine the patient or assay lipids. Not a medical device.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"abdominal_history":"none","age_years":40,"apo_b_g_l":1.2,"apo_b_mg_dl":120,"bmi_below_threshold":false,"htg_onset_before_age_10":false,"secondary_factors_present":true,"tg_mg_dl":500,"tg_mmol_l":8,"tg_tc_ratio_mg_dl":5,"tg_tc_ratio_mmol_l":2},{"abdominal_history":"none","age_years":40,"apo_b_g_l":1.2,"apo_b_mg_dl":120,"bmi_below_threshold":false,"htg_onset_before_age_10":false,"secondary_factors_present":true,"tg_mg_dl":500,"tg_mmol_l":8,"tg_tc_ratio_mg_dl":5,"tg_tc_ratio_mmol_l":2}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"age_years":40,"all_tg_severely_elevated":false,"citation":{"authors":"Hegele RA, Ahmad Z, Ashraf A, et al.","doi":"10.1016/j.jacl.2024.09.008","id":"hegele-2025","pmid":"39537503","source":"J Clin Lipidol. 2025;19(1):83-94","title":"Development and validation of clinical criteria to identify familial chylomicronemia syndrome (FCS) in North America"},"components":[{"factor":"early_htg_onset","points":0,"present":false},{"factor":"child_htg","points":0,"present":false},{"factor":"all_tg_severely_elevated","points":0,"present":false},{"factor":"high_tg_tc_ratio","points":0,"present":false},{"factor":"low_apo_b","points":0,"present":false},{"factor":"bmi_below_threshold","points":0,"present":false},{"factor":"abdominal_pain","points":0,"present":false},{"factor":"pancreatitis","points":0,"present":false},{"factor":"no_secondary_factors","points":0,"present":false},{"factor":"high_ratio_and_low_apo_b","points":0,"present":false},{"factor":"child_and_no_secondary","points":0,"present":false},{"factor":"high_ratio_and_no_secondary","points":0,"present":false}],"definite_classical_fcs":false,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"nafcs","formula_expression":"NAFCS = early_htg_onset 12 (age_years ≥10 and htg_onset_before_age_10) + child_htg 12 (age_years 1-9) + all_tg_severely_elevated 13 (all fasting TG \u003e880 mg/dL or \u003e10 mmol/L) + high_tg_tc_ratio 8 (TG/TC \u003e8 mg/dL or \u003e3.5 mmol/L) + low_apo_b 12 (apo B \u003c1.0 g/L or \u003c100 mg/dL) + bmi_below_threshold 9 (BMI \u003c25 kg/m2 or \u003c85th percentile) + abdominal_pain 9 (recurrent abdominal pain without pancreatitis) + pancreatitis 16 + no_secondary_factors 11 + high_ratio_and_low_apo_b 7 + child_and_no_secondary 7 + high_ratio_and_no_secondary 5 (Hegele 2025 Table 3, parameter estimates ×10); max 100; ≥60 definite classical FCS; ≥45 very likely classical FCS","high_tg_tc_ratio":false,"low_apo_b":false,"max_score":100,"score":0,"very_likely_classical_fcs":false},{"age_years":40,"all_tg_severely_elevated":false,"citation":{"authors":"Hegele RA, Ahmad Z, Ashraf A, et al.","doi":"10.1016/j.jacl.2024.09.008","id":"hegele-2025","pmid":"39537503","source":"J Clin Lipidol. 2025;19(1):83-94","title":"Development and validation of clinical criteria to identify familial chylomicronemia syndrome (FCS) in North America"},"components":[{"factor":"early_htg_onset","points":0,"present":false},{"factor":"child_htg","points":0,"present":false},{"factor":"all_tg_severely_elevated","points":0,"present":false},{"factor":"high_tg_tc_ratio","points":0,"present":false},{"factor":"low_apo_b","points":0,"present":false},{"factor":"bmi_below_threshold","points":0,"present":false},{"factor":"abdominal_pain","points":0,"present":false},{"factor":"pancreatitis","points":0,"present":false},{"factor":"no_secondary_factors","points":0,"present":false},{"factor":"high_ratio_and_low_apo_b","points":0,"present":false},{"factor":"child_and_no_secondary","points":0,"present":false},{"factor":"high_ratio_and_no_secondary","points":0,"present":false}],"definite_classical_fcs":false,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"nafcs","formula_expression":"NAFCS = early_htg_onset 12 (age_years ≥10 and htg_onset_before_age_10) + child_htg 12 (age_years 1-9) + all_tg_severely_elevated 13 (all fasting TG \u003e880 mg/dL or \u003e10 mmol/L) + high_tg_tc_ratio 8 (TG/TC \u003e8 mg/dL or \u003e3.5 mmol/L) + low_apo_b 12 (apo B \u003c1.0 g/L or \u003c100 mg/dL) + bmi_below_threshold 9 (BMI \u003c25 kg/m2 or \u003c85th percentile) + abdominal_pain 9 (recurrent abdominal pain without pancreatitis) + pancreatitis 16 + no_secondary_factors 11 + high_ratio_and_low_apo_b 7 + child_and_no_secondary 7 + high_ratio_and_no_secondary 5 (Hegele 2025 Table 3, parameter estimates ×10); max 100; ≥60 definite classical FCS; ≥45 very likely classical FCS","high_tg_tc_ratio":false,"low_apo_b":false,"max_score":100,"score":0,"very_likely_classical_fcs":false}],"path":"/api/calc/nafcs"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"abdominal_history":{"description":"Caller-assigned chylomicronemia-related abdominal history (Hegele 2025 Table 3): none (0), abdominal_pain = recurrent abdominal pain without pancreatitis (9), pancreatitis = history of pancreatitis with or without abdominal pain (16). magent does not diagnose pancreatitis.","enum":["none","abdominal_pain","pancreatitis"],"type":"string"},"age_years":{"description":"Current age in whole years (1-120). Hegele 2025 Table 3: ages 1-9 score child_htg 12; ages ≥10 score early_htg_onset 12 only when htg_onset_before_age_10 is true. The score does not provide a value for infants \u003c1 year. magent does not examine the patient.","type":"integer"},"apo_b_g_l":{"description":"Apolipoprotein B in g/L (0.1-3.0). \u003c1.0 scores 12 (Hegele 2025 Table 3). Provide exactly one of apo_b_g_l or apo_b_mg_dl. 1.0 g/L = 100 mg/dL in the paper. magent does not assay apo B.","type":"number"},"apo_b_mg_dl":{"description":"Apolipoprotein B in mg/dL (10-300). \u003c100 scores 12. Provide exactly one of apo_b_g_l or apo_b_mg_dl. magent does not assay apo B.","type":"number"},"bmi_below_threshold":{"description":"BMI \u003c25.0 kg/m2 in adults or \u003c85th percentile in children/adolescents as assigned by the caller (Hegele 2025 Table 3, 9 points). true or false. magent does not compute BMI or pediatric percentiles.","type":"boolean"},"htg_onset_before_age_10":{"description":"Hypertriglyceridemia onset in infancy or childhood (before age 10) as assigned by the caller (Hegele 2025 Table 1). true or false. Scores 12 only when age_years ≥10. For ages 1-9, child_htg is scored from age and this flag does not add points. magent does not date onset.","type":"boolean"},"secondary_factors_present":{"description":"One or more secondary factors that may contribute to hypertriglyceridemia as assigned by the caller (Hegele 2025 Table 1: lifestyle, medications, clinical conditions). true (≥1, 0 points) or false (none, 11 points, plus published interactions). magent does not take a history.","type":"boolean"},"tg_mg_dl":{"description":"Caller-assigned fasting triglycerides in mg/dL (440-20000) representing all readings used in the score (Hegele 2025 Table 1: last 3 labs in adults, last 2 in children). All readings \u003e880 score 13. Provide exactly one of tg_mg_dl or tg_mmol_l. magent does not assay lipids.","type":"number"},"tg_mmol_l":{"description":"Caller-assigned fasting triglycerides in mmol/L (5-226). All readings \u003e10 score 13. Provide exactly one of tg_mg_dl or tg_mmol_l. magent does not assay lipids.","type":"number"},"tg_tc_ratio_mg_dl":{"description":"Triglyceride/total-cholesterol ratio when both are in mg/dL (0.1-80). \u003e8 scores 8 (Hegele 2025 Table 1). Provide exactly one of tg_tc_ratio_mg_dl or tg_tc_ratio_mmol_l. magent does not assay lipids.","type":"number"},"tg_tc_ratio_mmol_l":{"description":"Triglyceride/total-cholesterol ratio when both are in mmol/L (0.1-35). \u003e3.5 scores 8. Provide exactly one of tg_tc_ratio_mg_dl or tg_tc_ratio_mmol_l. magent does not assay lipids.","type":"number"}},"required":["age_years","htg_onset_before_age_10","bmi_below_threshold","abdominal_history","secondary_factors_present"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T14:20:21.433Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T14:20:21.297Z"},"resource":"https://api.magentlab.com/api/calc/nafcs","serviceName":"magent","tags":["nafcs","fcs","lipids","chylomicronemia","hegele-2025"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/dutch_fh","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Dutch Lipid Clinic Network (Nordestgaard 2013 Table 1) familial hypercholesterolaemia score. One LDL (mmol/L or mg/dL / 38.67) plus family, clinical, physical, and DNA groups; per group only the highest. Max 26. Definite \u003e8, probable 6-8, possible 3-5, unlikely 0-2. Score 8 (mutation alone) is probable. Adult Table 1 only; not Simon Broome, not MEDPED, not homozygous FH. magent does not assay lipids, examine tendons or arcus, or sequence genes. Not a medical device and not a diagnosis of FH.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"causative_mutation_ldlr_apob_pcsk9":false,"child_ldl_gt_95th":false,"corneal_arcus_age_lt_45":false,"first_degree_ldl_gt_95th":false,"first_degree_premature_chd":false,"first_degree_xanthoma_or_arcus":false,"ldl_mg_dl":348,"ldl_mmol_l":9,"premature_cerebral_or_pvd":false,"premature_chd":false,"tendon_xanthoma":true},{"causative_mutation_ldlr_apob_pcsk9":false,"child_ldl_gt_95th":false,"corneal_arcus_age_lt_45":false,"first_degree_ldl_gt_95th":false,"first_degree_premature_chd":false,"first_degree_xanthoma_or_arcus":false,"ldl_mg_dl":348,"ldl_mmol_l":9,"premature_cerebral_or_pvd":false,"premature_chd":false,"tendon_xanthoma":true}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"citation":{"authors":"Nordestgaard BG, Chapman MJ, Humphries SE, et al.","doi":"10.1093/eurheartj/eht273","id":"nordestgaard-2013","pmid":"23956253","source":"Eur Heart J. 2013;34(45):3478-3490","title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society"},"classification":"definite","clinical_points":0,"components":[{"factor":"family","points":0,"present":false},{"factor":"clinical","points":0,"present":false},{"factor":"physical","points":6,"present":true},{"factor":"ldl","points":8,"present":true,"value":9},{"factor":"dna","points":0,"present":false}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","dna_points":0,"family_points":0,"formula":"dutch_fh","formula_expression":"DLCN (Nordestgaard 2013 Table 1) = family + clinical + physical + ldl + dna (per group only the highest); family: first_degree_xanthoma_or_arcus or child_ldl_gt_95th -\u003e 2 else first_degree_premature_chd or first_degree_ldl_gt_95th -\u003e 1; clinical: premature_chd -\u003e 2 else premature_cerebral_or_pvd -\u003e 1; physical: tendon_xanthoma -\u003e 6 else corneal_arcus_age_lt_45 -\u003e 4; ldl mmol/L: \u003e8.5 -\u003e 8, 6.5-8.4 -\u003e 5, 5.0-6.4 -\u003e 3, 4.0-4.9 -\u003e 1; dna causative_mutation_ldlr_apob_pcsk9 -\u003e 8; max 26; definite \u003e8, probable 6-8, possible 3-5, unlikely 0-2","ldl_mmol_l":9,"ldl_points":8,"max_score":26,"physical_points":6,"score":14},{"citation":{"authors":"Nordestgaard BG, Chapman MJ, Humphries SE, et al.","doi":"10.1093/eurheartj/eht273","id":"nordestgaard-2013","pmid":"23956253","source":"Eur Heart J. 2013;34(45):3478-3490","title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society"},"classification":"definite","clinical_points":0,"components":[{"factor":"family","points":0,"present":false},{"factor":"clinical","points":0,"present":false},{"factor":"physical","points":6,"present":true},{"factor":"ldl","points":8,"present":true,"value":9},{"factor":"dna","points":0,"present":false}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","dna_points":0,"family_points":0,"formula":"dutch_fh","formula_expression":"DLCN (Nordestgaard 2013 Table 1) = family + clinical + physical + ldl + dna (per group only the highest); family: first_degree_xanthoma_or_arcus or child_ldl_gt_95th -\u003e 2 else first_degree_premature_chd or first_degree_ldl_gt_95th -\u003e 1; clinical: premature_chd -\u003e 2 else premature_cerebral_or_pvd -\u003e 1; physical: tendon_xanthoma -\u003e 6 else corneal_arcus_age_lt_45 -\u003e 4; ldl mmol/L: \u003e8.5 -\u003e 8, 6.5-8.4 -\u003e 5, 5.0-6.4 -\u003e 3, 4.0-4.9 -\u003e 1; dna causative_mutation_ldlr_apob_pcsk9 -\u003e 8; max 26; definite \u003e8, probable 6-8, possible 3-5, unlikely 0-2","ldl_mmol_l":9,"ldl_points":8,"max_score":26,"physical_points":6,"score":14}],"path":"/api/calc/dutch_fh"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"causative_mutation_ldlr_apob_pcsk9":{"description":"Causative mutation in LDLR, APOB, or PCSK9 as assigned by the caller (Nordestgaard 2013 Table 1 DNA analysis, 8 points). true or false. magent does not sequence genes. Mutation alone is probable (score 8), not definite.","type":"boolean"},"child_ldl_gt_95th":{"description":"Child under 18 years with LDL cholesterol above the 95th percentile (Nordestgaard 2013 Table 1 family history, 2 points). true or false as assigned by the caller. magent does not assay lipids or take a pedigree.","type":"boolean"},"corneal_arcus_age_lt_45":{"description":"Arcus cornealis before age 45 years (Nordestgaard 2013 Table 1 physical examination, 4 points). true or false as assigned by the caller. magent does not examine the cornea or compute age.","type":"boolean"},"first_degree_ldl_gt_95th":{"description":"First-degree relative with LDL cholesterol above the 95th percentile (Nordestgaard 2013 Table 1 family history, 1 point). true or false as assigned by the caller. magent does not assay lipids or take a pedigree.","type":"boolean"},"first_degree_premature_chd":{"description":"First-degree relative with premature coronary heart disease (Nordestgaard 2013 Table 1 family history, 1 point). true or false as assigned by the caller. magent does not take a pedigree. Either this or first_degree_ldl_gt_95th scores 1 for the family group; a 2-point family item still yields family 2, not 3.","type":"boolean"},"first_degree_xanthoma_or_arcus":{"description":"First-degree relative with tendon xanthoma and/or arcus cornealis (Nordestgaard 2013 Table 1 family history, 2 points). true or false as assigned by the caller. magent does not examine relatives. Either this or child_ldl_gt_95th scores 2 for the family group (max of family items).","type":"boolean"},"ldl_mg_dl":{"description":"LDL cholesterol in mg/dL (40-800). Converted to mmol/L as mg/dL / 38.67, then scored on the mmol/L bands. Provide exactly one lipid parameter.","type":"number"},"ldl_mmol_l":{"description":"LDL cholesterol in mmol/L (1-20). Nordestgaard 2013 Table 1 bands: \u003e8.5 → 8, 6.5-8.4 → 5, 5.0-6.4 → 3, 4.0-4.9 → 1. Provide exactly one of ldl_mmol_l or ldl_mg_dl. magent does not assay lipids.","type":"number"},"premature_cerebral_or_pvd":{"description":"Premature cerebral or peripheral vascular disease in the subject (Nordestgaard 2013 Table 1 clinical history, 1 point). true or false as assigned by the caller. magent does not diagnose vascular disease.","type":"boolean"},"premature_chd":{"description":"Premature coronary heart disease in the subject (Nordestgaard 2013 Table 1 clinical history, 2 points; men \u003c55 years / women \u003c60 years as assigned by the caller). true or false. magent does not diagnose CHD or compute age or sex. If premature_cerebral_or_pvd is also true, the clinical group is 2, not 3.","type":"boolean"},"tendon_xanthoma":{"description":"Tendon xanthoma in the subject (Nordestgaard 2013 Table 1 physical examination, 6 points). true or false as assigned by the caller. magent does not examine tendons. If corneal_arcus_age_lt_45 is also true, the physical group is 6, not 10.","type":"boolean"}},"required":["first_degree_premature_chd","first_degree_ldl_gt_95th","first_degree_xanthoma_or_arcus","child_ldl_gt_95th","premature_chd","premature_cerebral_or_pvd","tendon_xanthoma","corneal_arcus_age_lt_45","causative_mutation_ldlr_apob_pcsk9"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T14:20:14.369Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T14:20:14.221Z"},"resource":"https://api.magentlab.com/api/calc/dutch_fh","serviceName":"magent","tags":["dutch-fh","fh","lipids","dlcn","xanthoma"],"type":"http","x402Version":2},{"accepts":[{"amount":"5000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"assetTransferMethod":"eip3009","name":"USD Coin","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/medped","version":"2"},"maxTimeoutSeconds":600,"network":"eip155:8453","payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"description":"Williams 1993 US MEDPED total cholesterol cutoffs by age and relative degree (first, second, third, or general population). Meets the published criterion iff total cholesterol in mg/dL is greater than the table cutoff (mmol/L converted as mg/dL = mmol/L * 38.67). Total cholesterol only; not Dutch Lipid Clinic or Simon Broome. Not a medical device and not a diagnosis of familial hypercholesterolemia.","extensions":{"bazaar":{"info":{"iconUrl":"https://api.magentlab.com/favicon.ico","input":{"body":{"items":[{"age":50,"relative_degree":"general_population","total_cholesterol_mg_dl":200,"total_cholesterol_mmol_l":10},{"age":50,"relative_degree":"general_population","total_cholesterol_mg_dl":200,"total_cholesterol_mmol_l":10}]},"method":"POST","type":"http"},"output":{"example":{"count":2,"items":[{"age":50,"citation":{"authors":"Williams RR, Hunt SC, Schumacher MC, Hegele RA, Leppert MF, Ludwig EH, Hopkins PN","doi":"10.1016/0002-9149(93)90155-6","id":"williams-1993","pmid":"8328379","source":"Am J Cardiol. 1993;72(2):171-176","title":"Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics"},"classification":"below_cutoff","criteria":[{"cutoff_mg_dl":360,"factor":"total_cholesterol_gt_cutoff","met":false,"value":200}],"cutoff_mg_dl":360,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"medped","formula_expression":"meets_criteria iff total_cholesterol_mg_dl \u003e cutoff_mg_dl (Williams 1993 US MEDPED total cholesterol); mmol/L converted as mg/dL = mmol/L * 38.67; age \u003c20: first 220, second 230, third 240, general_population 270; 20-29: 240/250/260/290; 30-39: 270/280/290/340; \u003e=40: 290/300/310/360","meets_criteria":false,"relative_degree":"general_population","total_cholesterol_mg_dl":200},{"age":50,"citation":{"authors":"Williams RR, Hunt SC, Schumacher MC, Hegele RA, Leppert MF, Ludwig EH, Hopkins PN","doi":"10.1016/0002-9149(93)90155-6","id":"williams-1993","pmid":"8328379","source":"Am J Cardiol. 1993;72(2):171-176","title":"Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics"},"classification":"below_cutoff","criteria":[{"cutoff_mg_dl":360,"factor":"total_cholesterol_gt_cutoff","met":false,"value":200}],"cutoff_mg_dl":360,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","formula":"medped","formula_expression":"meets_criteria iff total_cholesterol_mg_dl \u003e cutoff_mg_dl (Williams 1993 US MEDPED total cholesterol); mmol/L converted as mg/dL = mmol/L * 38.67; age \u003c20: first 220, second 230, third 240, general_population 270; 20-29: 240/250/260/290; 30-39: 270/280/290/340; \u003e=40: 290/300/310/360","meets_criteria":false,"relative_degree":"general_population","total_cholesterol_mg_dl":200}],"path":"/api/calc/medped"},"type":"json"}},"schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"age":{"description":"Age in years (integer 1-120). Selects the Williams 1993 US MEDPED total cholesterol row: \u003c20, 20-29, 30-39, or \u003e=40.","type":"integer"},"relative_degree":{"description":"Relative degree as assigned by the caller: first, second, third, or general_population (Williams 1993). magent does not take a pedigree.","type":"string"},"total_cholesterol_mg_dl":{"description":"Total cholesterol in mg/dL (50-800). Provide exactly one of total_cholesterol_mg_dl or total_cholesterol_mmol_l. Meets the published cutoff iff this value is greater than the age- and relative-degree-specific mg/dL cutoff. magent does not assay lipids.","type":"number"},"total_cholesterol_mmol_l":{"description":"Total cholesterol in mmol/L (1.3-20). Converted as mg/dL = mmol/L * 38.67, then compared with the US MEDPED mg/dL cutoff. Provide exactly one lipid parameter.","type":"number"}},"required":["age","relative_degree"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"}}},"lastUpdated":"2026-10-05T14:20:07.548Z","quality":{"l30DaysTotalCalls":2,"l30DaysUniquePayers":1,"lastCalledAt":"2026-10-05T14:20:07.41Z"},"resource":"https://api.magentlab.com/api/calc/medped","serviceName":"magent","tags":["medped","fh","lipids","cholesterol","calculator"],"type":"http","x402Version":2}],"pagination":{"limit":100,"offset":13100,"total":33779},"x402Version":2}